Sentence,class,file
Negative impact of immunosuppression on early HCC recurrence After LT http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.192important to predict HCC recurrence after LT.,Non-OADS,/arxiv_data1/oa_pdf/1a/52/cmh-20-192.PMC4099335.pdf
202 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.192REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/1a/52/cmh-20-192.PMC4099335.pdf
"FDA web site, <http://www.accessdata.",Non-OADS,/arxiv_data1/oa_pdf/1a/52/cmh-20-192.PMC4099335.pdf
"Negative impact of immunosuppression on early HCC recurrence After LT http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.192M, et al.",Non-OADS,/arxiv_data1/oa_pdf/1a/52/cmh-20-192.PMC4099335.pdf
"Copyright © 2014 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2014.20.2.204 Clinical and Molecular Hepatology 2014;20:204-207 Case Report INTRODUCTION  Acute hepatitis A (AHA) is usually a mild and self-limited infec - tion, especially when infected in early childhood.1 However, rarely,  AHA can be complicated by extrahepatic manifestations, such as  rash, arthralgia, leukocytoclastic vasculitis, glomerulonephritis, ar - thritis, toxic epidermal necrolysis, myocarditis, renal failure, optic  neuritis, transverse myelitis, or polyneuritis etc.2-8 Pure red cell anemia (PRCA) and autoimmune hemolytic anemia  (AIHA) are another rare extrahepatic manifestation of AHA.",Non-OADS,/arxiv_data1/oa_pdf/25/7c/cmh-20-204.PMC4099336.pdf
"Anemia in acute hepatitis A http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.204tion as AST 916 IU/L, ALT 1925 IU/L, TB 9.2 mg/dL, PT-INR 1.37,  and discharged after 5 days of admission.",Non-OADS,/arxiv_data1/oa_pdf/25/7c/cmh-20-204.PMC4099336.pdf
"206 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.204marrow examination shows almost complete absence of erythroid  precursors, but normal platelet and white cell precursors.14 To  achieve remission, treatment with corticosteroids, cyclophospha - mide, cyclosporine A, antithymocyte globulin, splenectomy, and  plasmapheresis can be considered.",Non-OADS,/arxiv_data1/oa_pdf/25/7c/cmh-20-204.PMC4099336.pdf
Anemia in acute hepatitis A http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.2043.,Non-OADS,/arxiv_data1/oa_pdf/25/7c/cmh-20-204.PMC4099336.pdf
"Copyright © 2014 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2014.20.2.208 Clinical and Molecular Hepatology 2014;20:208-213 Case Report INTRODUCTION  Tuberculosis (TB) is an infectious disease that is prevalent  worldwide, but obstructive jaundice secondary to abdominal TB  remains rare.1 Patients with bile duct involvement of TB causing  obstructive jaundice have protracted symptoms such as malaise,  jaundice, and weight loss, which are indistinguishable from those  of cholangiocarcinoma.2 Obstructive jaundice can be caused by  tuberculous enlargement of the head of the pancreas, tuberculous  lymphadenitis, tuberculous stricture of the biliary tree, or a tuber - culous mass of the retroperitoneum.1 Fifteen cases of pericholedo - cal tuberculous lymphadenitis were reported in Korea.3-17 There  were two cases of pericholedocal tuberculous lymphadenitis with  duodenal TB10,14 and two cases of pericholedocal tuberculous lymphadenitis with portal hypertension.11,13 This is the first case re - port of pericholedocal tuberculous lymphadenitis with portal hy - pertension concomitant with duodenal TB in Korea.",Non-OADS,/arxiv_data1/oa_pdf/0e/5a/cmh-20-208.PMC4099337.pdf
"Obstructive jaundice by tuberculous lymphadenitis http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.208rifampicin, etambutol and pyrazinamide for 2 months, then con - tinuing with isoniazid, rifampicin and ethambutol for the remain - ing 4 months) at local clinic.",Non-OADS,/arxiv_data1/oa_pdf/0e/5a/cmh-20-208.PMC4099337.pdf
210 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.208Central calcification was observed in the lesion and the main por - tal vein was encased by soft tissue mass.,Non-OADS,/arxiv_data1/oa_pdf/0e/5a/cmh-20-208.PMC4099337.pdf
Obstructive jaundice by tuberculous lymphadenitis http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.208Percutaneous ultrasonography-guided biopsy of the soft tissue  mass was performed and pathologic examination showed chronic  granulomatous inflammation with fibrosis (Fig.,Non-OADS,/arxiv_data1/oa_pdf/0e/5a/cmh-20-208.PMC4099337.pdf
212 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.208tion.,Non-OADS,/arxiv_data1/oa_pdf/0e/5a/cmh-20-208.PMC4099337.pdf
Obstructive jaundice by tuberculous lymphadenitis http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.2085.,Non-OADS,/arxiv_data1/oa_pdf/0e/5a/cmh-20-208.PMC4099337.pdf
"Copyright © 2014 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2014.20.2.214 Clinical and Molecular Hepatology 2014;20:214-217 Liver Pathology INTRODUCTION  Cholangiocarcinoma arising in the liver can be classified into in - trahepatic (or peripheral) cholangiocarcinoma (ICC) or perihilar  cholangiocarcinoma, depending on the topographic location of  the tumor along the intrahepatic biliary tree.1 Grossly, peripheral  ICC usually presents as a mass-forming type, while perihilar ICC  may present as mass-forming, periductal infiltrating, or intraduct - al-growth types.",Non-OADS,/arxiv_data1/oa_pdf/43/b5/cmh-20-214.PMC4099338.pdf
"Intrahepatic cholangiocarcinoma with predominant ductal plate malformation pattern http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.214marrow biopsy, urine/serum protein electrophoresis and immuno - fixation electrophoresis.",Non-OADS,/arxiv_data1/oa_pdf/43/b5/cmh-20-214.PMC4099338.pdf
216 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.214ably similar to DPM: they formed irregular distorted gland-like  structures with bridge/island formation and microcystic dilatation  (Fig.,Non-OADS,/arxiv_data1/oa_pdf/43/b5/cmh-20-214.PMC4099338.pdf
"Intrahepatic cholangiocarcinoma with predominant ductal plate malformation pattern http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.214been re-classified in the latest WHO classification as a subtype of  combined hepatocellular-cholangiocarcinomas with stem cell fea - ture.4  The recently described ICC with predominant DPM pattern is an  interesting variant of ICC that demonstrates large, irregular- shaped, tortuous glandular structures resembling fetal ductal  plates.2 Ductal plates are normally not found in the postnatal liver,  and persistence of these structures – referred to as DPM – have  been reported in association with congenital hepatic fibrosis, poly - cystic liver and kidney diseases, congenital biliary atresia, von  Meyenburg complex and Caroli’s disease.5 The mechanisms for the  development of this peculiar pattern in ICC is not understood, and  further studies would be required to elucidate whether 1) DPM  and DPM-like ICC have any common genetic mechanisms, 2)  whether some of these tumors may actually arise from a pre-exist - ing DPM, and 3) whether these tumors are a different morpholog - ic manifestation of CCC with extremely dilated glandular struc - tures, pointing to a hepatic progenitor cell origin.",Non-OADS,/arxiv_data1/oa_pdf/43/b5/cmh-20-214.PMC4099338.pdf
"Copyright © 2014 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2014.20.2.218 Clinical and Molecular Hepatology 2014;20:218-222 Liver Imaging INTRODUCTION  Hepatocellular carcinoma (HCC) is one of the leading causes of  cancer-related deaths worldwide.",Non-OADS,/arxiv_data1/oa_pdf/ce/fd/cmh-20-218.PMC4099339.pdf
"Liver MRI following sorafenib treatment http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.218In this mini-review article, we discuss the magnetic resonance  imaging (MRI) features of HCC after treatment with Sorafenib.",Non-OADS,/arxiv_data1/oa_pdf/ce/fd/cmh-20-218.PMC4099339.pdf
"220 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.218Following treatment with Sorafenib, HCC typically shows a de - crease in arterial phase enhancement following treatment with  declining enhancing fraction (Fig.",Non-OADS,/arxiv_data1/oa_pdf/ce/fd/cmh-20-218.PMC4099339.pdf
"Liver MRI following sorafenib treatment http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.218images should always be interpreted in conjunction with the T1WI,  to avoid the confounding effects of hemorrhage on ADC.7,8  The role of DWI for the evaluation of HCC response to Sorafenib  is gaining importance.",Non-OADS,/arxiv_data1/oa_pdf/ce/fd/cmh-20-218.PMC4099339.pdf
222 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.218Acknowledgement This work was supported in part by The GlaxoSmithKline Re - search Fund of the Korean Association for the study of the Liver.,Non-OADS,/arxiv_data1/oa_pdf/ce/fd/cmh-20-218.PMC4099339.pdf
"Copyright © 2014 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2014.20.2.89 Clinical and Molecular Hepatology 2014;20:89-136 Review PREAMBLE Aims Practice Guidelines for Management of Hepatitis C were first  established in 2004.",Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
"90 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89Literature review for evidence collection The committee systematically collected and reviewed the inter - national and domestic literature published in Pubmed, MEDLINE,  KoreaMed, and other databases.",OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
"91The Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: Management of Hepatitis C http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89transplant and other organ transplants, immunosuppressive  therapy or cytotoxic chemotherapy, intravenous drug use,  chronic kidney diseases, coinfection with HIV or HBV,  hemophilia, and pediatric patients) treated?",Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
Release of the guidelines and plan for updates The Korean version of the KASL Clinical Practice Guidelines for  the Management of Hepatitis C was released and published in  December 2013 on the KASL web site ( http://www.kasl.org ).,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
"92 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89centers was 0.78% using 3rd-generation EIA after adjusting for  age, sex, and area.11 The anti-HCV prevalence was higher in  women (0.83%) than in men (0.75%) showing an age-related  increase with the highest prevalence in those ≥60 years of age  (20-29 years: 0.34%, 30-39 years: 0.41%, 40-49 years: 0.60%,  50-59 years: 0.80%, 60-69 years: 1.53%, ≥70 years: 2.31%).",Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
93The Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: Management of Hepatitis C http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89wide HCV incidence rate in Korea.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
94 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89people can be infected via recklessly disposed needles.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
95The Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: Management of Hepatitis C http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89cirrhosis and HCC.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
96 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89needed to confirm HCV infection.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
97The Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: Management of Hepatitis C http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89Genotyping assays HCV genotyping is useful for epidemiologic studies as well as  for predicting treatment response.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
"98 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89negative, follow-up testing for anti-HCV and serum ALT level  should be performed 4-6 months after the exposure.125,149 If  anti-HCV is positive, a confirmative test is needed.",Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
99The Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: Management of Hepatitis C http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89AST) × 100/platelet count (×109/L).,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
100 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89fibrosis (stage F3-4) is required as soon as possible.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
101The Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: Management of Hepatitis C http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89A rapid virological response (RVR) is defined as undetectable  HCV RNA by a sensitive assay with lower limit of detection <50  IU/mL at week 4 of treatment.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
102 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89evaluate individual therapeutic responses and to modify  the duration of treatment (B1).,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
"103The Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: Management of Hepatitis C http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89feron alpha (40 kD PEG for peginterferon alpha-2a, 12 kD PEG for  peginterferon alpha-2b), which has a longer half-life and higher  blood concentration for an extended period of time.",Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
104 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.890-1%.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
"105The Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: Management of Hepatitis C http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89treatment can be considered, regardless of baseline  viral load (B2).",Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
"106 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89fibrosis, cirrhosis, and high baseline viral load, at the expense of a  higher chance of post-treatment relapse.",Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
"107The Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: Management of Hepatitis C http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89and sofosbuvir combination therapy on 70 treatment naïve HCV  genotype 2 or 3 patients reported a SVR12 rate of 97%.263 In  addition, a SVR12 rate of 94% was achieved after 16 weeks of  sofosbuvir and ribavirin combination therapy in 32 treatment  experienced chronic HCV genotype 2 patients.311 Therefore, inter - feron-free DAA combination regimens are effective in both  treatment failure and interferon intolerant patients, and are  expected to become available in Korea.",Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
108 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89C and acute exacerbation of chronic hepatitis is difficult.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
"109The Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: Management of Hepatitis C http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89patients discontinue the treatment and 20-30% of patients  experience dose reduction.334,335 Patients who received ≥ 80% of  both their planned peginterferon alpha and ribavirin doses for ≥  80% of the expected duration show an SVR rate of 63%, which  was significantly higher than that (52%) of the patients who  received reduced dose (<80%) of one or both drugs.255 Therefore,  meticulous monitoring and management of adverse effects can  improve therapeutic outcome by preventing from drug discontinu - ation or dose reduction.",Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
110 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89Table 9.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
"111The Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: Management of Hepatitis C http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89treatment especially when these diseases are well controlled.336,344  Other adverse effects related to peginterferon alpha, such as  visual field defect, retinal hemorrhage and edema, hearing defect,  tinnitus, vomiting, nausea, pruritus, weight loss or hair loss,  improve after termination of treatment.336 Frequency of retinal  defect is reported as about 3.8-30.9%352-356 with variable clinical  course from severe visual field defect to no symptoms, and it is  desirable to check the retina prior to the treatment in cases with  risk factors such as old age, hypertension, or diabetes356-358 even  though pretreatment and regular follow-up evaluation of retina  remains debatable.",Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
112 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89[Recommendations] 36.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
"113The Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: Management of Hepatitis C http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89treatment-related complications are necessary, since  cirrhotic patients often have hematological problems due  to portal hypertension and splenomegaly (A2).",Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
114 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89of HCV in heart transplant patients is not recommended except  life-threatening fibrosing cholestatic hepatitis because of limited  information.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
115The Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: Management of Hepatitis C http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89medical and psychiatric counseling services and social  su ppor t by specialist s about drug abu se and  improvement of social environment can raise degree of  compliance to treatment in intravenous drug users (B2).,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
"116 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89TREATMENT OF PATIENTS WITH HIV OR HBV  COINFECTION  Chronic hepatitis C patients with HIV coinfec - tion Coinfection rate of HIV and HCV is reported to be 25% in  western countries28 and 5.0-6.6% in South Korea.29,30,426 Since the  frequency of coinfection is relatively high, all HIV infected patients  should receive HCV testing consisting primarily of an anti-HCV  assay.",Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
"117The Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: Management of Hepatitis C http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89patients showed a occurrence rate of 45%, which was significantly  higher.457 In addition, risks of severe and fulminant hepatitis  increase and the incidence rate of cirrhosis and HCC increases in  case of HBV/HCV coinfected patients compared to HBV monoin - fection.458-460 In patients with HBV/HCV coinfection, blood levels of HCV RNA  and HBV DNA representing replicative status of each virus should  be evaluated, and if HCV infection is the dominant cause of the  liver disease, the same antiviral therapy as for HCV monoinfection  is recommended for an SVR rate, similar to that of HCV monoin - fection.461-463 Reactivation of HBV is possible during or after HCV  treatment,456 and administration of oral antiviral agents may be  indicated when significant proliferation of HBV is confirmed in this  case.464 [Recommendation] 55.",Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
"118 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89recently.480-484 Therefore, most studies have adapted the combi - nation therapy in children, since this approach is standard in  adults.",Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
"119The Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: Management of Hepatitis C http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89Barcelona, Spain: a prospective study.",Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
120 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.8949.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
121The Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: Management of Hepatitis C http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.892005;46:105-109.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
122 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89immunoassays for detecting antibodies to hepatitis C virus.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
123The Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: Management of Hepatitis C http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89et al.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
124 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89163.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
125The Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: Management of Hepatitis C http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89190.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
126 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89216.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
127The Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: Management of Hepatitis C http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89with interferon alfa-2b plus ribavirin for initial treatment of chronic  hepatitis C: a randomised trial.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
128 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89269.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
129The Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: Management of Hepatitis C http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89patients (G1/2/3/4): EMERGE phase IIb through week 12 [Abstract].,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
130 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89patients with hepatitis C virus genotype 6 infection: a pilot study.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
131The Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: Management of Hepatitis C http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89347.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
132 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89372.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
133The Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: Management of Hepatitis C http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89after chemotherapy for colon cancer.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
134 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.892006;54:3696-3706.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
"AIDSinfo website, <http://aidsinfo.nih.gov/ contentfiles/lvguidelines/adultandadolescentgl.pdf>.",Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
"135The Korean Association for the Study of the Liver (KASL) KASL clinical practice guidelines: Management of Hepatitis C http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.892b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a  randomized controlled trial.",Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
136 Clin Mol Hepatol Volume _20  Number _2  June 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.2.89477.,Non-OADS,/arxiv_data1/oa_pdf/53/11/cmh-20-89.PMC4099340.pdf
"4, 2012 *Corresponding author:  Tel: +82-2-2258-7343, Fax: +82-2-537-0572, E-maill: yejun@catholic.ac.kr Copyright © 2014 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).G&I    Genomics & InformaticseISSN 2234-0742 Genomics Inform  2014;12(2):49 http://dx.doi.org/10.5808/GI.2014.12.2.49 EDITORIAL Editor’s Introduction to This Issue Yeun-Jun Chung* IRCGP , The Catholic University of Korea College of Medicine, Seoul 137-701, Korea Recently, next-generation sequencing (NGS) techno- logies have become the most important part of genetic  testing to understand life phenomena and disease mecha-nisms.",Non-OADS,/arxiv_data1/oa_pdf/fe/51/gni-12-49.PMC4099347.pdf
"G&I    Genomics & InformaticseISSN 2234-0742 Genomics Inform  2014;12(2):50-57 http://dx.doi.org/10.5808/GI.2014.12.2.50 ORIGINAL ARTICLE Received April 22, 2014; Revised May 14, 2014; Accepted May 17, 2014 *Corresponding author:  Tel: +82-31-888-9312, Fax: +82-31-888-9314, E-mail: bckim00@gmail.com Copyright © 2014 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).New Lung Cancer Panel for High-Throughput  Targeted Resequencing Eun-Hye Kim1, Sunghoon Lee1, Jongsun Park2, Kyusang Lee3, Jong Bhak1,2, Byung Chul Kim2,3* 1Theragen Bio Institute, AICT, Suwon 443-270, Korea,  2Personal Genomics Institute, Genome Research Foundation, AICT , Suwon 443-270, Korea,  3Clinomics Inc., Seoul 138-961, Korea We present a new next-generation sequencing-based method to  identify somatic mutations of lung cancer.",Non-OADS,/arxiv_data1/oa_pdf/db/00/gni-12-50.PMC4099348.pdf
Supplementary materials Supplementary data including two tables can be found  with this article online at http://www.genominfo.org/src/  sm/gni-12-50-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/db/00/gni-12-50.PMC4099348.pdf
"G&I    Genomics & InformaticseISSN 2234-0742 Genomics Inform  2014;12(2):58-63 http://dx.doi.org/10.5808/GI.2014.12.2.58 ORIGINAL ARTICLE Received May 2, 2014; Revised May 20, 2014; Accepted May 26, 2014 *Corresponding author 1: Tel: +82-32-621-5105, Fax: +82-32-621-5016, E-mail: schalr@schbc.ac.kr **Corresponding author 2:  Tel: +82-2-3273-1671, Fax: +82-2-3273-1680, E-mail: hdshin@sogang.ac.kr †These two authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/de/41/gni-12-58.PMC4099349.pdf
"Copyright © 2014 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Association Analysis of TEC Polymorphisms with  Aspirin-Exacerbated Respiratory Disease in  a Korean Population Jin Sol Lee1,2†, Joon Seol Bae3†, Byung-Lae Park4, Hyun Sub Cheong4, Jeong-Hyun Kim1,  Jason Yongha Kim2, Suhg Namgoong2,4, Ji-On Kim2,4, Choon-Sik Park5*, Hyoung Doo Shin2,4** 1Research Institute for Basic Science, Sogang University, Seoul 121-742, Korea,  2Department of Life Science, Sogang University, Seoul 121-742, Korea,  3Laboratory of Translational Genomics, Samsung Genome Institute, Samsung Medical Center, Seoul 135-710, Korea,  4Department of Genetic Epidemiology, SNP Genetics, Inc., Seoul 153-801, Korea,  5Division of Allergy and Respiratory Medicine, Soonchunhyang University Seoul Hospital, Seoul 140-743, Korea The tyrosine-protein kinase Tec (TEC) is a member of non-recept or tyrosine kinases and has critical roles in cell signaling  transmission, calcium mobilization, gene expression, and transfor mation.",Non-OADS,/arxiv_data1/oa_pdf/de/41/gni-12-58.PMC4099349.pdf
Supplementary materials Supplementary data including three tables and one figure  can be found with this article online at http://www.geno-minfo.org/src/sm/gni-12-58-s001.pdf.,OADS,/arxiv_data1/oa_pdf/de/41/gni-12-58.PMC4099349.pdf
"G&I    Genomics & InformaticseISSN 2234-0742 Genomics Inform  2014;12(2):64-70 http://dx.doi.org/10.5808/GI.2014.12.2.64 ORIGINAL ARTICLE Received April 25, 2014; Revised May 16, 2014; Accepted May 22, 2014 *Corresponding author:  Tel: +91-7152-284038, Fax: +91-7152-284038, E-mail: satishangral@gmail.com Copyright © 2014 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Elucidating Molecular Interactions of Natural Inhibitors  with HPV-16 E6 Oncoprotein through Docking Analysis  Satish Kumar1*, Lingaraja Jena1, Sneha Galande1, Sangeeta Daf2,  Kanchan Mohod1, Ashok K. Varma3  1Bioinformatics Centre & Biochemistry, Mahatma Gandhi Institute of Medical Sciences, Sevagram 442-102, India,   2Datta Meghe Institute of Medical Sciences (Deemed University), Nagpur 440-022, India,  3Advanced Centre for Treatment, Research & Education in Cancer, Khargar, Navi Mumbai 410-210, India Human papillomavirus (HPV) infection is the leading caus e of cancer mortality among women worldwide.",Non-OADS,/arxiv_data1/oa_pdf/34/1b/gni-12-64.PMC4099350.pdf
The  HPV-16 E6 (GenBank ID: AAD33252.1) protein sequence was retrieved from NCBI (http://www.ncbi.nlm.nih.gov/).,OADS,/arxiv_data1/oa_pdf/34/1b/gni-12-64.PMC4099350.pdf
Visualization The visualization of structure files was done using the  graphical interface of the ADT tool and the PyMol molecular graphics system (http://www.pymol.org).,OADS,/arxiv_data1/oa_pdf/34/1b/gni-12-64.PMC4099350.pdf
"G&I    Genomics & InformaticseISSN 2234-0742 Genomics Inform  2014;12(2):71-75 http://dx.doi.org/10.5808/GI.2014.12.2.71 ORIGINAL ARTICLE Received December 28, 2013; Revised March 20, 2014; Accepted March 26, 2014 *Corresponding author:   Tel: +91-44-2817-8200 (ext 394), Fax: +91-44-2817-5566, E-mail: dsloy2003@gmail.com †These two authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/c7/1d/gni-12-71.PMC4099351.pdf
"Copyright © 2014 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Examining the Gm18 and m1G Modification Positions  in tRNA Sequences Mayavan Subramanian1†, Thangavelu Srinivasan2†, Dorairaj Sudarsanam2* 1Synthetic Biology and Biofuel Group, International Center for Genetic Engineering and Biotechnology (ICGEB),  New Delhi 110 067, India, 2DST-FIST Bioinformatics and Principal Investigator, School of Genomics and Bioinformatics,  Department of Advanced Zoology and Biotechnology, Loyola College, Chennai 600 034, India The tRNA structure contains cons erved modifications that are resp onsible for its stabilit y and are involved in the initiation a nd  accuracy of the translation process.",Non-OADS,/arxiv_data1/oa_pdf/c7/1d/gni-12-71.PMC4099351.pdf
"Methods FA S T A  fo r m a t  o f t R N A  g e n e  s e q u e n c e s  o f M. aquaeolei , M.  MWYL1 , N. hamburgensis , N. winogradskyi , and N. oceani were  retrieved from a tRNA database (http://gtrnadb.ucsc.edu/) [29]",OADS,/arxiv_data1/oa_pdf/c7/1d/gni-12-71.PMC4099351.pdf
Amino acid-specific tRNAs that lack a G residue at the 18th and 38th positions and used for multiple sequence alignment by BioEdit software (http://www.mbio.ncsu.edu/bioedit/bioedit.html) [30].,Non-OADS,/arxiv_data1/oa_pdf/c7/1d/gni-12-71.PMC4099351.pdf
Available from: http://gtrnadb.ucsc.edu/.,Non-OADS,/arxiv_data1/oa_pdf/c7/1d/gni-12-71.PMC4099351.pdf
Available from: http://www.mbio.ncsu.edu/bioedit/  bioedit.html.,Non-OADS,/arxiv_data1/oa_pdf/c7/1d/gni-12-71.PMC4099351.pdf
"G&I    Genomics & InformaticseISSN 2234-0742 Genomics Inform  2014;12(2):76-78 http://dx.doi.org/10.5808/GI.2014.12.2.76 APPLICATION NOTE Received May 9, 2014; Revised May 21, 2014; Accepted May 23, 2014 *Corresponding author:  Tel: +82-42-879-8521, Fax: +82-42-879-8519, E-mail: axxa76@kribb.re.kr Copyright © 2014 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).SFannotation: A Simple and Fast Protein Function  Annotation System Dong Su Yu1*, Byung Kwon Kim2 1Korean BioInformation Center (KOBIC), Korea Research Institute of  Bioscience and Biotechnology (KRIBB), Daejeon 305-806, Korea,  2BioNano Health Guard Research Center, Korea Research Institute of  Bioscience and Biotechnology (KRIBB), Daejeon 305-806, Korea Owing to the generation of vast amounts of sequencing da ta by using cost-effective, high-throughput sequencing  technologies with improved computational approaches, many putative proteins ha ve been discovered after assembly and  structural annotation.",Non-OADS,/arxiv_data1/oa_pdf/c2/25/gni-12-76.PMC4099352.pdf
Supplementary material Supplementary data including one figure can be found  with this article online at http://www.genominfo.org/src/  sm/gni-12-76-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c2/25/gni-12-76.PMC4099352.pdf
"43Copyright © 2014 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X  PROSTATE  INTERNATIONAL Current role of treatment in men with lower urinary  tract symptoms combined with overactive bladder Seung Hwan Lee, Ji Youl Lee1 Department of Urology, Severance Hospital, Yonsei University Health System, Seoul, Korea  1Department of Urology, The Catholic University of Korea, Seoul St. Mary’s Hospital, Seoul, Korea Lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) are highly prevalent in older men.",Non-OADS,/arxiv_data1/oa_pdf/fb/e6/pi-2-2-43.PMC4099395.pdf
"Keywords:  Prostatic hyperplasia, Overactive urinary bladder, PharmacologyProstate Int 2014;2(2):43-49 • http://dx.doi.org/10.12954/PI.14045Review Article Corresponding author:  Ji Youl Lee Department of Urology, The Catholic University of Korea, Seoul St. Mary’s Hospital, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea E-mail: uroljy@catholic.ac.kr / Tel: +82-2-2258-6227 / Fax: +82-2-599-7839 Submitted: 10 March 2014 / Accepted after revision: 7 April 2014INTRODUCTION  Lower urinary tract symptoms (LUTS) and benign prostatic  hyperplasia (BPH) are highly prevalent in older men.",Non-OADS,/arxiv_data1/oa_pdf/fb/e6/pi-2-2-43.PMC4099395.pdf
Treatment in male LUTS with OAB 44PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14045alpha-1 receptor subtype present in prostatic tissue.,Non-OADS,/arxiv_data1/oa_pdf/fb/e6/pi-2-2-43.PMC4099395.pdf
"2 / June 2014 45PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14045than in those given placebo (0 mL, P<0.004).",Non-OADS,/arxiv_data1/oa_pdf/fb/e6/pi-2-2-43.PMC4099395.pdf
"Treatment in male LUTS with OAB 46PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14045greater improvements versus placebo plus alpha-blocker in  24-hour micturitions, daytime micturitions, 24-hour urgency  episodes, daytime urgency episodes, nocturnal urgency epi - sodes, frequency–urgency sum, IPSS storage subscale, OAB-q  symptom bother scale, and OAB-q coping domain at week 12.",Non-OADS,/arxiv_data1/oa_pdf/fb/e6/pi-2-2-43.PMC4099395.pdf
2 / June 2014 47PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14045der and how are they managed?,Non-OADS,/arxiv_data1/oa_pdf/fb/e6/pi-2-2-43.PMC4099395.pdf
"Treatment in male LUTS with OAB 48PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14045of a phase III randomized, placebo-controlled, double-blind  study in Japanese men.",Non-OADS,/arxiv_data1/oa_pdf/fb/e6/pi-2-2-43.PMC4099395.pdf
2 / June 2014 49PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14045Eur Urol 2009;56:534-41.,Non-OADS,/arxiv_data1/oa_pdf/fb/e6/pi-2-2-43.PMC4099395.pdf
"50Copyright © 2014 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X  PROSTATE  INTERNATIONAL Seventh Joint Meeting of K-J-CaP and CaPSURE:   extending the global initiative to improve prostate   cancer management  Hideyuki Akaza, Choung Soo Kim1, Peter Carroll2, In Young Choi3, Byung Ha Chung4, Matthew R. Cooperberg2,   Yoshihiko Hirao5, Shiro Hinotsu6, Shigeo Horie7, Ji Youl Lee8, Mikio Namiki9, Chi-Fai Ng10, Mizuki Onozawa11,   Seiichiro Ozono12, Satoru Ueno9, Rainy Umbas13, Dingwei Ye14, Gang Zhu15 Department of Strategic Investigation on Comprehensive Cancer Network, Research Center for Advanced Science and Technology, The University of Tokyo,  Tokyo, Japan;  1Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;  2Department of Urology, Helen Diller  Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA; 3Graduate School of Healthcare Management  & Policy, The Catho - lic University of Korea, Seoul, Korea;  4Department of Urology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea; 5Osaka  Gyoumeikan Hospital, Osaka, Japan;  6Center for Innovative Clinical Medicine Okayama University Hospital, Japan;  7Department of Urology, Juntendo  University, Tokyo, Japan ;  8Department of Urology, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea;  9Department  of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Ishikawa, Japan;  10Division of Urology, Department  of Surgery, The  Chinese University of Hong Kong, Hong Kong, China;  11Department of Urology, Tokyo-kita Social Insurance Hospital, Tokyo, Japan; 12De- partment of Urology, Hamamatsu University School of Medicine, Shizuoka, Japan;  13Department of Urology, Cipto Mangunkusumo Hospital, University of  Indonesia, Jakarta, Indonesia;  14Department of Urology, Fudan University Cancer Hospital, Shanghai, China;  15Beijing Hospital of Ministry of Health, Beijing,  China This report summarizes the presentations and discussions that took place at the Seventh Joint Meeting of the Korea–Japan Study  Group of Prostate Cancer (K-J-CaP) and the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) held in Seoul,  Korea, in September 2013.",Non-OADS,/arxiv_data1/oa_pdf/60/26/pi-2-2-50.PMC4099396.pdf
"Keywords:  Prostatic neoplasms, Prostatectomy, Drug therapy for prostate cancer, Comorbidity, Quality of lifeProstate Int 2014;2(2):50-69 • http://dx.doi.org/10.12954/PI.14047Meeting Report Corresponding author:  Hideyuki Akaza Department of Strategic Investigation on Comprehensive Cancer Network, Research Center for Advanced Science and Technology, The University of Tokyo,  4-6-1 Komaba, Meguro-ku, Tokyo 1530041, Japan   E-mail: akazah@med.rcast.u-tokyo.ac.jp / Tel: +81-3-5432-5341, Fax +81-3-5432-5343   Submitted: 11 March 2014 / Accepted after revision: 17 March  2014",Non-OADS,/arxiv_data1/oa_pdf/60/26/pi-2-2-50.PMC4099396.pdf
2 / June 2014 51PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14047lished and collecting data for many years however when  creating a new national database ‘from scratch’ there are sev - eral challenges that need to be overcome to ensure that the  database is usable by healthcare professionals in the field and  that the data collected are of value.,Non-OADS,/arxiv_data1/oa_pdf/60/26/pi-2-2-50.PMC4099396.pdf
Report of the Seventh Joint Meeting of K-J-CaP and CaPSURE 52PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14047Dr.,OADS,/arxiv_data1/oa_pdf/60/26/pi-2-2-50.PMC4099396.pdf
2 / June 2014 53PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.140472.,Non-OADS,/arxiv_data1/oa_pdf/60/26/pi-2-2-50.PMC4099396.pdf
"Report of the Seventh Joint Meeting of K-J-CaP and CaPSURE 54PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14047multicentered clinical research studies in the Asia–Pacific  region, and holds an annual meeting to develops treatment  guidelines for the this region.",Non-OADS,/arxiv_data1/oa_pdf/60/26/pi-2-2-50.PMC4099396.pdf
2 / June 2014 55PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14047tial triggers for intervention.,Non-OADS,/arxiv_data1/oa_pdf/60/26/pi-2-2-50.PMC4099396.pdf
"Report of the Seventh Joint Meeting of K-J-CaP and CaPSURE 56PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14047combined androgen blockade (CAB) treatment with castra - tion monotherapy, found that disease-specific survival in the  CAB group was significantly higher than that of the castration  monotherapy group: 92.8% versus 78.5% survival at 10 years,  respectively ( P= 0.037).",Non-OADS,/arxiv_data1/oa_pdf/60/26/pi-2-2-50.PMC4099396.pdf
"2 / June 2014 57PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14047contrast, for the PADT group the scores for some domains,  including physical function, decreased slightly.",OADS,/arxiv_data1/oa_pdf/60/26/pi-2-2-50.PMC4099396.pdf
Report of the Seventh Joint Meeting of K-J-CaP and CaPSURE 58PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14047 Dr. Ueno concluded by noting that various considerations  were involved when choosing a treatment for prostate cancer  patients.,Non-OADS,/arxiv_data1/oa_pdf/60/26/pi-2-2-50.PMC4099396.pdf
2 / June 2014 59PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14047in those with CAPRA 0–2.,Non-OADS,/arxiv_data1/oa_pdf/60/26/pi-2-2-50.PMC4099396.pdf
Report of the Seventh Joint Meeting of K-J-CaP and CaPSURE 60PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14047significant differences between the other treatment groups in  terms of comorbidity count.,Non-OADS,/arxiv_data1/oa_pdf/60/26/pi-2-2-50.PMC4099396.pdf
2 / June 2014 61PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14047system was that it was not possible to distinguish between the  answer ‘no’ and missing data.,OADS,/arxiv_data1/oa_pdf/60/26/pi-2-2-50.PMC4099396.pdf
Report of the Seventh Joint Meeting of K-J-CaP and CaPSURE 62PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14047CaP received CAB compared with 45% of those in CaPSURE.,Non-OADS,/arxiv_data1/oa_pdf/60/26/pi-2-2-50.PMC4099396.pdf
"2 / June 2014 63PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14047physician to use, currently there is too much over-treatment  of low-risk disease coupled with under-treatment of high-risk  disease.",Non-OADS,/arxiv_data1/oa_pdf/60/26/pi-2-2-50.PMC4099396.pdf
"Report of the Seventh Joint Meeting of K-J-CaP and CaPSURE 64PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14047DX genomic prostate score (GPS), a quantitative 17-gene RT- PCR assay using manually microdissected tumor tissue from  needle biopsies.",Non-OADS,/arxiv_data1/oa_pdf/60/26/pi-2-2-50.PMC4099396.pdf
"2 / June 2014 65PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14047Yanqun, Ye Dingwei and Chi-Fai Ng) Professor Zhu gave an  overview of the development of the Chinese prostate cancer  database, C-CaP .",Non-OADS,/arxiv_data1/oa_pdf/60/26/pi-2-2-50.PMC4099396.pdf
Report of the Seventh Joint Meeting of K-J-CaP and CaPSURE 66PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14047(10 hospitals).,Non-OADS,/arxiv_data1/oa_pdf/60/26/pi-2-2-50.PMC4099396.pdf
2 / June 2014 67PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.1404710.,OADS,/arxiv_data1/oa_pdf/60/26/pi-2-2-50.PMC4099396.pdf
Available from: http://www.nccn.org/professionals/ physician_gls/f_guidelines.asp.,Non-OADS,/arxiv_data1/oa_pdf/60/26/pi-2-2-50.PMC4099396.pdf
Available from: http://www.nccn.,Non-OADS,/arxiv_data1/oa_pdf/60/26/pi-2-2-50.PMC4099396.pdf
Report of the Seventh Joint Meeting of K-J-CaP and CaPSURE 68PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.140472010;184:114-9.,OADS,/arxiv_data1/oa_pdf/60/26/pi-2-2-50.PMC4099396.pdf
Available from: http://www3.ha.org.hk/cancereg/.,Non-OADS,/arxiv_data1/oa_pdf/60/26/pi-2-2-50.PMC4099396.pdf
2 / June 2014 69PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14047 Appendix.,Non-OADS,/arxiv_data1/oa_pdf/60/26/pi-2-2-50.PMC4099396.pdf
"70Copyright © 2014 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X  PROSTATE  INTERNATIONAL Predictive factors of unfavorable prostate cancer in   patients who underwent prostatectomy but eligible for  active surveillance  Seol Ho Choo, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon,  Han Yong Choi,   Hyun Moo Lee  Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea  Purpose:  To investigate the predictive factors of unfavorable prostate cancer in Korean men who underwent radical prostatectomy  but eligible for active surveillance according to Epstein criteria.",Non-OADS,/arxiv_data1/oa_pdf/34/33/pi-2-2-70.PMC4099397.pdf
"Keywords:  Prostatic neoplasms, Surveillance, Prostatectomy, Pathology, Neoplasm gradingProstate Int 2014;2(2):70-75 • http://dx.doi.org/10.12954/PI.14042Original Article Corresponding author:  Hyun Moo Lee Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea   E-mail: besthml@medimail.co.kr / Tel: +82-2-3410-6543 / Fax: +82-2-3410-6992 Submitted: 26 February 2014  / Accepted after revision: 14 April 2014INTRODUCTION Low-risk prostate cancer is a very indolent disease with a  limited impact on life expectancy.",Non-OADS,/arxiv_data1/oa_pdf/34/33/pi-2-2-70.PMC4099397.pdf
2 / June 2014 71PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.140422.,Non-OADS,/arxiv_data1/oa_pdf/34/33/pi-2-2-70.PMC4099397.pdf
"Predictive factors of unfavorable prostate cancer 72PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14042 When comparing favorable and unfavorable prostate  cancer, there were significant differences in mean age (63.7  vs. 65.9, P= 0.007), prostate volume (47.1 mL vs. 42.2 mL, P=  0.021), PSA density (0.096 ng/mL2 vs. 0.104 ng/mL2, P= 0.03),  maximum tumor volume in biopsy core (11.6% vs. 18.3%, P<  0.001), and percentage of patients with two positive cores  (19.3% vs. 39.8%, P= 0.001) (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/34/33/pi-2-2-70.PMC4099397.pdf
2 / June 2014 73PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14042DISCUSSION Widespread use of PSA screening has increased detection  rates of low-risk prostate cancer.,Non-OADS,/arxiv_data1/oa_pdf/34/33/pi-2-2-70.PMC4099397.pdf
Predictive factors of unfavorable prostate cancer 74PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14042P= 0.01).,Non-OADS,/arxiv_data1/oa_pdf/34/33/pi-2-2-70.PMC4099397.pdf
2 / June 2014 75PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.140429.,Non-OADS,/arxiv_data1/oa_pdf/34/33/pi-2-2-70.PMC4099397.pdf
"76Copyright © 2014 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X  PROSTATE  INTERNATIONAL Analysis of different tumor volume thresholds of   insignificant prostate cancer and their implications for  active surveillance patient selection and monitoring Dong Hoon Lee, Kyo Chul Koo1, Seung Hwan Lee1, Koon Ho Rha1, Young Deuk Choi1, Sung Joon Hong1,   Byung Ha Chung1 Department of Urology, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital,   Pusan National University School of Medicine, Yangsan, Korea 1Department of Urology and Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea Purpose:  We compared oncological outcomes according to tumor volume (TV) thresholds defining both classical and updated  insignificant prostate cancer (IPC), since the TV threshold can be used as clinical parameter for active surveillance.",Non-OADS,/arxiv_data1/oa_pdf/d1/ea/pi-2-2-76.PMC4099398.pdf
"Keywords:  Insignificant prostate cancer, Tumor volume, Active surveillance Prostate Int 2014;2(2):76-81 • http://dx.doi.org/10.12954/PI.14044Original Article Corresponding author:  Byung Ha Chung Department of Urology, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, Korea E-mail: chung646@yuhs.ac / Tel: +82-2-2019-3470 / Fax: +82-2-3462-8887   Submitted: 5 March 2014  / Accepted after revision: 7 April 2014INTRODUCTION Urologists commonly use the classical definition of insignifi - cant prostate cancer (IPC), which describes cases as organ- confined, Gleason 6 disease with tumor volume (TV) < 0.5  mL [1].",Non-OADS,/arxiv_data1/oa_pdf/d1/ea/pi-2-2-76.PMC4099398.pdf
2 / June 2014 77PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14044thologist.,Non-OADS,/arxiv_data1/oa_pdf/d1/ea/pi-2-2-76.PMC4099398.pdf
Tumor volume for active surveillance 78PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14044were more likely to have a postoperative GS ≤ 6 than those  who had TV between 0.5 mL and 1.3 mL.,Non-OADS,/arxiv_data1/oa_pdf/d1/ea/pi-2-2-76.PMC4099398.pdf
"2 / June 2014 79PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14044between 0.5 mL and 1.3 mL showed an increased risk of BCR  if they had Gleason grade 4/5 disease, even if the patient was  an organ-confined prostate cancer patient with a preopera - tive PSA level lower than 10 ng/mL.",Non-OADS,/arxiv_data1/oa_pdf/d1/ea/pi-2-2-76.PMC4099398.pdf
"Tumor volume for active surveillance 80PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14044re-evaluate and reconfirm their suitability as AS candidates,  since they could miss their windows of curability if they ex - hibit unexpected Gleason grade 4/5 disease.",Non-OADS,/arxiv_data1/oa_pdf/d1/ea/pi-2-2-76.PMC4099398.pdf
2 / June 2014 81PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14044lateral low-risk prostate cancer.,Non-OADS,/arxiv_data1/oa_pdf/d1/ea/pi-2-2-76.PMC4099398.pdf
http://dx.doi.org/10.1111/bju.12750.,Non-OADS,/arxiv_data1/oa_pdf/d1/ea/pi-2-2-76.PMC4099398.pdf
"82Copyright © 2014 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X  PROSTATE  INTERNATIONAL Robotic assisted laparoscopic radical prostatectomy   following transurethral resection of the prostate:   perioperative, oncologic and functional outcomes Chi-Feng Hung1,2, Cheng-Kuang Yang1, Yen-Chuan Ou1 1Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan 2Institute of Medicine, Chung Sang Medical University, Taichung, Taiwan Purpose:  The aim of this study was to assess surgical, oncologic and functional results after robotic-assisted laparoscopic radical  prostatectomy (RALP) with and without previous transurethral resection of the prostate (TURP).",Non-OADS,/arxiv_data1/oa_pdf/64/08/pi-2-2-82.PMC4099399.pdf
"Keywords:  Prostatic neoplasm, Prostatectomy, Robotics, Transurethral resection of prostateProstate Int 2014;2(2):82-89 • http://dx.doi.org/10.12954/PI.14046Original Article Corresponding author:  Yen-Chuan Ou Division of Urology, Department of Surgery, Taichung Veterans General Hospital, 1650 Taiwan Boulevard Sect.",Non-OADS,/arxiv_data1/oa_pdf/64/08/pi-2-2-82.PMC4099399.pdf
"2 / June 2014 83PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14046including specimen volume, tumour volume, tumour per - centage, Gleason score, positive surgical margin (PSM) rate,  and nodal status.",Non-OADS,/arxiv_data1/oa_pdf/64/08/pi-2-2-82.PMC4099399.pdf
RALP after TURP84 PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14046P< 0.001).,Non-OADS,/arxiv_data1/oa_pdf/64/08/pi-2-2-82.PMC4099399.pdf
"2 / June 2014 85PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14046was attempted in 37.5% of patients in group 1 and 47.8% in  group 2, separately ( P= 0.594).",Non-OADS,/arxiv_data1/oa_pdf/64/08/pi-2-2-82.PMC4099399.pdf
RALP after TURP86 PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14046TURP in the literature are summarized on Table 5.,Non-OADS,/arxiv_data1/oa_pdf/64/08/pi-2-2-82.PMC4099399.pdf
2 / June 2014 87PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14046vesicles.,OADS,/arxiv_data1/oa_pdf/64/08/pi-2-2-82.PMC4099399.pdf
RALP after TURP88 PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14046efficacy of RALP in the patients with previous TURP .,Non-OADS,/arxiv_data1/oa_pdf/64/08/pi-2-2-82.PMC4099399.pdf
2 / June 2014 89PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.1404622.,OADS,/arxiv_data1/oa_pdf/64/08/pi-2-2-82.PMC4099399.pdf
"90Copyright © 2014 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X  PROSTATE  INTERNATIONAL Role of cyclin D1 immunoreactivity and AgNOR staining  in the evaluation of benign and malignant lesions of the  prostate Veena Gupta, Monika Garg1, Manish Chaudhry1, Sunita Singh, Rajeev Sen, Meenu Gill, Ashok Sangwaiya Department of Pathology, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, India 1Department of Pathology, MM Institute of Medical Sciences & Research, Mullana, India Purpose:  Prostatic carcinoma is a common and growing public health problem.",Non-OADS,/arxiv_data1/oa_pdf/69/f9/pi-2-2-90.PMC4099400.pdf
"Keywords:  Prostate, Carcinoma, Prostatic hyperplasia, Cyclin D1, AgNORs,  ImmunohistochemistryProstate Int 2014;2(2):90-96 • http://dx.doi.org/10.12954/PI.14041Original Article Corresponding author:  Monika Garg Department of Pathology, MM Institute of Medical Sciences & Research, Mullana - 133207 (Ambala) Haryana, India E-mail: monikakash7@yahoo.co.in / Tel: +91-94173-78514 / Fax: +91-1731-274375 Submitted: 20 Fedruary 2014 / Accepted after revision: 27 March  2014 INTRODUCTION Prostatic disease is responsible for significant morbidity and  mortality in men throughout the world.",Non-OADS,/arxiv_data1/oa_pdf/69/f9/pi-2-2-90.PMC4099400.pdf
2 / June 2014 91PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14041subjected to careful and detailed gross examination.,Non-OADS,/arxiv_data1/oa_pdf/69/f9/pi-2-2-90.PMC4099400.pdf
Cyclin D1 and AgNOR in prostatic lesions 92PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14041of < 0.01.,Non-OADS,/arxiv_data1/oa_pdf/69/f9/pi-2-2-90.PMC4099400.pdf
"2 / June 2014 93PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14041which interact with and activate cyclin-dependent kinases  to promote G1 progression during the cell cycle [10,13,14].",Non-OADS,/arxiv_data1/oa_pdf/69/f9/pi-2-2-90.PMC4099400.pdf
Cyclin D1 and AgNOR in prostatic lesions 94PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14041Table 3.,Non-OADS,/arxiv_data1/oa_pdf/69/f9/pi-2-2-90.PMC4099400.pdf
2 / June 2014 95PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14041cyclin D1 expression.,OADS,/arxiv_data1/oa_pdf/69/f9/pi-2-2-90.PMC4099400.pdf
Cyclin D1 and AgNOR in prostatic lesions 96PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.1404120.,Non-OADS,/arxiv_data1/oa_pdf/69/f9/pi-2-2-90.PMC4099400.pdf
"97Copyright © 2014 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X  PROSTATE  INTERNATIONAL Management of male lower urinary tract symptoms   suggestive of benign prostatic hyperplasia by general  practitioners in Jakarta  Faisal Abdi Matondang, Harrina Erlianti Rahardjo Department of Urology, Cipto Mangunkusumo Hospital, University of Indonesia Faculty of Medicine, Jakarta, Indonesia Purpose:  This study was performed to describe and evaluate the management of male lower urinary tract symptoms (LUTS)  suggestive of benign prostatic hyperplasia (BPH) by general practitioners (GPs) in Jakarta.",Non-OADS,/arxiv_data1/oa_pdf/9a/6e/pi-2-2-97.PMC4099401.pdf
"Keywords:  Prostatic hyperplasia, Lower urinary tract symptoms, General practitionerProstate Int 2014;2(2):97-103 • http://dx.doi.org/10.12954/PI.14040Original Article Corresponding author:  Faisal Abdi Matondang  Department of Urology, Cipto Mangunkusumo Hospital, Jl.",Non-OADS,/arxiv_data1/oa_pdf/9a/6e/pi-2-2-97.PMC4099401.pdf
"Male LUTS suggestive of BPH management by general practitioners 98PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14040symptoms of the patients, initial diagnostic workup, the most  common scoring system used, initial therapy, initial drugs  prescribed, time to follow-up, evalution at follow-up, referral  criteria, common α-adrenergic antagonists prescribed, and  common α-adrenergic antagonist-related side effects.",Non-OADS,/arxiv_data1/oa_pdf/9a/6e/pi-2-2-97.PMC4099401.pdf
2 / June 2014 99PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14040done.,OADS,/arxiv_data1/oa_pdf/9a/6e/pi-2-2-97.PMC4099401.pdf
"Male LUTS suggestive of BPH management by general practitioners 100PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14040in Europe than in Indonesia, where BPH patients tend to seek  medical help when severe symptoms or complications are  already present.",Non-OADS,/arxiv_data1/oa_pdf/9a/6e/pi-2-2-97.PMC4099401.pdf
"2 / June 2014 101PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14040ire only was used by 3.2% to 14.5% of GPs, except in Spain  (57.1%).",Non-OADS,/arxiv_data1/oa_pdf/9a/6e/pi-2-2-97.PMC4099401.pdf
Male LUTS suggestive of BPH management by general practitioners 102PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14040worked for more than 5 years.,Non-OADS,/arxiv_data1/oa_pdf/9a/6e/pi-2-2-97.PMC4099401.pdf
2 / June 2014 103PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.14040and treatment of male lower urinary tract symptoms in the  primary care setting.,Non-OADS,/arxiv_data1/oa_pdf/9a/6e/pi-2-2-97.PMC4099401.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/20/5e/ott-7-1247.PMC4099416.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2014:7 1247–1254OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1247Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S6430 3Role of calcium-dependent protein kinases in  chronic myeloid leukemia: combined effects  of PKC and BCR-ABL signaling on cellular  alterations during leukemia development André L Mencalha1 Stephany Corrêa2 eliana Abdelhay2 1Biophysics and Biometry Department,   Roberto Alcântara Gomes Biology  institute, Rio de Janeiro’s State  University (UeRJ), Rio de Janeiro,   Brazil; 2Bone Marrow Transplantation  Unit (CeMO), National Cancer  institute (iNCA), Rio de Janeiro, Brazil Correspondence: André Mencalha   Departamento de Biofísica e Biometria,  instituto de Biologia Roberto Alcântara  Gomes, Universidade do estado do Rio  de Janeiro,  28 Avenida de Setembro,   87 Fundos –  4 Andar, vila isabel,   Rio de Janeiro  20551-030, Brazil   Tel +55 21 2587 6507  email andre.mencalha@uerj.b rAbstract:  Calcium-dependent protein kinases (PKCs) function in a myriad of cellular pro - cesses, including cell-cycle regulation, proliferation, hematopoietic stem cell differentiation,  apoptosis, and malignant transformation.",Non-OADS,/arxiv_data1/oa_pdf/20/5e/ott-7-1247.PMC4099416.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/20/5e/ott-7-1247.PMC4099416.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/5e/ott-7-1247.PMC4099416.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e6/1b/ijn-9-3347.PMC4099417.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3347–3361International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3347OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6146 3Theranostic nanoparticles based on bioreducible  polyethylenimine-coated iron oxide for   reduction-responsive gene delivery   and magnetic resonance imaging correspondence: chao lin shanghai east hospital, The Institute for  Biomedical engineering and Nanoscience,  room 222, shixun Building,   T ongji University, shanghai, 200092,   People’s republic of china T el +86 21 6598 3706 803 Fax +86 21 6598 3706 0 email chaolin@tongji.edu.c n  Zhongwei lv Department of Nuclear Medicine,  shanghai 10th People’s hospital,   301 Yanchang road, shanghai,   200072, People’s republic of china email heyixue163@163.co mDan li1,* Xin Tang2,* Benjamin Pulli1 chao lin2 Peng Zhao2 Jian cheng2 Zhongwei lv1 Xueyu Yuan1 Qiong luo1 haidong cai1 Meng Ye1 1Department of Nuclear Medicine,   shanghai 10th People’s hospital,   2shanghai east hospital, The Institute  for Biomedical engineering and  Nanoscience, Tongji University   school of Medicine, T ongji University,   People’s republic of china *These authors contributed equally   to this workAbstract:  Theranostic nanoparticles based on superparamagnetic iron oxide (SPIO) have a  great promise for tumor diagnosis and gene therapy.",Non-OADS,/arxiv_data1/oa_pdf/e6/1b/ijn-9-3347.PMC4099417.pdf
"In order to achieve successful gene therapy, non-viral vectors must circumvent  a series of gene delivery barriers such as cellular membrane, endosomes/lysosomes,  and vector unpacking.7 Thus far, a lot of cationic polymers such as polyethylenimine Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Li et al Running head recto: Gene delivery and MR imaging DOI: http://dx.doi.org/10.2147/IJN.S61463",Non-OADS,/arxiv_data1/oa_pdf/e6/1b/ijn-9-3347.PMC4099417.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e6/1b/ijn-9-3347.PMC4099417.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 3361gene delivery and Mr imaging 20.,Non-OADS,/arxiv_data1/oa_pdf/e6/1b/ijn-9-3347.PMC4099417.pdf
Available online 17 May 2014 http://dx.doi.org/10.1016/j.molmet.2014.05.003 Commentary MOLECULAR METABOLISM 3 (2014) 505 e506/C2112014 The Authors.,OADS,/arxiv_data1/oa_pdf/1b/a0/main.PMC4099503.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/a0/main.PMC4099503.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/a0/main.PMC4099503.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/c4/main.PMC4099504.pdf
"Lavery), alex.odermatt@unibas.ch (A. Odermatt) Abbreviations: 11b-hydroxysteroid dehydrogenase 1, 11 b-HSD1; bile acids, BAs; BA coenzyme A: amino acid N-acyltransferase, Baat; cholesterol 7 a-hydroxylase, Cyp7a1; farnesoid X receptor, Fxr; fatty acid transport protein, Fatp; glucocorticoid receptor, GR; Naþ-taurocholate cotransporting polypeptide, Ntcp; Organic solute transporter, Ost; Organic anion-transporting polypeptide, Oatp; short heterodimer partner, Shp; sterol-regulatory element-binding protein 1C, Srebp1c Received April 9, 2014 /C15Revision received April 17, 2014 /C15Accepted April 19, 2014 /C15Available online 2 May 2014 http://dx.doi.org/10.1016/j.molmet.2014.04.008 Original article 554MOLECULAR METABOLISM 3 (2014) 554 e564/C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/4e/c4/main.PMC4099504.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/c4/main.PMC4099504.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/c4/main.PMC4099504.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/c4/main.PMC4099504.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/c4/main.PMC4099504.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/c4/main.PMC4099504.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/c4/main.PMC4099504.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/c4/main.PMC4099504.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/c4/main.PMC4099504.pdf
"SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.molmet.2014.04.008.REFERENCES [1]Hofmann, A.F., 1999.",OADS,/arxiv_data1/oa_pdf/4e/c4/main.PMC4099504.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/c4/main.PMC4099504.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/c4/main.PMC4099504.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/c4/main.PMC4099504.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/9b/main.PMC4099505.pdf
"Abbreviations: CV, Coxsackievirus; eIF4E-V5, eIF4E tagged at its C-terminus with a V5-epitope; ER, endoplasmic reticulum; EV, Enterovirus; F, Faulkner; FL, ﬁreﬂy luciferase; IRES, internal ribosomal entry site; ITAF, IRES-trans-acting factor; mTORC1, mammalian Target Of Rapamycin Complex 1; MCA, MIN6 cell adapted; PABP, poly(A)-binding protein; PC, prohormone convertase; PTBP1, polypyrimidine tract-binding protein 1; S6K1, p70S6 Kinase 1; T1D, type 1 diabetes; UTR, untranslated region Received April 22, 2014 /C15Revision received May 2, 2014 /C15Accepted May 6, 2014 /C15Available online 14 May 2014 http://dx.doi.org/10.1016/j.molmet.2014.05.002 Original article 518MOLECULAR METABOLISM 3 (2014) 518 e530/C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/32/9b/main.PMC4099505.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/9b/main.PMC4099505.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/9b/main.PMC4099505.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/9b/main.PMC4099505.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/9b/main.PMC4099505.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/9b/main.PMC4099505.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/9b/main.PMC4099505.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/9b/main.PMC4099505.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/9b/main.PMC4099505.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/9b/main.PMC4099505.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/9b/main.PMC4099505.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/9b/main.PMC4099505.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/9b/main.PMC4099505.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/9b/main.PMC4099505.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/c2/main.PMC4099506.pdf
Cultures were grown in a humidi ﬁed atmosphere of 5% CO 2/95% air at 37 1CContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.03.002 2213-2317/ &2014 The Authors.,OADS,/arxiv_data1/oa_pdf/f7/c2/main.PMC4099506.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/c2/main.PMC4099506.pdf
"Immunology 6 (2006)532 –540, http://dx.doi.org/10.1038/nri1865 16799472 .",Non-OADS,/arxiv_data1/oa_pdf/f7/c2/main.PMC4099506.pdf
"Stewart, J. Geddes, W.R. Markesbery, p38 kinase is activated in the Alzheimer ’s disease brain, Journal of Neurochemistry 72 (1999) 2053 –2058, http://dx.doi.org/10.1046/j.1471-4159.1999.0722053 10217284 .",Non-OADS,/arxiv_data1/oa_pdf/f7/c2/main.PMC4099506.pdf
"Nguyen, G. Bing, P38 MAP kinase is activated at early stages in Alzheimer ’s disease brain, Experimental Neurology 183 (2003) 394 –405, http://dx.doi.org/10.1016/s0014-4886(03)00180-8 14552880 .",Non-OADS,/arxiv_data1/oa_pdf/f7/c2/main.PMC4099506.pdf
"Mrak, W. S. Grif ﬁn, Interleukin-1 promotion of MAPK-p38 overexpression in experi- mental animals and in Alzheimer ’s disease: potential signi ﬁcance for Tau protein phosphorylation, Neurochemistry International 39 (2001) 341 –348, http://dx.doi.org/10.1016/s0197-0186(01)00041-9 11578769 .",Non-OADS,/arxiv_data1/oa_pdf/f7/c2/main.PMC4099506.pdf
"Campbell, R. Jakes, M. Goedert, A. Cuenda, Evidence that phosphorylation of the microtubule-associated protein tau by SAPK4/p38 δ at Thr50 promotes microtubule assembly, Journal of Cell Science 118 (2005) 397 –408, http://dx.doi.org/10.1242/jcs.01655 15632108 .",Non-OADS,/arxiv_data1/oa_pdf/f7/c2/main.PMC4099506.pdf
"[7] H. Yoshida, M. Goedert, Sequential phosphorylation of Tau protein by cAMP- dependent protein kinase and SAPK4/p38 delta or JNK2 in the presence of heparin generates the AT100 epitope, Journal of Neurochemistry 99 (2006) 154 –164, http://dx.doi.org/10.1111/j.1471-4159.2006.04052.x 16987243 .",Non-OADS,/arxiv_data1/oa_pdf/f7/c2/main.PMC4099506.pdf
"Anderton, W. Noble, Kinase activities increase during the development of tauopathy in htau mice, Journal ofNeurochemistry 103 (2007) 2256 –2267, http://dx.doi.org/10.1111/j.1471- 4159.2007.04930.x 17908241 .",Non-OADS,/arxiv_data1/oa_pdf/f7/c2/main.PMC4099506.pdf
"Alonso, H. Atamna, J. Viña, Gender and age-dependent differences in the mitochondrial apopto- genic pathway in Alzheimer ’s disease, Free Radical Biology & Medicine 44 (2008) 2019 –2025, http://dx.doi.org/10.1016/j.freeradbiomed.2008.02.017 18387371 .",Non-OADS,/arxiv_data1/oa_pdf/f7/c2/main.PMC4099506.pdf
"Xu, M. Karandikar, K. Berman, M. H. Cobb, Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions, Endocrine Reviews 22 (2001) 153 –183, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/f7/c2/main.PMC4099506.pdf
"Trends in Neurosciences 25 (2002) 22 –26,http://dx.doi.org/ 10.1016/s0166-2236(00)02031-2 11801334 .",Non-OADS,/arxiv_data1/oa_pdf/f7/c2/main.PMC4099506.pdf
"Yatin, S. Varadarajan, T. Koppal, Amyloid beta-peptide- associated free radical oxidative stress, neurotoxicity, and Alzheimer ’s disease, Methods in Enzymology 309 (1999) 746 –768, http://dx.doi.org/10.1016/s0076- 6879(99)09050-3 10507060 .",Non-OADS,/arxiv_data1/oa_pdf/f7/c2/main.PMC4099506.pdf
"Oliveira, Mitochondria dysfunc- tion of Alzheimer ’s disease cybrids enhances Abeta toxicity, Journal of Neurochemistry 89 (2004) 1417 –1426, http://dx.doi.org/10.1111/j.1471- 4159.2004.02438.x 15189344 .",Non-OADS,/arxiv_data1/oa_pdf/f7/c2/main.PMC4099506.pdf
"Davies, The DSCR1 (Adapt78) isoform 1 protein calcipressin 1 inhibits calcineurin and protects against acute calcium-mediated stress damage, including transient oxidative stress, FASEB Journal: Ofﬁcial Publication of the Federation of American Societies for ExperimentalBiology 16 (2002) 814 –824, http://dx.doi.org/10.1096/fj.01-0846com 12039863 .",Non-OADS,/arxiv_data1/oa_pdf/f7/c2/main.PMC4099506.pdf
"Powell, Anatomical correlates of the distribution of the pathological changes in the neocortex inAlzheimer disease, Proceedings of the National Academy of Sciences of the United States of America 82 (1985) 4531 –4534, http://dx.doi.org/10.1073/ pnas.82.13.4531 3859874 .",Non-OADS,/arxiv_data1/oa_pdf/f7/c2/main.PMC4099506.pdf
"The Alzheimer ’s disease Cooperative Study, New England Journal of Medicine 336 (1997) 1216 –1222, http://dx.doi.org/10.1056/ nejm199704243361704 9110909 .",Non-OADS,/arxiv_data1/oa_pdf/f7/c2/main.PMC4099506.pdf
"Guarino, Effect of vitamin E and memantine onfunctional decline in Alzheimer disease: the TEAM-AD VA cooperativerandomized trial, Journal of the American Medical Association 311 (2014) 33–44,http://dx.doi.org/10.1001/jama.2013.282834 24381967 .",Non-OADS,/arxiv_data1/oa_pdf/f7/c2/main.PMC4099506.pdf
"Ozer, Effects of vitamin E on peroxisome proliferator-activated receptor γand nuclear factor-erythroid 2-related factor 2 in hypercholesterolemia induced atherosclerosis, Free Radical Biology & Medicine (2014) , http://dx.doi.org/ 10.1016/j.freeradbiomed.2014.02.017 24583459 .",OADS,/arxiv_data1/oa_pdf/f7/c2/main.PMC4099506.pdf
"Berta, G. Poli, G. Leonarduzzi, Potentiation of amyloid- βpeptide neurotoxicity in human dental-pulp neuron-like cells by the membrane lipidperoxidation product 4-hydroxynonenal, Free Radical Biology & Medicine 53 (2012) 1708 –1717, http://dx.doi.org/10.1016/j.freeradbiomed.2012.08.581 22981873 .",Non-OADS,/arxiv_data1/oa_pdf/f7/c2/main.PMC4099506.pdf
"Nebreda, p38 αMAP kinase as a sensor of reactive oxygen species in tumorigenesis, Cancer Cell 11 (2007) 191 –205, http://dx.doi.org/10.1016/j.ccr.2006.12.013 17292829 .E.",OADS,/arxiv_data1/oa_pdf/f7/c2/main.PMC4099506.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
AccumulatingContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.04.003 2213-2317/ &2014 The Authors.,OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: 4-ONE, 4-oxo-2-nonenal; 4-HNE, 4-hydroxy-nonena; ApAP, acet- aminophen; ALDH2, aldehyde dehydrogenase-2; BHT, butylate hydroxytoluene; CL, cardiolipin cyt c cytochrome c; EAA-CL, epoxyalcohol-aldehyde-CL; ESI, electro- spray; ETC, electron transport chain; H 2O2, hydrogen peroxide; HODE, hydroxyoc- tadienoic acid; HpODE, hydroperoxyoctadecadienoic acid; KODE, keto-octadecadienoic acid; L 4CL, tetralinoleoyl cardiolipin; L 3OCL, trilinoleoyl oleoyl cardiolipin; LA, linoleic acid; LC –MS, liquid chromatography –mass spectrometry; LDLR/C0//C0, low density lipoprotein receptor knockout; M 4CL, tetramyristeoyl cardiolipin; MRM, multiple reaction monitoring; PHGPX, hospholipid hydroper-oxide glutathione peroxidase; Prdx3/Prx3, peroxiredoxin 3; PUFAs, Polyunsatu- rated fatty acids; ROS, reactive oxygen species ∗Correspondence to: Room 1826, New Life Science Building, 320 Yueyang Road, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences,Chinese Academy of Sciences, Shanghai 200031, China.",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"References [1] F. Gonzalvez, E. Gottlieb, Cardiolipin: setting the beat of apoptosis, Apoptosis: An international Journal on Programmed Cell Death 12 (5) (2007) 877 –885, http://dx.doi.org/10.1007/s10495-007-0718-8 17294083 .",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Abendschein, X. Han, et al., Myocardial regulation of lipidomic ﬂux by cardiolipin synthase: setting the beat for bioenergetic ef ﬁciency, Journal of Biological Chemistry 287 (30) (2012) 25086 –25097, http://dx.doi.",OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"[3] H. Yin, M. Zhu, Free radical oxidation of cardiolipin: chemical mechanisms, detection and implication in apoptosis, mitochondrial dysfunction and human diseases, Free Radical Research 46 (8) (2012) 959 –974, http://dx.doi.org/ 10.3109/10715762.2012.676642 22468920 .",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Belikova, A.A. Kapralov, V. Kini, et al., Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors, Nature Chemical Biology 1 (4) (2005) 223 –232, http://dx.doi.org/10.1038/nchem- bio727 16408039 .",OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Shrivastava, D. Mohammadyani, et al., Cardiolipin externa- lization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells, Nature Cell Biology 15 (10) (2013) 1197 –1205, http://dx.doi.org/10.1038/ncb2837 24036476 .",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Ruggiero, Role of cardiolipin peroxidation and Ca2þin mitochondrial dysfunction and disease, Cell Calcium 45 (6) (2009) 643 –650, http://dx.doi.org/10.1016/j.ceca.2009.03.012 19368971 .",OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Stoyanovsky, P. Wipf, P.M. Kochanek, et al., Cytochrome c/ cardiolipin relations in mitochondria: a kiss of death, Free Radical Biology and Medicine 46 (11) (2009) 1439 –1453, http://dx.doi.org/10.1016/j.freerad- biomed.2009.03.004 19285551 .H.",OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Porter, Free radical lipid peroxidation: mechanisms and analysis, Chemical Reviews 111 (10) (2011) 5944 –5972, http://dx.doi.org/ 10.1021/cr200084z 21861450 .",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Berliner, Role of phospholipid oxidation products in atherosclerosis, CirculationResearch 111 (6) (2012) 778 –799, http://dx.doi.org/10.1161/CIRCRE- SAHA.111.256859 22935534 .",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Marnett, Endogenous reactive intermediates as modulators of cell signaling and cell death, Chemical Research in Toxicology 19 (2) (2006) 173 –194, http://dx.doi.org/10.1021/tx050321u 16485894 .",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"[11] G. Poli, F. Biasi, G. Leonarduzzi, 4-Hydroxynonenal-protein adducts:a reliable biomarker of lipid oxidation in liver diseases, Molecular Aspects of Medicine 29 (1 –2) (2008) 67 –71, http://dx.doi.org/10.1016/j.mam.2007.09.016 18158180 .",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Kim, 4- Hydroxynonenal enhances CD36 expression on murine macrophages via p38MAPK-mediated activation of 5-lipoxygenase, Free Radical Biologyand Medi- cine 46 (5) (2009) 692 –698, http://dx.doi.org/10.1016/j.freerad- biomed.2008.12.013 19135147 .",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Brash, Routes to 4-hydroxynonenal: funda- mental issues in the mechanisms of lipid peroxidation, Journal of Biological Chemistry 283 (23) (2008) 15539 –15543, http://dx.doi.org/10.1074/jbc.",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Mechanisms of nonenzymatic transformationof the 9- and 13-hydroperoxides of linoleic acid to 4-hydroxyalkenals, Journal of Biological Chemistry 276 (24) (2001) 20831 –20838, http://dx.doi.org/ 10.1074/jbc.M101821200 11259420 .",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Masterson, S.S. Zinkel, et al., Acetaminophen inhibits cytochromec redox cycling induced lipid peroxidation, Biochemical and BiophysicalResearch Communications 423 (2) (2012) 224 –228, http://dx.doi.org/ 10.1016/j.bbrc.2012.05.058 22634010 .",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Brash, H. Yin, Formation of 4- hydroxynonenal from cardiolipin oxidation: intramolecular peroxyl radicaladdition and decomposition, Free Radical Biologyand Medicine 50 (1) (2011) 166 –178, http://dx.doi.org/10.1016/j.freeradbiomed.2010.10.709 21047551 .",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"[18] C. Frezza, S. Cipolat, L. Scorrano, Organelle isolation: functional mitochondria from mouse liver, muscle and cultured ﬁbroblasts, Nature Protocols 2 (2) (2007) 287 –295, http://dx.doi.org/10.1038/nprot.2006.478 17406588 .",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Mannella, S. J. Korsmeyer, A distinct pathway remodels mitochondrial cristae and mobi- lizes cytochrome c during apoptosis, Developmental Cell 2 (1) (2002) 55 –67, http://dx.doi.org/10.1016/S1534-5807(01)00116-2 11782314 .",OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"[22] A. Benedetti, M. Comporti, H. Esterbauer, Identi ﬁcation of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids, Biochimica et Biophysica Acta 620 (2) (1980) 281 –296, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Brash, Intermolecular peroxyl radical reactions during autoxidation of hydroxy and hydroperoxyarachidonic acids generate a novel series of epoxidized products, ChemicalResearch in Toxicology 21 (4) (2008) 895 –903, http://dx.doi.org/10.1021/ tx700357u 18324788 .",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Brash, Routes to 4-hydroxynonenal: funda- mental issues in the mechanisms of lipid peroxidation, Journal of Biological Chemistry 283 (23) (2008) 15539 –15543, http://dx.doi.org/10.1074/jbc.",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Oates, Determi- nants of the cellular speci ﬁcity of acetaminophen as an inhibitor of prosta- glandin H 2synthases, Proceedings of the National Academy of Sciences of theUnited States of America 99 (2002) 7130 –7135, http://dx.doi.org/10.1073/ pnas.102588199 12011469 .",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Masterson, T. Amin, D.W. Wright, et al., Acetaminophen inhibits hemoprotein-catalyzed lipid peroxidation and attenuates rhabdomyolysis- induced renal failure, Proceedings of the National Academy of Sciences of the United States of America 107 (6) (2010) 2699 –2704, http://dx.doi.org/ 10.1073/pnas.0910174107 20133658 .",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Belikova, A.A. Kapralov, V. Kini, et al., Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors, Nature Chemical Biology 1 (4) (2005) 223 –232, http://dx.doi.org/10.1038/nchem- bio727 16408039 .",OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Manole, A.M. Puccio, et al., Lipidomics identi ﬁes cardiolipin oxidation as a mitochondrial target for redox therapy of brain injury, Nature Neuroscience 15 (10) (2012) 1407 –1413, http://dx.doi.org/ 10.1038/nn.3195 22922784 .",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Marnett, 4-Hydroxynonenal induces apoptosis via caspase-3 activation and cytochrome c release, Chemical Research in Toxicology 14 (8) (2001) 1090 –1096, http://dx.doi.org/10.1021/ tx000186f 11511183 .",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"[31] J. Su, A.G. Frostegård, X. Hua, T. Gustafsson, T. Jogestrand, I. Hafström, J. Frostegård, Low levels of antibodies against oxidized but not nonoxidized cardiolipin and phosphatidylserine are associated with atherosclerotic plaques in systemic lupus erythematosus, Journal of Rheumatology 40 (11) (2013) 1856 –1864, http://dx.doi.org/10.3899/jrheum.121173 24037548 .",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Kagan, Targeting mitochondria, Accounts of Chemical Research 41 (1) (2008) 87 –97,http://dx.doi.org/10.1021/ ar700135m 18193822 .",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Kagan, Heterolytic reduction of fatty acid hydroperoxides by cytochrome c/cardiolipin complexes: antioxidant function in mitochondria, Journal of the American Chemical Society 131 (32) (2009) 11288 –11289, http://dx.doi.org/10.1021/ ja904343c 19627079 .",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Jang, D. Holstein, J. Lechleiter, T. McDonald-Marsh, A. Musatov, W. Song, H. Van Remmen, A. Richardson, Glutathione peroxidase 4 differentially regulates the release of apoptogenic proteins from mitochon- dria, Free Radical Biologyand Medicine 47 (3) (2009) 312 –320, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Morrow, Human biochemistry of the isoprostane pathway, Journal of Biological Chemistry 283 (23) (2008) 15533 –15537, http://dx.doi.org/10.1074/jbc.R700047200 18285331 .",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Roberts, Isoprostane generation and function, Chemical Reviews 111 (10) (2011) 5973 –5996, http://dx.doi.org/ 10.1021/cr200160h 21848345 .",OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Ran, Reduction of mitochondrial H 2O2by overexpressing peroxiredoxin 3 improves glucose tolerance in mice, Aging Cell 7 (6) (2008) 866 –878, http://dx.doi.org/10.1111/j.1474-9726.2008.00432.x 18778410 .",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Percival, Mechanism of acetaminophen inhibition of cycloox- ygenase isoforms, Archives of Biochemistry and Biophysics 387 (2) (2001) 273 –280, http://dx.doi.org/10.1006/abbi.2000.2232 11370851 .",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
"Masterson, T. Amin, D.W. Wright, et al., Acetaminophen inhibits hemoprotein-catalyzed lipid peroxidation and attenuates rhabdomyolysis- induced renal failure, Proceedings of the National Academy of Sciences of the United States of America 107 (6) (2010) 2699 –2704, http://dx.doi.org/ 10.1073/pnas.0910174107 20133658 .H.",Non-OADS,/arxiv_data1/oa_pdf/fb/68/main.PMC4099507.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/cc/main.PMC4099508.pdf
"Abbreviations: APE, atom percent enrichment; BSA, bovine serum albumin; CAC, citric acid cycle; FFA, free fatty acid; GC eMS, gas chromatography emass spectrometry; H 2DCFDA, 20,70-dichlor- odihydro ﬂuorescein diacetate; MFA, metabolic ﬂux analysis; MUFA, monounsaturated fatty acid; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; OA, oleate; PA, palmitate; PI, propidium iodide; ROS, reactive oxygen species; SERCA, sarcoplasmic-endoplasmic reticulum calcium ATPase; SFA, saturated fatty acid Received April 30, 2014 /C15Revision received May 12, 2014 /C15Accepted May 13, 2014 /C15Available online 22 May 2014 http://dx.doi.org/10.1016/j.molmet.2014.05.004 Original article 544MOLECULAR METABOLISM 3 (2014) 544 e553/C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/7b/cc/main.PMC4099508.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/cc/main.PMC4099508.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/cc/main.PMC4099508.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/cc/main.PMC4099508.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/cc/main.PMC4099508.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/cc/main.PMC4099508.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/cc/main.PMC4099508.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/cc/main.PMC4099508.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/cc/main.PMC4099508.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7b/cc/main.PMC4099508.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/cc/main.PMC4099508.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/cc/main.PMC4099508.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/ea/main.PMC4099509.pdf
"Non-standard abbreviations and acronyms: GLP-1, glucagon-like peptide-1; GLP-1R, glucagon-like peptide-1 receptor; tGLP-1, truncated forms of GLP-1 such as GLP-1(9 e36) or GLP-1(28 e36); HR, heart rate; LAD, left anterior descending; MI, myocardial infarction Received April 21, 2014 /C15Revision received April 27, 2014 /C15Accepted April 28, 2014 /C15Available online 9 May 2014 http://dx.doi.org/10.1016/j.molmet.2014.04.009 Original article MOLECULAR METABOLISM 3 (2014) 507 e517/C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/61/ea/main.PMC4099509.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/ea/main.PMC4099509.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/ea/main.PMC4099509.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/ea/main.PMC4099509.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/ea/main.PMC4099509.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/ea/main.PMC4099509.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/ea/main.PMC4099509.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/ea/main.PMC4099509.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/ea/main.PMC4099509.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/ea/main.PMC4099509.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found online at http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/61/ea/main.PMC4099509.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/ea/main.PMC4099509.pdf
http://dx.doi.org/10.2337/db13-1849 .,Non-OADS,/arxiv_data1/oa_pdf/61/ea/main.PMC4099509.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/ea/main.PMC4099509.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/13/main.PMC4099510.pdf
"Received April 23, 2014 /C15Revision received May 16, 2014 /C15Accepted May 20, 2014 /C15Available online 28 May 2014 http://dx.doi.org/10.1016/j.molmet.2014.05.005 Original article MOLECULAR METABOLISM 3 (2014) 531 e543/C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/9b/13/main.PMC4099510.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/13/main.PMC4099510.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/13/main.PMC4099510.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/13/main.PMC4099510.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/13/main.PMC4099510.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/13/main.PMC4099510.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/13/main.PMC4099510.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/13/main.PMC4099510.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/13/main.PMC4099510.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/13/main.PMC4099510.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/13/main.PMC4099510.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9b/13/main.PMC4099510.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/13/main.PMC4099510.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/13/main.PMC4099510.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/13/main.PMC4099510.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/b3/main.PMC4099511.pdf
"Received April 30, 2014 /C15Accepted May 6, 2014 /C15Available online 14 May 2014 http://dx.doi.org/10.1016/j.molmet.2014.05.001 Original article MOLECULAR METABOLISM 3 (2014) 581 e591/C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/eb/b3/main.PMC4099511.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/b3/main.PMC4099511.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/b3/main.PMC4099511.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/b3/main.PMC4099511.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/b3/main.PMC4099511.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/b3/main.PMC4099511.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/b3/main.PMC4099511.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/b3/main.PMC4099511.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/b3/main.PMC4099511.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/b3/main.PMC4099511.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/b3/main.PMC4099511.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/b3/main.PMC4099511.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/86/main.PMC4099512.pdf
"In adults, an AUC 0–24divided by the MIC for a given pathogen Z400 is considered to be the best predictor of vancomycin efﬁcacy.2,3During routine clinical care, vancomycin serum trough concentrations are used as a surrogate marker for AUC, aiming toContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/cuthreCurrent Therapeutic Research http://dx.doi.org/10.1016/j.curtheres.2014.06.001 0011-393X/ &2014.",Non-OADS,/arxiv_data1/oa_pdf/1b/86/main.PMC4099512.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/86/main.PMC4099512.pdf
http://www.kinderformularium.nl .,Non-OADS,/arxiv_data1/oa_pdf/1b/86/main.PMC4099512.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/78/main.PMC4099513.pdf
"Abbreviations: ACC, acetyl-CoA carboxylase; AMPK, AMP-activated protein kinase; ANT, adenine nucleotide translocase; Bhmt, betaine-homocysteine methyltransferase; C1, one-carbon; CACT, carnitine- acylcarnitine transporter; Cpt1a, carnitine palmitoyltransferase-1a; Cbs, cystathionine b-synthase; C, control diet; CMS, methyl-donor supplemented control diet; DIO, diet-induced obesity; Fasn, fatty acid synthase; Gapdh, glyceraldehyde 3-phosphate dehydrogenase; GNMT, glycine N-methyltransferase; HSP90, heat shock protein 90; HF, high-fat diet; HFMS, methyl-donor supplemented high-fat diet; HMW adiponectin, high molecular weight adiponectin; Hcy, homocysteine; b-HAD, b-hydroxyacyl CoA dehydrogenase; 3-HB, b-hydroxybutyrate; Hprt1, hypoxanthine phosphoribosyltransferase 1; LDL, low density lipoprotein; MAT, methionine adenosyltransferase; MCD, malonyl-CoA decarboxylase; MDS, methyl-donor supplementation; MTR, methionine synthase; NAFLD, non-alcoholic fatty liver disease;NEFA, non-esteri ﬁed fatty acids; PC, phosphatidylcholine; Pemt, phosphatidylethanolamine methyltransferase; PGC1a, peroxisome proliferator-activated receptor- gco-activator-1 a; PL, phospholipids; PPARa, peroxisome proliferator-activated receptor- a; SAH, S-adenosylhomocysteine; SAM, S-adenosylmethionine; SM, sphingomyelin; SREBP1c, sterol regulatory element-binding protein-1c; TG, tri- acylglycerol; VAT, visceral adipose tissue; VLDL, very low density lipoprotein Received March 18, 2014 /C15Revision received April 25, 2014 /C15Accepted April 30, 2014 /C15Available online 20 May 2014 http://dx.doi.org/10.1016/j.molmet.2014.04.010 Original article MOLECULAR METABOLISM 3 (2014) 565 e580/C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2e/78/main.PMC4099513.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/78/main.PMC4099513.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/78/main.PMC4099513.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/78/main.PMC4099513.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/78/main.PMC4099513.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/78/main.PMC4099513.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/78/main.PMC4099513.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/78/main.PMC4099513.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/78/main.PMC4099513.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/78/main.PMC4099513.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/78/main.PMC4099513.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/78/main.PMC4099513.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/78/main.PMC4099513.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/78/main.PMC4099513.pdf
SUPPORTING INFORMATION Supplementary data related to this article can be found online at http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2e/78/main.PMC4099513.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/78/main.PMC4099513.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/78/main.PMC4099513.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/78/main.PMC4099513.pdf
Venn diagram was created usingGoogle ( https://developers.google.com/chart/image/docs/ chart_wizard ).,OADS,/arxiv_data1/oa_pdf/6f/67/198_2014_Article_2720.PMC4099528.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5700 | DOI: 10.1038/srep05700 5",Non-OADS,/arxiv_data1/oa_pdf/99/3f/srep05700.PMC4099976.pdf
From the time tables of domestic flights in All Nippon Airways (http://www.ana.co.,Non-OADS,/arxiv_data1/oa_pdf/13/88/srep05522.PMC4099978.pdf
"jp) and Japan Airlines (http://www.jal.co.jp), we obtained the data about the total connectivity of the airline networks.",OADS,/arxiv_data1/oa_pdf/13/88/srep05522.PMC4099978.pdf
The data of the Japanese airport network were obtained from the timetables of domestic flights of All Nippon Airway (http://www.ana.co.jp) and Japan Airline (http://www.jal.co.jp).,OADS,/arxiv_data1/oa_pdf/13/88/srep05522.PMC4099978.pdf
Available at http://www.cdc.gov/oid/framework.,OADS,/arxiv_data1/oa_pdf/13/88/srep05522.PMC4099978.pdf
Available at http://www.who.int/csr/ outbreaknetwork/en/ (last accessed February 2 2014).,OADS,/arxiv_data1/oa_pdf/13/88/srep05522.PMC4099978.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/13/88/srep05522.PMC4099978.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/68/22/srep05704.PMC4099979.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/bb/40/srep05698.PMC4099980.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5698 | DOI: 10.1038/srep05698 8",Non-OADS,/arxiv_data1/oa_pdf/bb/40/srep05698.PMC4099980.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ea/e5/srep05701.PMC4099981.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2f/cc/srep05708.PMC4099982.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5708 | DOI: 10.1038/srep05708 6",Non-OADS,/arxiv_data1/oa_pdf/2f/cc/srep05708.PMC4099982.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/.0/),whichpermitsnon-commercialre-use,distribution,andreproductioninanymedium,providedtheoriginalworkisproperlycited.Forcom- mercial re-use, please contact journals.permissions@oup.com4",Non-OADS,/arxiv_data1/oa_pdf/44/45/rrt224.PMC4099985.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/.0/),whichpermitsnon-commercialre-use,distribution,andreproductioninanymedium,providedtheoriginalworkisproperlycited.For commercial re-use, please contact journals.permissions@oup.com4",Non-OADS,/arxiv_data1/oa_pdf/07/4d/rrt227.PMC4099987.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/.0/),whichpermitsnon-commercialre-use,distribution,andreproductioninanymedium,providedtheoriginalworkisproperlycited.Forcom- mercial re-use, please contact journals.permissions@oup.com4",Non-OADS,/arxiv_data1/oa_pdf/c3/b2/rrt232.PMC4099990.pdf
http://www.nccn.,Non-OADS,/arxiv_data1/oa_pdf/c3/b2/rrt232.PMC4099990.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/.0/),whichpermitsnon-commercialre-use,distribution,andreproductioninanymedium,providedtheoriginalworkisproperlycited.Forcom- mercial re-use, please contact journals.permissions@oup.com4",Non-OADS,/arxiv_data1/oa_pdf/17/62/rru008.PMC4100000.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/.0/),whichpermitsnon-commercialre-use,distribution,andreproductioninanymedium,providedtheoriginalworkisproperlycited.Forcom- mercial re-use, please contact journals.permissions@oup.com4",Non-OADS,/arxiv_data1/oa_pdf/bd/25/rru011.PMC4100003.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/.0/),whichpermitsnon-commercialre-use,distribution,andreproductioninanymedium,providedtheoriginalworkisproperlycited.Forcom- mercial re-use, please contact journals.permissions@oup.com4",Non-OADS,/arxiv_data1/oa_pdf/77/63/rru013.PMC4100005.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/.0/),whichpermitsnon-commercialre-use,distribution,andreproductioninanymedium,providedtheoriginalworkisproperlycited.Forcommercial re-use, please contact journals.permissions@oup.com4",Non-OADS,/arxiv_data1/oa_pdf/25/ad/rru014.PMC4100006.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/97/45/srep05699.PMC4100015.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5699 | DOI: 10.1038/srep05699 6",Non-OADS,/arxiv_data1/oa_pdf/97/45/srep05699.PMC4100015.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/49/aa/srep05696.PMC4100016.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5696 | DOI: 10.1038/srep05696 8",Non-OADS,/arxiv_data1/oa_pdf/49/aa/srep05696.PMC4100016.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5362 | DOI: 10.1038/srep05362 6",Non-OADS,/arxiv_data1/oa_pdf/0c/47/srep05362.PMC4100017.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/28/ad/srep05712.PMC4100018.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5712 | DOI: 10.1038/srep05712 8",Non-OADS,/arxiv_data1/oa_pdf/28/ad/srep05712.PMC4100018.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/53/e5/srep05710.PMC4100020.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5710 | DOI: 10.1038/srep05710 8",Non-OADS,/arxiv_data1/oa_pdf/53/e5/srep05710.PMC4100020.pdf
URL http://dx.doi.org/10.1038/35019019.,Non-OADS,/arxiv_data1/oa_pdf/78/c9/srep05659.PMC4100021.pdf
"9780199211517 in OUP Catalogue (Oxford University Press, 2007).URL http://ideasrepec.org/b/oxp/obooks/9780199211517.html.",Non-OADS,/arxiv_data1/oa_pdf/78/c9/srep05659.PMC4100021.pdf
"Science 326, 943–944 (2009).URL http://www.sciencemag.org/content/326/5955/943.short http://www.sciencemag.org/content/326/5955/943.full.pdf.",Non-OADS,/arxiv_data1/oa_pdf/78/c9/srep05659.PMC4100021.pdf
"5094 of Lecture Notes in Computer Science , 283–296 (Springer Berlin Heidelberg, 2008).URL http://dxdoi.org/10.1007/978-3-540-70567-3_22.",Non-OADS,/arxiv_data1/oa_pdf/78/c9/srep05659.PMC4100021.pdf
URL http://www.sciencedirect.,Non-OADS,/arxiv_data1/oa_pdf/78/c9/srep05659.PMC4100021.pdf
URL http://dx.doi.org/10.1038/nprot.2010.182.,OADS,/arxiv_data1/oa_pdf/78/c9/srep05659.PMC4100021.pdf
URL http://dx.doi.org/10.1038/nrg2344.,OADS,/arxiv_data1/oa_pdf/78/c9/srep05659.PMC4100021.pdf
URL http://dx.doi.org/10.1038/nrg1916.,OADS,/arxiv_data1/oa_pdf/78/c9/srep05659.PMC4100021.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/78/c9/srep05659.PMC4100021.pdf
"Genotyping .We searched the National Center for Biotechnology Information (NCBI) SNP database (dbSNP; http://www.ncbi.nlm.nih.gov/snp/) and related literature to identify mSNPs from the DPD, TP, TS andENOSF1 genes.",OADS,/arxiv_data1/oa_pdf/21/36/srep05697.PMC4100023.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/21/36/srep05697.PMC4100023.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.How to cite this article: Wang, W.J.",Non-OADS,/arxiv_data1/oa_pdf/b7/8f/srep05711.PMC4100030.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f3/1a/srep05706.PMC4100031.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Figure 6 |(A) FTIR transmission spectrum of diluted ( a(‘)50.8%) ferrofluid exhibits clear set of kerosene absorption lines.",Non-OADS,/arxiv_data1/oa_pdf/f3/1a/srep05706.PMC4100031.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(6) 1–7 DOI: 10.1177/2042533313514048",Non-OADS,/arxiv_data1/oa_pdf/a3/3f/10.1177_2042533313514048.PMC4100222.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(6) 1–4 DOI: 10.1177/2054270414523409",Non-OADS,/arxiv_data1/oa_pdf/d3/73/10.1177_2054270414523409.PMC4100223.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(6) 1–3 DOI: 10.1177/2054270414527280",Non-OADS,/arxiv_data1/oa_pdf/c5/77/10.1177_2054270414527280.PMC4100224.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(6) 1–4 DOI: 10.1177/2054270414527937",Non-OADS,/arxiv_data1/oa_pdf/34/d6/10.1177_2054270414527937.PMC4100225.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(6) 1–3 DOI: 10.1177/2054270414531125",Non-OADS,/arxiv_data1/oa_pdf/37/51/10.1177_2054270414531125.PMC4100226.pdf
"London: BMJ Group and Pharmaceutical Press, http://www.medicinescomplete.com (accessed on 27 February 2014).",Non-OADS,/arxiv_data1/oa_pdf/37/51/10.1177_2054270414531125.PMC4100226.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(6) 1–3 DOI: 10.1177/2054270414531126",Non-OADS,/arxiv_data1/oa_pdf/6c/af/10.1177_2054270414531126.PMC4100227.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(6) 1–7 DOI: 10.1177/2054270414531127",Non-OADS,/arxiv_data1/oa_pdf/f7/30/10.1177_2054270414531127.PMC4100228.pdf
(http://onlinelibrary.wiley.com/doi/10.1111/j.1440- 1843.2006.00873.x/abstract?deniedAccessCustomisedMessage=&userIsAuthenticated=false (accessed September 2012).3.,Non-OADS,/arxiv_data1/oa_pdf/f7/30/10.1177_2054270414531127.PMC4100228.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(7) 1–8 DOI: 10.1177/2042533313515863",Non-OADS,/arxiv_data1/oa_pdf/f4/15/10.1177_2042533313515863.PMC4100229.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(7) 1–3 DOI: 10.1177/2054270414527281",Non-OADS,/arxiv_data1/oa_pdf/5d/ac/10.1177_2054270414527281.PMC4100230.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/3d/39/10.1177_2054270414527935.PMC4100231.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(7) 1–5 DOI: 10.1177/2054270414528898",Non-OADS,/arxiv_data1/oa_pdf/f5/73/10.1177_2054270414528898.PMC4100232.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(7) 1–3 DOI: 10.1177/2054270414531120",Non-OADS,/arxiv_data1/oa_pdf/31/b3/10.1177_2054270414531120.PMC4100233.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(7) 1–2 DOI: 10.1177/2054270414531122",Non-OADS,/arxiv_data1/oa_pdf/0f/bd/10.1177_2054270414531122.PMC4100234.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(7) 1–2 DOI: 10.1177/2054270414533324",Non-OADS,/arxiv_data1/oa_pdf/20/b6/10.1177_2054270414533324.PMC4100235.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(8) 1–6 DOI: 10.1177/2054270414527933",Non-OADS,/arxiv_data1/oa_pdf/87/0a/10.1177_2054270414527933.PMC4100236.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(8) 1–5 DOI: 10.1177/2054270414531121",Non-OADS,/arxiv_data1/oa_pdf/fc/00/10.1177_2054270414531121.PMC4100237.pdf
See http://www.siemens.com/diagnostics (lastchecked 22 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/fc/00/10.1177_2054270414531121.PMC4100237.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(8) 1–3 DOI: 10.1177/2054270414533322",Non-OADS,/arxiv_data1/oa_pdf/ef/41/10.1177_2054270414533322.PMC4100238.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(8) 1–7 DOI: 10.1177/2054270414533323",Non-OADS,/arxiv_data1/oa_pdf/44/b4/10.1177_2054270414533323.PMC4100239.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(8) 1–12 DOI: 10.1177/2054270414533325",Non-OADS,/arxiv_data1/oa_pdf/f4/a8/10.1177_2054270414533325.PMC4100240.pdf
See http://www.nhshistory.net/chapter_4.htm (last checked 22 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/f4/a8/10.1177_2054270414533325.PMC4100240.pdf
See https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/213823/ dh_117794.pdf (last checked 22 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/f4/a8/10.1177_2054270414533325.PMC4100240.pdf
See http://www.cqc.org.uk/public/hospital-intelligent- monitoring (last checked 22 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/f4/a8/10.1177_2054270414533325.PMC4100240.pdf
See http://www.qie.eoe.nhs.uk/qualityprofiles/qpindex.aspx (last checked 29 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/f4/a8/10.1177_2054270414533325.PMC4100240.pdf
See https://www.primarycare.nhs.uk/ (lastchecked 22 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/f4/a8/10.1177_2054270414533325.PMC4100240.pdf
See https://www.primarycare.nhs.uk/ 14.,Non-OADS,/arxiv_data1/oa_pdf/f4/a8/10.1177_2054270414533325.PMC4100240.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(8) 1–11 DOI: 10.1177/2054270414533326",Non-OADS,/arxiv_data1/oa_pdf/b5/73/10.1177_2054270414533326.PMC4100241.pdf
See http://www.ons.,Non-OADS,/arxiv_data1/oa_pdf/b5/73/10.1177_2054270414533326.PMC4100241.pdf
See https://www.gov.uk/government/ uploads/system/uploads/attachment_data/file/98121/ alcohol-strategy.pdf (last checked 16 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/b5/73/10.1177_2054270414533326.PMC4100241.pdf
See https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/181103/Living_well_for_ longer.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/73/10.1177_2054270414533326.PMC4100241.pdf
See http://www.ons.gov.uk/ons/rel/subnational-health4/alcohol-related-deaths-in-the- united-kingdom/2011/alcohol- related-deaths-in-the-uk–2011.html (last checked 21 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/b5/73/10.1177_2054270414533326.PMC4100241.pdf
See http://data.gov.uk/ dataset/index_of_multiple_deprivation_imd_2007 (last checked 12 December 2012).,Non-OADS,/arxiv_data1/oa_pdf/b5/73/10.1177_2054270414533326.PMC4100241.pdf
See http://www.hscic.gov.uk/ datalinkage (last checked 21 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/b5/73/10.1177_2054270414533326.PMC4100241.pdf
See http://www.ons.gov.uk/ons/publications/re-reference- tables.html?edition ¼tcm%3A77-274529 (last checked 4 June 2013).,Non-OADS,/arxiv_data1/oa_pdf/b5/73/10.1177_2054270414533326.PMC4100241.pdf
See http://www.rcpsych.,Non-OADS,/arxiv_data1/oa_pdf/b5/73/10.1177_2054270414533326.PMC4100241.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).Journal of the Royal Society of Medicine Open; 5(8) 1–5 DOI: 10.1177/2054270414536550",Non-OADS,/arxiv_data1/oa_pdf/6a/44/10.1177_2054270414536550.PMC4100242.pdf
"Thez-scores for height and BMI were calculated using the 2007 WHO growth reference data for chil-dren and adolescents, using WHO AnthroPlus soft-ware (http://www.who.int/growthref/tools/) 5This enabled us to calculate a z-score for each student and then to characterise them as underweight(z-score </C02), healthy or normal weight ( z-score /C02 to 1), overweight ( z-score þ1 to 2) or obese (z-score >2).",Non-OADS,/arxiv_data1/oa_pdf/6a/44/10.1177_2054270414536550.PMC4100242.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/4a/42/IJPsyM-36-246.PMC4100408.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/4b/dd/IJPsyM-36-255.PMC4100409.pdf
Available from:  http://www.blog.nielson.com/nielsonwire/wp-content/  [Last accessed on Jan 2013].,Non-OADS,/arxiv_data1/oa_pdf/37/91/IJPsyM-36-260.PMC4100410.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/d2/cb/IJPsyM-36-270.PMC4100412.pdf
Available from: http://www.priory.com/ psychiatry/telepsychiatry.htm.,Non-OADS,/arxiv_data1/oa_pdf/b8/8a/IJPsyM-36-299.PMC4100417.pdf
Available from: http://www.csi-india.org.,Non-OADS,/arxiv_data1/oa_pdf/b8/8a/IJPsyM-36-299.PMC4100417.pdf
Available from:  http://www.apps.who.int/iris/bitstream/10665/20378/1/ WHA58_28-en.pdf.,OADS,/arxiv_data1/oa_pdf/b8/8a/IJPsyM-36-299.PMC4100417.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/94/db/IJPsyM-36-312.PMC4100421.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/94/db/IJPsyM-36-312.PMC4100421.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/29/ea/srep05702.PMC4100542.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5702 | DOI: 10.1038/srep05702 5",Non-OADS,/arxiv_data1/oa_pdf/29/ea/srep05702.PMC4100542.pdf
Open AccessK Gunganah and others Treatment of recurrent pancreatitis in FHHID: 14-0050; July 2014 DOI: 10.1530/EDM-14-0050 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2014 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd,Non-OADS,/arxiv_data1/oa_pdf/21/91/edmcr-2014-140050.PMC4100598.pdf
K Gunganah and others Treatment of recurrent pancreatitis in FHHID: 14-0050; July 2014 DOI: 10.1530/EDM-14-0050 http://www.edmcasereports.com 2,Non-OADS,/arxiv_data1/oa_pdf/21/91/edmcr-2014-140050.PMC4100598.pdf
(doi:10.1186/1752-1947-5-564 ) Received in ﬁnal form 26 May 2014 Accepted 2 July 2014 K Gunganah and others Treatment of recurrent pancreatitis in FHHID: 14-0050; July 2014 DOI: 10.1530/EDM-14-0050 http://www.edmcasereports.com 3,Non-OADS,/arxiv_data1/oa_pdf/21/91/edmcr-2014-140050.PMC4100598.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9c/7d/pgpm-7-137.PMC4100688.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPharmacogenomics and Personalized Medicine 2014:7 137–144Pharmacogenomics and Personalized Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  137Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PGPM.S4758 2Targeting metastatic colorectal cancer – present  and emerging treatment options Kristen K Ciombor1 Jordan Berlin2 1Division of Medical Oncology,   Department of Medicine, The Ohio  State University Comprehensive  Cancer Center, Columbus, OH, USA;   2Division of Hematology/Oncology,   Department of Medicine, vanderbilt- ingram Cancer Center, Nashville,    TN, USA Correspondence: Jordan Berlin   Division of Hematology/Oncology,  Department of Medicine, vanderbilt- ingram Cancer Center,  777 Preston  Research Building,  2220 Pierce Avenue,  Nashville, TN  37232, USA   Tel +1 615 322 4967  Fax +1 615 343 7602  email j ordan.berlin@vanderbilt.ed uAbstract:  Metastatic colorectal cancer is a significant cause of morbidity and mortality in  the US and around the world.",Non-OADS,/arxiv_data1/oa_pdf/9c/7d/pgpm-7-137.PMC4100688.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype  on pharmacology leading to the development of personalized treatment  programs and individualized drug selection for improved safety, efficacy  and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/9c/7d/pgpm-7-137.PMC4100688.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/9c/7d/pgpm-7-137.PMC4100688.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/34/32/pgpm-7-145.PMC4100727.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpPharmacogenomics and Personalized Medicine 2014:7 145–162Pharmacogenomics and Personalized Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  145Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/PGPM.S6371 5Pharmacogenomic knowledge gaps   and educational resource needs among   physicians in selected specialties Katherine a Johansen Taber Barry D Dickinson Department of science and  Biotechnology, american Medical  association, chicago, il, Usa correspondence: Katherine a   Johansen Taber   Department of science and  Biotechnology, american Medical  association, suite  39300,   330 north Wabash avenue,   chicago, il  60611, Usa   Tel +1 312 464 4964  email katherine.johansen@ama-assn.or gBackground:  The use of pharmacogenomic testing in the clinical setting has the potential to  improve the safety and effectiveness of drug therapy, yet studies have revealed that physicians  lack knowledge about the topic of pharmacogenomics, and are not prepared to implement it in  the clinical setting.",Non-OADS,/arxiv_data1/oa_pdf/34/32/pgpm-7-145.PMC4100727.pdf
Available from: http://osp.od.nih.,Non-OADS,/arxiv_data1/oa_pdf/34/32/pgpm-7-145.PMC4100727.pdf
"Available from: http://www.fda.gov/drugs/ scienceresearch/researchareas/pharmacogenetics/ucm083378.ht m.  Accessed March  5, 2014.",Non-OADS,/arxiv_data1/oa_pdf/34/32/pgpm-7-145.PMC4100727.pdf
"Available from: http://www.genomeweb.com/ dxpgx/fdaama-launch-free-online-course-aiming-improve-basic-pgx- literac y. Accessed March  5, 2014.",Non-OADS,/arxiv_data1/oa_pdf/34/32/pgpm-7-145.PMC4100727.pdf
Available from: http://www.pharmacytimes.com/publications/ issue/2013/July2013/Top-200-Drugs-of-201 2.,Non-OADS,/arxiv_data1/oa_pdf/34/32/pgpm-7-145.PMC4100727.pdf
Available from: http://medicine.iupui.edu/clinpharm/ ddis/main- table.,Non-OADS,/arxiv_data1/oa_pdf/34/32/pgpm-7-145.PMC4100727.pdf
"Available from: http://www.pharmgkb.or g. Accessed March  5, 2014.",Non-OADS,/arxiv_data1/oa_pdf/34/32/pgpm-7-145.PMC4100727.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype  on pharmacology leading to the development of personalized treatment  programs and individualized drug selection for improved safety, efficacy  and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/34/32/pgpm-7-145.PMC4100727.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/34/32/pgpm-7-145.PMC4100727.pdf
Available from: http://clinicaltrials.gov/show/NCT00004451  NLM Identifier: NCT02056821 .,Non-OADS,/arxiv_data1/oa_pdf/19/2d/wjem-15-345.PMC4100822.pdf
Available at: http://www.doh.wa.gov/ehp/sf/BiotoxinProgram.htm.,Non-OADS,/arxiv_data1/oa_pdf/99/61/wjem-15-378.PMC4100837.pdf
Available at: http://www.americanpyro.com/industry.html.,Non-OADS,/arxiv_data1/oa_pdf/c1/6d/wjem-15-387.PMC4100840.pdf
Available at: http://www.atf.gov/publications/ factsheets/factsheet-fireworks.html.,Non-OADS,/arxiv_data1/oa_pdf/c1/6d/wjem-15-387.PMC4100840.pdf
Available at: http://www.fda.gov/downloads/Drugs/DrugSafety/ UCM277384.pdf.,Non-OADS,/arxiv_data1/oa_pdf/42/50/wjem-15-395.PMC4100842.pdf
Available at:  http://www.hc-sc.ca/dhp-mps/medeff/bulletin/carn-bcei_v18nl-eng.,Non-OADS,/arxiv_data1/oa_pdf/42/50/wjem-15-395.PMC4100842.pdf
Alliance for Clinical Education available at; http://www.allianceforclinical - education.org/ .,Non-OADS,/arxiv_data1/oa_pdf/e5/15/wjem-15-398.PMC4100843.pdf
Available at; http://www.allianceforclinicaleducation.,Non-OADS,/arxiv_data1/oa_pdf/e5/15/wjem-15-398.PMC4100843.pdf
Available at: http://www.downstate.edu/emergency_ medicine/geriatrics.html.,Non-OADS,/arxiv_data1/oa_pdf/e1/77/wjem-15-409.PMC4100845.pdf
Available at:  http://www.acgme.org Last accessed 6th February 2012.,Non-OADS,/arxiv_data1/oa_pdf/e1/77/wjem-15-409.PMC4100845.pdf
Available at: http://www.abem.org  Last accessed 10th February 2012.,Non-OADS,/arxiv_data1/oa_pdf/e1/77/wjem-15-409.PMC4100845.pdf
"Available at: http://www.healthypeople.gov/ , Last accessed  November 27, 2011.",Non-OADS,/arxiv_data1/oa_pdf/1d/0b/wjem-15-438.PMC4100850.pdf
"INTRODUCTION Sickle cell disease (SCD) is a painful, chronic, genetic  condition that affects 90,000-100,000 individuals in the U.S.1  and shortens life expectancy to around 40 years.2-5 While  there is wide variation in the use patterns of healthcare by  SCD patients, particularly of emergency department (ED)  care, there is also substantial evidence of generally poor  quality of care for SCD patients in the ED.6-8 The Emergency  Department Sickle Cell Assessment of Needs and Strengths Duke University School of Medicine, Duke Medical Center, Department of  Surgery, Division of Emergency Medicine, Durham, North Carolina Northwestern University, Feinberg School of Medicine, Ann and Robert H. Lurie  Children’s Hospital of Chicago, Chicago, Illinois Wake Forest School of Medicine, Department of Emergency Medicine, Winston- Salem, North Carolina Duke School of Nursing, Duke University Medical Center, Durham, North  Carolina* † ‡ § (ED-SCANS, http://sickleemergency.duke.edu/) was  developed as a quality improvement (QI) framework for seven  key clinical processes of SCD ED care.",Non-OADS,/arxiv_data1/oa_pdf/28/af/wjem-15-446.PMC4100851.pdf
The  ED-SCANS is a decision support tool developed as a quality  improvement framework to address the complex healthcare needs  of SCD patients in the ED; it is comprised of seven algorithms  (http://sickleemergency.duke.edu/).10 The ED-SCANS can be  used to guide the clinical management of individual SCD patients  in the ED and develop best practice protocols to support their  care in that setting.,OADS,/arxiv_data1/oa_pdf/28/af/wjem-15-446.PMC4100851.pdf
4 : July 2014 Application of a Proactive Risk Analysis  Thornton et alReferrals The ED-SCANS recommends a brief psychosocial  assessment to identify unmet needs of patients who might  benefit from follow-up services after discharge to the  community (http://sickleemergency.duke.edu/sites/default/ files/ED-Scans_Adult-Algorithms.pdf).,Non-OADS,/arxiv_data1/oa_pdf/28/af/wjem-15-446.PMC4100851.pdf
"http://www.cdc.gov/nchs/ahcd/web_ tables.htm#2009 , accessed March 28, 2012.",OADS,/arxiv_data1/oa_pdf/8c/49/wjem-15-471.PMC4100854.pdf
Available at: http://www.acep.org/Content.,Non-OADS,/arxiv_data1/oa_pdf/8e/d8/wjem-15-480.PMC4100855.pdf
Available at: http://www.cdc.gov/ncidod/dhqp/ ar_mrsa_ca.html.,OADS,/arxiv_data1/oa_pdf/c9/1e/wjem-15-491.PMC4100857.pdf
Available at: http://www.cdc.gov/nchs/ahcd/about_ahcd.htm.,OADS,/arxiv_data1/oa_pdf/c9/1e/wjem-15-491.PMC4100857.pdf
Available at: http://ems.gov/pdf/2011/National_EMS_ Assessment_Final_Draft_12202011.pdf .,Non-OADS,/arxiv_data1/oa_pdf/4f/10/wjem-15-504.PMC4100859.pdf
Available at: http://www.psnet.ahrq.gov/ primer.aspx?primerID=9 .,Non-OADS,/arxiv_data1/oa_pdf/4f/10/wjem-15-504.PMC4100859.pdf
Available at http://www.acphospitalist.org/ archives/2009/07/handoffs.htm .,Non-OADS,/arxiv_data1/oa_pdf/4f/10/wjem-15-504.PMC4100859.pdf
Available at: http://kff.org/other/state-indicator/ total-hmo-enrollment/.,Non-OADS,/arxiv_data1/oa_pdf/b1/d8/wjem-15-518.PMC4100861.pdf
Available at: http://www.dmhc.ca.gov/,Non-OADS,/arxiv_data1/oa_pdf/b1/d8/wjem-15-518.PMC4100861.pdf
Available  at: http://www.chcf.org/publications/2009/04/unexpected-charges-what- states-are-doing-about-balance-billing.,Non-OADS,/arxiv_data1/oa_pdf/b1/d8/wjem-15-518.PMC4100861.pdf
Available at: http://www.dmhc.ca.gov/healthplans/rep/ rep_rbo.aspx.,Non-OADS,/arxiv_data1/oa_pdf/b1/d8/wjem-15-518.PMC4100861.pdf
Available at: https://wpso.dmhc.ca.gov/secure/auth/default.,OADS,/arxiv_data1/oa_pdf/b1/d8/wjem-15-518.PMC4100861.pdf
Available from http://wpso.dmhc.ca.gov/enfactions/ actionSearch.aspx.,OADS,/arxiv_data1/oa_pdf/b1/d8/wjem-15-518.PMC4100861.pdf
Available at: http://articles.latimes.,Non-OADS,/arxiv_data1/oa_pdf/b1/d8/wjem-15-518.PMC4100861.pdf
Available at: http://www.dmhc.ca.gov/HealthPlans/enf/ enf_default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/b1/d8/wjem-15-518.PMC4100861.pdf
Available  at: http://www.naic.org/documents/legal_ama_settlement.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b1/d8/wjem-15-518.PMC4100861.pdf
Available at: http://www.leginfo.,Non-OADS,/arxiv_data1/oa_pdf/b1/d8/wjem-15-518.PMC4100861.pdf
"For example, the Baltimore-based Thunderbirds MC  answers to the Pagans MC.8,9 The Hells Angels, Bandidos, Mongols (Figure 2),  Outlaws, Sons of Silence, and Pagans MCs are the most  powerful OMGs.7 Statistics regarding membership for these  clubs can be found at http://www.justice.gov/criminal/ocgs/ gangs/motorcycle.html .",Non-OADS,/arxiv_data1/oa_pdf/16/44/wjem-15-523.PMC4100862.pdf
"However, not all  clubs will have such websites (e.g., Pagans MC): •	Bandidos MC: http://www.bandidosmc.com •	Hells Angels MC: http://www.hells-angels.com •	Outlaws MC: http://wwww.outlawsmc.com •	Sons of Silence MC: http://www.sonsofsilence.com  •	Mongols MC: http://www.mongolsmc.com In addition, links to the websites of major OMGs can be  found at http://www.bikernews.org/wtn/news.php.",Non-OADS,/arxiv_data1/oa_pdf/16/44/wjem-15-523.PMC4100862.pdf
Available at: http://www.physiciansweekly.com/emergency- department-violence-prevention/.,Non-OADS,/arxiv_data1/oa_pdf/16/44/wjem-15-523.PMC4100862.pdf
Available at : http://www.campussafetymagazine.com/Channel/ Hospital-Security/Articles/Print/Story/2012/06/Gangs-Healthcare- Security-Preparation-Education-Are-the-Keys.aspx.,Non-OADS,/arxiv_data1/oa_pdf/16/44/wjem-15-523.PMC4100862.pdf
Available at: http://www.chosenfewmc.org/.,Non-OADS,/arxiv_data1/oa_pdf/16/44/wjem-15-523.PMC4100862.pdf
Available at: http://blackmotorcycleclubs.net/index.php/ black-motorcycle-clubs.,Non-OADS,/arxiv_data1/oa_pdf/16/44/wjem-15-523.PMC4100862.pdf
Available at: http://www.abc22now.com/shared/,Non-OADS,/arxiv_data1/oa_pdf/16/44/wjem-15-523.PMC4100862.pdf
Available from: http://www.telegraph.co.uk/news/uknews/ law-and-order/5579341/Hells-Angels-and-Outlaws-biker-gangs-jailed- for-airport-riot.html.,Non-OADS,/arxiv_data1/oa_pdf/16/44/wjem-15-523.PMC4100862.pdf
"We collected  information on state-level insurance rates was from the U.S.  Census Bureau’s 2009 Current Population Survey Annual  Social and Economic Supplements (http://www.census.gov   accessed October 29, 2012).",OADS,/arxiv_data1/oa_pdf/2c/7f/wjem-15-529.PMC4100863.pdf
Available at: http://www.cdc.gov/nchs/data/ahcd/ NHAMCS_Factsheet_ED_2009.pdf.,OADS,/arxiv_data1/oa_pdf/2c/7f/wjem-15-529.PMC4100863.pdf
Available at: http://www.coverageforall.org/pdf/BC-BS_Un - insured-America.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2c/7f/wjem-15-529.PMC4100863.pdf
Available at:  http://ccf.georgetown.edu/ccf-resources/despite-economic-challeng - es-progress-continues-childrens-health-insurance-coverage-in-the- united-states-from-2008-2010.,Non-OADS,/arxiv_data1/oa_pdf/2c/7f/wjem-15-529.PMC4100863.pdf
Available at: http://www.healthaffairs.org/healthpolicybriefs/brief.,Non-OADS,/arxiv_data1/oa_pdf/2c/7f/wjem-15-529.PMC4100863.pdf
Avail - able at: http://www.healthcarefinancenews.com/news/eligibility-quiz- saves-san-diego-hospitals-millions-self-pay-revenue.,Non-OADS,/arxiv_data1/oa_pdf/2c/7f/wjem-15-529.PMC4100863.pdf
Avail - able at: http://www.cbo.gov/publication/43472.,Non-OADS,/arxiv_data1/oa_pdf/2c/7f/wjem-15-529.PMC4100863.pdf
September 2010. http://www.census.gov/prod/2011pubs/p60-239.pdf .,OADS,/arxiv_data1/oa_pdf/2c/7f/wjem-15-529.PMC4100863.pdf
Available at: http://www.cdc.gov/nchs/data/ahcd/nhamcs_ emergency/2009_ed_web_tables.pdf.,OADS,/arxiv_data1/oa_pdf/2c/7f/wjem-15-529.PMC4100863.pdf
Available at: http://www.acep.org/WorkArea/ DownloadAsset.aspx?id=32878.,Non-OADS,/arxiv_data1/oa_pdf/9b/d4/wjem-15-536.PMC4100864.pdf
Available at: http://archive.ahrq.gov/ clinic/ptsafety/.,OADS,/arxiv_data1/oa_pdf/9b/d4/wjem-15-536.PMC4100864.pdf
Available at: http://www.ahrq.gov/clinic/ptsafety/chap21.,Non-OADS,/arxiv_data1/oa_pdf/9b/d4/wjem-15-536.PMC4100864.pdf
Available at: http://www.cdc.gov/growthcharts/charts.htm.,OADS,/arxiv_data1/oa_pdf/02/87/wjem-15-554.PMC4100867.pdf
CDC Website.Available at: http://www.cdc.gov/nchs/data/hestat/obesity_child_07_08/ obesity_child_07_08.htm.,Non-OADS,/arxiv_data1/oa_pdf/02/87/wjem-15-554.PMC4100867.pdf
Available at:  http://healthyamericans.org/reports/drugabuse2013/release.,Non-OADS,/arxiv_data1/oa_pdf/c1/06/wjem-15-561.PMC4100869.pdf
"Available at: http://migration.kentucky.gov/ newsroom/governor/20130305hb217.htm Accessed January 5, 2014.",Non-OADS,/arxiv_data1/oa_pdf/c1/06/wjem-15-561.PMC4100869.pdf
Available at: http://www.justice.gov/dea/,Non-OADS,/arxiv_data1/oa_pdf/c1/06/wjem-15-561.PMC4100869.pdf
Available at http://www.kentucky.com.,Non-OADS,/arxiv_data1/oa_pdf/c1/06/wjem-15-561.PMC4100869.pdf
Available at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c1/06/wjem-15-561.PMC4100869.pdf
Available at http://californiawatch.org/health-and- welfare/rise-young-painkiller-abusers-officials-see-more-heroin- overdoses-17550.,Non-OADS,/arxiv_data1/oa_pdf/c1/06/wjem-15-561.PMC4100869.pdf
2003  http://www.who.int/chp/knowledge/publications /adherence_report/en/ (accessed 3-29-2014).,Non-OADS,/arxiv_data1/oa_pdf/c9/1f/pharmpract-12-378.PMC4100947.pdf
"Available from:  http://www.who.int/patientsafety/implementation/amr/publication/en/index.html  (accessed April 8, 2014)  2.",Non-OADS,/arxiv_data1/oa_pdf/6b/d4/pharmpract-12-384.PMC4100948.pdf
"Available at: http://www.hwa.gov.au/ sites/uploads/FinalReport_Volume1_FINAL-20120424.pdf  (Accessed October 24, 2012).",Non-OADS,/arxiv_data1/oa_pdf/8d/8b/pharmpract-12-392.PMC4100949.pdf
"Available at:  http://www.guild.org.au/The_Guild/tab- TheGuild/Community_Pharmacy_Agreements/Communi ty+Pharmacy+Agreement.page (Accessed June 7, 2012).",Non-OADS,/arxiv_data1/oa_pdf/8d/8b/pharmpract-12-392.PMC4100949.pdf
"Av ailable at: http://www.psa.org.au/download/early-career- pharmacists/ECPWG-response-to-future-of-pharmacy-review.pdf (Accessed May 1, 2012).",Non-OADS,/arxiv_data1/oa_pdf/8d/8b/pharmpract-12-392.PMC4100949.pdf
"Available at:  http://www.psa.org.au/download/early-career-pharmacists/ecp-survey-report.pdf (Accessed May 1, 2012).",Non-OADS,/arxiv_data1/oa_pdf/8d/8b/pharmpract-12-392.PMC4100949.pdf
"Available at:  http://www.pprt.org.uk/documents/publications/pharmacy_unde rgraduate_students_career_choices_and_expectations.p df (Accessed October 25, 2012).",Non-OADS,/arxiv_data1/oa_pdf/8d/8b/pharmpract-12-392.PMC4100949.pdf
Magnesium Sulphate use for prevention of Preecla mpsia and Eclampsia related mortality in Ethiopia 2011;  Available from: http://www.esog.org.et/Projects.htm (accessed 2012 February 3).,Non-OADS,/arxiv_data1/oa_pdf/a9/00/pharmpract-12-400.PMC4100951.pdf
Available from:  http://www.ju.edu.et/jimma-university-specia lized-hospital-jush (accessed 2012 February 3).,Non-OADS,/arxiv_data1/oa_pdf/a9/00/pharmpract-12-400.PMC4100951.pdf
Available at http://www.annalskemu.org/journal/index.php/annals/article/viewArticle/84    19.,Non-OADS,/arxiv_data1/oa_pdf/a9/00/pharmpract-12-400.PMC4100951.pdf
The BRFSS dataset is  available to the public through the CDC website  (http://www.cdc.gov/brfss/annual_data/annual_2011 .htm).,OADS,/arxiv_data1/oa_pdf/a4/0a/pharmpract-12-410.PMC4100953.pdf
"http://www.cdc .gov/flu/about/qa/disease.htm  (Accessed Sep 25, 2013).",Non-OADS,/arxiv_data1/oa_pdf/a4/0a/pharmpract-12-410.PMC4100953.pdf
"http://www.cdc.gov/diabetes/news /flu.htm (Accessed Sep 21, 2013).",Non-OADS,/arxiv_data1/oa_pdf/a4/0a/pharmpract-12-410.PMC4100953.pdf
"http://www.healthypeople.gov/2020/about/DisparitiesAbout.aspx (Accessed Sep 20, 2013).",Non-OADS,/arxiv_data1/oa_pdf/a4/0a/pharmpract-12-410.PMC4100953.pdf
"http://www.healthypeople.gov/2020/topics objectives2020/objectiveslist.aspx?t opicId=23 (Accessed Sep 15, 2013).",Non-OADS,/arxiv_data1/oa_pdf/a4/0a/pharmpract-12-410.PMC4100953.pdf
"http://www.cdc.gov/brfss/annual_dat a/annual_2011.htm (Accessed July 20, 2013).",OADS,/arxiv_data1/oa_pdf/a4/0a/pharmpract-12-410.PMC4100953.pdf
"http://www.cdc.gov/brfss/pdf/2011_Summary_Dat a_Quality_Report.pdf (Accessed July 12, 2013).",OADS,/arxiv_data1/oa_pdf/a4/0a/pharmpract-12-410.PMC4100953.pdf
"http://care.diabetesjournals.org/content/32/ Supplement_1/S13.full (Accessed Sep 29, 2013).",Non-OADS,/arxiv_data1/oa_pdf/a4/0a/pharmpract-12-410.PMC4100953.pdf
"http://www.who.int/whr/2002/ (Accessed Feb 14, 2014).",OADS,/arxiv_data1/oa_pdf/2a/b3/pharmpract-12-419.PMC4100954.pdf
"Available from: http://www.jointcommission.org/assets/1 /6/HAP_NPSG_Chapter_2014.pdf (Accessed March 13, 2014).",OADS,/arxiv_data1/oa_pdf/3f/c6/pharmpract-12-439.PMC4100955.pdf
"Available from:  http://www.hospitalmedicine.org/ResourceRoomRedesi gn/RR_CareTransitions/html_ CC/06Boost/02_TARGET.cfm  (Accessed August 26, 2013).",Non-OADS,/arxiv_data1/oa_pdf/3f/c6/pharmpract-12-439.PMC4100955.pdf
"Available from:  http://www.va.gov/health/aboutVHA.asp (Accessed July 24, 2013).",Non-OADS,/arxiv_data1/oa_pdf/3f/c6/pharmpract-12-439.PMC4100955.pdf
"Available from:  http://www.philadelphia.va.gov/index .asp (Accessed August 15, 2013).",Non-OADS,/arxiv_data1/oa_pdf/3f/c6/pharmpract-12-439.PMC4100955.pdf
"Indeed, the inhibition of the BRAF V600E oncoprotein by the  small-molecule drug vemurafenib, which is highly effective in melanoma, 9 showed a very limited response in the mCRC  setting.7,8 Coherently, only a prognostic significance has been  attributed to BRAF mutations in CRC, so far.7 Interest - ingly however, preclinical studies have indicated that EGFR  *Correspondence to: Carlo Capalbo; Email: carlo.capalbo@uniroma1.it Submitted: 02/24/2014; Revised: 04/04/2014; Accepted: 04/13/2014; Published Online: 04/22/2014http://dx.doi.org/10.4161/cbt.28878Vemurafenib and panitumumab combination  tailored therapy in BRAF-mutated metastatic  colorectal cancer A case report Carlo Capalbo1,2,*, pa olo Marchetti2,3, Anna Coppa4, Antonella Calogero5, em anuela Anastasi1, Amelia Buffone1,  Francesca Belardinilli1, Matteo Gulino6, pa ola Frati6,7, Carlo Catalano8, en rico Cortesi8, Giuseppe Giannini1,†,   and Alberto Gulino7,9,† 1de partment of Molecular Medicine; sa pienza University of Rome; Rome, Italy; 2Medical on cology; I dI I RCC s; R ome, Italy; 3de partment of Clinical and Molecular Medicine;  sa pienza University of Rome; Rome, Italy; 4de partment of ex perimental Medicine; sa pienza University of Rome; Rome, Italy; 5de partment of Medical- sur gical sc iences   and Biotechnologies;  sa pienza University of Rome; Rome, Italy; 6de partment of Anatomical, hi stological, Forensic Medicine and or thopedic sc ience;   Forensic Medicine  se ction;  sa pienza University of Rome; Rome, Italy; 7ne uromed IRCC s; po zzilli, Italy; 8de partment of Radiological, on cological and pa thological sc iences;  sa pienza University of Rome; Rome, Italy; 9de partment of Molecular Medicine; Center for Life na noscience@ sa pienza; Italian Institute of Technology and Istituto pa steur;  Fondazione Cenci-Bolognetti;  sa pienza University of Rome; Rome, Italy †These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
Therap Adv Gastroenterol 2013; 6:381-95; PMID:24003339 ;  http://dx.doi.org/10.1177/1756283X13491797 2.,Non-OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
Expert Rev  Anticancer Ther  2013 ; 13:597-611; PMID:23617351 ;  http://dx.doi.org/10.1586/era.13.37 3.,Non-OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
N Engl J Med 2004 ;  351:337-45; PMID :15269313 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
N Engl J Med 2013 ; 369:1023 -34; PMID:24024839 ;  http://dx.doi.org/10.1056/NEJMoa13052755.,OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
Oncologist   2011 ; 16:1061 -8; PMID:21737577 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
J Clin Oncol 2010 ; 28:1254 - 61; PMID:20100961 ; http://dx.doi.org/10.1200/ JCO.2009.24.6116 7.,Non-OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
J Clin Oncol  2009 ; 27:5931 -7; PMID:19884549 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
N Engl J Med 2011 ; 364:2507 - 16; PMID:21639808 ; http://dx.doi.org/10.1056/ NEJMoa1103782 10.,OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
Cancer Discov   2012 ; 2:227-35; PMID:22448344 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
Nature  2012 ; 483:100-3;  PMID:22281684 ; http://dx.doi.org/10.1038/ nature10868 12.,Non-OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
Med J Aust 2013 ;  199:471-3; PMID:24099207 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
J Hematol  Oncol  2013 ; 6:30; PMID:23617957 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
N Engl J Med 2012 ; 366:707- 14; PMID:22356324 ; http://dx.doi.org/10.1056/ NEJMoa1112302 17.,OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
Nat Med  2013 ; 19:1401 - 9; PMID:24202393 ; http://dx.doi.org/10.1038/ nm.3392 18.,OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
Cancer Cell  2011 ; 19:11- 5; PMID:21251612 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
Cancer Cell  2012 ; 22:668-82; PMID:23153539 ;  http://dx.doi.org/10.1016/j.ccr.2012.10.009 20.,Non-OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
Nature   2010 ; 468:973-7; PMID:21107323 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
Cancer Res 2012 ; 72:969-78; PMID:22205714 ;  http://dx.doi.org/10.1158/0008-5472.CAN-11-1875 23.,Non-OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
Cancer Cell  2010 ; 18:683-95;  PMID :21156289 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
Cancer Res  2012 ; 72:779-89; PMID:22180495 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
Cancer Biol Ther  2013 ; 14:703-10; PMID:23792568 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
Curr Oncol Rep 2013 ; 15:249- 59; PMID:23463215 ; http://dx.doi.org/10.1007/ s11912-013-0308-627.,Non-OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
N Engl J Med  2010 ; 363:809-19; PMID:20818844 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
Clin Cancer Res 2013 ; 19:657-67; PMID:23251002 ;  http://dx.doi.org/10.1158/1078-0432.CCR-11-1446 29.,Non-OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
Cancer Discov  2013 ; 3:742-50;  PMID:23614898 ; http://dx.doi.org/10.1158/2159- 8290.CD-13-0070 30.,Non-OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
Nature  2013 ; 494:251- 5; PMID:23302800 ; http://dx.doi.org/10.1038/ nature11814 31.,Non-OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
Nat Med   2013 ; 19:619-25; PMID:23584089 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/11/ab/cbt-15-826.PMC4100983.pdf
Hum Vaccin i mmunother  2014 ; 10; PMid:24732667 ;  http://dx.doi.org/10.4161/hv.28549Recombinant bacteria as a treatment option for bowel diseases Phage therapies: An alternative to antibiotics?,Non-OADS,/arxiv_data1/oa_pdf/19/e7/bbug-5-149.PMC4101003.pdf
Bacteriophage   2013 ; 3:e24872 ; PM id:24228220 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/e7/bbug-5-149.PMC4101003.pdf
Mob g enet e lements   2013 ; 3:e26219 ; PM id:24251069 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/e7/bbug-5-149.PMC4101003.pdf
"science  2014 ; 344 :55-8; PM iD:24674868 ;  http://dx.doi.org/10.1126/science.1249252Eukaryotic chromosome synthesized Proposed U.S. science budget flat the proposed 2015 budgets for the  major U. s.-based scientific funding agencies,  including the National i nstitutes of Health  (NiH), the National s cience Foundation  (NsF), and the research efforts at the   Department of e nergy (D oe), are essentially  flat.",Non-OADS,/arxiv_data1/oa_pdf/46/3a/bbug-5-151.PMC4101004.pdf
Available from: http://www.the- scientist.com//?articles.view/articleNo/39345/ title/Proposed-N sF–N iH-Budgets-Flat Don’t hide the decline [ internet].,Non-OADS,/arxiv_data1/oa_pdf/46/3a/bbug-5-151.PMC4101004.pdf
Available from: http://www.nature.com/ news/don-t-hide-the-decline-1.14848?W t. ec_id=NA tURe-2014031 Engineered bacteria as living detectors Escherichia coli  have been engineered  to function as a molecular switch to detect  tetracycline exposure in the murine gut.,Non-OADS,/arxiv_data1/oa_pdf/46/3a/bbug-5-151.PMC4101004.pdf
Proc Natl Acad s ci U s A  2014 ; 111:4838 - 43; PM iD:24639514 ; http://dx.doi.org/10.1073/ pnas.1321321111 GE tobacco produces plant pheromone A team of s wedish scientists has  engineered tobacco plants to synthesize moth  mating pheromones.,Non-OADS,/arxiv_data1/oa_pdf/46/3a/bbug-5-151.PMC4101004.pdf
Nat Commun  2014 ;  5:3353 ; PM iD:24569486 ; http://dx.doi.org/10.1038/ ncomms4353  Grens  K. Pheromone Factories [ internet].,OADS,/arxiv_data1/oa_pdf/46/3a/bbug-5-151.PMC4101004.pdf
Available from: http://www.the-scientist.,Non-OADS,/arxiv_data1/oa_pdf/46/3a/bbug-5-151.PMC4101004.pdf
"Proteins isolated from human  serum represent a useful strategy to replace Human leukemia inhibitory factor produced by the ExpressTec method  from rice ( Oryza sativa  L.) is active in human neural stem cells   and mouse induced pluripotent stem cells Randall Alfano1, Bradford A Youngblood2, Deshui Zhang3, Ning Huang3, and Clinton C MacDonald2,* 1InVitria; Fort Collins, CO USA; 2Department of Cell Biology & Biochemistry; Texas Tech University Health Sciences Center; Lubbock, TX USA;   3Ventria Bioscience Inc; Fort Collins, CO USA Keywords:  LIF, embryonic stem cell,  recombinant protein expression, growth  rate, Oct 4, Nanog *Correspondence to: Clinton C MacDonald;   Email: clint.macdonald@ttuhsc.edu Submitted: 03/28/2014; Revised: 04/16/2014;   Accepted: 04/23/2014;   Published Online: 04/28/2014 http://dx.doi.org/10.4161/bioe.28996 Addendum to: Youngblood BA, Alfano R, Pettit  SC, Zhang D, Dallmann HG, Huang N, Macdon - ald CC.",Non-OADS,/arxiv_data1/oa_pdf/0c/c8/bbug-5-180.PMC4101010.pdf
J Biotechnol 2014; 172:67- 72; PMID:24380819; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0c/c8/bbug-5-180.PMC4101010.pdf
Acta Pharmacol Sin 2013; 34:741- 6; PMID:23736002 ; http://dx.doi.org/10.1038/ aps.2013.77 2.,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/bbug-5-180.PMC4101010.pdf
EMBO J  2014; 33:409-17;  PMID:24500035 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/c8/bbug-5-180.PMC4101010.pdf
J Biol Chem 2014; 289:4585-93;  PMID:24362021 ;  http://dx.doi.org/10.1074/jbc.R113.463737 4.,OADS,/arxiv_data1/oa_pdf/0c/c8/bbug-5-180.PMC4101010.pdf
Vascul  Pharmacol 2012; 56:288-96;  PMID:22387745 ;  http://dx.doi.org/10.1016/j.vph.2012.02.010 5.,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/bbug-5-180.PMC4101010.pdf
J Inorg Biochem  2012; 116:37-44;  PMID:23010327 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/c8/bbug-5-180.PMC4101010.pdf
BMC Biotechnol  2013; 13:102;  PMID:24228851 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/c8/bbug-5-180.PMC4101010.pdf
BMC Biotechnol 2012; 12:92;  PMID:23194296 ;  http://dx.doi.org/10.1186/1472-6750-12-92 12.,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/bbug-5-180.PMC4101010.pdf
J Biotechnol 2014; 172:67-72;  PMID:24380819 ;  http://dx.doi.org/10.1016/j.jbiotec.2013.12.012 13.,OADS,/arxiv_data1/oa_pdf/0c/c8/bbug-5-180.PMC4101010.pdf
Development 2009;  136:2311-22;  PMID:19542351 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/c8/bbug-5-180.PMC4101010.pdf
J Biol Chem 2011;  286:24855-64;  PMID:21613225 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/c8/bbug-5-180.PMC4101010.pdf
Cell  Res 2007; 17:42-9;  PMID:17211451 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/c8/bbug-5-180.PMC4101010.pdf
JAKSTAT 2013; 2:e24935;   PMID:24470976 ; http://dx.doi.org/10.4161/ jkst.24935 19.,OADS,/arxiv_data1/oa_pdf/0c/c8/bbug-5-180.PMC4101010.pdf
PLoS One  2012; 7:e39022;  PMID:22720020 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/c8/bbug-5-180.PMC4101010.pdf
Proc Natl Acad Sci U S A 2010; 107:9222- 7; PMID:20442331 ; http://dx.doi.org/10.1073/ pnas.1004584107 21.,OADS,/arxiv_data1/oa_pdf/0c/c8/bbug-5-180.PMC4101010.pdf
Stem Cells 2012; 30:2387- 99; PMID:22899336 ; http://dx.doi.org/10.1002/ stem.1201,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/bbug-5-180.PMC4101010.pdf
J Cell Sci 2012; 125:3343-56;  PMID:22467856 ;  http://dx.doi.org/10.1242/jcs.096537 25.,OADS,/arxiv_data1/oa_pdf/0c/c8/bbug-5-180.PMC4101010.pdf
Plant Biotechnol  J 2010; 8:564-87;  PMID:20233335 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/c8/bbug-5-180.PMC4101010.pdf
Protein Expr Purif  2010; 74:69-79;  PMID:20447458 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/c8/bbug-5-180.PMC4101010.pdf
Transgenic Res  2002; 11:337-46;  PMID:12212837 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/c8/bbug-5-180.PMC4101010.pdf
OA Biotechnology 2013; 2:17; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/c8/bbug-5-180.PMC4101010.pdf
Mol Breed 2002; 10: 83-94;  http://dx.doi.org/10.1023/A:1020355511981 30.,Non-OADS,/arxiv_data1/oa_pdf/0c/c8/bbug-5-180.PMC4101010.pdf
"A systems Biotechnological production of value-added carotenoids   from microalgae Emerging technology and prospects Kristine Wichuk1, Sigurður Brynjólfsson1,2, and Weiqi Fu1,* 1Center for Systems Biology; University of Iceland; Reykjavík, Iceland; 2Faculty of Industrial Engineering, Mechanical Engineering, and Computer Science;  University of Iceland; Reykjavík, Iceland Keywords:  microalgae, carotenoid  metabolism, environmental stress,  Dunaliella salina , adaptive laboratory  evolution, LED-based photobioreactors *Correspondence to: Weiqi Fu; Email: weiqi@hi.is Submitted: 02/28/2014; Revised: 03/25/2014;   Accepted: 03/31/2014;   Published Online: 04/01/2014 http://dx.doi.org/10.4161/bioe.28720 Addendum to: Fu W, Paglia G, Magnúsdóttir  M, Steinarsdóttir EA, Gudmundsson S, Palsson  BØ, Andrésson ÓS, Brynjólfsson S. Effects of  abiotic stressors on lutein production in the  green microalga Dunaliella salina .",Non-OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
Microb Cell  Fact 2014; 13:3; PMID:24397433; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
Nutrition 2010; 26:175-83;  PMID:19660910 ;  http://dx.doi.org/10.1016/j.nut.2009.03.010 2.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
Appl Microbiol  Biotechnol 2004; 65:635-48;  PMID:15300417 ;  http://dx.doi.org/10.1007/s00253-004-1647-x 3.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
Science 2010; 329:796-9;  PMID:20705853 ;  http://dx.doi.org/10.1126/science.1189003 4.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
Curr  Opin Biotechnol 2008; 19:235-40;  PMID:18539450 ;  http://dx.doi.org/10.1016/j.copbio.2008.05.007 5.,OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
Nature 2009; 459:185-92;  PMID:19444204 ;  http://dx.doi.org/10.1038/nature08057 6.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
Eukaryot Cell 2010; 9:486- 501; PMID:20139239 ; http://dx.doi.org/10.1128/ EC.00364-09 7.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
Mar Drugs 2011; 9:1607- 24; PMID:22131961 ; http://dx.doi.org/10.3390/ md9091607 8.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
Microb Cell Fact 2014; 13:3;  PMID:24397433 ;  http://dx.doi.org/10.1186/1475-2859-13-3 9.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
Biochim Biophys Acta  2002 ; 1579:26-34 ;  PMID:12401216 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
Biochim Biophys Acta  2011; 1807:912-8;  PMID:21167125 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
Mar Drugs 2011; 9:1101- 18; PMID:21747749 ; http://dx.doi.org/10.3390/ md906110112.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
Biofuels 2012; 3:221-40; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
Enzyme Microb  Technol 2004; 35:81-6; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
Trends Microbiol 2006; 14:11-4;   PMID:16356718 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
Nature 2002; 420:186- 9; PMID:12432395 ; http://dx.doi.org/10.1038/ nature01149 16.,OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
PLoS Comput Biol 2009; 5:e1000410;   PMID:19521528 ; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
J Biotechnol 2012; 161:242-9;  PMID:22796827 ;  http://dx.doi.org/10.1016/j.jbiotec.2012.07.004 20.,OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
Appl Microbiol  Biotechnol 2013; 97:2395-403;  PMID:23095941 ;  http://dx.doi.org/10.1007/s00253-012-4502-5 21.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
Bioresour  Technol 2013; 147:499-507;  PMID:24012738 ;  http://dx.doi.org/10.1016/j.biortech.2013.08.069 22.,OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
Mol Biol Rep 2009; 36:1433- 9; PMID:18792804 ; http://dx.doi.org/10.1007/ s11033-008-9333-123.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
Microb Cell Fact  2012; 11:126;  PMID:22970838 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
Chem Eng Sci 2004; 69:4369-76; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
Appl Environ Microbiol 2007; 73:4342- 50; PMID:17496128 ; http://dx.doi.org/10.1128/ AEM.02759-06 28.,OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
J Phycol 1982; 18:529-37; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
Biotechnol Bioeng 2007; 98:300-5;  PMID:17318905 ;  http://dx.doi.org/10.1002/bit.21391,Non-OADS,/arxiv_data1/oa_pdf/74/2e/bbug-5-204.PMC4101014.pdf
"Copyright © 2014 Korean Neurological Association  175Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.3.175REVIEW J Clin Neurol 2014 ;10(3):175-188 Introduction More than 2000 years ago, Hippocrates described a bidirec- tional relationship between depression and epilepsy.1 He wrote,  “Melancholics ordinarily become epileptics, and epileptics, melancholics : what determines the preference is the direction  the malady takes.” 1 Many physicians have since noticed a con - nection between epilepsy and depression and anxiety.",Non-OADS,/arxiv_data1/oa_pdf/22/43/jcn-10-175.PMC4101093.pdf
"Copyright © 2014 Korean Neurological Association  189Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.3.189REVIEW J Clin Neurol 2014 ;10(3):189-196 Introduction More than 100000 Korean people experience a new or recur - rent stroke each year.1 Ischemic stroke accounts for more  than 75% of all strokes, and one in five ischemic strokes is a  recurrent stroke.1,2 The introduction of therapies with proven  efficacy into clinical practice has resulted in a substantial de-cline in the rates of recurrent stroke and major vascular events over the last 5 decades, and antiplatelet therapy has contribut-ed to the significant decline in vascular event rates in patients with ischemic stroke or transient ischemic attack (TIA).",Non-OADS,/arxiv_data1/oa_pdf/f4/61/jcn-10-189.PMC4101094.pdf
"Copyright © 2014 Korean Neurological Association  197Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.3.197ORIGINAL ARTICLE J Clin Neurol 2014 ;10(3):197-202 T2 Relaxometry Using 3.0-Tesla Magnetic Resonance Imaging   of the Brain in Early- and Late-Onset Restless Legs Syndrome Hye-Jin Moon,a* Yongmin Chang,b* Yeong Seon Lee,a Hee Jin Song,c   Hyuk Won Chang,d Jeonghun Ku,e Yong Won Choa aDepartments of Neurology, dRadiology, and eBiomedical Engineering, Dongsan Medical Center,   Keimyung University School of Medicine, Daegu, Korea  bDepartments of Molecular Medicine and cMedical & Biological Engineering, Kyungpook National University Hospital, Daegu, Korea Received  July 4, 2013 Revised  November 12, 2013 Accepted  December 2, 2013 Correspondence Yong Won Cho, MD, PhDDepartment of Neurology, Dongsan Medical Center, Keimyung University School of Medicine,56 Dalseong-ro, Jung-gu, Daegu 700-712, KoreaTel    +82-53-250-7831 Fax   +82-53-250-7840E-mail    neurocho@gmail.com *Two first authors contributed  equally to this work.Background and Purpose zzPrevious T2 relaxometry studies have provided evidence for re- gional brain iron deficiency in patients with restless legs syndrome (RLS).",Non-OADS,/arxiv_data1/oa_pdf/8a/e7/jcn-10-197.PMC4101095.pdf
Image analysis T2 and T2* maps were processed using an MRI analysis cal-culator plug-in in the ImageJ software (http://rsb.info.nih.gov/ ij/) created by Karl Schmidt (kfschmidt@bwh.harvard.edu ).,OADS,/arxiv_data1/oa_pdf/8a/e7/jcn-10-197.PMC4101095.pdf
Copyright © 2014 Korean Neurological Association  203Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.3.203ORIGINAL ARTICLE J Clin Neurol 2014 ;10(3):203-209 Introduction Sleep problems are common in Alzheimer’s disease (AD) pa - tients as well as cognitively normal elderly.,Non-OADS,/arxiv_data1/oa_pdf/12/32/jcn-10-203.PMC4101096.pdf
"210   Copyright © 2014 Korean Neurological Association  Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.3.210ORIGINAL ARTICLE J Clin Neurol 2014 ;10(3):210-215 Validation of a Korean Version of the Insomnia Severity Index Yong Won Cho,a Mei Ling Song,b Charles M. Morinc aDepartment of Neurology, Keimyung University Dongsan Medical Center, Daegu, Korea  bDepartment of Graduate School in Nursing Science, College of Nursing, Keimyung University, Daegu, Korea  cEcole de Psychologie, Universite Laval, Québec, QC, Canada Received  September 23, 2013 Revised  November 3, 2013 Accepted  January 10, 2014 Correspondence Yong Won Cho, MD, PhD Department of Neurology, Keimyung University Dongsan Medical Center,56 Dalseong-ro, Jung-gu, Daegu 700-712, KoreaTel    +82-53-250-7831 Fax   +82-53-250-7840E-mail    neurocho@gmail.comBackground and Purpose zzThe purposes of this study were to standardize and validate a  Korean version of the Insomnia Severity Index (ISI-K ), and to evaluate its clinical usefulness.",Non-OADS,/arxiv_data1/oa_pdf/c9/55/jcn-10-210.PMC4101097.pdf
216  Copyright © 2014 Korean Neurological AssociationPrint ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.3.216ORIGINAL ARTICLE J Clin Neurol 2014 ;10(3):216-221 Introduction Multiple sclerosis (MS) is one of the leading causes of dis - ability among young adults1 and presents a major health bur - den in the US and other Western countries.,Non-OADS,/arxiv_data1/oa_pdf/36/5d/jcn-10-216.PMC4101098.pdf
Available from : http://icahn.mssm.edu/ about-us/services-and-resources/computer-services/resources/re - search-information-technology/mount-sinai-data-warehouse.,OADS,/arxiv_data1/oa_pdf/36/5d/jcn-10-216.PMC4101098.pdf
"222  Copyright © 2014 Korean Neurological Association  Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.3.222ORIGINAL ARTICLE J Clin Neurol 2014 ;10(3):222-228 Introduction Cerebral microbleeds (CMBs ) are tiny perivascular hemor - rhages characterized by the presence of hemosiderin-laden  macrophages close to disrupted cerebral small vessels, which appear as small and rounded lesions of low signal intensity on gradient-recalled echo (GRE ) magnetic resonance imag-ing (MRI).",Non-OADS,/arxiv_data1/oa_pdf/fc/83/jcn-10-222.PMC4101099.pdf
"Copyright © 2014 Korean Neurological Association  229Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.3.229ORIGINAL ARTICLE J Clin Neurol 2014 ;10(3):229-235 Abnormal Brain Activity Changes in Patients with Migraine:   A Short-Term Longitudinal Study Ling Zhao,a,b Jixin Liu,a Xuemei Yan,a Wanghuan Dun,c Jing Yang,c Liyu Huang,a   Yuan Kai,a Dahua Yu,d Wei Qin,a Tian Jie,a Fanrong Liangb aSchool of Life Science and Technology, Xidian University, Xi’an, PR China  bThe 3rd Teaching Hospital, Chengdu University of Traditional Chinese Medicine, Chengdu, PR China  cDepartment of Medical Imaging, First Affiliated Hospital, Xi’an Jiaotong University College of Medicine, Xi’an, PR China  dInformation Processing Laboratory, School of Information Engineering, Inner Mongolia University of Science and Technology, Baotou,  Inner Mongolia, PR China Received  October 21, 2013 Revised  December 27, 2013 Accepted  February 4, 2014 Correspondence Jixin Liu, PhDSchool of Life Science and Technology, Xidian University, Xi’an 710071, PR ChinaTel    +86 29 81891070 Fax   +86 29 81891060E-mail    liujixin@life.xidian.edu.cn Fanrong Liang, PhD The 3rd Teaching Hospital, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, PR ChinaTel    +86 28 66704320 Fax   +86 28 87784606E-mail    lfr@cdutcm.edu.cnBackground and Purpose zzWhether or not migraine can cause cumulative brain alterations  due to frequent migraine-related nociceptive input in patients is largely unclear.",Non-OADS,/arxiv_data1/oa_pdf/29/2d/jcn-10-229.PMC4101100.pdf
Image preprocessing was carried out using Statistical Parametric Mapping 5 soft-ware (http://www.fil.ion.ucl.ac.uk/spm ).,OADS,/arxiv_data1/oa_pdf/29/2d/jcn-10-229.PMC4101100.pdf
"236   Copyright © 2014 Korean Neurological Association  Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.3.236ORIGINAL ARTICLE J Clin Neurol 2014 ;10(3):236-243 Chronic Daily Headache in Korea: Prevalence, Clinical   Characteristics, Medical Consultation and Management Jeong-Wook Park,a Heui-Soo Moon,b Jae-Moon Kim,c Kwang-Soo Lee,d Min Kyung Chue aDepartment of Neurology, Uijeongbu St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Uijeongbu, Korea  bDepartment of Neurology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea  cDepartment of Neurology, Chungnam National University College of Medicine, Daejeon, Korea  dDepartment of Neurology, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea  eDepartment of Neurology, Hallym University College of Medicine, Anyang, Korea Received  April 22, 2013 Revised  March 20, 2014 Accepted  March 24, 2014 Correspondence Min Kyung Chu, MD, PhDDepartment of Neurology, Hallym University College of Medicine, 22 Gwanpyeong-ro 170beon-gil,Dongan-gu, Anyang 431-796, KoreaTel    +82-31-380-3744 Fax   +82-31-381-9474E-mail    chumk@hallym.ac.krBackground and Purpose zzChronic daily headache (CDH ) is a commonly reported reason  for visiting hospital neurology departments, but its prevalence, clinical characteristics, and  management have not been well documented in Korea.",Non-OADS,/arxiv_data1/oa_pdf/6b/40/jcn-10-236.PMC4101101.pdf
Available from : http://www.cioms.ch/publications/guidelines/guide- lines_nov_2002_blurb.htm.,Non-OADS,/arxiv_data1/oa_pdf/6b/40/jcn-10-236.PMC4101101.pdf
Available from : http://kosis.kr.,Non-OADS,/arxiv_data1/oa_pdf/6b/40/jcn-10-236.PMC4101101.pdf
"244  Copyright © 2014 Korean Neurological Association  Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.3.244ORIGINAL ARTICLE J Clin Neurol 2014 ;10(3):244-248 Introduction Several causative genes for Parkinson’s disease (PD) have  been identified in familial PD, with autosomal-dominant or  autosomal-recessive inheritance patterns.1 Among these, mu- tation in the gene encoding parkin (P ARK2 ) is the most com- mon genetic risk factor for early-onset PD (EOPD ).2,3 The fre - quency of P ARK2 mutations has been reported to be as high as 49% in patients with EOPD, with an autosomal-recessive mode of inheritance, 2 whereas it has been reported to be 14 – 15% in patients with EOPD without a family history of PD.3,4 The types of mutations found in P ARK2 are highly variable,  such as point mutations, small deletions/insertions, and ex-onic rearrangement (either deletion or duplication ), and have  been reported in all exons of the gene.",Non-OADS,/arxiv_data1/oa_pdf/b2/00/jcn-10-244.PMC4101102.pdf
"Copyright © 2014 Korean Neurological Association  249Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.3.249ORIGINAL ARTICLE J Clin Neurol 2014 ;10(3):249-256 Diffusion Tensor Tractography Analysis of the Corpus Callosum  Fibers in Amyotrophic Lateral Sclerosis Jee-Eun Kim,a* Jungsu S. Oh,b* Jung-Joon Sung,c Kwang-Woo Lee,c In Chan Song,d Yoon-Ho Honge aDepartment of Neurology, Seoul Medical Center, Seoul, Korea  bDepartment of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea  cDepartments of Neurology and dRadiology, Seoul National University Hospital, Seoul, Korea  eDepartment of Neurology, Seoul National University College of Medicine,   Seoul Metropolitan Government Boramae Medical Center, Seoul, Korea Received  December 31, 2013 Revised  March 18, 2014 Accepted  March 20, 2014 Correspondence Yoon-Ho Hong, MD, PhDDepartment of Neurology, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul 156-707, KoreaTel    +82-2-870-2474 Fax   +82-2-831-2826E-mail    nrhong@gmail.com In Chan Song, PhD Department of Radiology, Seoul National University Hospital, 103 Daehak-ro, Jongno-gu, Seoul 110-744, KoreaTel    +82-2-760-3941 Fax   +82-2-763-0379E-mail    icsong@radcom.snu.ac.kr *Drs.",Non-OADS,/arxiv_data1/oa_pdf/42/17/jcn-10-249.PMC4101103.pdf
"23 The second approach  is based on a sulcal-gyral segmentation of the cortical gray  matter produced by a program called FreeSurfer (version 5.0,  http://surfer.nmr.mgh.harvard.edu/ ).24 For the BA ROI ap- proach, the BA template was projected onto the canonical 3D T1-weighted image of all participants, as in our previous study.",Non-OADS,/arxiv_data1/oa_pdf/42/17/jcn-10-249.PMC4101103.pdf
Atlases of BAs and FreeSurfer ROIs were adapted from http://en.wikipedia.org/wiki/Brodmann_area and the aparc+aseg segmentation in FreeSurfer software.,OADS,/arxiv_data1/oa_pdf/42/17/jcn-10-249.PMC4101103.pdf
"   Copyright © 2014 Korean Neurological Association   257Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.3.257ORIGINAL ARTICLE J Clin Neurol 2014 ;10(3):257-261 Introduction Hereditary spastic paraplegia (HSP) is a genetically heteroge - neous group of neurodegenerative disorders that are character - ized by progressive spasticity and weakness of the lower limbs.1 Clinically, HSP can be classified as either “pure” or “compli - cated” depending on the presence of additional features such  as ataxia, extrapyramidal signs, severe amyotrophy, peripheral neuropathy, optic atrophy, pigmentary retinopathy, mental re - tardation, dementia, and epilepsy.",Non-OADS,/arxiv_data1/oa_pdf/a1/37/jcn-10-257.PMC4101104.pdf
"262  Copyright © 2014 Korean Neurological Association  Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.3.262CASE REPORT J Clin Neurol 2014 ;10(3):262-266 Introduction Paraneoplastic neurological syndromes (PNS) are rare re- gardless of the causal cancer, and while gynecological ma- lignancies (particularly ovarian carcinoma ) are the most  commonly associated tumors, cervical cancer is a very rare cause.",Non-OADS,/arxiv_data1/oa_pdf/10/b6/jcn-10-262.PMC4101105.pdf
Copyright © 2014 Korean Neurological Association  267Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.3.267CASE REPORT J Clin Neurol 2014 ;10(3):267-271 Introduction Primary angiitis of the central nervous system (PACNS ) is  characterized by the inflammation and destruction of central  nervous system (CNS ) vessels without vasculitis outside of  the CNS.,Non-OADS,/arxiv_data1/oa_pdf/93/38/jcn-10-267.PMC4101106.pdf
272  Copyright © 2014 Korean Neurological AssociationPrint ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.3.272CASE REPORT J Clin Neurol 2014 ;10(3):272-275 Introduction Opsoclonus-myoclonus syndrome (OMS ) is a rare neuro- ophthalmological disorder that occurs more commonly in  children than in adults.,Non-OADS,/arxiv_data1/oa_pdf/7a/25/jcn-10-272.PMC4101107.pdf
"276  Copyright © 2014 Korean Neurological AssociationPrint ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.3.276LETTER TO THE EDITOR  J Clin Neurol 2014 ;10(3):276-277 Dear Editor,  We would like to share an interesting case of congestive  myelopathy involving a 26-year-old female with chronic gy - necological chylous reflux disease who presented with bilat- eral lower extremities weakness, decreased sensation, and  urinary incontinence of 2 months duration.",Non-OADS,/arxiv_data1/oa_pdf/e5/e1/jcn-10-276.PMC4101108.pdf
278  Copyright © 2014 Korean Neurological Association  Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.3.278LETTER TO THE EDITOR J Clin Neurol 2014 ;10(3):278-278 I write concerning the case described as Unilateral revers- ible posterior leukoencephalopathy syndrome after coiling of an aneurysm reported by Huijgen et al.,Non-OADS,/arxiv_data1/oa_pdf/17/8e/jcn-10-278.PMC4101109.pdf
"Copyright © 2014 Korean Neurological Association  279Print ISSN 1738-6586 / On-line ISSN 2005-5013 http://dx.doi.org/10.3988/jcn.2014.10.3.279LETTER TO THE EDITOR J Clin Neurol 2014 ;10(3):279-279 We would like to thank Dr. Caplan for his useful comments.1  The abnormalities in our patients are indeed quite similar to  the abnormalities found in some migraine patients, as shown to us by Dr. Caplan.",Non-OADS,/arxiv_data1/oa_pdf/ab/2a/jcn-10-279.PMC4101110.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 435 Korean J Urol 2014;55:435http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.7 .1&domain=pdf&date_stamp=2014-07-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.7.435 Editorial KJU Indexed in MEDLINE The Korean Journal of Urology (KJU) has taken a great  leap towards becoming a highly regarded international journal.",Non-OADS,/arxiv_data1/oa_pdf/21/dc/kju-55-435.PMC4101111.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 436 Korean J Urol 2014;55:436-445http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.7 .436&domain=pdf&date_stamp=2014-07-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.7.436 Review Article Clinical Use of [-2]proPSA (p2PSA) and Its Derivatives (%p2PSA  and Prostate Health Index) for the Detection of Prostate Cancer: A Review of the Literature Alberto Abrate, Giovanni Lughezzani, Giulio Maria Gadda, Giuliana Lista, Ella Kinzikeeva,  Nicola Fossati, Alessandro Larcher, Paolo Dell’Oglio, Francesco Mistretta, Nicolòmaria Buffi,  Giorgio Guazzoni, Massimo Lazzeri Department of Urology, Ville Turro, IRCC S Ospedale San Raffaele, Milan, Italy Prostate-specific antigen (PSA) is recognized  as an organ-specific marker with low spe- cificity and sensitivity in discriminating pr ostate cancer (PCa) fr om other benign con- ditions, such as prostatic hype rplasia or chronic prostatitis.",Non-OADS,/arxiv_data1/oa_pdf/7d/7b/kju-55-436.PMC4101112.pdf
"A syst ematic search of the PubMed and Scopus  electronic databases was performed in accordance with the PRISMA statement  (http://www.prisma-statement.org), consider ing the time period from January 1990 to  January 2014 and using the following search terms: proprostate specific antigen, pro-enzyme PSA, proPSA, [-2]proPSA, p2PSA, Pr ostate Health Index, and PHI.",OADS,/arxiv_data1/oa_pdf/7d/7b/kju-55-436.PMC4101112.pdf
"Keywords:  [-2]proPSA; Diagnosis; Prostate  cancer; Prostate health index This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 10 March, 2014 accepted 29 May, 2014 Corresponding Author: Alberto Abrate Department of Urology, Ville  Turro, IRCCS Ospedale San Raffaele, Via Stamira d’Ancona  20, Milan 20127, Italy TEL: +82-02.2643.3357FAX: +82-02.2643.3442 E-mail: alberto.abrate@gmail.com INTRODUCTION Prostate-specific antigen (PSA) is widely known as a serum  biomarker for the early detection of prostate cancer (PCa).",Non-OADS,/arxiv_data1/oa_pdf/7d/7b/kju-55-436.PMC4101112.pdf
in accordance with the PRISMA statement (http://www.prisma-statement.org).,Non-OADS,/arxiv_data1/oa_pdf/7d/7b/kju-55-436.PMC4101112.pdf
http://dx.doi.org/10.1016/j.eururo.2013.12.005.,OADS,/arxiv_data1/oa_pdf/7d/7b/kju-55-436.PMC4101112.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 446 Korean J Urol 2014;55:446-452http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.7 .446&domain=pdf&date_stamp=2014-07-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.7.446 Original Article - Urological Oncology The Type of Nephrectomy Has Little Effect on Overall Survival or  Cardiac Events in Patients of 70 Years and Older With Localized Clinical T1 Stage Renal Masses Yoon Soo Kyung, Dalsan You1, Taekmin Kwon1, Sang Hoon Song1, In Gab Jeong1, Cheryn Song1,  Bumsik Hong1, Jun Hyuk Hong1, Hanjong Ahn1, Choung-Soo Kim1 Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 1Department of Urology,  Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Purpose:  To compare the outcomes of nephro n-sparing options (e.g., partial neph- rectomy [PN]) and low-surgical -morbidity options (e.g., ra dical nephrectomy [RN]) in  elderly patients with limited life expectancy.",Non-OADS,/arxiv_data1/oa_pdf/91/ab/kju-55-446.PMC4101113.pdf
"Keywords:  Aged; Cardiovascular diseases; Kidney; Mortality; Nephrectomy This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 27 March, 2014 accepted 22 April, 2014 Corresponding Author: Choung-Soo Kim Department of Urology, Asan  Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736,  Korea TEL: +82-2-3010-3734FAX: +82-2-477-8929 E-mail: cskim@amc.seoul.kr INTRODUCTION The greatest increase in the incidence of renal cell carcino- ma (RCC) occurs in the later ye ars of life, with the highest  incidence reported in patients  between 75 and 84 years of  age (approximately 56 cases per 100,000 persons) [1,2].",Non-OADS,/arxiv_data1/oa_pdf/91/ab/kju-55-446.PMC4101113.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 453 Korean J Urol 2014;55:453-459http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.7 .453&domain=pdf&date_stamp=2014-07-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.7.453 Original Article - Urological Oncology Predictors of Intravesical Recurrence After Radical  Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma: An Inflammation-Based Prognostic Score Yang Hyun Cho, Young Ho Seo, Seung Jun Chung, Insang Hwang, Ho Song Yu, Sun-Ouck Kim,  Seung Il Jung, Taek Won Kang, Dong Deuk Kwon, Kwangsung Park, Jun Eul Hwang1, Suk Hee Heo2,  Geun Soo Kim3, Eu Chang Hwang Departments of Urology, 1Hematology-Oncology, and 2Radiology, Chonnam National University Medical School, Gwangju, 3Department  of Urology, Gwangju Hospital, Gwangju, Korea Purpose:  Systemic inflammatory responses, which are defined in terms of the Glasgow  prognostic score (GPS), have been reported to be independ ent predictors of unfavorable  outcomes in various human cancers.",Non-OADS,/arxiv_data1/oa_pdf/13/96/kju-55-453.PMC4101114.pdf
"Keywords:  Inflammation; Recurrence;  Risk factors; Transitional cell carcinoma This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 18 February, 2014 accepted 9 April, 2014 Corresponding Author: Eu Chang HwangDepartment of Urology,  Chonnam National University  Hospital, Chonnam National University Medical School, 42  Jebong-ro, Dong-gu, Gwangju  501-757, KoreaTEL: +82-62-220-6700 FAX: +82-62-227-1643 E-mail: urohwang@gmail.com INTRODUCTION Upper urinary tract urothelial carcinoma (UTUC) is rela- tively uncommon, accounting fo r only approximately 5% to  7% of all urothelial cancers [1-9].",Non-OADS,/arxiv_data1/oa_pdf/13/96/kju-55-453.PMC4101114.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 460 Korean J Urol 2014;55:460-464http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.7 .460&domain=pdf&date_stamp=2014-07-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.7.460 Original Article - Urological Oncology Factors Influencing the Acceptance of Transrectal  Ultrasound-Guided Prostate Biopsies Ji Won Hwang, Woo Jin Bang, Cheol Young Oh, Changhee Yoo, Jin Seon Cho Department of Urology, Hallym University College of Medicine, Chuncheon, Korea Purpose:  This study aimed to improve prostate biopsy compliance by analyzing the fac- tors that influence the acceptance of prostate biopsy by patients to whom transrectal  ultrasound (TRUS)-guided prostate biopsy  is recommended for suspected prostate  cancer.Materials and Methods:  The subjects of this study were 268 patients to whom  TRUS-guided prostate biopsy was recommen ded from January to June 2011 and who  completed a questionnaire.",Non-OADS,/arxiv_data1/oa_pdf/75/bb/kju-55-460.PMC4101115.pdf
"Keywords:  Compliance; Demography; Prostatic neoplasms This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 28 June, 2013 accepted 18 October, 2013 Corresponding Author: Jin Seon ChoDepartment of Urology, Hallym  University Sacred Heart  Hospital, Hallym University College of Medicine, 22  Gwanpyeong-ro  170beon-gil,  Dongan-gu, Anyang 431-796, Korea TEL: +82-31-380-3851 FAX: +82-31-380-3852E-mail: js315@hallym.or.kr INTRODUCTION Recently, as the proportion of the elderly in the South  Korean population has increased, and as dietary life has been progressively westernized, the incidence of prostate cancer has increased.",Non-OADS,/arxiv_data1/oa_pdf/75/bb/kju-55-460.PMC4101115.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 465 Korean J Urol 2014;55:465-469http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.7 .465&domain=pdf&date_stamp=2014-07-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.7.465 Original Article - Urological Oncology Is There an Association Between Serum Prostate-Specific Antigen  Values and Serum Testosterone Levels in Healthy Men?",Non-OADS,/arxiv_data1/oa_pdf/d4/f2/kju-55-465.PMC4101116.pdf
"Keywords:  Prostate; Prostate neoplasms; Pros tate-specific antigen; Testosterone  This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 2 July, 2013 accepted 24 July, 2013 See Editorial on page 468.",Non-OADS,/arxiv_data1/oa_pdf/d4/f2/kju-55-465.PMC4101116.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 470 Korean J Urol 2014;55:470-474http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.7 .470&domain=pdf&date_stamp=2014-07-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.7.470 Original Article - Voiding Dysfunction Prostate Volume Measurement by Transrectal Ultrasonography:  Comparison of Height Obtained by Use of Transaxial and Midsagittal Scanning Sung Bin Kim, In-Chang Cho, Seung Ki Min Department of Urology, National Police Hospital, Seoul, Korea Purpose:  The purpose of this study was to comp are prostate volume measured by trans- rectal ultrasonography (TRUS) between transaxial scanning and midsagittal  scanning.",Non-OADS,/arxiv_data1/oa_pdf/38/1e/kju-55-470.PMC4101117.pdf
"Keywords:  Prostate; Prostatic hyp erplasia; Ultrasonography This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 23 September, 2013 accepted 21 October, 2013 Corresponding Author: Seung Ki Min Department of Urology, National  Police Hospital, 123, Songi-ro, Songpa-gu, Seoul 138-708, Korea TEL: +82-2-3400-1263 FAX: +82-2-431-3192E-mail: drmsk@korea.com INTRODUCTION Benign prostatic hyperplasia (BPH) is common in mid- dle-aged men, is found in over half of 60-year-old men, and is found in almost all 80-year-old men [1].",Non-OADS,/arxiv_data1/oa_pdf/38/1e/kju-55-470.PMC4101117.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 475 Korean J Urol 2014;55:475-481http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.7 .475&domain=pdf&date_stamp=2014-07-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.7.475 Original Article - Endourology/Urolithiasis Laparoscopic Stone Surgery With the Aid of Flexible Nephroscopy Jae Hyun Jung, Sung Yong Cho1, Chang Wook Jeong, Hyeon Jeong1, Hwancheol Son1,  Seung Hyo Woo2, Dae Kyung Kim2, Sun-Ho Min, Seung-June Oh, Hyeon-Hoe Kim, Seung Bae Lee1 Department of Urology, Seoul National University Hospital, Seoul, 1Department of Urology, SMG-SNU Boramae Medical Center, Seoul,  2Department of Urology, Eulji University School of Medicine, Daejeon, Korea Purpose:  To report the outcome of laparoscopic pyelo- and ureterolithotomies with the  aid of flexible nephroscopy.Materials and Methods:  A retrospective analysis was performed in 71 patients with  complex renal stones or large and impacted proximal ureteral stones.",Non-OADS,/arxiv_data1/oa_pdf/c0/38/kju-55-475.PMC4101118.pdf
"Keywords:  Cystoscopes; Kidney calculi;  Laparoscopes; Ureteral calculi This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 16 October, 2013 accepted 16 June, 2014 Corresponding Author: Seung Bae LeeDepartment of Urology,  SMG-SNU Boramae Medical  Center, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul 156-707,  Korea TEL: +82-2-870-2393FAX: +82-2-870-3863 E-mail: urseungbaelee@gmail.com INTRODUCTION Recently, patients with urinar y stones have mostly under- gone extracorporeal shock-wave lithotripsy (ESWL), ureter-orenoscopic lithotomy, or percutaneous nephrolithotomy (PNL).",Non-OADS,/arxiv_data1/oa_pdf/c0/38/kju-55-475.PMC4101118.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 482 Korean J Urol 2014;55:482-486http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.7 .482&domain=pdf&date_stamp=2014-07-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.7.482 Original Article - Infection/Inflammation Relationship Between Uncommon Computed Tomography  Findings and Clinical Aspects in Patients With Acute Pyelonephritis Jang Sik Kim, Sangwook Lee, Kwang Woo Lee, Jun Mo Kim, Young Ho Kim, Min Eui Kim Department of Urology, Soonchunhyang University College of Medicine, Cheonan, Korea Purpose:  Computed tomography (CT) has become popular in the diagnosis of acute pye- lonephritis (APN) and its related complicatio ns in adults.",Non-OADS,/arxiv_data1/oa_pdf/ab/14/kju-55-482.PMC4101119.pdf
"Keywords:  Pyelonephritis; X-ray computed tomography This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 12 March, 2014 accepted 17 April, 2014 Corresponding Author: Jun Mo KimDepartment of Urology,  Soonchunhyang University  Bucheon Hospital, Soonchunhyang University  College of Medicine, 170  Jomaru-ro, Wonmi-gu, Bucheon 420-767, Korea TEL: +82-32-621-5462 FAX: +82-32-621-5016E-mail: urojun@schmc.ac.kr INTRODUCTION Acute pyelonephritis (APN) is the most common upper uri- nary tract infection, and approximately 20% to 35% of fe-males experience an episode of APN in their lifetime [1].",Non-OADS,/arxiv_data1/oa_pdf/ab/14/kju-55-482.PMC4101119.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 487 Korean J Urol 2014;55:487-492http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.7 .487&domain=pdf&date_stamp=2014-07-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.7.487 Original Article - Basic and Translational Research Growth Inhibition After Exposure to Transforming Growth  Factor- β1 in Human Bladder Cancer Cell Lines Changho Lee1,2, Sang-Han Lee3, Doo Sang Kim1, Yun Soo Jeon1, Nam Kyu Lee1, Sang Eun Lee2,4 1Department of Urology, Soonchunhyang University Cheonan Hospital, Cheonan, 2Department of Urology, Seoul National University  College of Medicine, Seoul, 3Department of Biochemistry, Soonchunhyang University College of Medicine, Cheonan, 4Department of  Urology, Seoul National University Bundang Hospital, Seongnam, Korea Purpose:  Transforming growth factor- β1 (TGF- β1) plays a dual role in apoptosis and  in proapoptotic responses in th e support of survival in a variety of cells.",Non-OADS,/arxiv_data1/oa_pdf/be/38/kju-55-487.PMC4101120.pdf
"Keywords:  Cell line; Cell survival; Transforming  growth factor beta; Urinary bladder  neoplasms This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 12 March, 2014 accepted 12 May, 2014 Corresponding Author: Sang Eun Lee Department of Urology, Seoul  National University Bundang Hospital, 82 Gumi-ro 173beon-gil,  Bundang-gu, Seongnam 463-707,  KoreaTEL: +82-31-787-7341 FAX: +82-31-787-4057 E-mail: selee@snubh.org INTRODUCTION In human tissues, cells and their surrounding ex- tracellular matrix microenvir onment interact throughout  all stages of life.",Non-OADS,/arxiv_data1/oa_pdf/be/38/kju-55-487.PMC4101120.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 493 Korean J Urol 2014;55:493-495http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.7 .493&domain=pdf&date_stamp=2014-07-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.7.493 Case Report Laparoscopic Management of a Hydatid Cyst of the Adrenal Gland Santosh Kumar, Bhuvanesh Nanjappa, Kiran Krishne Gowda1 Departments of Urology and 1Pathology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India Hydatid disease is endemic in parts of Indi a, yet genitourinary involvement is rare.",Non-OADS,/arxiv_data1/oa_pdf/5b/7f/kju-55-493.PMC4101121.pdf
"Keywords:  Cyst aspiration; Cyst excision; Ec hinococcosis; Hydati d cyst; Laparoscopy This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 18 April, 2012 accepted 27 September, 2012 Corresponding Author: Santosh KumarDepartment of Urology,  Postgraduate Institute of Medical  Education and Research (PGIMER), Chandigarh 160012,  India TEL: +91-941-7374067FAX: +91-172-2744401 E-mail: santoshsp1967jaimatadi  @yahoo.co.in FIG.",Non-OADS,/arxiv_data1/oa_pdf/5b/7f/kju-55-493.PMC4101121.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 496 Korean J Urol 2014;55:496-498http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.7 .496&domain=pdf&date_stamp=2014-07-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.7.496 Case Report Vesicoenteric Fistula due to Bladder Squamous Cell Carcinoma Yu Jin Kang, Dong Jin Park, Soon Kim1, Sung Woo Kim1, Kyung Seop Lee, Nak Gyeu Choi, Ki Ho Kim Departments of Urology and 1Radiology, Dongguk University College of Medicine, Gyeongju, Korea Vesicoenteric fistula is a rare complication of bladder squamous cell carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/93/14/kju-55-496.PMC4101122.pdf
"Keywords:  Squamous cell carcinoma; Urinary bladder; Urinary bladder fistula This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 15 June, 2012 accepted 6 August, 2012 Corresponding Author: Ki Ho KimDepartment of Urology, Dongguk  University Gyeongju Hospital,  Dongguk University College of Medicine, 87 Dongdae-ro,  Gyeongju 780-350, Korea TEL: +82-54-770-8265FAX: +82-54-770-8378 E-mail: honda400@dreamwiz.com FIG.",Non-OADS,/arxiv_data1/oa_pdf/93/14/kju-55-496.PMC4101122.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/8f/TOMINFOJ-8-1.PMC4101190.pdf
Available at: http://tabnet.datasus.,OADS,/arxiv_data1/oa_pdf/5f/89/CCR-10-355.PMC4101200.pdf
"Received 23 August 2013; Revised 23 August 2013; Accepted 10 December 2013 Copyright © 2014 Neoplasia Press, Inc. All rights reserved 1936-5233/14 http://dx.doi.org/10.1016/j.tranon.2014.02.018",Non-OADS,/arxiv_data1/oa_pdf/07/c6/main.PMC4101291.pdf
"Received 23 September 2013; Revised 23 September 2013; Accepted 11 February 2014 Copyright © 2014 Neoplasia Press, Inc. All rights reserved 1936-5233/14 http://dx.doi.org/10.1016/j.tranon.2014.02.017",Non-OADS,/arxiv_data1/oa_pdf/3d/6b/main.PMC4101294.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3d/6b/main.PMC4101294.pdf
"Front Genet 4, 163. http://dx.doi.org/10.3389/ fgene.2013.00163 .",Non-OADS,/arxiv_data1/oa_pdf/3d/6b/main.PMC4101294.pdf
"3This article refers to supplementary materials, which are designated by Tables W1 and W2 and Figures W1 to W4 and are available online at http://www.transonc.com .",Non-OADS,/arxiv_data1/oa_pdf/32/74/main.PMC4101295.pdf
"Received 28 October 2013; Revised 14 January 2014; Accepted 15 January 2014 Copyright © 2014 Neoplasia Press, Inc. All rights reserved 1936-5233/14 http://dx.doi.org/10.1016/j.tranon.2014.02.002",Non-OADS,/arxiv_data1/oa_pdf/32/74/main.PMC4101295.pdf
"E-mail: kadem001@umn.edu Received 16 December 2013; Revised 16 December 2013; Accepted 20 December 2013 Copyright © 2014 Neoplasia Press, Inc. All rights reserved 1936-5233/14 http://dx.doi.org/10.1016/j.tranon.2014.02.006",Non-OADS,/arxiv_data1/oa_pdf/00/8d/main.PMC4101339.pdf
"Received 9 January 2014; Revised 5 February 2014; Accepted 6 February 2014 Copyright © 2014 Neoplasia Press, Inc. All rights reserved 1936-5233/14 http://dx.doi.org/10.1016/j.tranon.2014.02.015",Non-OADS,/arxiv_data1/oa_pdf/2e/74/main.PMC4101340.pdf
"The authors have declared that they have no competing interests.Received 5 July 2013; Revised 9 November 2013; Accepted 2 January 2014 Copyright © 2014 Neoplasia Press, Inc. All rights reserved 1936-5233/14 http://dx.doi.org/10.1016/j.tranon.2014.02.007",Non-OADS,/arxiv_data1/oa_pdf/cf/c1/main.PMC4101341.pdf
"81101588).Received 20 January 2014; Revised 9 February 2014; Accepted 10 February 2014 Copyright © 2014 Neoplasia Press, Inc. All rights reserved 1936-5233/14 http://dx.doi.org/10.1016/j.tranon.2014.02.014",Non-OADS,/arxiv_data1/oa_pdf/32/a0/main.PMC4101342.pdf
"Received 7 December 2013; Revised 7 January 2014; Accepted 15 February 2014 Copyright © 2014 Neoplasia Press, Inc. All rights reserved 1936-5233/14 http://dx.doi.org/10.1016/j.tranon.2014.02.011",Non-OADS,/arxiv_data1/oa_pdf/74/31/main.PMC4101343.pdf
"was supported by BONFOR grant O-142.0005.Received 4 September 2013; Revised 3 February 2014; Accepted 4 February 2014 Copyright © 2014 Neoplasia Press, Inc. All rights reserved 1936-5233/14 http://dx.doi.org/10.1016/j.tranon.2014.02.005",Non-OADS,/arxiv_data1/oa_pdf/9e/fd/main.PMC4101344.pdf
Statisticalanalysis was performed using Fisher exact test on GraphPad'sQuickCalcs platform ( http://graphpad.com/quickcalcs/ contingency1.cfm ).Pb.05 was considered statistically significant.,OADS,/arxiv_data1/oa_pdf/9e/fd/main.PMC4101344.pdf
KEGG Pathway ID pNDE pPERT pG pGFDR pGFWER Status KEGG Link p53 signaling pathway 4115 1.524E −06 0.1260 3.1620E −06 0.0003 0.0003 Activated http://www.genome.jp/dbget-bin/show_pathway?,Non-OADS,/arxiv_data1/oa_pdf/9e/fd/main.PMC4101344.pdf
hsa04115+3486+1647+4616+7057+8795+54205+1021+27244 MAPK signaling pathway 4010 1.829E −04 0.3150 6.2009E −04 0.0248 0.0670 Inhibited http://www.genome.jp/dbget-bin/show_pathway?,Non-OADS,/arxiv_data1/oa_pdf/9e/fd/main.PMC4101344.pdf
"hsa04010+11221+2247+627+9261+1649+51776+1647+4616+3554+4609+2872 Cell cycle 4110 6.475E −02 0.0010 6.8925E −04 0.0248 0.0744 Activated http://www.genome.jp/dbget-bin/show_pathway?hsa04110+1647+4616+1021+4609 KEGG, Kyoto encyclopedia of genes and genomes; pNDE, probability value for overrepresentation of differentially expressed genes in a given pathway ; pPERT, probability value for abnormal perturbation of that pathway, as measured by propagating measured expression changes across the pathway topology; pG, global probability value combining pNDE and pPERT ; pGFDR, pG (after false discovery rate-correction); pGFWER, pG (after familywise error rate-correction).",Non-OADS,/arxiv_data1/oa_pdf/9e/fd/main.PMC4101344.pdf
"E-mail: j.spliethoff@nki.nl Received 30 October 2013; Revised 7 December 2013; Accepted 2 January 2014 Copyright © 2014 Neoplasia Press, Inc. All rights reserved 1936-5233/14 http://dx.doi.org/10.1016/j.tranon.2014.02.009",Non-OADS,/arxiv_data1/oa_pdf/09/50/main.PMC4101345.pdf
"Received 3 December 2013; Revised 3 February 2014; Accepted 10 February 2014 Copyright © 2014 Neoplasia Press, Inc. All rights reserved 1936-5233/14 http://dx.doi.org/10.1016/j.tranon.2014.02.016",Non-OADS,/arxiv_data1/oa_pdf/08/bd/main.PMC4101347.pdf
Primers specific to each gene were designed using the Primer3Plus software ( http://www.bioinformatics.nl/cgi-bin/ primer3plus/primer3plus.cgi ) and synthesized by Invitrogen.,OADS,/arxiv_data1/oa_pdf/08/bd/main.PMC4101347.pdf
"E-mail: Linucmed@gmail.com Received 10 December 2013; Revised 2 January 2014; Accepted 15 January 2014 Copyright © 2014 Neoplasia Press, Inc. All rights reserved 1936-5233/14 http://dx.doi.org/10.1016/j.tranon.2014.02.010",Non-OADS,/arxiv_data1/oa_pdf/7b/89/main.PMC4101348.pdf
"Received 2 September 2013; Revised 3 January 2014; Accepted 30 January 2014 Copyright © 2014 Neoplasia Press, Inc. All rights reserved 1936-5233/14 http://dx.doi.org/10.1016/j.tranon.2014.02.012",Non-OADS,/arxiv_data1/oa_pdf/e2/fd/main.PMC4101349.pdf
"2This article refers to supplementary materials, which are designated by Tables W1 and W2 and Figures W1 and W2 and are available online at www.transonc.com.Received 14 November 2013; Revised 31 January 2014; Accepted 3 February 2014 Copyright © 2014 Neoplasia Press, Inc. All rights reserved 1936-5233/14 http://dx.doi.org/10.1016/j.tranon.2014.02.013",Non-OADS,/arxiv_data1/oa_pdf/f6/87/main.PMC4101350.pdf
"R Foundation for Statistical Computing, Vienna, Austria.ISBN 3-900051-07-0, http://www.r-project.org .",Non-OADS,/arxiv_data1/oa_pdf/f6/87/main.PMC4101350.pdf
"E-mail: jscicinski@radiorx.com Received 21 November 2013; Revised 7 January 2014; Accepted 30 January 2014 Copyright © 2014 Neoplasia Press, Inc. All rights reserved 1936-5233/14 http://dx.doi.org/10.1016/j.tranon.2014.02.001",Non-OADS,/arxiv_data1/oa_pdf/f7/ff/main.PMC4101386.pdf
"1This work was supported by the Dana-Farber/Harvard Cancer Center Kidney Cancer SPORE (Specialized Programs of Research Excellence) (NIH, National Institutes of Health,2P50CA101942-08), NIH K08 CA138900-03 to R.S.B., and a grant from Amgen.Received 19 September 2013; Revised 10 December 2013; Accepted 2 January 2014 Copyright © 2014 Neoplasia Press, Inc. All rights reserved 1936-5233/14 http://dx.doi.org/10.1016/j.tranon.2014.02.003",Non-OADS,/arxiv_data1/oa_pdf/d0/0a/main.PMC4101387.pdf
[25] http://wwwext.amgen.com/media/media_pr_detail.jsp?year=2013&releaseID= 1829205 .Translational Oncology Vol.,Non-OADS,/arxiv_data1/oa_pdf/d0/0a/main.PMC4101387.pdf
"Received 18 September 2013; Revised 18 September 2013; Accepted 22 November 2013 Copyright © 2014 Neoplasia Press, Inc. All rights reserved 1936-5233/14 http://dx.doi.org/10.1016/j.tranon.2014.02.004",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/main.PMC4101389.pdf
We present a series of five suchFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services 1,Non-OADS,/arxiv_data1/oa_pdf/0c/c4/tre-04-228-5577-1.PMC4101398.pdf
DBS in Ataxia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/0c/c4/tre-04-228-5577-1.PMC4101398.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/0c/c4/tre-04-228-5577-1.PMC4101398.pdf
DBS in Ataxia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/0c/c4/tre-04-228-5577-1.PMC4101398.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/0c/c4/tre-04-228-5577-1.PMC4101398.pdf
"Subthalamic-thalamic DBS in a case with spinocerebellar ataxia type 2 and severe tremor-A unusual clinical benefit.Mov Disord 2007;22:732–735, doi: http://dx.doi.org/10.1002/mds.21338.",Non-OADS,/arxiv_data1/oa_pdf/0c/c4/tre-04-228-5577-1.PMC4101398.pdf
"Annu Rev Med 2012;63:511–524, doi: http://dx.doi.org/ 10.1146/annurev-med-052209-100401.",Non-OADS,/arxiv_data1/oa_pdf/0c/c4/tre-04-228-5577-1.PMC4101398.pdf
"Mov Disord 2010;25:578–586, doi: http://dx.doi.org/10.1002/mds.22735.",OADS,/arxiv_data1/oa_pdf/0c/c4/tre-04-228-5577-1.PMC4101398.pdf
"Stereotact Funct Neurosurg 2012;90:84–91, doi: http://dx.doi.org/10.1159/000335706.",Non-OADS,/arxiv_data1/oa_pdf/0c/c4/tre-04-228-5577-1.PMC4101398.pdf
"Mov Disord 2011;26 Suppl 1:S54–62, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/0c/c4/tre-04-228-5577-1.PMC4101398.pdf
"Mov Disord 2009;24:149– 151, doi: http://dx.doi.org/10.1002/mds.22354.",OADS,/arxiv_data1/oa_pdf/0c/c4/tre-04-228-5577-1.PMC4101398.pdf
"Mov Disord 2003;18: 222–225, doi: http://dx.doi.org/10.1002/mds.10192.",OADS,/arxiv_data1/oa_pdf/0c/c4/tre-04-228-5577-1.PMC4101398.pdf
"Stereotact Funct Neurosurg 2005;83:131–134, doi: http://dx.doi.org/10.1159/000088159.",Non-OADS,/arxiv_data1/oa_pdf/0c/c4/tre-04-228-5577-1.PMC4101398.pdf
"Mov Disord 2012;27:799–800, doi: http://dx.doi.org/10.1002/mds.24958.",OADS,/arxiv_data1/oa_pdf/0c/c4/tre-04-228-5577-1.PMC4101398.pdf
"Arch Neurol 2003;60:117–121, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/0c/c4/tre-04-228-5577-1.PMC4101398.pdf
"Mov Disord 2012;27:797–9, doi: http://dx.doi.org/10.1002/mds.24923.",OADS,/arxiv_data1/oa_pdf/0c/c4/tre-04-228-5577-1.PMC4101398.pdf
"J Neurol 2011;258:1643–1648, doi: http://dx.doi.org/10.1007/s00415-011-5986-0.",Non-OADS,/arxiv_data1/oa_pdf/0c/c4/tre-04-228-5577-1.PMC4101398.pdf
"Parkinsonism Relat Disord 2013;19:684–686, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/0c/c4/tre-04-228-5577-1.PMC4101398.pdf
DBS in Ataxia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/0c/c4/tre-04-228-5577-1.PMC4101398.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial u se, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Microbial Ecology in Health & Disease 2014, 25: 23062 - http://dx.doi.org/10.3402/mehd.v25.23062 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/27/62/MEHD-25-23062.PMC4101457.pdf
"2 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2014, 25: 23062 - http://dx.doi.org/10.3402/mehd.v25.23062",Non-OADS,/arxiv_data1/oa_pdf/27/62/MEHD-25-23062.PMC4101457.pdf
"Composition and supplier of prebiotic oligosaccharides and soluble starch Carbohydrate source Purity (%) according to specification Other ingredients Supplier GOS90 PF , powder 96 2.3% lactose, 1.2% glucose, 0.3% galactoseFriesland Campina (Amersfoort, Netherlands) FOS, powder 95 5%: glucose, fructose and sucrose Orafti (Tienen, Belgium)XOS, powder 95 B5% xylose, arabinose Sweet Town Biotech (Taipei, Taiwan) Soluble starch from potato100 ND Merck (Darmstadt, Germany) GOS/C1galactooligosaccharides; FOS /C1fructooligosaccharides; XOS /C1xylooligosaccharides.Multistrain synbiotics in GITS Citation: Microbial Ecology in Health & Disease 2014, 25: 23062 - http://dx.doi.org/10.3402/mehd.v25.23062 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/27/62/MEHD-25-23062.PMC4101457.pdf
"4 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2014, 25: 23062 - http://dx.doi.org/10.3402/mehd.v25.23062",Non-OADS,/arxiv_data1/oa_pdf/27/62/MEHD-25-23062.PMC4101457.pdf
"B107/C1not detected ( B107cfu/mL); /C1strain not used in this experiment.Multistrain synbiotics in GITS Citation: Microbial Ecology in Health & Disease 2014, 25: 23062 - http://dx.doi.org/10.3402/mehd.v25.23062 5 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/27/62/MEHD-25-23062.PMC4101457.pdf
"6 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2014, 25: 23062 - http://dx.doi.org/10.3402/mehd.v25.23062",Non-OADS,/arxiv_data1/oa_pdf/27/62/MEHD-25-23062.PMC4101457.pdf
"(35), acetate produc- tion positively correlated with the concentration ofbifidobacteria ( R/C300.76, PB0.05) suggesting acetateMultistrain synbiotics in GITS Citation: Microbial Ecology in Health & Disease 2014, 25: 23062 - http://dx.doi.org/10.3402/mehd.v25.23062 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/27/62/MEHD-25-23062.PMC4101457.pdf
"8 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2014, 25: 23062 - http://dx.doi.org/10.3402/mehd.v25.23062",Non-OADS,/arxiv_data1/oa_pdf/27/62/MEHD-25-23062.PMC4101457.pdf
"Appl Environ Microbiol 2006; 72: 1006/C112.Multistrain synbiotics in GITS Citation: Microbial Ecology in Health & Disease 2014, 25: 23062 - http://dx.doi.org/10.3402/mehd.v25.23062 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/27/62/MEHD-25-23062.PMC4101457.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5719 | DOI: 10.1038/srep05719 4",Non-OADS,/arxiv_data1/oa_pdf/fc/f2/srep05719.PMC4101468.pdf
We expanded the investigationin this genetic area by also searching for additional SNPs identified in IL-6 in the database of dbSNP (http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/40/7e/srep05714.PMC4101469.pdf
We assessed the LD of the SNPs in our sample by using SHEsis (http://analysis.bio-x.cn).,OADS,/arxiv_data1/oa_pdf/40/7e/srep05714.PMC4101469.pdf
Additional information Funding: This work was supported by grants from National Natural Science Foundation of China (http://www.nsfc.gov.cn) (No.,Non-OADS,/arxiv_data1/oa_pdf/40/7e/srep05714.PMC4101469.pdf
"30801025),Excellent Young Scientist Foundation of Shandong Province (http://www.sdstc.gov.cn) (No.",Non-OADS,/arxiv_data1/oa_pdf/40/7e/srep05714.PMC4101469.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/40/7e/srep05714.PMC4101469.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5714 | DOI: 10.1038/srep05714 5",Non-OADS,/arxiv_data1/oa_pdf/40/7e/srep05714.PMC4101469.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c8/0f/srep05727.PMC4101470.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5727 | DOI: 10.1038/srep05727 7",Non-OADS,/arxiv_data1/oa_pdf/c8/0f/srep05727.PMC4101470.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5724 | DOI: 10.1038/srep05724 6",Non-OADS,/arxiv_data1/oa_pdf/f3/72/srep05724.PMC4101471.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e7/da/srep05718.PMC4101474.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1d/c0/srep05725.PMC4101522.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5725 | DOI: 10.1038/srep05725 6",Non-OADS,/arxiv_data1/oa_pdf/1d/c0/srep05725.PMC4101522.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5732 | DOI: 10.1038/srep05732 8",Non-OADS,/arxiv_data1/oa_pdf/b1/40/srep05732.PMC4101523.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e7/20/srep05717.PMC4101524.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5717 | DOI: 10.1038/srep05717 11",Non-OADS,/arxiv_data1/oa_pdf/e7/20/srep05717.PMC4101524.pdf
"Higuera, P. E. CRSModel: A program for chronology development from lead-210 measurements in continuous sediment record; http://code.google.com/p/crsmodel/.",OADS,/arxiv_data1/oa_pdf/a7/21/srep05723.PMC4101525.pdf
http://sites.google.com/site/charanalysis/.,Non-OADS,/arxiv_data1/oa_pdf/a7/21/srep05723.PMC4101525.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5723 | DOI: 10.1038/srep05723 7",Non-OADS,/arxiv_data1/oa_pdf/a7/21/srep05723.PMC4101525.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/80/aa/srep05715.PMC4101526.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5715 | DOI: 10.1038/srep05715 11",Non-OADS,/arxiv_data1/oa_pdf/80/aa/srep05715.PMC4101526.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4f/5b/srep05609.PMC4101527.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5609 | DOI: 10.1038/srep05609 10",Non-OADS,/arxiv_data1/oa_pdf/4f/5b/srep05609.PMC4101527.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/2b/main.PMC4101542.pdf
"Speci ﬁcations Organism/cell line/tissue Human dental pulp stem cells Sex N/A Sequencer or array type Affymetrix Human Genome Plus 2.0Data format Raw and analyzed Experimental factors Normal human dental pulp stem cells treated with various concentrations of ethanol in vitro Experimental features Time and dose dependency exposure experiment to compare molecular effects of ethanol on normalhuman dental pulp stem cells Consent N/A Sample source location N/A Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE57255Experimental design, materials and methods Cell culture Early passage DPSCs (P1 –P2) isolated from deciduous teeth have been obtained from Dr. Songtao Shi (Univ.",OADS,/arxiv_data1/oa_pdf/0e/2b/main.PMC4101542.pdf
http://dx.doi.org/10.1016/j.gdata.2014.06.011 2213-5960/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/2b/main.PMC4101542.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/2b/main.PMC4101542.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/0e/2b/main.PMC4101542.pdf
Q-values were generated to control the false discovery rate using “Qvalue ”Rp a c k a g e( http://www.bioconductor.org/ Fig.,OADS,/arxiv_data1/oa_pdf/0e/2b/main.PMC4101542.pdf
All statistical analysis was performed using R- 3.0.2 ( http://cran.r-project.org/bin/windows/base/old/3.0.2/ ).,OADS,/arxiv_data1/oa_pdf/0e/2b/main.PMC4101542.pdf
"REVIEW Korean J Intern Med 2014;29:409-415 http://dx.doi.org/10.3904/kjim.2014.29.4.409 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDiet, microbiota, and inflammatory bowel    disease: lessons from Japanese foods Takanori Kanai, Katsuyoshi Matsuoka, Makoto Naganuma, Atsushi Hayashi , and Tadakazu Hisamatsu Division of Gastroenterology  and Hepatology, Department of  Internal Medicine, Keio University  School of Medicine, Tokyo, Japan Received : June 3, 2014 Accepted: June 22, 2014 Correspondence to Takanori Kanai, M.D.",Non-OADS,/arxiv_data1/oa_pdf/68/86/kjim-29-409.PMC4101585.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.409had no contact with Western people or Western dietary  habits, and ate traditional Japanese foods.",Non-OADS,/arxiv_data1/oa_pdf/68/86/kjim-29-409.PMC4101585.pdf
"Diet, microbiota, and IBD www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.409proposed as major etiologic factors in the development  of both UC and CD [40,41].",Non-OADS,/arxiv_data1/oa_pdf/68/86/kjim-29-409.PMC4101585.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.409rine conjugation of hepatic bile acids by B. wadsworthi ,  with direct evidence showing that IL-10-deficient mice  fed a low-fat diet containing taurocholic acid, but not  glycocholic acid, developed colitis.",Non-OADS,/arxiv_data1/oa_pdf/68/86/kjim-29-409.PMC4101585.pdf
"Diet, microbiota, and IBD www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.409Acknowledgments We thank A. Hayashi at Keio University School of Med - icine for critical comments.",Non-OADS,/arxiv_data1/oa_pdf/68/86/kjim-29-409.PMC4101585.pdf
Available from: http://www.nanbyou.or.jp/entry/1356.,Non-OADS,/arxiv_data1/oa_pdf/68/86/kjim-29-409.PMC4101585.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/86/kjim-29-409.PMC4101585.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.409human microbiota.",OADS,/arxiv_data1/oa_pdf/68/86/kjim-29-409.PMC4101585.pdf
http://dx.doi.org/10.1016/j.feb - slet.2014.03.035.,OADS,/arxiv_data1/oa_pdf/68/86/kjim-29-409.PMC4101585.pdf
http://dx.doi.org/10.1016/j.crohns.2014.02.025.,OADS,/arxiv_data1/oa_pdf/68/86/kjim-29-409.PMC4101585.pdf
"Diet, microbiota, and IBD www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.409ducing macrophages to suppress acute experimental  colitis in mice.",Non-OADS,/arxiv_data1/oa_pdf/68/86/kjim-29-409.PMC4101585.pdf
"REVIEW Korean J Intern Med 2014;29:416-427 http://dx.doi.org/10.3904/kjim.2014.29.4.416 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgVitamin D and chronic kidney disease Chang Seong Kim and Soo Wan Kim Department of Internal Medicine,  Chonnam National University  Medical School, Gwangju, Korea Received : May 10, 2014 Accepted: May 23, 2014 Correspondence to Soo Wan Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/18/cc/kjim-29-416.PMC4101586.pdf
"417 Kim CS  and Kim SW. Vitamin D and CKD www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.416critical role of the vitamin D endocrine system in dis - ease prevention extends beyond the classic regulation  of calcium and phosphorous homeostasis and skeletal  integrity, to its potentially pleiotropic effects on extra - mineral metabolism, including kidney function.",Non-OADS,/arxiv_data1/oa_pdf/18/cc/kjim-29-416.PMC4101586.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.416messenger ribonucleic acid (mRNA), independently of  changes in parathyroid hormone (PTH) and calcium  levels [15,29].",OADS,/arxiv_data1/oa_pdf/18/cc/kjim-29-416.PMC4101586.pdf
419 Kim CS  and Kim SW. Vitamin D and CKD www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.416Table 1.,Non-OADS,/arxiv_data1/oa_pdf/18/cc/kjim-29-416.PMC4101586.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.416in CsA-treated rat kidneys [38].",Non-OADS,/arxiv_data1/oa_pdf/18/cc/kjim-29-416.PMC4101586.pdf
421 Kim CS  and Kim SW. Vitamin D and CKD www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.416peutic agents against solid tumors.,OADS,/arxiv_data1/oa_pdf/18/cc/kjim-29-416.PMC4101586.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.416hypertrophy in patients with stage 3 and 4 CKD [82].",Non-OADS,/arxiv_data1/oa_pdf/18/cc/kjim-29-416.PMC4101586.pdf
"423 Kim CS  and Kim SW. Vitamin D and CKD www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.416is that paricalcitol may have increased FGF-23 expres - sion, which directly induces cardiomyopathy in animal  models [84].",Non-OADS,/arxiv_data1/oa_pdf/18/cc/kjim-29-416.PMC4101586.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.416disease equation in Korean adult population.",Non-OADS,/arxiv_data1/oa_pdf/18/cc/kjim-29-416.PMC4101586.pdf
http://dx.doi.org/10.1002/ jcla.21688.,Non-OADS,/arxiv_data1/oa_pdf/18/cc/kjim-29-416.PMC4101586.pdf
425 Kim CS  and Kim SW. Vitamin D and CKD www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.41632.,OADS,/arxiv_data1/oa_pdf/18/cc/kjim-29-416.PMC4101586.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.4161253.",Non-OADS,/arxiv_data1/oa_pdf/18/cc/kjim-29-416.PMC4101586.pdf
427 Kim CS  and Kim SW. Vitamin D and CKD www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.41681.,Non-OADS,/arxiv_data1/oa_pdf/18/cc/kjim-29-416.PMC4101586.pdf
"EDITORIAL Korean J Intern Med 2014;29:428-429 http://dx.doi.org/10.3904/kjim.2014.29.4.428 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgReflux esophagitis is one of highly prevalent   comorbidities among patients with chronic    obstructive pulmonary disease Ki-Suck Jung Division of Pulmonary, Allergy  and Critical Care Medicine,  Department of Internal Medicine,  Hallym University Sacred Heart  Hospital, Anyang, Korea Received : June 5, 2014 Accepted: June 12, 2014 Correspondence to Ki-Suck Jung, M.D.",Non-OADS,/arxiv_data1/oa_pdf/33/a8/kjim-29-428.PMC4101587.pdf
Reflux esophagitis and chronic obstructive pulmonary disease http://dx.doi.org/10.3904/kjim.2014.29.4.428ergics were associated with a decreased risk of RE.,Non-OADS,/arxiv_data1/oa_pdf/33/a8/kjim-29-428.PMC4101587.pdf
"EDITORIAL Korean J Intern Med 2014;29:430-433 http://dx.doi.org/10.3904/kjim.2014.29.4.430 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgCan we more efficiently save patients with    vitamin K-dependent coagulopathy caused by   superwarfarin intoxication?",Non-OADS,/arxiv_data1/oa_pdf/7e/0a/kjim-29-430.PMC4101588.pdf
Efficient save patients with superwarfarin intoxication http://dx.doi.org/10.3904/kjim.2014.29.4.430lowed by a remeasurement after 24 to 48 hours can provide  an estimate of the duration of treatment needed [4].,Non-OADS,/arxiv_data1/oa_pdf/7e/0a/kjim-29-430.PMC4101588.pdf
"4, July 2014 http://dx.doi.org/10.3904/kjim.2014.29.4.430 cians must also be aware of more recent case reports that  highlight the potential simultaneous occurrence of co - agulopathy and thrombosis with superwarfarin intoxi - cation [6,10].",Non-OADS,/arxiv_data1/oa_pdf/7e/0a/kjim-29-430.PMC4101588.pdf
Efficient save patients with superwarfarin intoxication http://dx.doi.org/10.3904/kjim.2014.29.4.430Conflict of interest No potential conflict of interest relevant to this article  was reported.,Non-OADS,/arxiv_data1/oa_pdf/7e/0a/kjim-29-430.PMC4101588.pdf
"EDITORIAL Korean J Intern Med 2014;29:434-436 http://dx.doi.org/10.3904/kjim.2014.29.4.434 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgProper time to initiate antiosteoporotic treatment  in rheumatoid arthritis with or without     glucocorticoid use Sang-Won Lee Division of Rheumatology,  Department of Internal Medicine,  Yonsei University College of  Medicine, Seoul, Korea Received : May 5, 2014 Accepted: May 12, 2014 Correspondence to  Sang-Won Lee, M.D.",Non-OADS,/arxiv_data1/oa_pdf/65/04/kjim-29-434.PMC4101589.pdf
"435 www.kjim.org Lee SW. Antiosteoporotic treatment in rheumatoid arthritis  http://dx.doi.org/10.3904/kjim.2014.29.4.434determined to be a high risk factor for fracture, and thus  the authors suggested that the automatically calculated  FRAX should be considered first, before an assessment  of BMD [4].",Non-OADS,/arxiv_data1/oa_pdf/65/04/kjim-29-434.PMC4101589.pdf
"4, July 2014 http://dx.doi.org/10.3904/kjim.2014.29.4.434 be encouraged to apply one more the guidelines for an - tiosteoporotic treatment other than the ACR 2010 rec - ommendations for GIOP to patients with RA regardless  of glucocorticoid use, to reduce the fracture rate by early  detection and treatment.",Non-OADS,/arxiv_data1/oa_pdf/65/04/kjim-29-434.PMC4101589.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:437-444 http://dx.doi.org/10.3904/kjim.2014.29.4.437  Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDepartment of Internal Medicine,  Chonnam National University  Medical School, Gwangju, Korea Received : September 29, 2013 Revised : October 28, 2013 Accepted : December 3, 2013 Correspondence to  Sung Kyu Choi, M.D.",Non-OADS,/arxiv_data1/oa_pdf/01/d3/kjim-29-437.PMC4101590.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.437using N-butyl-2-cyanoacrylate (NBC; Histoacryl, B.  Braun Dexon GmbH, Spangenberg, Germany) [5,6].",Non-OADS,/arxiv_data1/oa_pdf/01/d3/kjim-29-437.PMC4101590.pdf
GVO in gastric var  iceal hemorrhage www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.437Statistical analysis Continuous variables are expressed as means ± stan - dard deviation.,OADS,/arxiv_data1/oa_pdf/01/d3/kjim-29-437.PMC4101590.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.437(61.5%) had GOV1 and 175 (38.5%) had GOV2.",OADS,/arxiv_data1/oa_pdf/01/d3/kjim-29-437.PMC4101590.pdf
"GVO in gastric var  iceal hemorrhage www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.437Cause of bleeding-related death During the long-term follow-up, 31 patients (6.8%)  died.",Non-OADS,/arxiv_data1/oa_pdf/01/d3/kjim-29-437.PMC4101590.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.437and more often fatal than is hemorrhage from EVs [3].",Non-OADS,/arxiv_data1/oa_pdf/01/d3/kjim-29-437.PMC4101590.pdf
"GVO in gastric var  iceal hemorrhage www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.437Child-Pugh score and associated HCC are risk factors  for bleeding-related death [6,22,23], while another  study reported that MELD score is a risk factor [24,25];  our study showed these relationships only on univari - ate analysis.",Non-OADS,/arxiv_data1/oa_pdf/01/d3/kjim-29-437.PMC4101590.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.437endoscopic sclerotherapy with N-butyl-2-cyanoacrylate  for bleeding gastric varices.",Non-OADS,/arxiv_data1/oa_pdf/01/d3/kjim-29-437.PMC4101590.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:445-453 http://dx.doi.org/10.3904/kjim.2014.29.4.445 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Division of C ardiology, Severance  Cardiovascular Hospital, Yonsei  University College of Medicine,  Seoul ; Divisions of 2Hematology  and Oncology and 3Cardiology,  Department of Internal Medicine,  Ewha Womans University School  of Medicine , Seoul, Korea Received : August 3, 2013 Revised : September 4, 2013 Accepted : October 28, 2013 Correspondence to  Ki Hwan Kwon, M.D.",Non-OADS,/arxiv_data1/oa_pdf/da/e3/kjim-29-445.PMC4101591.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.445but its association with diastolic dysfunction is not  well understood.",Non-OADS,/arxiv_data1/oa_pdf/da/e3/kjim-29-445.PMC4101591.pdf
"Effect of anemia correction on left ventricle www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.445Statistical analysis Continuous variables are expressed as means ± stan - dard deviations, and categorical variables as numbers  and proportions (%).",Non-OADS,/arxiv_data1/oa_pdf/da/e3/kjim-29-445.PMC4101591.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.445cantly lower on follow-up, and mean hemoglobin was  increased significantly compared with the baseline  level (5.8 ± 1.3 g/dL vs. 12.5 ± 1.4 g/dL; p < 0.001).",Non-OADS,/arxiv_data1/oa_pdf/da/e3/kjim-29-445.PMC4101591.pdf
Effect of anemia correction on left ventricle www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.445Treatment of anemia improved exercise capacity and  symptoms in symptomatic heart failure patients [17- 19].,Non-OADS,/arxiv_data1/oa_pdf/da/e3/kjim-29-445.PMC4101591.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.445et al.",OADS,/arxiv_data1/oa_pdf/da/e3/kjim-29-445.PMC4101591.pdf
Effect of anemia correction on left ventricle www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.445E/E’ and LV structural changes in anemic patients.,Non-OADS,/arxiv_data1/oa_pdf/da/e3/kjim-29-445.PMC4101591.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.445failure.",Non-OADS,/arxiv_data1/oa_pdf/da/e3/kjim-29-445.PMC4101591.pdf
Effect of anemia correction on left ventricle www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.445and blood vessels.,Non-OADS,/arxiv_data1/oa_pdf/da/e3/kjim-29-445.PMC4101591.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:454-465 http://dx.doi.org/10.3904/kjim.2014.29.4.454 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDepartments of 1Radiology and  2Internal Medicine, Chosun  University School of Medicine,  Gwangju, Korea Received : April 24, 2013 Revised : September 4, 2013 Accepted : October 28, 2013 Correspondence to Dong-Hyun Choi, M.D.",Non-OADS,/arxiv_data1/oa_pdf/08/e4/kjim-29-454.PMC4101592.pdf
Infarct transmurality prediction by T3 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.454[10-12].,Non-OADS,/arxiv_data1/oa_pdf/08/e4/kjim-29-454.PMC4101592.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.454LV volume).",Non-OADS,/arxiv_data1/oa_pdf/08/e4/kjim-29-454.PMC4101592.pdf
Infarct transmurality prediction by T3 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.454of glycoprotein IIb/IIIa inhibitor(s).,Non-OADS,/arxiv_data1/oa_pdf/08/e4/kjim-29-454.PMC4101592.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.454Angiographic and procedural data on patients with  T3 values below and above the cutoff Table 2 shows the angiographic and procedural results.",Non-OADS,/arxiv_data1/oa_pdf/08/e4/kjim-29-454.PMC4101592.pdf
Infarct transmurality prediction by T3 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.454the high T3 group upon CE-CMR imaging.,OADS,/arxiv_data1/oa_pdf/08/e4/kjim-29-454.PMC4101592.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.454independent risk factor for transmural infarction was  a high T3 level ( ≥ 68.3 ng/dL) (Table 4).",OADS,/arxiv_data1/oa_pdf/08/e4/kjim-29-454.PMC4101592.pdf
Infarct transmurality prediction by T3 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.454analysis.,Non-OADS,/arxiv_data1/oa_pdf/08/e4/kjim-29-454.PMC4101592.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.454To our knowledge, this is the first study to explore the  predictive utility of thyroid hormone levels (especially  that of T3) as biomarkers of the extent of transmural  infarction in STEMI patients.",Non-OADS,/arxiv_data1/oa_pdf/08/e4/kjim-29-454.PMC4101592.pdf
"Infarct transmurality prediction by T3 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.454in such patients but also the involvement of other (un - known) intracellular signaling pathways associated  with the response to stress and cardiac remodeling  [37,38].",Non-OADS,/arxiv_data1/oa_pdf/08/e4/kjim-29-454.PMC4101592.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.4541997;82:765-770.",Non-OADS,/arxiv_data1/oa_pdf/08/e4/kjim-29-454.PMC4101592.pdf
Infarct transmurality prediction by T3 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.454mance in patients with heart failure: potential thera - peutic implications.,Non-OADS,/arxiv_data1/oa_pdf/08/e4/kjim-29-454.PMC4101592.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/e4/kjim-29-454.PMC4101592.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:466-473 http://dx.doi.org/10.3904/kjim.2014.29.4.466 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Division of Pulmonary and Criti - cal Care Medicine, Department of  Internal Medicine, Ewha Medical  Research Institute , Ewha Womans  University School of Medicine,  Seoul;  2Division of Pulmonary, Al - lergy and Critical Care Medicine,  Department of Internal Medicine,  Hallym University Kangnam Sa - cred Heart Hospital , Seoul, Korea Received : May 9, 2013 Revised : October 2, 2013 Accepted : December 4, 2013 Correspondence to  Jin Hwa Lee, M.D.",Non-OADS,/arxiv_data1/oa_pdf/f0/f0/kjim-29-466.PMC4101593.pdf
Reflux esophagitis in COPD patients www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.466without COPD [4-7].,Non-OADS,/arxiv_data1/oa_pdf/f0/f0/kjim-29-466.PMC4101593.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.466predicted ( p = 0.017), and FEV1 than those without RE  (p = 0.010), there was no difference in FEV1% predicted  or the severity of airflow limitation by GOLD (Table 3).",OADS,/arxiv_data1/oa_pdf/f0/f0/kjim-29-466.PMC4101593.pdf
"Reflux esophagitis in COPD patients www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.466body mass indices, lower secretion of gastric acid, and  higher pressure in the lower esophageal sphincter than  Westerners.",Non-OADS,/arxiv_data1/oa_pdf/f0/f0/kjim-29-466.PMC4101593.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.466al studies measuring esophageal pH have shown sim - ilar results [7,15].",Non-OADS,/arxiv_data1/oa_pdf/f0/f0/kjim-29-466.PMC4101593.pdf
"Reflux esophagitis in COPD patients www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.466Inhaled anticholinergics, which block the muscarinic  receptors from the larynx to the smallest airway and  alveoli, are prescribed as a bronchodilator for COPD  patients.",Non-OADS,/arxiv_data1/oa_pdf/f0/f0/kjim-29-466.PMC4101593.pdf
Available from:  http://www.goldcopd.,Non-OADS,/arxiv_data1/oa_pdf/f0/f0/kjim-29-466.PMC4101593.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.466exacerbations and mortality in patients with chronic ob - structive pulmonary disease.",Non-OADS,/arxiv_data1/oa_pdf/f0/f0/kjim-29-466.PMC4101593.pdf
Reflux esophagitis in COPD patients www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.46627.,Non-OADS,/arxiv_data1/oa_pdf/f0/f0/kjim-29-466.PMC4101593.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:474-481 http://dx.doi.org/10.3904/kjim.2014.29.4.474 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Division of Endocrinology,   De partment of Internal Medicine,  Asan Medical Center , University of  Ulsan College of Medicine , Seoul;  2Asan Institute for Life Science ,  Seoul, Korea Received : April 23, 2013 Revised : July 23, 2013 Accepted : September 1, 2013 Correspondence to  Tae Yong Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/59/51/kjim-29-474.PMC4101594.pdf
"Anticancer effects of AMPK activation www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.474azole-4-carboxamide-ribonucleotide (AICAR), a strong  AMPK activator, are mediated by genetic mutations or  are regulated in a cell-type specific manner [4-6].",Non-OADS,/arxiv_data1/oa_pdf/59/51/kjim-29-474.PMC4101594.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.474siRNA) were used at the same concentration to screen  for effective siRNAs.",OADS,/arxiv_data1/oa_pdf/59/51/kjim-29-474.PMC4101594.pdf
"Anticancer effects of AMPK activation www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.474changes in the phosphorylation status of MAPK mol - ecules (ERK, p38, and JNK) by Western blot analysis.",OADS,/arxiv_data1/oa_pdf/59/51/kjim-29-474.PMC4101594.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.474(Fig.",Non-OADS,/arxiv_data1/oa_pdf/59/51/kjim-29-474.PMC4101594.pdf
Anticancer effects of AMPK activation www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.474activity and thereby inhibited the metastatic potential  of human melanoma cells [10].,Non-OADS,/arxiv_data1/oa_pdf/59/51/kjim-29-474.PMC4101594.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.474REFERENCES  1.",Non-OADS,/arxiv_data1/oa_pdf/59/51/kjim-29-474.PMC4101594.pdf
Anticancer effects of AMPK activation www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.47422.,Non-OADS,/arxiv_data1/oa_pdf/59/51/kjim-29-474.PMC4101594.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:482-488 http://dx.doi.org/10.3904/kjim.2014.29.4.482 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDivision of Nephrology,  Department of Internal Medicine,  The Catholic University of Korea  College of Medicine, Seoul, Korea Received : July 9, 2013 Revised : August 27, 2013 Accepted : September 23, 2013 Correspondence to Chul Woo Yang, M.D.",Non-OADS,/arxiv_data1/oa_pdf/58/69/kjim-29-482.PMC4101595.pdf
Plasmapheresis and rituximab in FSGS www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.482METHODS This study was approved by the Institutional Review  Board (IRB) of Seoul St. Mary’s Hospital (IRB No.,Non-OADS,/arxiv_data1/oa_pdf/58/69/kjim-29-482.PMC4101595.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.482Chicago, IL, USA).",Non-OADS,/arxiv_data1/oa_pdf/58/69/kjim-29-482.PMC4101595.pdf
"Plasmapheresis and rituximab in FSGS www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.482DISCUSSION Risk factors for FSGS recurrence include prior history  of allograft loss due to FSGS recurrence, which is the  most important, as well as rapidly progressive disease  in native kidney and pediatric renal transplantation.",Non-OADS,/arxiv_data1/oa_pdf/58/69/kjim-29-482.PMC4101595.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.482pediatric FSGS cases, favorable responses to PP and  high-dose cyclosporine after recurrence have been re - ported [6,7].",Non-OADS,/arxiv_data1/oa_pdf/58/69/kjim-29-482.PMC4101595.pdf
Plasmapheresis and rituximab in FSGS www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.482plantation.,Non-OADS,/arxiv_data1/oa_pdf/58/69/kjim-29-482.PMC4101595.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.48216.",Non-OADS,/arxiv_data1/oa_pdf/58/69/kjim-29-482.PMC4101595.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:489-497 http://dx.doi.org/10.3904/kjim.2014.29.4.489 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDivision of Nephrology,  Department of Internal Medicine,  Soonchunhyang University Bu - cheon Hospital, Bucheon , Korea Received : September 23, 2013 Revised : October 31, 2013 Accepted : November 11, 2013 Correspondence to  Soo Jeong Choi, M.D.",Non-OADS,/arxiv_data1/oa_pdf/88/f1/kjim-29-489.PMC4101596.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.489es reactive oxygen species formation [9].",OADS,/arxiv_data1/oa_pdf/88/f1/kjim-29-489.PMC4101596.pdf
Ferritin and residual renal function in PD patients www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.489complete data sets followed up for at least 1 year were  enrolled.,Non-OADS,/arxiv_data1/oa_pdf/88/f1/kjim-29-489.PMC4101596.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.489cantly at the 1-year follow-up (2.45 mL/min/1.73 m2 [1.34,  4.01] vs. 1.37 mL/min/1.73 m2 [0.18, 2.37], p < 0.001; data  not shown).",OADS,/arxiv_data1/oa_pdf/88/f1/kjim-29-489.PMC4101596.pdf
"Ferritin and residual renal function in PD patients www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.489respectively, p = 0.007) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/88/f1/kjim-29-489.PMC4101596.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.489PD patients after adjusting for other risk factors.",Non-OADS,/arxiv_data1/oa_pdf/88/f1/kjim-29-489.PMC4101596.pdf
"Ferritin and residual renal function in PD patients www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.489tumor necrosis factor, increase the synthesis of both the  H and L subunits of ferritin by inducing ferritin gene  expression independently of iron-dependent ferritin  gene expression [20,26].",Non-OADS,/arxiv_data1/oa_pdf/88/f1/kjim-29-489.PMC4101596.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.489REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/88/f1/kjim-29-489.PMC4101596.pdf
Ferritin and residual renal function in PD patients www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.4891999;33:63-72.,Non-OADS,/arxiv_data1/oa_pdf/88/f1/kjim-29-489.PMC4101596.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:498-508 http://dx.doi.org/10.3904/kjim.2014.29.4.498 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDivision of Hematology and  Oncology, Department of Internal  Medicine, Chosun University  Hospital, Gwangju, Korea Received : May 14, 2013 Revised : July 22, 2013 Accepted : October 4, 2013 Correspondence to  Sang-Gon Park, M.D.",Non-OADS,/arxiv_data1/oa_pdf/aa/4f/kjim-29-498.PMC4101597.pdf
"Vitamin K-dependent coagulopathy by exposure to brodifacoum www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.498ports suggest that patients manifested Munchausen  syndrome, or had developed rodenticide intoxication  via a nonoral route, such as inhalation or absorption  through the skin [1,3,4].",Non-OADS,/arxiv_data1/oa_pdf/aa/4f/kjim-29-498.PMC4101597.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.498gested, because of their psychological conditions.",Non-OADS,/arxiv_data1/oa_pdf/aa/4f/kjim-29-498.PMC4101597.pdf
Vitamin K-dependent coagulopathy by exposure to brodifacoum www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.498various hemorrhagic symptoms and were diagnosed  with vitamin K-dependent coagulopathies based on  evaluation of the levels of coagulation factors.,Non-OADS,/arxiv_data1/oa_pdf/aa/4f/kjim-29-498.PMC4101597.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.498(patient 1); and one was a demolition worker (patient 6).",Non-OADS,/arxiv_data1/oa_pdf/aa/4f/kjim-29-498.PMC4101597.pdf
"Vitamin K-dependent coagulopathy by exposure to brodifacoum www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.498ductions in the levels of vitamin K-dependent clotting  factors (factor II, VII, IX, and X; protein C; protein S;  and antithrombin III).",Non-OADS,/arxiv_data1/oa_pdf/aa/4f/kjim-29-498.PMC4101597.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.498quires a blood test featuring the use of HPLC.",Non-OADS,/arxiv_data1/oa_pdf/aa/4f/kjim-29-498.PMC4101597.pdf
Vitamin K-dependent coagulopathy by exposure to brodifacoum www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.498centration ratios (ca.,Non-OADS,/arxiv_data1/oa_pdf/aa/4f/kjim-29-498.PMC4101597.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.498superwarfarin intoxication.",Non-OADS,/arxiv_data1/oa_pdf/aa/4f/kjim-29-498.PMC4101597.pdf
Vitamin K-dependent coagulopathy by exposure to brodifacoum www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.498soning leading to prolonged coagulopathy.,Non-OADS,/arxiv_data1/oa_pdf/aa/4f/kjim-29-498.PMC4101597.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.49841.",Non-OADS,/arxiv_data1/oa_pdf/aa/4f/kjim-29-498.PMC4101597.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:509-515 http://dx.doi.org/10.3904/kjim.2014.29.4.509 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Department of Internal Medicine ,  Inje University Ilsan Paik Hospital,  Goyang ; 2Department of Rheu - matology, Hanyang University  Hospital for Rheumatic Diseases,  Seoul, Korea   Received : March 30, 2013 Revised : May 8, 2013 Accepted : September 4, 2013 Correspondence to  Yoon-Kyoung Sung, M.D.",Non-OADS,/arxiv_data1/oa_pdf/63/24/kjim-29-509.PMC4101598.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.509contributors to the risk of fracture [3].",Non-OADS,/arxiv_data1/oa_pdf/63/24/kjim-29-509.PMC4101598.pdf
The 10-year probabilities of a major osteoporotic  fracture and of a hip fracture were calculated using  the FRAX tool (http://www.shef.ac.uk/FRAX) with  femoral neck BMD.,OADS,/arxiv_data1/oa_pdf/63/24/kjim-29-509.PMC4101598.pdf
Osteoporosis treatment guidelines in RA patients www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.509Assessment of VFs All enrolled patients underwent lateral plain radio - graphs of the thoracolumbar spine.,Non-OADS,/arxiv_data1/oa_pdf/63/24/kjim-29-509.PMC4101598.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.509during  this time, and the combination of suppressed  bone formation and increased bone resorption during  the early phase of therapy [10].",Non-OADS,/arxiv_data1/oa_pdf/63/24/kjim-29-509.PMC4101598.pdf
Osteoporosis treatment guidelines in RA patients www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.509GIOP recommendations should be assessed using the  NOF guidelines.,Non-OADS,/arxiv_data1/oa_pdf/63/24/kjim-29-509.PMC4101598.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.509for these patients.",Non-OADS,/arxiv_data1/oa_pdf/63/24/kjim-29-509.PMC4101598.pdf
Osteoporosis treatment guidelines in RA patients www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.509Rheumatol Rep 2007;9:78-84.,Non-OADS,/arxiv_data1/oa_pdf/63/24/kjim-29-509.PMC4101598.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:516-524 http://dx.doi.org/10.3904/kjim.2014.29.4.516 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Division of Rheumatology,  Department of Internal Medicine,  Arthritis and Autoimmunity  Research Center, 2Division of  Infectious Diseases, Department  of Internal Medicine, Catholic  University of Daegu School of  Medicine, Daegu, Korea Received : December 11, 2013 Revised : January 7, 2014 Accepted : January 28, 2014 Correspondence to  Seong-Kyu Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/c5/86/kjim-29-516.PMC4101599.pdf
"REE and disease activity index www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.516mass (FFM), and loss of body cell mass [3,4].",OADS,/arxiv_data1/oa_pdf/c5/86/kjim-29-516.PMC4101599.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.516Diagnostics GmbH, Mannheim, Germany).",Non-OADS,/arxiv_data1/oa_pdf/c5/86/kjim-29-516.PMC4101599.pdf
"REE and disease activity index www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.516steroids, taken in the nonremission group were higher  than in the remission group, but those of HCQ, SSZ,  lef lunomide, tacrolimus, and biologics were similar  between the two groups.",OADS,/arxiv_data1/oa_pdf/c5/86/kjim-29-516.PMC4101599.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.516Table 2.",Non-OADS,/arxiv_data1/oa_pdf/c5/86/kjim-29-516.PMC4101599.pdf
"REE and disease activity index www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.516patient-reported functional capacity, BMI, disease  duration, and anti-CCP antibody level, using the AN - COVA method (Table 5).",OADS,/arxiv_data1/oa_pdf/c5/86/kjim-29-516.PMC4101599.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.516dividual components or composites of disease activity  indices were associated with REE.",OADS,/arxiv_data1/oa_pdf/c5/86/kjim-29-516.PMC4101599.pdf
REE and disease activity index www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.516systemic inflammation characteristic of RA.,OADS,/arxiv_data1/oa_pdf/c5/86/kjim-29-516.PMC4101599.pdf
"4, July 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.516activity on fat-free mass and resting energy expenditure  in patients with rheumatoid arthritis versus nonin - flammatory arthropathies/soft tissue rheumatism.",Non-OADS,/arxiv_data1/oa_pdf/c5/86/kjim-29-516.PMC4101599.pdf
"LETTER TO THE EDITOR Korean J Intern Med 2014;29:525-528 http://dx.doi.org/10.3904/kjim.2014.29.4.525 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgThe Heart Center, Chonnam  National University Hospital, and  Research Institute of Medical  Sciences, Chonnam National  University Medical School,  Gwangju, KoreaA case of myocardial involvement in lung cancer  that mimics ST segment elevation in myocardial  infarction Kye Hun Kim, Myung Ho Jeong, Hyun Ju Yoon, Youngkeun Ahn, Jeong Gwan Cho, Jong Chun Park,   and Jung Chaee Kang Received : July 24, 2008 Revised : August 18, 2008 Accepted : September 8, 2008 Correspondence to Myung Ho Jeong, M.D.",Non-OADS,/arxiv_data1/oa_pdf/cd/f3/kjim-29-525.PMC4101600.pdf
526 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.525 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/cd/f3/kjim-29-525.PMC4101600.pdf
"527 http://dx.doi.org/10.3904/kjim.2014.29.4.525 Kim KH, et al.",OADS,/arxiv_data1/oa_pdf/cd/f3/kjim-29-525.PMC4101600.pdf
528 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.525 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/cd/f3/kjim-29-525.PMC4101600.pdf
"LETTER TO THE EDITOR Korean J Intern Med 2014;29:529-531 http://dx.doi.org/10.3904/kjim.2014.29.4.529 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgThe Heart Center , Chonnam  National University Hospital , and  The Research Institute of Medical  Science, Chonnam National Uni - versity Medical School , Gwangju ,  KoreaAcute right heart failure caused by iatrogenic   brachiocephalic arteriovenous fistula following  orthopedic surgery Kye Hun Kim, Hyun Ju Yoon, Youngkeun Ahn, Myung Ho Jeong , Jeong Gwan Cho, Jong Chun Park ,   and Jung Chaee Kang Received : October 13, 2008 Revised : December 4, 2008 Accepted : December 11, 2008 Correspondence to  Jong Chun Park, M.D.",Non-OADS,/arxiv_data1/oa_pdf/8c/96/kjim-29-529.PMC4101601.pdf
530 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.529 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/8c/96/kjim-29-529.PMC4101601.pdf
"531 http://dx.doi.org/10.3904/kjim.2014.29.4.529 Kim KH, et al.",OADS,/arxiv_data1/oa_pdf/8c/96/kjim-29-529.PMC4101601.pdf
"LETTER TO THE EDITOR Korean J Intern Med 2014;29:532-534 http://dx.doi.org/10.3904/kjim.2014.29.4.532 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDepartment of Internal Medicine,  Seoul St. Mary’s Hospital, The  Catholic University of Korea  College of Medicine, Seoul, KoreaRecurrent neutropenia induced by rifabutin in    a renal transplant recipient Ji Yeun Chang, Eun Gyo Jeong, Ji Hyun Yu, Byung Ha Chung , and Chul Woo Yang Received : August 30, 2013 Revised : December 31, 2013 Accepted : March 9, 2014 Correspondence to Chul Woo Yang, M.D.",Non-OADS,/arxiv_data1/oa_pdf/fa/c1/kjim-29-532.PMC4101602.pdf
"533 http://dx.doi.org/10.3904/kjim.2014.29.4.532 Chang JY, et al.",OADS,/arxiv_data1/oa_pdf/fa/c1/kjim-29-532.PMC4101602.pdf
534 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.532 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/fa/c1/kjim-29-532.PMC4101602.pdf
"LETTER TO THE EDITOR Korean J Intern Med 2014;29:535-538 http://dx.doi.org/10.3904/kjim.2014.29.4.535 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDepartments of 1Internal Medicine  and 2Pathology, Eulji General  Hospital, Eulji University School of  Medicine, Seoul; 3Department of  Internal Medicine, Inje University  Ilsan Paik Hospital, Goyang, KoreaSubcutaneous sarcoidosis presenting as a suprapubic  mass, acute kidney injury, and hypercalcemia Jeong Min Kim1, Yoon Kyeong Song1, Seon Jin Park1, Young-Hwan Hwang1, Su Ah Sung1, So Young Lee1,  Jong Eun Joo2, and Se Won Oh3 Received : December 16, 2013 Revised : January 6, 2014 Accepted : April 7, 2014 Correspondence to  Se Won Oh, M.D.",Non-OADS,/arxiv_data1/oa_pdf/20/75/kjim-29-535.PMC4101603.pdf
536 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.535 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/20/75/kjim-29-535.PMC4101603.pdf
"537 http://dx.doi.org/10.3904/kjim.2014.29.4.535 Kim JM, et al.",OADS,/arxiv_data1/oa_pdf/20/75/kjim-29-535.PMC4101603.pdf
538 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.535 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/20/75/kjim-29-535.PMC4101603.pdf
"LETTER TO THE EDITOR Korean J Intern Med 2014;29:539-541 http://dx.doi.org/10.3904/kjim.2014.29.4.539 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Department of General Medicine,  Hokkaido Social Insurance  Hospital, Sapporo; 2Department of  Medicine Ⅱ, Hokkaido University  Graduate School of Medicine,  Sapporo, JapanSuccessful treatment with clarithromycin for   patients with polymyalgia rheumatica Masashi Ohe1 and Toshiyuki Bohgaki2 Received : January 20, 2014 Revised : February 26, 2014 Accepted : March 13, 2014 Correspondence to  Masashi Ohe, M.D.",Non-OADS,/arxiv_data1/oa_pdf/0b/f2/kjim-29-539.PMC4101604.pdf
540 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.4.539 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/0b/f2/kjim-29-539.PMC4101604.pdf
"541 http://dx.doi.org/10.3904/kjim.2014.29.4.539 Ohe M and Bohgaki T. Clarithromycin for polymyalgia rheumatica www.kjim.orging effects via their influence on corticosteroid metab - olism, not only the above-mentioned anti-inflamma - tory effects but also their steroid-sparing effects might  have resulted in the improved signs and symptoms.",Non-OADS,/arxiv_data1/oa_pdf/0b/f2/kjim-29-539.PMC4101604.pdf
"Korean J Intern Med 2014;29:542-543 http://dx.doi.org/10.3904/kjim.2014.29.4.542 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org IMAGE OF INTERESTA 25-year-old female with a 3-year history  of rheumatoid arthritis (RA) underwent  a 3-dimensional volume-rendered com - puted tomography (CT) scan of the tho - racic spine for further investigation of  thoracic spine abnormalities incidentally  discovered on a routine chest X-ray.",Non-OADS,/arxiv_data1/oa_pdf/fd/47/kjim-29-542.PMC4101605.pdf
543 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.,Non-OADS,/arxiv_data1/oa_pdf/fd/47/kjim-29-542.PMC4101605.pdf
"Korean J Intern Med 2014;29:544-545 http://dx.doi.org/10.3904/kjim.2014.29.4.544 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org IMAGE OF INTERESTA 52-year-old male was referred for  treatment of a 4-month history of right  palmar numbness and tingling that  was unresponsive to analgesics.",Non-OADS,/arxiv_data1/oa_pdf/f9/d1/kjim-29-544.PMC4101606.pdf
545 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.,Non-OADS,/arxiv_data1/oa_pdf/f9/d1/kjim-29-544.PMC4101606.pdf
"ERRATUM Korean J Intern Med 2014;29:546 http://dx.doi.org/10.3904/kjim.2014.29.4.546 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgKorean J Intern Med.",Non-OADS,/arxiv_data1/oa_pdf/d6/8a/kjim-29-546.PMC4101607.pdf
"2014;29:393-397. http://dx.doi.org/10.3904/kjim.2014.29.3.393 In the article cited above, Fig.",Non-OADS,/arxiv_data1/oa_pdf/d6/8a/kjim-29-546.PMC4101607.pdf
"[a]C. I. M. Santos University of Aveiro and BIOSCOPE GroupMonte de Caparica, Campus de Caparica 2829-516 Caparica (Portugal) E-mail: csantos420@gmail.com Supporting information for this article is available on the WWW under http://dx.doi.org/10.1002/open.201402001.",Non-OADS,/arxiv_data1/oa_pdf/60/6c/open0003-0088.PMC4101723.pdf
R. China) E-mail: Mshi@mail.sioc.ac.cn Supporting information for this article is available on the WWW underhttp://dx.doi.org/10.1002/open.201402003.,Non-OADS,/arxiv_data1/oa_pdf/50/32/open0003-0093.PMC4101724.pdf
"D. Sçnnichsen, Prof. T. K. LindhorstOtto Diels Institute of Organic Chemistry Christiana Albertina University of Kiel Otto-Hahn-Platz 3/4, 24118 Kiel (Germany) E-mail: tklind@oc.uni-kiel.de Supporting information for this article is available on the WWW underhttp://dx.doi.org/10.1002/open.201402010.",Non-OADS,/arxiv_data1/oa_pdf/98/3b/open0003-0099.PMC4101725.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Does Intravenous Ketamine Enhance Analgesia after  Arthroscopic Shoulder Surgery with Ultrasound Guided Single- Injection Interscalene Block?",Non-OADS,/arxiv_data1/oa_pdf/82/f6/jkms-29-1001.PMC4101767.pdf
"Keywords:  Ketamine; Interscalene Nerve Block; Shoulder Surgery; Pain, PostoperativeJae Hee Woo, Youn Jin Kim,   Hee Jung Baik, Jong In Han,   and Rack Kyung Chung Department of Anesthesiology and Pain Medicine,  School of Medicine, Ewha Womans University,  Seoul, Korea Received: 26 December 2013 Accepted: 30 April 2014 Address for Correspondence: Youn Jin Kim, MD Department of Anesthesiology and Pain Medicine, School of  Medicine, Ewha Womans University, 1071 Anyangcheon-ro,  Yangcheon-gu, Seoul 158-710, Korea Tel: +82.2-2650-2885, Fax: +82.2-2655-2924 E-mail: ankyj@ewha.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.7.1001  • J Korean Med Sci 2014; 29: 1001-1006 INTRODUCTION Arthroscopic shoulder surgery (ASS) is associated with moder - ate to severe postoperative pain, which is comparable to the  pain following a gastrectomy or thoracotomy and can require  intensive pain management for several days (1-3).",Non-OADS,/arxiv_data1/oa_pdf/82/f6/jkms-29-1001.PMC4101767.pdf
• Ketamine and Single Shot Interscalene Block  1002  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.1001operative ketamine infusion during general anesthesia com - bined with an SSISB would provide an additional benefit to the  SSISB with a limited duration.,Non-OADS,/arxiv_data1/oa_pdf/82/f6/jkms-29-1001.PMC4101767.pdf
• Ketamine and Single Shot Interscalene Block  http://jkms.org   1003 http://dx.doi.org/10.3346/jkms.2014.29.7.1001tically significant.,Non-OADS,/arxiv_data1/oa_pdf/82/f6/jkms-29-1001.PMC4101767.pdf
• Ketamine and Single Shot Interscalene Block  1004  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.1001group K; all cases resolved by the following day.,Non-OADS,/arxiv_data1/oa_pdf/82/f6/jkms-29-1001.PMC4101767.pdf
"• Ketamine and Single Shot Interscalene Block  http://jkms.org   1005 http://dx.doi.org/10.3346/jkms.2014.29.7.1001the neurologic risk of single use of small amounts (less than 8  mg) of dexamethasone, or use within 24 hr is considered to be  small for adults (7, 26).",Non-OADS,/arxiv_data1/oa_pdf/82/f6/jkms-29-1001.PMC4101767.pdf
ORCID Jae Hee Woo http://orcid.org/0000-0002-1993-1687  Youn Jin Kim http://orcid.org/0000-0001-9189-5839 Hee Jung Baik http://orcid.org/0000-0002-8877-0274 Jong In Han http://orcid.org/0000-0002-8231-7161 Rack Kyung Chung http://orcid.org/0000-0003-4216-1665 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/82/f6/jkms-29-1001.PMC4101767.pdf
• Ketamine and Single Shot Interscalene Block  1006  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.1001amine in man.,Non-OADS,/arxiv_data1/oa_pdf/82/f6/jkms-29-1001.PMC4101767.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Application of Damage Control Resuscitation Strategies to  Patients with Severe Traumatic Hemorrhage: Review of Plasma  to Packed Red Blood Cell Ratios at a Single Institution When treating trauma patients with severe hemorrhage, massive transfusions are often  needed.",Non-OADS,/arxiv_data1/oa_pdf/9a/db/jkms-29-1007.PMC4101768.pdf
"Keywords:  Resuscitation; Transfusion; Blood Product Ratio; Survival; TraumaYounghwan Kim,1 KiYoung Lee,2,3   Jihyun Kim,2,3 Jiyoung Kim,1   Yunjung Heo,4 Heejung Wang,1   Kugjong Lee,1 and Kyoungwon Jung1 Departments of 1Surgery and 2Biomedical  Informatics, Ajou University School of Medicine,  Suwon; 3Department of Biomedical Sciences,  Graduate School, 4Department of Medical  Humanities and Social Medicine, Ajou University  School of Medicine, Suwon, Korea Received: 14 December 2013 Accepted: 24 April 2014 Address for Correspondence: Kyoungwon Jung, MD Department of Surgery, Ajou University School of Medicine,   206 World cup-ro, Yeoungtong-gu, Suwon 443-749, Korea Tel: +82.31-219-4452, Fax: +82.31-219-7765 E-mail: jake98@daum.net Funding:  This research was supported by Basic Science  Research Program through the National Research Foundation of  Korea (NRF) funded by the Ministry of Education, Science and  Technology (2013R1A2A2A04013317, 2010-0028631).http://dx.doi.org/10.3346/jkms.2014.29.7.1007  • J Korean Med Sci 2014; 29: 1007-1011 INTRODUCTION Hemorrhage is a preventable yet major cause of death among  patients with severe trauma (1-5), as it can quickly cause acido - sis, hypothermia, and coagulopathy, the so-called lethal triad,  which is irreversible.",Non-OADS,/arxiv_data1/oa_pdf/9a/db/jkms-29-1007.PMC4101768.pdf
• Damage Control Resuscitation in Traumatic Hemorrhage 1008  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.1007the need to thoroughly analyze the recent data on patients with  severe trauma who had received massive transfusions to estab - lish an effective PRBC:FFP administration ratio.,Non-OADS,/arxiv_data1/oa_pdf/9a/db/jkms-29-1007.PMC4101768.pdf
• Damage Control Resuscitation in Traumatic Hemorrhage http://jkms.org   1009 http://dx.doi.org/10.3346/jkms.2014.29.7.1007Table 2.,Non-OADS,/arxiv_data1/oa_pdf/9a/db/jkms-29-1007.PMC4101768.pdf
• Damage Control Resuscitation in Traumatic Hemorrhage 1010  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.1007hypotension for severe traumatic hemorrhagic patients.,Non-OADS,/arxiv_data1/oa_pdf/9a/db/jkms-29-1007.PMC4101768.pdf
• Damage Control Resuscitation in Traumatic Hemorrhage http://jkms.org   1011 http://dx.doi.org/10.3346/jkms.2014.29.7.1007for our future prospective study is expected to contribute signif - icantly to the establishment of a massive transfusion protocol.,Non-OADS,/arxiv_data1/oa_pdf/9a/db/jkms-29-1007.PMC4101768.pdf
ORCID Younghwan Kim http://orcid.org/0000-0003-3836-8743 KiYoung Lee http://orcid.org/0000-0003-3720-6574 Jihyun Kim http://orcid.org/0000-0002-2639-1594 Jiyoung Kim http://orcid.org/0000-0003-4813-1096 Yunjung Heo http://orcid.org/0000-0001-5708-1428 Heejung Wang http://orcid.org/0000-0002-0687-007X Kugjong Lee http://orcid.org/0000-0002-5468-3340 Kyoungwon Jung http://orcid.org/0000-0001-7895-0362 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9a/db/jkms-29-1007.PMC4101768.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357A Case Report of Preoperative and Postoperative 7.0T Brain MRI  in a Patient with a Small Cell Glioblastoma  A 45-yr-old female patient was admitted with one-month history of headache and  progressive left hemiparesis.",Non-OADS,/arxiv_data1/oa_pdf/87/22/jkms-29-1012.PMC4101769.pdf
"http://dx.doi.org/10.3346/jkms.2014.29.7.1012  • J Korean Med Sci 2014; 29: 1012-1017 INTRODUCTION Since its clinical introduction in the 1980s, the high-field magnetic resonance (MR)  scanners has been progressively developed to improve the signal-to noise ratio (SNR)  and contrast susceptibility for the better human brain images (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/87/22/jkms-29-1012.PMC4101769.pdf
• 7.0T Brain MRI in Small Cell Glioblastoma http://jkms.org   1013 http://dx.doi.org/10.3346/jkms.2014.29.7.1012Fig.,Non-OADS,/arxiv_data1/oa_pdf/87/22/jkms-29-1012.PMC4101769.pdf
• 7.0T Brain MRI in Small Cell Glioblastoma 1014  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.1012Fig.,Non-OADS,/arxiv_data1/oa_pdf/87/22/jkms-29-1012.PMC4101769.pdf
• 7.0T Brain MRI in Small Cell Glioblastoma http://jkms.org   1015 http://dx.doi.org/10.3346/jkms.2014.29.7.1012specific PCR study.,Non-OADS,/arxiv_data1/oa_pdf/87/22/jkms-29-1012.PMC4101769.pdf
"• 7.0T Brain MRI in Small Cell Glioblastoma 1016  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.10121.5 mm, gap = 1.5 mm, flip angle = 30°, number of slices = 20,  voxel size = 0.25 × 0.25 × 1.5 μL, and matrix size = 704 × 1,024.",Non-OADS,/arxiv_data1/oa_pdf/87/22/jkms-29-1012.PMC4101769.pdf
• 7.0T Brain MRI in Small Cell Glioblastoma http://jkms.org   1017 http://dx.doi.org/10.3346/jkms.2014.29.7.1012trast-enhanced T2-WI in 34 C57BL6 mice at different stages of  tumor development.,Non-OADS,/arxiv_data1/oa_pdf/87/22/jkms-29-1012.PMC4101769.pdf
We think this case report is an impor - tant landmark for the clinical application of ultra-high field MRI  in the field of neuro-oncology in near future.ORCID Sun Ha Paek http://orcid.org/0000-0003-3007-8653  Jae Ha Hwang http://orcid.org/0000-0001-7556-3594  Dong Gyu Kim http://orcid.org/0000-0002-5740-6189  Seung Hong Choi http://orcid.org/0000-0002-0412-2270  Chul-Ho Sohn http://orcid.org/0000-0003-0039-5746  Sung Hye Park http://orcid.org/0000-0002-4253-7047  Young Don Son http://orcid.org/0000-0001-7029-2422  Young Bo Kim http://orcid.org/0000-0003-0214-3964   Zang-Hee Cho http://orcid.org/0000-0001-5140-1689   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/87/22/jkms-29-1012.PMC4101769.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357A Case Report of Testicular Sparganosis Misdiagnosed as  Testicular Tumor Sparganosis is a parasitic infestation of human by plerocercoid larvae.",Non-OADS,/arxiv_data1/oa_pdf/47/17/jkms-29-1018.PMC4101770.pdf
"Keywords:  Sparganosis; TestisWon Hee Park,1 Tae Young Shin,2   Sang Min Yoon,1 Soo-Hwan Park,1   Yong Jin Kang,1 Do Kyung Kim,1   Jee-Young Han,3 and Do Hwan Seong1 Departments of 1Urology and 3Pathology,   Inha University College of Medicine, Incheon;  2Department of Urology, Hallym University College  of Medicine, Chuncheon, Korea Received: 14 January 2014 Accepted: 16 January 2014 Address for Correspondence: Do Hwan Seong, MD Department of Urology, Inha University College of Medicine,   27 Inhang-ro, Jung-gu, Incheon 400-711, Korea Tel: +82.32-890-3440, Fax: +82.32-890-3097 E-mail: dhseong@inha.ac.kr  Funding:  This study was supported by Inha University Research  Grant.http://dx.doi.org/10.3346/jkms.2014.29.7.1018  • J Korean Med Sci 2014; 29: 1018-1020 INTRODUCTION Sparganosis is a rare zoonotic disease of humans in Asia and  South America, resulting from infection of plerocercoid larvae,  sparganum, of the genus Spirometra .",Non-OADS,/arxiv_data1/oa_pdf/47/17/jkms-29-1018.PMC4101770.pdf
• A Case Report of Testicular Sparganosis http://jkms.org   1019 http://dx.doi.org/10.3346/jkms.2014.29.7.1018 A B Fig.,Non-OADS,/arxiv_data1/oa_pdf/47/17/jkms-29-1018.PMC4101770.pdf
• A Case Report of Testicular Sparganosis 1020  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.1018 The infection route of the sparganosis in this case was not  clearly identified.,Non-OADS,/arxiv_data1/oa_pdf/47/17/jkms-29-1018.PMC4101770.pdf
ORCID Won Hee Park http://orcid.org/0000-0002-4712-0048  Tae Young Shin http://orcid.org/0000-0002-3910-9252  Sang Min Yoon http://orcid.org/0000-0003-4209-7085  Soo-Hwan Park http://orcid.org/0000-0002-0302-8397  Yong Jin Kang http://orcid.org/0000-0002-2987-3249  Do Kyung Kim http://orcid.org/0000-0002-3696-8756  Jee-Young Han http://orcid.org/0000-0003-3224-4029  Do Hwan Seong http://orcid.org/0000-0001-7987-5819  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/47/17/jkms-29-1018.PMC4101770.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Significance of Clinical and Laboratory Features in the  Diagnosis of Glycogen Storage Disease Type V: A Case Report Glycogen storage disease type V (GSD-V) is the most common disorder of muscle  glycogenosis with characteristic clinical and laboratory findings.",Non-OADS,/arxiv_data1/oa_pdf/2e/2f/jkms-29-1021.PMC4101771.pdf
"The present case recognizes that detail clinical and laboratory analysis is the first  step in the diagnosis of GSD-V. Keywords:  Glycogen Storage Disease Type V; McArdle’s Disease; Phosphorylase, Glycogen,  Muscle ( PYGM )Hyung Jun Park,1 Ha Young Shin,2   Yu Na Cho,2 Seung Min Kim,2   and Young-Chul Choi2,3 1Department of Neurology, Mokdong Hospital, Ewha  Womans University School of Medicine, Seoul;  2Department of Neurology, Yonsei University College  of Medicine, Seoul; 3Rehabilitation Institute of  Neuromuscular Disease, Yonsei University College of  Medicine, Seoul, Korea Received: 8 October 2013 Accepted: 8 January 2014 Address for Correspondence: Young-Chul Choi, MD Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, 612 Eonju-ro,   Gangnam-gu, Seoul 135-720, Korea  Tel: +82.2-2019-3323, Fax: +82.2-3462-5904 E-mail: ycchoi@yuhs.ac http://dx.doi.org/10.3346/jkms.2014.29.7.1021  • J Korean Med Sci 2014; 29: 1021-1024 INTRODUCTION Glycogen storage disease type V (GSD-V), also known as McAr - dle’s disease, is the most common disorder of muscle glyco - genosis (1).",Non-OADS,/arxiv_data1/oa_pdf/2e/2f/jkms-29-1021.PMC4101771.pdf
• Glycogen Storage Disease Type V with PYGM  Mutation 1022  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.1021tudes of the compound muscle action potentials did not de - crease after maximal contraction and nerve stimulation.,Non-OADS,/arxiv_data1/oa_pdf/2e/2f/jkms-29-1021.PMC4101771.pdf
• Glycogen Storage Disease Type V with PYGM  Mutation http://jkms.org   1023 http://dx.doi.org/10.3346/jkms.2014.29.7.1021with GSD-V even in the absence of exercise.,Non-OADS,/arxiv_data1/oa_pdf/2e/2f/jkms-29-1021.PMC4101771.pdf
ORCID Hyung Jun Park http://orcid.org/0000-0003-4165-8901  Ha Young Shin http://orcid.org/0000-0002-4408-8265  Yu Na Cho http://orcid.org/0000-0003-2865-6012  Seung Min Kim http://orcid.org/0000-0002-4384-9640  Young-Chul Choi http://orcid.org/0000-0001-5525-6861  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/2e/2f/jkms-29-1021.PMC4101771.pdf
• Glycogen Storage Disease Type V with PYGM  Mutation 1024  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.1021second “second wind” in McArdle disease: oxidative mechanisms.,Non-OADS,/arxiv_data1/oa_pdf/2e/2f/jkms-29-1021.PMC4101771.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Paradoxical Increase of IgE Binding Components during  Allergen-Specific Immunotherapy in Pollinosis Patients Allergen-specific immunotherapy (SIT) reduces allergen specific IgE (sIgE) levels and  achieves clinical and immunological tolerance by modulating innate and adaptive  immunological responses.",Non-OADS,/arxiv_data1/oa_pdf/c4/93/jkms-29-1025.PMC4101772.pdf
"Keywords:  Pollinosis; Immunotherapy; Specific IgE; Climate ChangeMi-Ae Kim,1 Moon-Gyung Yoon,2   Hyun-Jung Jin,3 Yoo-Seob Shin,2   and Hae-Sim Park2,4 1Department of Allergy and Clinical Immunology,  CHA Bundang Medical Center, CHA University,  Seongnam; 2Department of Allergy and Clinical  Immunology, Ajou University School of Medicine,  Suwon; 3Department of Internal Medicine,  Yeungnam University College of Medicine, Daegu;  4Department of Biomedical Sciences, Ajou University  Graduate School, Suwon, Korea Received: 20 January 2014 Accepted: 30 April 2014 Address for Correspondence: Hae-Sim Park, MD Department of Allergy and Clinical Immunology, Ajou University  Hospital, Ajou University School of Medicine, 164 World cup-ro,  Yeongtong-gu, Suwon 443-380, Korea Tel: +82.31-219-5196, Fax: +82.31-219-5154 E-mail: hspark@ajou.ac.kr Funding:  This study was supported by the National Research  Foundation (NRF) and a grant from the Korean government  (MEST, 2013-003341).http://dx.doi.org/10.3346/jkms.2014.29.7.1025  • J Korean Med Sci 2014; 29: 1025-1029 Pollen grains are the second most common allergen that cause  allergic diseases (pollinosis) such as allergic rhinitis, conjuncti - vitis, asthma and atopic dermatitis (1-6).",Non-OADS,/arxiv_data1/oa_pdf/c4/93/jkms-29-1025.PMC4101772.pdf
"• Changes of IgE Binding Components in Pollinosis Patients 1026  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.1025mugwort pollens during the pollen-SIT from the Allergy and  Clinical Immunology Department of Ajou University Hospital,  Suwon, Korea.",OADS,/arxiv_data1/oa_pdf/c4/93/jkms-29-1025.PMC4101772.pdf
• Changes of IgE Binding Components in Pollinosis Patients http://jkms.org   1027 http://dx.doi.org/10.3346/jkms.2014.29.7.1025components (11 kDa).,Non-OADS,/arxiv_data1/oa_pdf/c4/93/jkms-29-1025.PMC4101772.pdf
• Changes of IgE Binding Components in Pollinosis Patients 1028  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.1025 175 125 80 52 39 26 19 13 9kDa M 1 (i) 1 (f) 2 (i) 2 (f) 3 (i) 3 (f) B Aln g 1 A 175 125 80 52 39 26 19 13 9kDa  1 (i) 1 (f) 4 (i) 4 (f) 5 (i) 5 (f) B Bet v 1 B 175 125 80 52 39 26 19 13 9kDa M 6 (i) 6 (f) 7 (i) 7 (f) 8 (i) 8 (f) B Amb a 1 C 175 125 80 52 39 26 19 13 9kDa M 1(i) 1(f) 9(i) 9(f) B Art v 1 D Fig.,Non-OADS,/arxiv_data1/oa_pdf/c4/93/jkms-29-1025.PMC4101772.pdf
• Changes of IgE Binding Components in Pollinosis Patients http://jkms.org   1029 http://dx.doi.org/10.3346/jkms.2014.29.7.1025ORCID Hae-Sim Park http://orcid.org/0000-0003-2614-0303  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c4/93/jkms-29-1025.PMC4101772.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357http://dx.doi.org/10.3346/jkms.2014.29.7.1030  • J Korean Med Sci 2014; 29: 1030-1031 Patient Preference and Satisfaction in  Decision-Making Process Chi-Un Pae1,2 1Department of Psychiatry, The Catholic University of Korea College of Medicine,  Seoul, Korea; 2Department of Psychiatry and Behavioral Sciences, Duke University  Medical Center, Durham, NC, USA To the Editor: Sir: Dr. Hwang et al.",Non-OADS,/arxiv_data1/oa_pdf/32/c1/jkms-29-1030.PMC4101773.pdf
"• Patient Preference and Satisfaction in Decision-Making Process http://jkms.org   1031 http://dx.doi.org/10.3346/jkms.2014.29.7.1030ACKNOWLEDGMENTS This work was supported by a grant of the Korean Health Tech - nology R&D Project, Ministry of Health & Welfare, Republic of  Korea (HI12C0003).",Non-OADS,/arxiv_data1/oa_pdf/32/c1/jkms-29-1030.PMC4101773.pdf
ORCID Chi-Un Pae http://orcid.org/0000-0002-6774-9417  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/32/c1/jkms-29-1030.PMC4101773.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Increasing Burden of Alzheimer’s Disease by Aging Seol-Heui Han Department of Neurology, Konkuk University School of Medicine, Seoul, Koreahttp://dx.doi.org/10.3346/jkms.2014.29.7.885  • J Korean Med Sci 2014; 29: 885 Alzheimer’s disease (AD), the most common cause of dementia  in elderly individuals, is a devastating chronic disorder charac - terized by a progressive loss of memory, cognitive decline and  functional impairment causing difficulties in performing activi - ties of daily living.",Non-OADS,/arxiv_data1/oa_pdf/b0/93/jkms-29-885.PMC4101774.pdf
ORCID Seol-Heui Han http://orcid.org/0000-0003-3608-2514  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b0/93/jkms-29-885.PMC4101774.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Primary Prevention of Alzheimer’s Disease: Is It an Attainable  Goal?",Non-OADS,/arxiv_data1/oa_pdf/4e/2c/jkms-29-886.PMC4101775.pdf
"Keywords:  Alzheimer’s Disease; Primary Prevention; Lifestyle Modification; NutritionJee-Young Han1 and Seol-Heui Han2,3 1Department of Neurology, Seoul National  University Hospital, Seoul; 2Department of  Neurology, Konkuk University School of Medicine;  3Center for Geriatric Neuroscience Research,  Institute of Biomedical Science and Technology,  Konkuk University, Seoul, Korea Received: 12 March 2014 Accepted: 13 May 2014 Address for Correspondence: Seol-Heui Han, MD Department of Neurology, Konkuk University School of Medicine  and Konkuk University Medical Center, 120-1 Neungdong-ro,  Gwangjin-gu, Seoul 143-729, Korea Tel: +82.2-2030-7561, Fax: +82.2-2030-7018 E-mail: alzdoc@kuh.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.7.886  • J Korean Med Sci 2014; 29: 886-892 INTRODUCTION Astonishing advancement in medical knowledge and everlast - ing improvements in healthcare services in recent years have  contributed to an increased longevity in the worldwide popula - tion (1), which is projected to continue to increase.",Non-OADS,/arxiv_data1/oa_pdf/4e/2c/jkms-29-886.PMC4101775.pdf
"http://jkms.org   887 http://dx.doi.org/10.3346/jkms.2014.29.7.886age: from 3% among 65-74-yr-olds to 19% among 75-84-yr-olds,  and nearly half (47%) of those aged 85 yr and older (6).",Non-OADS,/arxiv_data1/oa_pdf/4e/2c/jkms-29-886.PMC4101775.pdf
888  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.886as cardiovascular disease.,Non-OADS,/arxiv_data1/oa_pdf/4e/2c/jkms-29-886.PMC4101775.pdf
"http://jkms.org   889 http://dx.doi.org/10.3346/jkms.2014.29.7.886Nutritional approaches Among other factors, ample evidence suggests that cognitive  function is influenced by nutrition (46).",Non-OADS,/arxiv_data1/oa_pdf/4e/2c/jkms-29-886.PMC4101775.pdf
890  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.886cognitive decline.,Non-OADS,/arxiv_data1/oa_pdf/4e/2c/jkms-29-886.PMC4101775.pdf
ORCID Seol-Heui Han http://orcid.org/0000-0003-3608-2514  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4e/2c/jkms-29-886.PMC4101775.pdf
http://jkms.org   891 http://dx.doi.org/10.3346/jkms.2014.29.7.886the-science conference statement: preventing Alzheimer’s disease and  cognitive decline.,Non-OADS,/arxiv_data1/oa_pdf/4e/2c/jkms-29-886.PMC4101775.pdf
892  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.88644.,Non-OADS,/arxiv_data1/oa_pdf/4e/2c/jkms-29-886.PMC4101775.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Diverse Molecular Targets for Therapeutic Strategies in  Alzheimer’s Disease  Alzheimer’s disease (AD) is the most common form of dementia caused by  neurodegenerative process and is tightly related to amyloid β (Aβ) and neurofibrillary  tangles.",Non-OADS,/arxiv_data1/oa_pdf/6e/5c/jkms-29-893.PMC4101776.pdf
"Key Words:  Alzheimer Disease; Amyloid Beta-Peptides; Tau Protein; Immunotherapy;  Glucose Metabolism; Aggregation Sun-Ho Han and Inhee Mook-Jung Department of Biochemistry and Biomedical  Sciences, Seoul National University,  College of Medicine, Seoul, Korea Received: 27 February 2014 Accepted: 12 June 2014 Address for Correspondence: Inhee Mook-Jung, MD Department of Biochemistry and Biomedical Sciences,   Seoul National University, College of Medicine,   101 Daehak-ro, Jongro-gu, Seoul 110-799, Korea Tel: +82.2-740-8245, Fax: +82.2-3672-7352 E-mail: inhee@snu.ac.kr Funding:  This work was supported by grants from the NRF  (2012R1A2A1A01002881), the KNIH ROAD R&D Program  Project (A092058 to I. M-J) and KIST ORP program.http://dx.doi.org/10.3346/jkms.2014.29.7.893  • J Korean Med Sci 2014; 29: 893-902 INTRODUCTION Alzheimer’s disease (AD) is a pernicious neurodegenerative  disease which is incurable with remedies developed up to date.",Non-OADS,/arxiv_data1/oa_pdf/6e/5c/jkms-29-893.PMC4101776.pdf
• Possible therapeutic strategy in AD 894  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.893(BBB) disruption (17).,Non-OADS,/arxiv_data1/oa_pdf/6e/5c/jkms-29-893.PMC4101776.pdf
"• Possible therapeutic strategy in AD http://jkms.org   895 http://dx.doi.org/10.3346/jkms.2014.29.7.893Aβ PRODUCTION/AGGREGATION MODULATOR Abnormal A β production and accumulation in brain parenchy - ma have been regarded as the central etiological hypothesis in  AD pathogenesis (5, 10, 32).",Non-OADS,/arxiv_data1/oa_pdf/6e/5c/jkms-29-893.PMC4101776.pdf
"• Possible therapeutic strategy in AD 896  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.893genesis, enhanced clearance of A β via the administration of  anti-Aβ monoclonal antibody, including bapineuzumab and  solanezumab (passive vaccination), or A β antigen with adju - vant such as AN1792 (active vaccination) seemed fairly promis - ing (67, 68).",Non-OADS,/arxiv_data1/oa_pdf/6e/5c/jkms-29-893.PMC4101776.pdf
• Possible therapeutic strategy in AD http://jkms.org   897 http://dx.doi.org/10.3346/jkms.2014.29.7.893loidogenic APP processing in insulin-resistant condition (102).,Non-OADS,/arxiv_data1/oa_pdf/6e/5c/jkms-29-893.PMC4101776.pdf
"• Possible therapeutic strategy in AD 898  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.893time-consuming process, likely to require more than two de - cades (125).",Non-OADS,/arxiv_data1/oa_pdf/6e/5c/jkms-29-893.PMC4101776.pdf
• Possible therapeutic strategy in AD http://jkms.org   899 http://dx.doi.org/10.3346/jkms.2014.29.7.893now and where are we headed?,Non-OADS,/arxiv_data1/oa_pdf/6e/5c/jkms-29-893.PMC4101776.pdf
• Possible therapeutic strategy in AD 900  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.893Study: role of APOE and NSAID type.,Non-OADS,/arxiv_data1/oa_pdf/6e/5c/jkms-29-893.PMC4101776.pdf
• Possible therapeutic strategy in AD http://jkms.org   901 http://dx.doi.org/10.3346/jkms.2014.29.7.893tau aggregation and dissolve Alzheimer’s paired helical filaments in vi - tro and in cells.,Non-OADS,/arxiv_data1/oa_pdf/6e/5c/jkms-29-893.PMC4101776.pdf
• Possible therapeutic strategy in AD 902  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.893sporadic Alzheimer’s disease.,Non-OADS,/arxiv_data1/oa_pdf/6e/5c/jkms-29-893.PMC4101776.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Prevalence and Trends of Dementia in Korea: A Systematic  Review and Meta-Analysis Through a systematic review and meta-analysis of epidemiological studies on dementia,  we assessed the prevalence of dementia and its subtypes—Alzheimer’ disease (AD) and  vascular dementia (VaD)—in Korea.",Non-OADS,/arxiv_data1/oa_pdf/02/85/jkms-29-903.PMC4101777.pdf
"A092077).http://dx.doi.org/10.3346/jkms.2014.29.7.903  • J Korean Med Sci 2014; 29: 903-912 INTRODUCTION Although a rapid increase in the number of patients with de - mentia is a worldwide problem with significant health and eco - nomic consequences, the rates of increase is not uniform.",Non-OADS,/arxiv_data1/oa_pdf/02/85/jkms-29-903.PMC4101777.pdf
• Prevalence and Trends of Dementia in Korea 904  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.903alence.,Non-OADS,/arxiv_data1/oa_pdf/02/85/jkms-29-903.PMC4101777.pdf
• Prevalence and Trends of Dementia in Korea http://jkms.org   905 http://dx.doi.org/10.3346/jkms.2014.29.7.903(assuming that prevalence rates grow exponentially): Time   of doubling = (t 2-t1)*[log(2)/log(q 1/q 2)].,Non-OADS,/arxiv_data1/oa_pdf/02/85/jkms-29-903.PMC4101777.pdf
"• Prevalence and Trends of Dementia in Korea 906  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.90395% CI, 5.3%-8.6%; P= 0.005).",Non-OADS,/arxiv_data1/oa_pdf/02/85/jkms-29-903.PMC4101777.pdf
• Prevalence and Trends of Dementia in Korea http://jkms.org   907 http://dx.doi.org/10.3346/jkms.2014.29.7.903Table 2.,Non-OADS,/arxiv_data1/oa_pdf/02/85/jkms-29-903.PMC4101777.pdf
"• Prevalence and Trends of Dementia in Korea 908  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.903yr to 4.2% in those aged 80-84 yr, and then decreased thereafter  (P= 0.001) (Table 5).",Non-OADS,/arxiv_data1/oa_pdf/02/85/jkms-29-903.PMC4101777.pdf
• Prevalence and Trends of Dementia in Korea http://jkms.org   909 http://dx.doi.org/10.3346/jkms.2014.29.7.903ing the study methodologies were warranted.,Non-OADS,/arxiv_data1/oa_pdf/02/85/jkms-29-903.PMC4101777.pdf
"• Prevalence and Trends of Dementia in Korea 910  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.903since the 1990s (1, 24).",Non-OADS,/arxiv_data1/oa_pdf/02/85/jkms-29-903.PMC4101777.pdf
• Prevalence and Trends of Dementia in Korea http://jkms.org   911 http://dx.doi.org/10.3346/jkms.2014.29.7.903Table 5.,Non-OADS,/arxiv_data1/oa_pdf/02/85/jkms-29-903.PMC4101777.pdf
ORCID You Joung Kim http://orcid.org/0000-0002-1103-3858  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/02/85/jkms-29-903.PMC4101777.pdf
Available at http://www.kosis.kr [accessed on 20 December  2013].,Non-OADS,/arxiv_data1/oa_pdf/02/85/jkms-29-903.PMC4101777.pdf
Available at http://esa.un.org/unpd/wpp [accessed on 20 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/02/85/jkms-29-903.PMC4101777.pdf
• Prevalence and Trends of Dementia in Korea 912  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.903on Health and Aging (KLoSHA).,Non-OADS,/arxiv_data1/oa_pdf/02/85/jkms-29-903.PMC4101777.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Recent Decline in Prevalence of Dementia in Developed  Countries: Implications for Prevention in the Republic of Korea With the rapid aging of the population in Korea, the number of older people with  dementia is projected to increase, forecasting an epidemic of dementia.",Non-OADS,/arxiv_data1/oa_pdf/03/5c/jkms-29-913.PMC4101778.pdf
"Keywords:  Dementia; Prevalence; Incidence; Risk Factors; Prevention and Control; Health  Promotion; Health BehaviorYunhwan Lee Department of Preventive Medicine and Public  Health, Ajou University School of Medicine, Institute  on Aging, Ajou University Medical Center, Suwon,  Korea Received: 25 February 2014 Accepted: 8 May 2014 Address for Correspondence: Yunhwan Lee, MD Department of Preventive Medicine and Public Health, Ajou  University School of Medicine, 164 World cup-ro,   Youngtong-gu, Suwon 443-380, Korea Tel: +82.31-219-5085, Fax: +82.31-219-5084 E-mail: yhlee@ajou.ac.kr Funding:  This study was supported by a grant of the Korea  Healthcare Technology R&D Project, Ministry of Health and  Welfare, Republic of Korea (HI10C2020).http://dx.doi.org/10.3346/jkms.2014.29.7.913  • J Korean Med Sci 2014; 29: 913-918 INTRODUCTION With the aging of the population, dementia is widely recogniz­ ed as a serious threat to health in later life.",Non-OADS,/arxiv_data1/oa_pdf/03/5c/jkms-29-913.PMC4101778.pdf
"Lee Y • Dementia Trends and Prevention 914  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.913RECENT TRENDS IN DEMENTIA WORLDWIDE Dementia prevalence Although the prevalence of dementia worldwide has been pro ­ jected to increase due to population aging, a growing number  of studies in recent years are reporting a decreasing trend in the  dementia prevalence (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/03/5c/jkms-29-913.PMC4101778.pdf
"Lee Y • Dementia Trends and Prevention http://jkms.org   915 http://dx.doi.org/10.3346/jkms.2014.29.7.913mentia in 1991, 884,000 were expected to have dementia in 2011  due to population aging.",Non-OADS,/arxiv_data1/oa_pdf/03/5c/jkms-29-913.PMC4101778.pdf
Lee Y • Dementia Trends and Prevention 916  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.913actually increase the prevalence by 2.8 million.,Non-OADS,/arxiv_data1/oa_pdf/03/5c/jkms-29-913.PMC4101778.pdf
Lee Y • Dementia Trends and Prevention http://jkms.org   917 http://dx.doi.org/10.3346/jkms.2014.29.7.913ority should be assigned to support prevention research and  program development that informs policy and practice.,Non-OADS,/arxiv_data1/oa_pdf/03/5c/jkms-29-913.PMC4101778.pdf
ORCID Yunhwan Lee http://orcid.org/0000-0001-8484-4750  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/03/5c/jkms-29-913.PMC4101778.pdf
Available at http://kosis.kr/ups/ups_02List01.,Non-OADS,/arxiv_data1/oa_pdf/03/5c/jkms-29-913.PMC4101778.pdf
Available at http://www.alz.co.uk/research/files/World AlzheimerReport2010.pdf [accessed on 11 October 2013].,Non-OADS,/arxiv_data1/oa_pdf/03/5c/jkms-29-913.PMC4101778.pdf
Available at  https://www.kihasa.re.kr/html/jsp/publication/policy/list.jsp [accessed  on 12 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/03/5c/jkms-29-913.PMC4101778.pdf
"Lee Y • Dementia Trends and Prevention 918  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.913and Social Affairs, 2012.",Non-OADS,/arxiv_data1/oa_pdf/03/5c/jkms-29-913.PMC4101778.pdf
Available at https://www.kihasa.re.kr/html/ jsp/publication/research/list.jsp?key=title&ryear_value=2014&query=  %BA%F3%B0%EF [accessed on 11 January 2014].,OADS,/arxiv_data1/oa_pdf/03/5c/jkms-29-913.PMC4101778.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Moving toward Universal Coverage of Health Insurance in  Vietnam: Barriers, Facilitating Factors, and Lessons from Korea Vietnam has pursued universal health insurance coverage for two decades but has yet to  fully achieve this goal.",Non-OADS,/arxiv_data1/oa_pdf/2a/8c/jkms-29-919.PMC4101779.pdf
"Keywords:  Universal Coverage; Insurance, Health; Facilitating Factors; Korea, VietnamNgan Do,1 Juhwan Oh,2   and Jin-Seok Lee1,3 1Department of Health Policy and Management,  Seoul National University College of Medicine; 2JW  Lee Center for Global Medicine, Seoul National  University College of Medicine; 3Institute of Health  Policy and Management, Medical Research Center,  Seoul National University, Seoul, Korea  Received: 25 June 2013 Accepted: 30 April 2014 Address for Correspondence: Jin-Seok Lee, MD Department of Health Policy and Management, Seoul National  University College of Medicine, 103 Daehak-ro, Jongno-gu,  Seoul 110-799, Korea Tel: +82.2-740-8361, Fax: +82.2-740-2009 E-mail: phealth@snu.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.7.919  • J Korean Med Sci 2014; 29: 919-925 INTRODUCTION Following the economic reform in the late 1980s from a central - ized economy to a market-oriented economy, the free universal  access healthcare system was shifted to a user fee system subsi - dized by the government.",Non-OADS,/arxiv_data1/oa_pdf/2a/8c/jkms-29-919.PMC4101779.pdf
"• Korean Lessons for Universal Health Coverage in Vietnam 920  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.919all the citizens, categorized into 25 groups on individual basis.",Non-OADS,/arxiv_data1/oa_pdf/2a/8c/jkms-29-919.PMC4101779.pdf
• Korean Lessons for Universal Health Coverage in Vietnam http://jkms.org   921 http://dx.doi.org/10.3346/jkms.2014.29.7.919(17).,Non-OADS,/arxiv_data1/oa_pdf/2a/8c/jkms-29-919.PMC4101779.pdf
• Korean Lessons for Universal Health Coverage in Vietnam 922  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.919the country was recovering from the Korean War with a GNI  per capita of USD 209.,Non-OADS,/arxiv_data1/oa_pdf/2a/8c/jkms-29-919.PMC4101779.pdf
"• Korean Lessons for Universal Health Coverage in Vietnam http://jkms.org   923 http://dx.doi.org/10.3346/jkms.2014.29.7.919health insurance through wages, which ensures stable revenue  for health insurance.",Non-OADS,/arxiv_data1/oa_pdf/2a/8c/jkms-29-919.PMC4101779.pdf
• Korean Lessons for Universal Health Coverage in Vietnam 924  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.919universal coverage to reduce the financial burden of subsiding  contribution for more than half of the population of the govern - ment of Vietnam.,Non-OADS,/arxiv_data1/oa_pdf/2a/8c/jkms-29-919.PMC4101779.pdf
ORCID Ngan Do http://orcid.org/000-0002-2153-4904  Juhwan Oh http://orcid.org/0000-0002-074-5108  Jin-Seok Lee http://orcid.org/0000-0003-4329-0784  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/2a/8c/jkms-29-919.PMC4101779.pdf
Available at http://www.equitap.,Non-OADS,/arxiv_data1/oa_pdf/2a/8c/jkms-29-919.PMC4101779.pdf
• Korean Lessons for Universal Health Coverage in Vietnam http://jkms.org   925 http://dx.doi.org/10.3346/jkms.2014.29.7.9196.,Non-OADS,/arxiv_data1/oa_pdf/2a/8c/jkms-29-919.PMC4101779.pdf
Available at http://www.equitap.org/ publications/docs/EquitapWP20.pdf [accessed on December 2012].,Non-OADS,/arxiv_data1/oa_pdf/2a/8c/jkms-29-919.PMC4101779.pdf
Avail - able at http://www.gso.gov.vn/default_en.aspx?tabid=467 [accessed on  January 2013].,Non-OADS,/arxiv_data1/oa_pdf/2a/8c/jkms-29-919.PMC4101779.pdf
Available at http://www.un.org.vn/vi/publications/doc_ details/185-vietnam-employment-trends-report-2010.html [accessed on  January 2013].,Non-OADS,/arxiv_data1/oa_pdf/2a/8c/jkms-29-919.PMC4101779.pdf
Available at http://www.who.int/ health_financing/documents/hsfr_e_09-korea.pdf [accessed on January  2013].,Non-OADS,/arxiv_data1/oa_pdf/2a/8c/jkms-29-919.PMC4101779.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Clinical Significance of Previously Cryptic Copy Number  Alterations and Loss of Heterozygosity in Pediatric Acute Myeloid  Leukemia and Myelodysplastic Syndrome Determined Using  Combined Array Comparative Genomic Hybridization plus  Single-Nucleotide Polymorphism Microarray Analyses  The combined array comparative genomic hybridization plus single-nucleotide  polymorphism microarray (CGH+SNP microarray) platform can simultaneously detect copy  number alterations (CNA) and copy-neutral loss of heterozygosity (LOH).",Non-OADS,/arxiv_data1/oa_pdf/a1/b2/jkms-29-926.PMC4101780.pdf
"http://dx.doi.org/10.3346/jkms.2014.29.7.926  • J Korean Med Sci 2014; 29: 926-933 INTRODUCTION Although chromosomal aberrations demonstrate important  prognostic impacts in acute myeloid leukemia (AML) and my - elodysplastic syndrome (MDS), a significant proportion of pa - tients do not demonstrate cytogenetic aberrations on metaphase  cytogenetic (MC) analysis (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/a1/b2/jkms-29-926.PMC4101780.pdf
"• CNA and LOH in pediatric AML and MDS http://jkms.org   927 http://dx.doi.org/10.3346/jkms.2014.29.7.926ray CGH and SNP microarray are insufficient for studying pedi - atric AML and MDS, and their clinical and biological implications  still need to be determined for use in pediatric populations.",Non-OADS,/arxiv_data1/oa_pdf/a1/b2/jkms-29-926.PMC4101780.pdf
• CNA and LOH in pediatric AML and MDS 928  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.926Table 2.,Non-OADS,/arxiv_data1/oa_pdf/a1/b2/jkms-29-926.PMC4101780.pdf
• CNA and LOH in pediatric AML and MDS http://jkms.org   929 http://dx.doi.org/10.3346/jkms.2014.29.7.926sion 6.3; P/N G4410-90010).,Non-OADS,/arxiv_data1/oa_pdf/a1/b2/jkms-29-926.PMC4101780.pdf
• CNA and LOH in pediatric AML and MDS 930  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.926 Chromosome 12 Patient 6 Patient 15 Patient 12Chromosome 9 Chromosome 6 A B C Fig.,Non-OADS,/arxiv_data1/oa_pdf/a1/b2/jkms-29-926.PMC4101780.pdf
• CNA and LOH in pediatric AML and MDS http://jkms.org   931 http://dx.doi.org/10.3346/jkms.2014.29.7.926Fig.,Non-OADS,/arxiv_data1/oa_pdf/a1/b2/jkms-29-926.PMC4101780.pdf
• CNA and LOH in pediatric AML and MDS 932  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.926sulted in a high allelic FLT3 -ITD ratio.,Non-OADS,/arxiv_data1/oa_pdf/a1/b2/jkms-29-926.PMC4101780.pdf
ORCID Kyung-Nam Koh http://orcid.org/0000-0002-6376-672X Jin Ok Lee http://orcid.org/0000-0002-0917-5312 Eul Ju Seo http://orcid.org/0000-0002-8247-3746 Seong Wook Lee http://orcid.org/0000-0001-7471-2287 Jin Kyung Suh http://orcid.org/0000-0002-4572-514X Ho Joon Im http://orcid.org/0000-0001-8799-4068 Jong Jin Seo http://orcid.org/0000-0002-0191-7836 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a1/b2/jkms-29-926.PMC4101780.pdf
• CNA and LOH in pediatric AML and MDS http://jkms.org   933 http://dx.doi.org/10.3346/jkms.2014.29.7.92611.,Non-OADS,/arxiv_data1/oa_pdf/a1/b2/jkms-29-926.PMC4101780.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Imaging Mass Spectrometry in Papillary Thyroid Carcinoma for  the Identification and Validation of Biomarker Proteins Direct tissue imaging mass spectrometry (IMS) by matrix-assisted laser desorption  ionization and time-of-flight (MALDI-TOF) mass spectrometry has become increasingly  important in biology and medicine, because this technology can detect the relative  abundance and spatial distribution of interesting proteins in tissues.",Non-OADS,/arxiv_data1/oa_pdf/d3/24/jkms-29-934.PMC4101781.pdf
"Received: 10 March 2014 Accepted: 24 April 2014 Address for Correspondence: Wan-Seop Kim, MD Department of Pathology, Konkuk University School of Medicine, 120-1 Neungdong-ro, Gwangjin-gu, Seoul 143-729, Korea Tel: +82.2-2030-5642, Fax: +82.2-2030-5629 E-mail: wskim@kuh.ac.kr Funding:  The research was supported by grants from the  National Research Foundation of Korea (Grant No., 2009- 0072346) and the Converging Research Center Program  (2011K000898) through the Ministry of Education, Science and  Technology, Korea.http://dx.doi.org/10.3346/jkms.2014.29.7.934  • J Korean Med Sci 2014; 29: 934-940 INTRODUCTION Papillary thyroid carcinomas (PTC) are the most common form  of thyroid cancer, accounting for nearly 85% of primary thyroid  malignancies.",Non-OADS,/arxiv_data1/oa_pdf/d3/24/jkms-29-934.PMC4101781.pdf
• Imaging Mass Spectrometry in Papillary Thyroid Carcinoma http://jkms.org   935 http://dx.doi.org/10.3346/jkms.2014.29.7.934flight (MALDI-TOF) mass spectrometry (MS) technology.,Non-OADS,/arxiv_data1/oa_pdf/d3/24/jkms-29-934.PMC4101781.pdf
• Imaging Mass Spectrometry in Papillary Thyroid Carcinoma 936  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.934avoid OCT contamination in sections where it has been used to  stabilize the tissue.,Non-OADS,/arxiv_data1/oa_pdf/d3/24/jkms-29-934.PMC4101781.pdf
• Imaging Mass Spectrometry in Papillary Thyroid Carcinoma http://jkms.org   937 http://dx.doi.org/10.3346/jkms.2014.29.7.934intense peaks in the full MS scan.,Non-OADS,/arxiv_data1/oa_pdf/d3/24/jkms-29-934.PMC4101781.pdf
"3.3.1 SP1, Thermo  Fisher Scientific Inc., CA, USA) with the SEQUEST search en - gines against the National Center for Biotechnology Informa - tion (http://www.ncbi.nlm.nih.gov/) non-redundant human  database.",OADS,/arxiv_data1/oa_pdf/d3/24/jkms-29-934.PMC4101781.pdf
• Imaging Mass Spectrometry in Papillary Thyroid Carcinoma 938  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.934amino acids.,Non-OADS,/arxiv_data1/oa_pdf/d3/24/jkms-29-934.PMC4101781.pdf
• Imaging Mass Spectrometry in Papillary Thyroid Carcinoma http://jkms.org   939 http://dx.doi.org/10.3346/jkms.2014.29.7.934LC-MS/MS (Fig.,Non-OADS,/arxiv_data1/oa_pdf/d3/24/jkms-29-934.PMC4101781.pdf
ORCID Kyueng-Whan Min http://orcid.org/0000-0002-4757-9211 Joo-Young Bang http://orcid.org/0000-0002-2314-1530 Kwang Pyo Kim http://orcid.org/0000-0003-0095-3787 Wan-Seop Kim http://orcid.org/0000-0001-7704-5942 Sang Hwa Lee http://orcid.org/0000-0003-2692-9881 Selina Rahman Shanta http://orcid.org/0000-0003-0602-1323,Non-OADS,/arxiv_data1/oa_pdf/d3/24/jkms-29-934.PMC4101781.pdf
• Imaging Mass Spectrometry in Papillary Thyroid Carcinoma 940  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.934Jeong Hwa Lee http://orcid.org/0000-0001-9787-6591 Ji Hye Hong http://orcid.org/0000-0001-8175-9147 So Dug Lim http://orcid.org/0000-0003-2036-0313 Young-Bum Yoo http://orcid.org/0000-0002-6910-5076 Chan-Hyun Na http://orcid.org/0000-0002-5711-2842   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d3/24/jkms-29-934.PMC4101781.pdf
• Imaging Mass Spectrometry in Papillary Thyroid Carcinoma http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.934 Supplementary Fig.,Non-OADS,/arxiv_data1/oa_pdf/d3/24/jkms-29-934.PMC4101781.pdf
• Imaging Mass Spectrometry in Papillary Thyroid Carcinoma http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.934Supplementary  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/d3/24/jkms-29-934.PMC4101781.pdf
• Imaging Mass Spectrometry in Papillary Thyroid Carcinoma http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.934 Supplementary Fig.,Non-OADS,/arxiv_data1/oa_pdf/d3/24/jkms-29-934.PMC4101781.pdf
• Imaging Mass Spectrometry in Papillary Thyroid Carcinoma http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.934 Supplementary Fig.,Non-OADS,/arxiv_data1/oa_pdf/d3/24/jkms-29-934.PMC4101781.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Elevated Brachial-Ankle Pulse Wave Velocity Is Independently  Associated with Microalbuminuria in a Rural Population Microalbuminuria is a marker of generalized endothelial dysfunction resulting from arterial  stiffness or insulin resistance, and brachial-ankle pulse wave velocity (baPWV) is a good  measure of arterial stiffness.",Non-OADS,/arxiv_data1/oa_pdf/d0/d8/jkms-29-941.PMC4101782.pdf
"Elevated baPWV was independently associated with  microalbuminuria regardless of insulin resistance among rural subjects over 40 yr. Keywords:  Albuminuria; Insulin Resistance; Risk Factors; Vascular StiffnessJoo Youn Seo,1 Mi Kyung Kim,2   Bo Youl Choi,2 Yu-Mi Kim,3   Sung-il Cho,4 and Jinho Shin5 1Department of Family Medicine, Hanyang  University College of Medicine, Seoul; 2Department  of Preventive Medicine/Institute of Community  Health, Hanyang University College of Medicine,  Seoul; 3Department of Preventive Medicine, Dong-A  University College of Medicine, Busan; 4Graduate  School of Public Health, Seoul National University,  Seoul; 5Division of Cardiology, Department of  Internal Medicine, Hanyang University College of  Medicine, Seoul, Korea Received: 16 January 2013 Accepted: 22 April 2014 Address for Correspondence: Jinho Shin, MD Division of Cardiology, Department of Internal Medicine,  Hanyang University College of Medicine, 222 Wangsimni-ro,  Seongdong-gu, Seoul 133-792, Korea  Tel: +82.2-2290-8308, Fax: +82.2-2299-0278 E-mail: jhs2003@hanyang.ac.kr Funding:  This work was supported by the research fund of  Hanyang University Institute of Aging Society in 2009  (200900000000243).http://dx.doi.org/10.3346/jkms.2014.29.7.941  • J Korean Med Sci 2014; 29: 941-949 INTRODUCTION Microalbuminuria is a well-known risk factor or predictor for  cardiovascular morbidity and mortality in individuals with hy - pertension or diabetes mellitus (3, 4) and even in the general  population (1, 2) as well.",Non-OADS,/arxiv_data1/oa_pdf/d0/d8/jkms-29-941.PMC4101782.pdf
• Brachial-Ankle Pulse Wave Velocity and Microalbuminuria 942  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.941 The purpose of this study was to assess whether baPWV is an  independent risk factor of microalbuminuria regardless of in - sulin resistance in the elderly population (over-40 yr).,Non-OADS,/arxiv_data1/oa_pdf/d0/d8/jkms-29-941.PMC4101782.pdf
• Brachial-Ankle Pulse Wave Velocity and Microalbuminuria http://jkms.org   943 http://dx.doi.org/10.3346/jkms.2014.29.7.941and clinical results were compared using Student’s t-test and  the chi-square or Fisher’s exact test.,Non-OADS,/arxiv_data1/oa_pdf/d0/d8/jkms-29-941.PMC4101782.pdf
• Brachial-Ankle Pulse Wave Velocity and Microalbuminuria 944  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.941Table 2.,Non-OADS,/arxiv_data1/oa_pdf/d0/d8/jkms-29-941.PMC4101782.pdf
• Brachial-Ankle Pulse Wave Velocity and Microalbuminuria http://jkms.org   945 http://dx.doi.org/10.3346/jkms.2014.29.7.941HOMA IR and history of hypertension were significantly differ - ent among the quartiles in both men and women.,Non-OADS,/arxiv_data1/oa_pdf/d0/d8/jkms-29-941.PMC4101782.pdf
• Brachial-Ankle Pulse Wave Velocity and Microalbuminuria 946  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.941Table 4.,Non-OADS,/arxiv_data1/oa_pdf/d0/d8/jkms-29-941.PMC4101782.pdf
"• Brachial-Ankle Pulse Wave Velocity and Microalbuminuria http://jkms.org   947 http://dx.doi.org/10.3346/jkms.2014.29.7.941was an independent risk factor; however, (HOMA IR) (OR, 1.560;  95% CI, 0.794-3.063) was not.",Non-OADS,/arxiv_data1/oa_pdf/d0/d8/jkms-29-941.PMC4101782.pdf
• Brachial-Ankle Pulse Wave Velocity and Microalbuminuria 948  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.941insulin resistance.,Non-OADS,/arxiv_data1/oa_pdf/d0/d8/jkms-29-941.PMC4101782.pdf
ORCID Joo Youn Seo http://orcid.org/0000-0001-9338-643X.,Non-OADS,/arxiv_data1/oa_pdf/d0/d8/jkms-29-941.PMC4101782.pdf
Mi Kyung Kim http://orcid.org/0000-0001-8503-2631 Bo Youl Choi http://orcid.org/0000-0003-0115-5736 Yu-Mi Kim http://orcid.org/0000-0003-1123-8690 Sung-il Cho http://orcid.org/0000-0003-4085-1494 Jinho Shin http://orcid.org/0000-0003-2872-6105 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/d0/d8/jkms-29-941.PMC4101782.pdf
• Brachial-Ankle Pulse Wave Velocity and Microalbuminuria http://jkms.org   949 http://dx.doi.org/10.3346/jkms.2014.29.7.941maker of cardiovascular disease.,Non-OADS,/arxiv_data1/oa_pdf/d0/d8/jkms-29-941.PMC4101782.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Relationship between Neutrophil-to-Lymphocyte Ratio and  Plaque Components in Patients with Coronary Artery Disease:  Virtual Histology Intravascular Ultrasound Analysis The aim of this study was to evaluate the relation between neutrophil-to-lymphocyte ratio  (NLR) and plaque components assessed by virtual histology-intravascular ultrasound in 399  coronary artery disease (CAD) patients with 471 coronary lesions.",Non-OADS,/arxiv_data1/oa_pdf/02/5f/jkms-29-950.PMC4101783.pdf
"Keywords:  Coronary Disease; Neutrophils; Lymphocytes; Plaque; Ultrasonography;  InterventionalYun Ha Choi,1,2 Young Joon Hong,1  Youngkeun Ahn,1 In Hyae Park,2   and Myung Ho Jeong1 1The Division of Cardiology, Chonnam National  University Hospital, Gwangju; 2College of Nursing,  Chonnam National University, Gwangju, Korea Received: 30 December 2013 Accepted: 14 April 2014 Address for Correspondence: Young Joon Hong, MD Division of Cardiology, Heart Center of Chonnam National  University Hospital, Cardiovascular Convergence Research  Center Nominated by Korea Ministry of Health and Welfare,   671 Jaebong-ro, Dong-gu, Gwangju 501-757, Korea Tel: +82.62-220-6978, Fax: +82.62-223-3105 E-mail: hyj200@hanmail.net Funding:  This study was supported by a grant of the Korean  Health Technology R&D Project, Ministry of Health & Welfare,  Republic of Korea (HI13C0163), and a grant of The Korean  Society of Cardiology, The Korea Centers for Disease Control and  Prevention (2013-E63005-00), and The Korean Health Technology  R&D Project (HI13C1527), Ministry of Health & Welfare, and  the Bio & Medical Technology Development Program of the  National Research Foundation (NRF) funded by the Korean  government (MEST) (2012M3A9C6049744), and the National  Research Foundation of Korea Grant funded by the Korean  Government (2011-0008875), and the Korea Healthcare technology  R&D Project, Ministry for Health, Welfare and Family Affairs  (HI12C0275), and Chonnam National University Hospital Research  Institute of Clinical Medicine (CRI 11080-21), Republic of Korea.http://dx.doi.org/10.3346/jkms.2014.29.7.950  • J Korean Med Sci 2014; 29: 950-956 INTRODUCTION Inflammatory processes promote initiation and evolution of  atheroma and contribute decisively to acute thrombotic com - plications of atheroma (1).",Non-OADS,/arxiv_data1/oa_pdf/02/5f/jkms-29-950.PMC4101783.pdf
"• Neutrophil to Lymphocyte and Plaque Components  http://jkms.org   951 http://dx.doi.org/10.3346/jkms.2014.29.7.950continuous chest pain, a new ST-segment elevation ≥ 2 mm on  at least two contiguous electrocardiographic leads, and creatine  kinase-myocardial band (MB) > 3 times normal.",Non-OADS,/arxiv_data1/oa_pdf/02/5f/jkms-29-950.PMC4101783.pdf
"• Neutrophil to Lymphocyte and Plaque Components  952  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.950tional review board of Chonnam National University Hospital,  Gwangju, Korea (CNUH-2013-054).",Non-OADS,/arxiv_data1/oa_pdf/02/5f/jkms-29-950.PMC4101783.pdf
• Neutrophil to Lymphocyte and Plaque Components  http://jkms.org   953 http://dx.doi.org/10.3346/jkms.2014.29.7.950group.,Non-OADS,/arxiv_data1/oa_pdf/02/5f/jkms-29-950.PMC4101783.pdf
• Neutrophil to Lymphocyte and Plaque Components  954  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.950patients.,Non-OADS,/arxiv_data1/oa_pdf/02/5f/jkms-29-950.PMC4101783.pdf
• Neutrophil to Lymphocyte and Plaque Components  http://jkms.org   955 http://dx.doi.org/10.3346/jkms.2014.29.7.950greater role in the progression of atherosclerosis in diabetic  subjects who experienced sudden coronary death (25).,Non-OADS,/arxiv_data1/oa_pdf/02/5f/jkms-29-950.PMC4101783.pdf
ORCID Yun Ha Choi http://orcid.org/0000-0002-0224-0062  Young Joon Hong http://orcid.org/0000-0003-0192-8161  Youngkeun Ahn http://orcid.org/0000-0003-2022-9366  In Hyae Park http://orcid.org/0000-0001-5113-2095 Myung Ho Jeong http://orcid.org/0000-0003-4173-1494  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/02/5f/jkms-29-950.PMC4101783.pdf
• Neutrophil to Lymphocyte and Plaque Components  956  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.95016.,Non-OADS,/arxiv_data1/oa_pdf/02/5f/jkms-29-950.PMC4101783.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Clinical Association of the Blood Pressure Variability with the  Target Organ Damage in Hypertensive Patients with Chronic  Kidney Disease It is known that blood pressure variability (BPV) can independently affect target organ  damage (TOD), even with normal blood pressure.",Non-OADS,/arxiv_data1/oa_pdf/1e/0b/jkms-29-957.PMC4101784.pdf
"Keywords:  Blood Pressure Variability; Kidney Failure, Chronic; Hypertension; Hypertrophy,  Left Ventricular; Target Organ Damage Jiwon Ryu,1 Ran-hui Cha,2 Dong Ki Kim,9  Ju Hyun Lee,3 Sun Ae Yoon,4   Dong Ryeol Ryu,5 Ji Eun Oh,6   Sejoong Kim,1 Sang-Youb Han,7   Eun Young Lee,8 Yon Su Kim,9 on behalf  of the APrODiTe investigators10 1Department of Internal Medicine, Seoul National  University Bundang Hospital, Seongnam;  2Department of Internal Medicine, National Medical  Center, Seoul; 3Medical Research Collaborating  Center of Seoul National University Bundang  Hospital, Seongnam; 4Department of Internal  Medicine, The Catholic University of Korea College  of Medicine, Uijeongbu; 5Department of Internal  Medicine, Ewha Womans University College of  Medicine, Seoul; 6Department of Internal Medicine,  Hallym University College of Medicine, Seoul;  7Department of Internal Medicine, Inje University  College of Medicine, Ilsan; 8Department of Internal  Medicine, Soon Chun Hyang University College of  Medicine, Cheonan; 9Department of Internal  Medicine, Seoul National University College of  Medicine, Seoul; 10Kidney Research Institute, Seoul  National University Medical Research Center, Seoul,  Korea Received: 31 December 2013 Accepted: 29 April 2014 Address for Correspondence: Sejoong Kim, MD Department of Internal Medicine, Seoul National University  Bundang Hospital, 82 Gumi-ro, 173beon-gil, Bundang-gu,  Seongnam 463-707, Korea Tel: +82.31-787-7051, Fax: +82.31-787-4052 E-mail: imsejoong@hanmail.net Funding:  This work was sponsored by Sanofi Korea Co., Ltd.  (Study duration: 10/22/2009-06/08/2011) (Study number:  DIREG_L_04497).http://dx.doi.org/10.3346/jkms.2014.29.7.957  • J Korean Med Sci 2014; 29: 957-964 INTRODUCTION The regulation of blood pressure (BP) is an important factor in the prevention of target  organ damage (TOD).",Non-OADS,/arxiv_data1/oa_pdf/1e/0b/jkms-29-957.PMC4101784.pdf
• The BP Variability in Hypertensive CKD Patients 958  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.957and CKD.,Non-OADS,/arxiv_data1/oa_pdf/1e/0b/jkms-29-957.PMC4101784.pdf
• The BP Variability in Hypertensive CKD Patients http://jkms.org   959 http://dx.doi.org/10.3346/jkms.2014.29.7.957tal mean eGFR was 48.9 ± 19.2 mL/min/1.73 m2 and approxi - mately 56% of patients had proteinuria.,Non-OADS,/arxiv_data1/oa_pdf/1e/0b/jkms-29-957.PMC4101784.pdf
• The BP Variability in Hypertensive CKD Patients 960  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.957Table 2.,Non-OADS,/arxiv_data1/oa_pdf/1e/0b/jkms-29-957.PMC4101784.pdf
• The BP Variability in Hypertensive CKD Patients http://jkms.org   961 http://dx.doi.org/10.3346/jkms.2014.29.7.957Fig.,Non-OADS,/arxiv_data1/oa_pdf/1e/0b/jkms-29-957.PMC4101784.pdf
• The BP Variability in Hypertensive CKD Patients 962  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.957had LVH.,Non-OADS,/arxiv_data1/oa_pdf/1e/0b/jkms-29-957.PMC4101784.pdf
ORCID Jiwon Ryu http://orcid.org/0000-0003-0251-7858  Ran-hui Cha http://orcid.org/0000-0003-2783-2600  Dong Ki Kim http://orcid.org/0000-0002-5195-7852  Ju Hyun Lee http://orcid.org/0000-0001-5743-6751,Non-OADS,/arxiv_data1/oa_pdf/1e/0b/jkms-29-957.PMC4101784.pdf
• The BP Variability in Hypertensive CKD Patients http://jkms.org   963 http://dx.doi.org/10.3346/jkms.2014.29.7.957Sun Ae Yoon http://orcid.org/0000-0003-1175-8098  Dong Ryeol Ryu http://orcid.org/0000-0002-5309-7606  Ji Eun Oh http://orcid.org/0000-0001-9429-9602  Sejoong Kim http://orcid.org/0000-0002-7238-9962  Sang-Youb Han http://orcid.org/0000-0003-3312-0597  Eun Young Lee http://orcid.org/0000-0002-4513-9888  Yon Su Kim http://orcid.org/000-0003-3091-2388  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/1e/0b/jkms-29-957.PMC4101784.pdf
• The BP Variability in Hypertensive CKD Patients 964  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.957inflammatory marker in hypertensive patients.,Non-OADS,/arxiv_data1/oa_pdf/1e/0b/jkms-29-957.PMC4101784.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Association of Vitamin B 12 Deficiency and Metformin Use in  Patients with Type 2 Diabetes We evaluated the prevalence of vitamin B 12 deficiency and associated factors in type 2  diabetes patients using metformin.",Non-OADS,/arxiv_data1/oa_pdf/53/8a/jkms-29-965.PMC4101785.pdf
http://dx.doi.org/10.3346/jkms.2014.29.7.965  • J Korean Med Sci 2014; 29: 965-972 INTRODUCTION Metformin is one of the most widely used oral hypoglycemic  agents (1).,Non-OADS,/arxiv_data1/oa_pdf/53/8a/jkms-29-965.PMC4101785.pdf
"• Association of Vitamin B 12 and Metformin in Type 2 Diabetes 966  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.965MATERIALS AND METHODS Between January and September 2012, patients with type 2 dia - betes, aged 20 to 80 yr, who had taken metformin for at least  three months were recruited consecutively at the university-af - filiated diabetes center of St. Vincent’s Hospital in Korea.",Non-OADS,/arxiv_data1/oa_pdf/53/8a/jkms-29-965.PMC4101785.pdf
• Association of Vitamin B 12 and Metformin in Type 2 Diabetes http://jkms.org   967 http://dx.doi.org/10.3346/jkms.2014.29.7.965Table 1.,Non-OADS,/arxiv_data1/oa_pdf/53/8a/jkms-29-965.PMC4101785.pdf
• Association of Vitamin B 12 and Metformin in Type 2 Diabetes 968  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.965Fig.,Non-OADS,/arxiv_data1/oa_pdf/53/8a/jkms-29-965.PMC4101785.pdf
• Association of Vitamin B 12 and Metformin in Type 2 Diabetes http://jkms.org   969 http://dx.doi.org/10.3346/jkms.2014.29.7.965Table 2.,Non-OADS,/arxiv_data1/oa_pdf/53/8a/jkms-29-965.PMC4101785.pdf
• Association of Vitamin B 12 and Metformin in Type 2 Diabetes 970  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.965ficiency confined to an Asian population with type 2 diabetes  treated with metformin.,Non-OADS,/arxiv_data1/oa_pdf/53/8a/jkms-29-965.PMC4101785.pdf
• Association of Vitamin B 12 and Metformin in Type 2 Diabetes http://jkms.org   971 http://dx.doi.org/10.3346/jkms.2014.29.7.965fect.,Non-OADS,/arxiv_data1/oa_pdf/53/8a/jkms-29-965.PMC4101785.pdf
ORCID Sun-Hye Ko http://orcid.org/0000-0003-3387-3986  Sun-Hee Ko http://orcid.org/0000-0001-6638-1609  Ki-Ho Song http://orcid.org/0000-0003-1883-7039  Kyung-Do Han http://orcid.org/0000-0002-6096-1263 Yong-Moon Park http://orcid.org/0000-0002-5879-6879  Hye-Soo Kim http://orcid.org/0000-0002-2419-4669  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/53/8a/jkms-29-965.PMC4101785.pdf
• Association of Vitamin B 12 and Metformin in Type 2 Diabetes 972  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.965tween metformin and cancer in patients with type 2 diabetes.,Non-OADS,/arxiv_data1/oa_pdf/53/8a/jkms-29-965.PMC4101785.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Clinical Significance of Non-Alcoholic Fatty Liver Disease as a  Risk Factor for Prehypertension  Previous epidemiologic studies have shown the clinical association between non-alcoholic  fatty liver disease (NAFLD) and cardiovascular disease (CVD).",Non-OADS,/arxiv_data1/oa_pdf/19/f8/jkms-29-973.PMC4101786.pdf
"Received: 11 December 2013 Accepted: 24 April 2014 Address for Correspondence: Sung Keun Park, MD Total Healthcare Center, Kangbuk Samsung Hospital, 78  Saemunan-gil, Jongro-gu, Seoul 110-746, Korea Tel: +82.10-3377-6314, Fax: +82.2-2001-2626 E-mail: kkkmin7@hotmail.com http://dx.doi.org/10.3346/jkms.2014.29.7.973  • J Korean Med Sci 2014; 29: 973-979 INTRODUCTION  Non-alcoholic fatty liver disease (NAFLD) is being recognized  as not only most common liver disease but also metabolic dis - ease (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/19/f8/jkms-29-973.PMC4101786.pdf
"• Clinical Association between NAFLD and Prehypertension 974  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.973population was composed of Korean male workers, and the  system of medical health check up was described in our previ - ous study in detail (9).",Non-OADS,/arxiv_data1/oa_pdf/19/f8/jkms-29-973.PMC4101786.pdf
• Clinical Association between NAFLD and Prehypertension http://jkms.org   975 http://dx.doi.org/10.3346/jkms.2014.29.7.973Statistical analysis Data were expressed as means ± (SD) or medians (interquartile  range) for continuous variables and percentages of the number  for categorical variables.,OADS,/arxiv_data1/oa_pdf/19/f8/jkms-29-973.PMC4101786.pdf
• Clinical Association between NAFLD and Prehypertension 976  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.973Table 2.,Non-OADS,/arxiv_data1/oa_pdf/19/f8/jkms-29-973.PMC4101786.pdf
• Clinical Association between NAFLD and Prehypertension http://jkms.org   977 http://dx.doi.org/10.3346/jkms.2014.29.7.973Table 3.,Non-OADS,/arxiv_data1/oa_pdf/19/f8/jkms-29-973.PMC4101786.pdf
"• Clinical Association between NAFLD and Prehypertension 978  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.973tively lower in woman than man, and known to increase in post - menopausal state (29, 30).",Non-OADS,/arxiv_data1/oa_pdf/19/f8/jkms-29-973.PMC4101786.pdf
ORCID Jae-Hong Ryoo http://orcid.org/0000-0002-5232-1426  Woo Taek Ham http://orcid.org/0000-0003-3212-1627  Joong-Myung Choi http://orcid.org/0000-0002-3610-6662  Min A Kang http://orcid.org/0000-0003-1889-8122  So Hee An http://orcid.org/0000-0002-8436-7402  Jong-Keun Lee http://orcid.org/0000-0003-1376-3202  Ho Cheol Shin http://orcid.org/0000-0003-0212-1917  Sung Keun Park http://orcid.org/0000-0003-4703-9917  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/19/f8/jkms-29-973.PMC4101786.pdf
• Clinical Association between NAFLD and Prehypertension http://jkms.org   979 http://dx.doi.org/10.3346/jkms.2014.29.7.9731779-85.,Non-OADS,/arxiv_data1/oa_pdf/19/f8/jkms-29-973.PMC4101786.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Toxicity Profile of Temozolomide in the Treatment of 300  Malignant Glioma Patients in Korea This study evaluated the toxicity profiles of temozolomide in the treatment of malignant  glioma as either concurrent or adjuvant chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/cd/ea/jkms-29-980.PMC4101787.pdf
"Keywords:  Glioma; Temozolomide; Toxicity; Chemoradiotherapy; Chemotherapy,  AdjuvantSo Hyun Bae,1 Min-Jung Park,2   Min Mi Lee,1 Tae Min Kim,3,6   Se-Hoon Lee,3,6 Sung Yun Cho,4   Young-Hoon Kim,1,6 Yu Jung Kim,5,6   Chul-Kee Park,2,6 and Chae-Yong Kim1,6 1Department of Neurosurgery, Seoul National  University Bundang Hospital, Seongnam;  Departments of 2Neurosurgery and 3Internal  Medicine, Seoul National University Hospital, Seoul;  4Department of Neurosurgery, Dong-Eui Medical  Center, Busan; 5Department of Internal Medicine,  Seoul National University Bundang Hospital,  Seongnam; 6Seoul National University College of  Medicine, Seoul National University, Seoul, Korea Received: 28 November 2013 Accepted: 29 April 2014 Address for Correspondence: Chae-Yong Kim, MD Department of Neurosurgery, Seoul National University Bundang  Hospital, Seoul National University College of Medicine, 166  Gumi-ro, Bundang-gu, Seongnam 463-707, Korea Tel: +82.31-787-7165, Fax: +82.31-787-4097 E-mail: chaeyong@snu.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.7.980  • J Korean Med Sci 2014; 29: 980-984 INTRODUCTION  Gliomas are the most frequently occurring malignant primary  brain tumors in adults (1-4).",Non-OADS,/arxiv_data1/oa_pdf/cd/ea/jkms-29-980.PMC4101787.pdf
• Toxicity Profile of Temozolomide http://jkms.org   981 http://dx.doi.org/10.3346/jkms.2014.29.7.980Table 1.,Non-OADS,/arxiv_data1/oa_pdf/cd/ea/jkms-29-980.PMC4101787.pdf
• Toxicity Profile of Temozolomide 982  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.980(54.7%) could not complete 6 cycles.,Non-OADS,/arxiv_data1/oa_pdf/cd/ea/jkms-29-980.PMC4101787.pdf
• Toxicity Profile of Temozolomide http://jkms.org   983 http://dx.doi.org/10.3346/jkms.2014.29.7.980DISCUSSION We thoroughly evaluated the toxicity profile of temozolomide  in the 300 patients diagnosed with malignant gliomas.,Non-OADS,/arxiv_data1/oa_pdf/cd/ea/jkms-29-980.PMC4101787.pdf
• Toxicity Profile of Temozolomide 984  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.980vomiting.,Non-OADS,/arxiv_data1/oa_pdf/cd/ea/jkms-29-980.PMC4101787.pdf
ORCID So Hyun Bae http://orcid.org/0000-0001-9842-6584 Min-Jung Park http://orcid.org/0000-0003-1638-3491 Min Mi Lee http://orcid.org/0000-0003-3467-8859 Tae Min Kim http://orcid.org/0000-0001-6145-4426 Se-Hoon Lee http://orcid.org/0000-0002-9219-3350 Sung Yun Cho http://orcid.org/0000-0001-8239-1639 Young-Hoon Kim http://orcid.org/0000-0002-8852-6503 Yu Jung Kim http://orcid.org/0000-0002-5037-0523 Chul-Kee Park http://orcid.org/0000-0002-2350-9876 Chae-Yong Kim http://orcid.org/0000-0001-9773-5553 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/cd/ea/jkms-29-980.PMC4101787.pdf
Available at http://www.cancer.,Non-OADS,/arxiv_data1/oa_pdf/cd/ea/jkms-29-980.PMC4101787.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Comparison of Epidemiology, Emergency Care, and Outcomes  of Acute Ischemic Stroke between Young Adults and Elderly in  Korean Population: A Multicenter Observational Study Stroke in young adults has been known to show a lower incidence and a better prognosis.",Non-OADS,/arxiv_data1/oa_pdf/92/84/jkms-29-985.PMC4101788.pdf
"Keywords:  Stroke; Age Distribution; Epidemiology; Outcome AssessmentWon-Bin Park,1 Jin-Seong Cho,1   Sang-Do Shin,2 So-Yeon Kong,3   Jin-Joo Kim,1 Yong-Su Lim,1   Hyuk-Jun Yang,1 and Gun Lee1 1Department of Emergency Medicine, Gachon  University Gil Medical Center, Incheon; 2Department  of Emergency Medicine, Seoul National University  Hospital, Seoul, Korea; 3World Health Organization,  International Agency for Research on Cancer, Lyon,  France Received: 10 December 2013 Accepted: 29 April 2014 Address for Correspondence: Jin-Seong Cho, MD Department of Emergency Medicine, Gachon University Gil  Medical Center, 21 Namdong-daero 774 beon-gil,   Namdong-gu, Incheon 405-760, Korea Tel: +82.32-460-3015, Fax: +82.32-460-3019 E-mail: truecho@hanmail.net Funding:  The current study was financially supported by the  Korea Centers for Disease Control and Prevention (2008-2011).http://dx.doi.org/10.3346/jkms.2014.29.7.985  • J Korean Med Sci 2014; 29: 985-991 INTRODUCTION Cerebrovascular disease is the second leading cause of death  and the major cause of disability in Korea (1).",Non-OADS,/arxiv_data1/oa_pdf/92/84/jkms-29-985.PMC4101788.pdf
• Young Adults Ischemic Stroke in Korea 986  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.985cians and cardiovascular/ neurovascular specialty doctors (11).,Non-OADS,/arxiv_data1/oa_pdf/92/84/jkms-29-985.PMC4101788.pdf
"• Young Adults Ischemic Stroke in Korea http://jkms.org   987 http://dx.doi.org/10.3346/jkms.2014.29.7.985ing mental change, sensory abnormality, unable to walk, and  dizziness were significantly different between two age groups  (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/92/84/jkms-29-985.PMC4101788.pdf
• Young Adults Ischemic Stroke in Korea 988  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.985Table 2.,Non-OADS,/arxiv_data1/oa_pdf/92/84/jkms-29-985.PMC4101788.pdf
"• Young Adults Ischemic Stroke in Korea http://jkms.org   989 http://dx.doi.org/10.3346/jkms.2014.29.7.985ed for 5.5% of total ischemic stroke patients, which is greater  than 3.7% on the National Survey of Stroke in North America  (3), but lower than 8.5% reported by Bevan et al.",Non-OADS,/arxiv_data1/oa_pdf/92/84/jkms-29-985.PMC4101788.pdf
"• Young Adults Ischemic Stroke in Korea 990  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.985 Although this is one of the largest ED-based studies, there are  a number of limitations.",Non-OADS,/arxiv_data1/oa_pdf/92/84/jkms-29-985.PMC4101788.pdf
ORCID Won-Bin Park http://orcid.org/0000-0003-3557-6547  Jin-Seong Cho http://orcid.org/0000-0001-6762-4692  Sang-Do Shin http://orcid.org/0000-0003-4953-2916  So-Yeon Kong http://orcid.org/0000-0001-5106-7342  Jin-Joo Kim http://orcid.org/0000-0002-5678-2019  Yong-Su Lim http://orcid.org/0000-0003-4390-4010  Hyuk-Jun Yang http://orcid.org/0000-0001-8324-9749  Gun Lee http://orcid.org/0000-0001-7967-8663  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/92/84/jkms-29-985.PMC4101788.pdf
Avail - able at http://kostat.go.kr/portal/korea/kor_nw/2/6/1/index.board?b mode=read&bSeq=&aSeq=260046&pageNo=1&rowNum=10&navCou nt=10&currPg=&sTarget=title&sTxt= [accessed on 13 September 2012].,Non-OADS,/arxiv_data1/oa_pdf/92/84/jkms-29-985.PMC4101788.pdf
Available at http://knhanes.cdc.go.kr/knhanes/index.,OADS,/arxiv_data1/oa_pdf/92/84/jkms-29-985.PMC4101788.pdf
Available at  http://www.oecd.org/els/health-systems/49105858.pdf [accessed on 23  November 2011].,Non-OADS,/arxiv_data1/oa_pdf/92/84/jkms-29-985.PMC4101788.pdf
• Young Adults Ischemic Stroke in Korea http://jkms.org   991 http://dx.doi.org/10.3346/jkms.2014.29.7.98522.,Non-OADS,/arxiv_data1/oa_pdf/92/84/jkms-29-985.PMC4101788.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Incidence and Risk Factors of Subsequent Hip Fractures in Korea:  Multicenter Study This study analyzes the incidence of subsequent hip fractures and its risk factors in the  northwestern region of Korea.",Non-OADS,/arxiv_data1/oa_pdf/ae/36/jkms-29-992.PMC4101789.pdf
"Keywords:  Subsequent Hip Fractures; Risk Factors; IncidenceKee Haeng Lee,1 Ju Young Kim,2   Soo Jae Yim,3 Do Hyun Moon,4   Geun Hong Choi,5 and Kyoung Ho Moon5 1Department of Orthopedic Surgery, Bucheon St.  Mary’s Hospital, The Catholic University of Korea,  Bucheon; 2Department of Orthopedic Surgery,  Incheon St. Mary’s Hospital, The Catholic University  of Korea, Incheon; 3Department of Orthopedic  Surgery, Soonchunhyang University Bucheon  Hospital, Bucheon; 4Department of Orthopedic  Surgery, Gil Medical Center, College of Medicine,  Gachon University, Incheon; 5Department of  Orthopaedic Surgery, College of Medicine, Inha  University, Incheon, Korea Received: 29 October 2013 Accepted: 30 April 2014 Address for Correspondence: Kyoung Ho Moon, MD Department of Orthopaedic Surgery, College of Medicine,   Inha University, 27 Inhang-ro, Jung-gu, Incheon 400-711, Korea  Tel: +82.32-890-3663, Fax: +82.32-890-3467 E-mail: moon@inha.ac.kr Funding:  This study was supported by a grant of Inha University.http://dx.doi.org/10.3346/jkms.2014.29.7.992  • J Korean Med Sci 2014; 29: 992-994 INTRODUCTION The one-year mortality of hip fractures in elderly patients rang - es from 14%-36%, and the incidence of hip fractures is increas - ing each year because of increasing the number of the elderly.",Non-OADS,/arxiv_data1/oa_pdf/ae/36/jkms-29-992.PMC4101789.pdf
• Incidence and Risk Factors of Subsequent Hip Fractures in Korea http://jkms.org   993 http://dx.doi.org/10.3346/jkms.2014.29.7.992Table 1.,Non-OADS,/arxiv_data1/oa_pdf/ae/36/jkms-29-992.PMC4101789.pdf
• Incidence and Risk Factors of Subsequent Hip Fractures in Korea 994  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.992Additionally eating fish and sleeping on Japanese mattress might  exert preventive effects against hip fracture (20).,Non-OADS,/arxiv_data1/oa_pdf/ae/36/jkms-29-992.PMC4101789.pdf
ORCID Do Hyun Moon http://orcid.org/0000-0003-4806-6650 Ju Young Kim http://orcid.org/0000-0003-0182-8523 Kee Haeng Lee http://orcid.org/0000-0002-2137-2992 Soo Jae Yim http://orcid.org/0000-0003-2107-7384 Kyoung Ho Moon http://orcid.org/0000-0002-9186-0473 Geun Hong Choi http://orcid.org/0000-0003-3776-1877 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ae/36/jkms-29-992.PMC4101789.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Association between the Low Muscle Mass and Osteoporosis  in Elderly Korean People The purpose of this study was to predict osteoporosis risk as decreasing muscle mass and to  declare the cut-off value of low muscle mass in an elderly Korean population.",Non-OADS,/arxiv_data1/oa_pdf/ee/ee/jkms-29-995.PMC4101790.pdf
"Keywords:  Osteoporosis; Sarcopenia; Korea; KNHANES; Elderly PopulationSunyoung Kim,1,2 Chang Won Won,1  Byung Sung Kim,1 Hyun Rim Choi,1   and Min Young Moon1 1Department of Family Medicine, College of  Medicine, Kyung Hee University, Seoul; 2Department  of Medicine, Graduate School Ewha Womans  University, Seoul, Korea Received: 23 December 2013 Accepted: 24 April 2014 Address for Correspondence: Chang Won Won, MD Department of Family Medicine, Kyung Hee University Hospital,  23 Kyunghee dae-ro, Dongdaemun-gu, Seoul 130-872, Korea Tel: +82.2-958-8697, Fax: +82.2-958-8699  E-mail: chunwon62@dreamwiz.com Funding:  There is no research grant or funding with respect to  this manuscript.http://dx.doi.org/10.3346/jkms.2014.29.7.995  • J Korean Med Sci 2014; 29: 995-1000 INTRODUCTION According to the 2010 data from the Statistics Korea, the elderly  population in Korea increased 24.3% from 2005 to 2010, which  was 12.2 times greater than the increase in the total population  (2.0%) during the same time period (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/ee/ee/jkms-29-995.PMC4101790.pdf
• Sarcopenia and Osteoporosis 996  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.995the KNHANES V (2).,Non-OADS,/arxiv_data1/oa_pdf/ee/ee/jkms-29-995.PMC4101790.pdf
• Sarcopenia and Osteoporosis http://jkms.org   997 http://dx.doi.org/10.3346/jkms.2014.29.7.995Table 1.,Non-OADS,/arxiv_data1/oa_pdf/ee/ee/jkms-29-995.PMC4101790.pdf
• Sarcopenia and Osteoporosis 998  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.995Fig.,Non-OADS,/arxiv_data1/oa_pdf/ee/ee/jkms-29-995.PMC4101790.pdf
"• Sarcopenia and Osteoporosis http://jkms.org   999 http://dx.doi.org/10.3346/jkms.2014.29.7.9951.15; P= 0.44), even after adjusting for age, fat mass, calcium  intake, vitamin D status, smoking, alcohol consumption, and  physical activity.",Non-OADS,/arxiv_data1/oa_pdf/ee/ee/jkms-29-995.PMC4101790.pdf
ORCID Sunyoung Kim http://orcid.org/0000-0003-4115-4455  Chang Won Won http://orcid.org/0000-0002-6429-4461  Byung Sung Kim http://orcid.org/0000-0002-4984-6918  Hyun Rim Choi http://orcid.org/0000-0003-4356-2831  Min Young Moon http://orcid.org/0000-0002-7207-8155  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ee/ee/jkms-29-995.PMC4101790.pdf
Available at http://knhanes.cdc.go.kr [ac - cessed on 20 February 2014].,Non-OADS,/arxiv_data1/oa_pdf/ee/ee/jkms-29-995.PMC4101790.pdf
• Sarcopenia and Osteoporosis 1000  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.7.995tal muscle mass is the strongest independent factor associated with fem - oral neck bone mineral density in adult and older men.,Non-OADS,/arxiv_data1/oa_pdf/ee/ee/jkms-29-995.PMC4101790.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/71/3a/srep05627.PMC4102077.pdf
Methodology Data sources .The datasets used in this study include: 1) version 2.2 monthly average Global Precipitation Climatology Project (GPCP) products (available at http://precip.gsfc.nasa.gov/) on a 2.5 u32.5u grid.,OADS,/arxiv_data1/oa_pdf/4e/c3/srep05693.PMC4102078.pdf
All authors reviewed the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4e/c3/srep05693.PMC4102078.pdf
"* Centre for Innovative Ageing, College of Human and Health Sciences, Swansea University, UK.Ageing & Society , , – .fCambridge University Press  The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence<http://creativecommons.org/licenses/by-nc-sa/ ./>.",Non-OADS,/arxiv_data1/oa_pdf/8a/c1/S0144686X12001511a.PMC4102105.pdf
CST Microwave Studios http://www.cst.com (2012).,Non-OADS,/arxiv_data1/oa_pdf/ff/e9/ncomms5354.PMC4102110.pdf
Additional Information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests : The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/ff/e9/ncomms5354.PMC4102110.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article : Dregely, D. et al.",Non-OADS,/arxiv_data1/oa_pdf/ff/e9/ncomms5354.PMC4102110.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5354 8 NATURE COMMUNICATIONS | 5:4354 | DOI: 10.1038/ncomms5354 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/ff/e9/ncomms5354.PMC4102110.pdf
Video recordings were done using a PS3 camera(PlayStation) at 60 frames per second and online tracking was done using a custom data processing stream programmed in Bonsai (https://bitbucket.org/horizongir/ bonsai).,Non-OADS,/arxiv_data1/oa_pdf/08/5a/ncomms5315.PMC4102112.pdf
"To calculate the rostrocaudal axis, the coordinates of the head centre and the tail were determined using a custom-made software developed in Python (https://github.com/joseaccruz/SimpleMouseTracker).",OADS,/arxiv_data1/oa_pdf/08/5a/ncomms5315.PMC4102112.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/08/5a/ncomms5315.PMC4102112.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Tecuapetla, F. et al.",Non-OADS,/arxiv_data1/oa_pdf/08/5a/ncomms5315.PMC4102112.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5315 10 NATURE COMMUNICATIONS | 5:4315 | DOI: 10.1038/ncomms5315 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/08/5a/ncomms5315.PMC4102112.pdf
"ISBN 3-900051-07-0, URL http://www.R-project.org/ (2013).",Non-OADS,/arxiv_data1/oa_pdf/cf/d3/ncomms5274.PMC4102113.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Thorrold, S. R. et al.",Non-OADS,/arxiv_data1/oa_pdf/cf/d3/ncomms5274.PMC4102113.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5274 ARTICLE NATURE COMMUNICATIONS | 5:4274 | DOI: 10.1038/ncomms5274 | www.nature.com/naturecommunications 7 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/cf/d3/ncomms5274.PMC4102113.pdf
"Because of its low cost, high reliability and compatibility with the complementary metal-oxide semiconductor (CMOS) technology, Ge2Sb2Te5(GST)-based PCM has already been applied to mobile electronics, replacing NOR ﬂash memory (Micron announces availability of PCM for mobile devices- http://investors.micron.",Non-OADS,/arxiv_data1/oa_pdf/39/0d/ncomms5086.PMC4102114.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interest.,Non-OADS,/arxiv_data1/oa_pdf/39/0d/ncomms5086.PMC4102114.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Zhu, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/39/0d/ncomms5086.PMC4102114.pdf
"To view a copy of this license, visit http://creativecommon-s.org/licenses/by-nc-nd/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5086 6 NATURE COMMUNICATIONS | 5:4086 | DOI: 10.1038/ncomms5086 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/39/0d/ncomms5086.PMC4102114.pdf
http://arxiv.org/abs/1310.3125 (2013).,Non-OADS,/arxiv_data1/oa_pdf/41/a5/ncomms5237.PMC4102117.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Xue, Y. et al.",Non-OADS,/arxiv_data1/oa_pdf/41/a5/ncomms5237.PMC4102117.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5237 8 NATURE COMMUNICATIONS | 5:4237 | DOI: 10.1038/ncomms5237 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/41/a5/ncomms5237.PMC4102117.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/8a/15/ncomms5305.PMC4102119.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Nilsson, H. et al.",Non-OADS,/arxiv_data1/oa_pdf/8a/15/ncomms5305.PMC4102119.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5305 ARTICLE NATURE COMMUNICATIONS | 5:4305 | DOI: 10.1038/ncomms5305 | www.nature.com/naturecommunications 7 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/8a/15/ncomms5305.PMC4102119.pdf
"Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: He, R. et al.",Non-OADS,/arxiv_data1/oa_pdf/3f/0e/ncomms5327.PMC4102124.pdf
"This is an open access article, published  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0).",Non-OADS,/arxiv_data1/oa_pdf/3d/98/JVR-05-16.PMC4102125.pdf
"This is an open access article, published  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0).",Non-OADS,/arxiv_data1/oa_pdf/08/72/JVR-05-01.PMC4102126.pdf
The segmentation of the densities corresponding to the major capsid protein and the outer capsid proteinswere done using Chimera and Avizo (http://www.vsg3d.com/avizo/overview).,OADS,/arxiv_data1/oa_pdf/31/3e/ncomms5278.PMC4102127.pdf
"The authors acknowledge the Texas Advanced Com- puting Center (TACC, http://www.tacc.utexas.edu) at The University of Texas in Austin for providing HPC resources that have contributed to the research results reportedwithin this paper.",Non-OADS,/arxiv_data1/oa_pdf/31/3e/ncomms5278.PMC4102127.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/31/3e/ncomms5278.PMC4102127.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Gipson, P. et al.",Non-OADS,/arxiv_data1/oa_pdf/31/3e/ncomms5278.PMC4102127.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5278 10 NATURE COMMUNICATIONS | 5:4278 | DOI: 10.1038/ncomms5278 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/31/3e/ncomms5278.PMC4102127.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Vallina, S. M. et al.",Non-OADS,/arxiv_data1/oa_pdf/9f/a8/ncomms5299.PMC4102128.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5299 10 NATURE COMMUNICATIONS | 5:4299 | DOI: 10.1038/ncomms5299 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/9f/a8/ncomms5299.PMC4102128.pdf
"3   July,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm14022 Effects of Chili Treatment on Gastrointestinal  and Rectal Sensation in Diarrhea-predominant  Irritable Bowel Syndrome: A Randomized, Double-blinded, Crossover Study Satimai Aniwan and Sutep Gonlachanvit * Gastrointestinal Motility Research Unit, Division of Gastroente rology, Department of Internal Medicine, Chulalongkorn Universi ty, Bangkok, Thailand Background/Aims Whether, chronic chili ingestion can desensitize transient receptor potential vanilloid type 1 receptors in gastrointestinal (G I)  tract leading to decrease GI symptoms and sensation in diarrhea-predominant irritable bowel syndrome (IBS-D) patients has not been well explored.",Non-OADS,/arxiv_data1/oa_pdf/79/0d/jnm-20-400.PMC4102147.pdf
"ORCID: Satimai Aniwan, http://orcid.org/0000-0002-2730-2450.",Non-OADS,/arxiv_data1/oa_pdf/79/0d/jnm-20-400.PMC4102147.pdf
"3   July,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm14019 338Effects of the New Prokinetic Agent DA-9701  Formulated With Corydalis Tuber and Pharbitis  Seed in Patients With Minimal Change Esophagitis: A Bicenter, Randomized, Double  Blind, Placebo-controlled Study Chan Hyuk Park,1 Hyun-Soo Kim2 and Sang Kil Lee1* 1Division of Gastroenterology, Department of Internal Medicine, Severance Hospital, Institute of Gastroenterology, Brain Korea 21 PLUS project  for Medical Science, Yonsei University College of Medicine, Seo ul, Korea; and2Division of Gastroenterology and Hepatology, Department of  Internal Medicine, Yonsei University Wonju College of Medicine,  Wonju, Gangwon-do, Korea Background/Aims DA-9701 (Motilitone) is a new prokinetic agent formulated with Corydalis Tuber and Pharbitis Seed.",Non-OADS,/arxiv_data1/oa_pdf/2c/58/jnm-20-338.PMC4102148.pdf
"ORCID: Sang Kil Lee, http://orcid.org/0000-0002-0721-0364.",Non-OADS,/arxiv_data1/oa_pdf/2c/58/jnm-20-338.PMC4102148.pdf
"3   July,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm14007 Impedance Analysis Using High-resolution  Impedance Manometry Facilitates Assessment  of Pharyngeal Residue in Patients With Oropharyngeal Dysphagia Tae Hee Lee,1 Joon Seong Lee,1* Su Jin Hong,2 Ji Sung Lee,3 Seong Ran Jeon,1 Wan Jung Kim,4 Hyun Gun Kim,1  Joo Young Cho,1 Jin-Oh Kim,1 Jun-Hyung Cho,1 Mi-Young Kim1 and Soon Ha Kwon1 1Institute for Digestive Research, Digestive Disease Center Soon chunhyang University College of Medicine, Seoul, Korea;2Department of  Internal Medicine, Soonchunhyang University College of Medicine , Bucheon, Gyeonggi-do, Korea;3Biostatistical Consulting Unit,  Soonchunhyang University College of Medicine, Seoul, Korea; and4Department of Internal Medicine, Soonchunhyang University Hospi tal,  Gumi, Gyeongsangbuk-do, Korea Background/Aims Impedance analysis using high-resolution impedance manometry (HRIM) enables the recognition of pharyngeal residue in pa- tients with oropharyngeal dysphagia.",Non-OADS,/arxiv_data1/oa_pdf/e4/f3/jnm-20-362.PMC4102149.pdf
"ORCID: Tae Hee Lee, http://orcid.org/0000-0003-3049-8252.",Non-OADS,/arxiv_data1/oa_pdf/e4/f3/jnm-20-362.PMC4102149.pdf
"3   July,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm14060 294The Significance of Interstitial Cells in  Neurogastroenterology Peter J Blair,1* Poong-Lyul Rhee,2 Kenton M Sanders1 and Sean M Ward1 1Department of Physiology and Cell Biology, University of Nevada  School of Medicine, Reno, NV, USA; and2Division of Gastroenterology,  Department of Medicine, Samsung Medical Center, Sungkyunkwan Un iversity School of Medicine, Seoul, Korea Smooth muscle layers of the gastrointestinal tract consist of a heterogeneous population of cells that include enteric neurons,   several classes of interstitial cells of mesenchymal origin, a variety of immune cells and smooth muscle cells (SMCs).",Non-OADS,/arxiv_data1/oa_pdf/99/f8/jnm-20-294.PMC4102150.pdf
"ORCID: Peter J Blair, http://orcid.org/0000-0002-9935-396X; Poo ng-Lyul Rhee, http://orcid.org/0000-0003-0495-5296; Kenton M Sa nders,  http://orcid.org/0000-0002-4196-1583; Sean M Ward, http://orcid .org/0000-0003-0217-1535.Introduction and Background Interstitial cells of Cajal (ICC) were first described by the  Spanish neuroanatomist Santiago Ramóny Cajal.",Non-OADS,/arxiv_data1/oa_pdf/99/f8/jnm-20-294.PMC4102150.pdf
"3   July,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm14026 Bone Marrow Derived Kit-positive Cells Colonize  the Gut but Fail to Restore Pacemaker Function  in Intestines Lacking Interstitial Cells of Cajal Conor J McCann,1,2 Sung-Jin Hwang,1 Grant W Hennig,1 Sean M Ward1 and Kenton M Sanders1* 1Department of Physiology and Cell Biology, University of Nevada  School of Medicine, Reno, NV, USA; and2University College London Institute  of Child Health, Birth Defects R esearch Center, Neural Developm ent Unit, London, UK Background/Aims Several motility disorders are associated with disruption of interstitial cells of Cajal (ICC), which provide important functio ns,  such as pacemaker activity, mediation of neural inputs and responses to stretch in the gastrointestinal (GI) tract.",Non-OADS,/arxiv_data1/oa_pdf/72/48/jnm-20-326.PMC4102151.pdf
"ORCID: Conor J McCann, http://orcid.org/0000-0002-9324-5984; Su ng-Jin Hwang, http://orcid.org/0000-0002-7571-7650; Grant W Hen nig,  http://orcid.org/0000-0001-7436-9458; Sean M Ward, http://orcid .org/0000-0003-0217-1535; Kenton M Sanders, http://orcid.org/00 00-  0002-4196-1583.",Non-OADS,/arxiv_data1/oa_pdf/72/48/jnm-20-326.PMC4102151.pdf
"3   July,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm14068 407How to Perform and Interpret Balloon  Expulsion Test Bong Eun Lee and Gwang Ha Kim * Department of Internal Medicine, Pusan National University Scho ol of Medicine, Busan, Korea The balloon expulsion test is a simple and usef ul method for investigatin g a defecatory disorder as sessing the subject’s abilit y  to evacuate a simulated stool.",Non-OADS,/arxiv_data1/oa_pdf/2d/f8/jnm-20-407.PMC4102152.pdf
"Conflicts of interest: None.ORCID: Gwang Ha Kim, http://orcid.org/0000-0001-9721-5734.Introduction The balloon expulsion test (BET) is a simple and inexpensive  bedside procedure that can identify patients with pelvic floor dyssynergia.",Non-OADS,/arxiv_data1/oa_pdf/2d/f8/jnm-20-407.PMC4102152.pdf
"3   July,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm14061 417What Happened When CrossCheck Was Not  Used for a Month in Journal of  Neurogastroenterology and Motility ?",Non-OADS,/arxiv_data1/oa_pdf/1b/3b/jnm-20-417.PMC4102153.pdf
"3   July,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm14065 412Abnormal Sensory Perception or Peristaltic  Dysfunction: Which One Is Associated With  Symptoms?",Non-OADS,/arxiv_data1/oa_pdf/90/7f/jnm-20-412.PMC4102154.pdf
"*Correspondence: Jung Ho Park, MD Department of Internal Medicine, Kangbuk Samsung Hospital, 29, Saemunan-ro, Jongno-Ku, Seoul 110-746, Korea Tel: +82-2-2001-2059, Fax: +82-2-2001-2485, E-mail: pjho3@hotma il.com Financial support: None.Conflicts of interest: None.ORCID: http://orcid.org/0000-0003-2568-128X.Summary The generation of esophageal symptoms while swallowing is  a multifactorial phenomenon.",Non-OADS,/arxiv_data1/oa_pdf/90/7f/jnm-20-412.PMC4102154.pdf
"3   July,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm13137 287Electrical Stimulation Therapy for Gastroesophageal Reflux Disease Nicolaas F Rinsma,1 Nicole D Bouvy,2 Ad A M Masclee1 and José M Conch illo1* Departments of1Gastroenterology and Hepatology, and2General Surgery, Maastricht University Medical Center, Maastric ht,  The Netherlands Electrical stimulation therapy (EST) of the lower esophageal sphincter is a relatively new technique for the treatment of gastr o- esophageal reflux disease (GERD) that may address the need of GERD patients, unsatisfied with acid suppressive medication  and concerned with the potential risks of surgical fundoplication.",Non-OADS,/arxiv_data1/oa_pdf/58/20/jnm-20-287.PMC4102155.pdf
"3   July,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm14035 410An Interesting Case of Post-fundoplication  Dysphagia Mayank Jain Department of Gastroenterology, Choithram Hospital and Research  Center, Indore, India Received: March 26, 2014 Revised: March 29, 2014 Accepted: March 31, 2014 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/94/1e/jnm-20-410.PMC4102156.pdf
"*Correspondence: Mayank Jain, MD, DNB Department of Gastroenterology, Choithram Hospital and Research  Center, Manik Bagh, Indore 452014, India Tel: +91-895-924-5040, E-mail: mayank4670@rediffmail.com Financial support: None.Conflicts of interest: None.ORCID: http://orcid.org/0000-0003-1176-5167.",Non-OADS,/arxiv_data1/oa_pdf/94/1e/jnm-20-410.PMC4102156.pdf
"3   July,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm13098 Nitrergic Pathway Is the Major Mechanism for  the Effect of DA-9701 on the Rat Gastric  Fundus Relaxation Yang Won Min,1 Eun-ju Ko,2 Ji Yeon Lee,2 Byung-Hoon Min,1 Jun Haeng Lee,1 Jae J Kim1 and Poong-Lyul Rhee1* 1Department of Medicine and2Biomedical Research Institute, Samsung Medical Center, Sungkyun kwan University School of Medicine, Seoul,  Korea Background/Aims DA-9701 significantly improved gastric accommodation by increasing the postprandial gastric volume.",Non-OADS,/arxiv_data1/oa_pdf/7f/a0/jnm-20-318.PMC4102157.pdf
"ORCID: Yang Won Min, http://orcid.org/0000-0001-7471-1305; Jae J Kim, http://orcid.org/0000-0002-0226-1330; Poong-Lyul Rhee,  http://orcid.org/0000-0003-0495-5296.",Non-OADS,/arxiv_data1/oa_pdf/7f/a0/jnm-20-318.PMC4102157.pdf
"3   July,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm13114 Normal Solid Gastric Emptying Values Measured  by Scintigraphy Using Asian-style Meal:  A Multicenter Study in Healthy Volunteers Pataramon Vasavid,1 Tawatchai Chaiwatanarat,1 Pawana Pusuwan,2 Chanika Sritara,3 Krisana Roysri,4 Sirianong  Namwongprom,5 Pichit Kuanrakcharoen,6 Teerapon Premprabha,7 Kitti Chunlertrith,8 Satawat Thongsawat,9  Siam Sirinthornpunya,10 Bancha Ovartlarnporn,11 Udom Kachintorn,12 Somchai Leelakusolvong,12 Chomsri Kositchaiwat,13  Suriya Chakkaphak13 and Sutep Gonlachanvit14* 1Department of Radiology, Faculty of Medicine, Chulalongkorn Uni versity, Bangkok, Thailand;2Department of Radiology, Faculty of Medicine,  Siriraj Hospital, Mahidol University, Bangkok, Thailand;3Department of Radiology, Faculty of Medicine Ramathibodi Hospit al, Mahidol  University, Bangkok, Thailand;4Department of Radiology, Faculty of Medicine, Khon Kaen Univers ity, Khon Kaen, Thailand;5Department of  Radiology, Faculty of Medicine, Chiang Mai University, Chiangma i, Thailand;6Department of Radiology, Rajavithi Hospital, Bangkok, Thailand;   7Department of Radiology, Faculty of Medicine, Prince of Songkla  University, Songkhla, Thailand;8Department of Medicine, Faculty of  Medicine, Khon Kaen University, Khon Kaen, Thailand;9Department of Internal Medicine, Faculty of Medicine, Chiang Ma i University,  Chiangmai, Thailand;10Department of Medicine, Rajavithi Hospital, Bangkok, Thailand;11Department of Medicine, Faculty of Medicine, Prince  of Songkla University, Songkhla, Thailand;12Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok,  Thailand;13Department of Medicine, Faculty of Medicine Ramathibodi Hospita l, Mahidol University, Bangkok, Thailand; and14GI Motility  Research Unit, Division of Gast roenterology, Department of Medi cine Faculty of Medicine, Chulalongkorn University, Bangkok, Th ailand Background/Aims To report gastric emptying scintigraphy, normal values should be established for a specific protocol.",Non-OADS,/arxiv_data1/oa_pdf/20/4a/jnm-20-371.PMC4102158.pdf
"ORCID: Pataramon Vasavid, http://orcid.org/0000-0002-0067-8319;  Tawatchai Chaiwatanarat, http://orcid.org/0000-0002-0562-1223;  Pawana  Pusuwan, http://orcid.org/0000-0002-1518-3837; Chanika Sritara,  http://orcid.org/0000-0001-7607-1786; Krisana Roysri,  http://orcid.org/0000-0002-0745-1088; Teerapon Premprabha, http ://orcid.org/0000-0003-3630-1203; Kitti Chunlertrith,  http://orcid.org/0000-0003-1833-6744; Satawat Thongsawat, http: //orcid.org/0000-0003-3302-3930; Bancha Ovartlarnporn,  http://orcid.org/0000-0001-9464-885X; Udom Kachintorn, http://o rcid.org/0000-0001-7776-5157; Somchai Leelakusolvong,  http://orcid.org/0000-0001-7104-2759; Chomsri Kositchaiwat, htt p://orcid.org/0000-0002-8253-8132; Suriya Chakkaphak,  http://orcid.org/0000-0001-7314-1523; Sutep Gonlachanvit, http: //orcid.org/0000-0002-8279-8778.",Non-OADS,/arxiv_data1/oa_pdf/20/4a/jnm-20-371.PMC4102158.pdf
"3   July,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm14011 Constipation Misperception Is Associated With  Gender, Marital Status, Treatment Utilization  and Constipation Symptoms Experienced Tae Hee Lee,1 Suck Chei Choi,2* Moo In Park,3 Kyung Sik Park,4 Jeong Eun Shin,5 Seong-Eun Kim,6 Kee Wook Jung,7  Hoon Sup Koo,8 Wan Jung Kim,9 Young Kwan Cho,10 Yeon Soo Kim11 and Ji Sung Lee12; Constipation Group of the Korean  Society of Neurogastroenterology and Motility 1Institute for Digestive Research, Digestive Disease Center, Soo nchunhyang University Hospital, Seoul, Korea;2Department of Internal Medicine  and Digestive Disease Research I nstitute, Wonkwang University C ollege of Medicine, Iksan, Korea;3Department of Internal Medicine, Kosin  University College of Medicine, Busan, Korea;4Department of Internal Medicine, Keimyung University College of  Medicine, Daegu, Korea;  5Division of Gastroenterology, Department of Internal Medicine, Dankook University Hospital, Dankook University College of Medi cine,  Cheonan, Chungcheongnam-do, Korea;6Department of Internal Medicine, Ewha Mokdong Hospital, Ewha Wo mans University School of  Medicine, Seoul, Korea: 7Asan Digestive Disease Research Institute, Department of Gastro enterology, Asan Medical Center, University of Ulsan  College of Medicine, Seoul, Korea;8Department of Internal Medicine, Konyang University College of Medicine, Daejeon, Korea;9Department  of Internal Medicine, Soonchunhyan University Gumi Hospital, Gu mi, Korea;10Department of Internal Medicine, Eulji General Hospital, Eulji  University College of Medicine, Seoul, Korea;11Department of Internal Medicine, Hallym University College of M edicine, Chuncheon Sacred  Heart Hospital, Gangwon-do, Korea; and12Biostatistical Consulting Unit, Soonchunhyang University Medica l Center, Seoul, Korea Background/Aims It is essential that clinicians have an understanding of pati ents’ perceptions of constipation as well as constipation mis- perception (CM), which can be defined as failure to recognize the six constipation symptoms (infrequency, straining, hard stool ,  incomplete evacuation, anorectal obstruction or manual maneuver).",Non-OADS,/arxiv_data1/oa_pdf/24/d9/jnm-20-379.PMC4102159.pdf
"ORCID: Tae Hee Lee, http://orcid.org/0000-0003-3049-8252.",Non-OADS,/arxiv_data1/oa_pdf/24/d9/jnm-20-379.PMC4102159.pdf
"3   July,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm14021 Videofluoroscopic and Manometric Evaluation  of Pharyngeal and Upper Esophageal  Sphincter Function During Swallowing Kyung Jae Yoon,1 Jung Ho Park,2* Jung Hwan Park3 and Il Seok Jung3 Departments of1Physical and Rehabilitation, and2Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan Unive rsity College of  Medicine, Seoul, Korea; and3Department of Bionano Technology, Gachon University, Seongnam, Gyeonggi-do, Korea  Background/Aims The purpose of this study was to determine important manometric metrics for the analysis of pharyngeal and upper esophageal  sphincter (UES) function and to investigate the effect of viscosity and other confounding factors on manometric results.",Non-OADS,/arxiv_data1/oa_pdf/8c/a1/jnm-20-352.PMC4102160.pdf
"ORCID: Jung Ho Park, http://orcid.org/0000-0003-2568-128X.",Non-OADS,/arxiv_data1/oa_pdf/8c/a1/jnm-20-352.PMC4102160.pdf
"3   July,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm14071 284Pathogenesis of Irritable Bowel Syndrome:  Is It Really in the Gene?",Non-OADS,/arxiv_data1/oa_pdf/0d/68/jnm-20-284.PMC4102161.pdf
"ORCID: Uday C Ghoshal, http://orcid.org/0000-0003-0221-8495.Irritable bowel syndrome (IBS) is a common gastrointestinal  (GI) disorder in the community and clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/0d/68/jnm-20-284.PMC4102161.pdf
"3   July,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm14020 Association Between SLC6A 4Serotonin  Transporter Gene Linked Polymorphic Region  and ADRA2A  −1291C>G and Irritable Bowel  Syndrome in Korea Yoon Jin Choi,1 Sung Wook Hwang,2 Nayoung Kim,1,2* Ji Hyun Park,2 Jane C Oh3 and Dong Ho Lee1,2 1Department of Internal Medicine, Seoul National University Bund ang Hospital, Seongnam, Gyeonggi-do, Korea;2Department of Internal  Medicine and Liver Research Institute, Seoul National Universit y College of Medicine, Seoul, Korea; and3Yonsei Plus Clinic, Seongnam,  Gyeonggi-do, Korea Background/Aims Despite numerous studies on the relation of genetic polymorphisms with irritable bowel syndrome (IBS), the results still remain   inconclusive.",Non-OADS,/arxiv_data1/oa_pdf/70/9f/jnm-20-388.PMC4102162.pdf
"ORCID: Nayoung Kim, http://orcid.org/0000-0002-9397-0406; Yoon Jin Choi, http://orcid.org/0000-0002-1922-9388.",Non-OADS,/arxiv_data1/oa_pdf/70/9f/jnm-20-388.PMC4102162.pdf
"3   July,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm14067 414Obesity and Functional Gastrointestinal  Diseases in Children (Int J Obes [Lond] Published Online First: 2 May 2014. doi: 10.1038/ijo.2014.67) Shaman Rajindrajith,1* Niranga M Devanarayana2 and Marc A Benninga3 Departments of1Pediatrics and2Physiology, Faculty of Medicine, University of Kelaniya, Ragama , Sri Lanka; and3Department of Pediatric  Gastroenterology and Nutrition, Emma Children ’s Hospital, Academic Medical Cent er, Amsterdam, The Netherlands Received: May 30, 2014 Revised: None Accepted: June 2, 2014 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/d4/0b/jnm-20-414.PMC4102164.pdf
"ORCID: Shaman Rajindrajith, http://orcid.org/0000-0003-1379-505 2; Niranga M Devanarayana, http://orcid.org/0000-0002-2988-110X ; Marc A  Benninga, http://orcid.org/0000-0001-9406-9188.Summary Childhood obesity is spreading across the world very fast.",Non-OADS,/arxiv_data1/oa_pdf/d4/0b/jnm-20-414.PMC4102164.pdf
"3   July,  2014 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm13138 347A Study to Draw a Normative Database of  Laryngopharynx pH Profile in Chinese Guijian Feng,1* Junyao Wang,1 Lihong Zhang2 and Yulan Liu1 Departments of1Gastroenterology and2Otorhinolaryngology , Peking University People's Hospital, Beij ing, China Background/Aims To draw a normative database of laryngopharynx pH profile in Chinese subjects.",Non-OADS,/arxiv_data1/oa_pdf/24/75/jnm-20-347.PMC4102165.pdf
"ORCID: Guijian Feng, http://orcid.org/0000-0002-6400-847X.",Non-OADS,/arxiv_data1/oa_pdf/24/75/jnm-20-347.PMC4102165.pdf
"7–9,30–38For example, the multi-scale modeling platforms CompuCell 3D (www.compucell3d.org), Simmune, and Virtual Cell (http://www.ibiblio.org/virtualcell/) all provideapproaches for model linking.",OADS,/arxiv_data1/oa_pdf/e3/97/wsbm0006-0289.PMC4102180.pdf
Research to improve model modularity is an actively expanding activ- ity (http://www.imagwiki.nibib.nih.gov/mediawiki/ index.php?title =Main_Page).,Non-OADS,/arxiv_data1/oa_pdf/e3/97/wsbm0006-0289.PMC4102180.pdf
"During eachtuning exercise, there are frequent opportunities tointroduce bias, artifacts, and/or seed an inscription error 7,105(http://furm.org/glossary.html), which—if unnoticed—will jeopardize the scientific usefulness ofsubsequent model refinements.",Non-OADS,/arxiv_data1/oa_pdf/e3/97/wsbm0006-0289.PMC4102180.pdf
Available at: http://plato.stanford.edu/archives/ fall2013/entries/reasoning-analogy/.,Non-OADS,/arxiv_data1/oa_pdf/e3/97/wsbm0006-0289.PMC4102180.pdf
"Meghan E. Hermance1and Saravanan Thangamani1,2,3 1Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA; 2Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston,Texas, USA and 3Galveston National Laboratory, University of Texas Medical Branch,Galveston, Texas, USAE-mail: sathanga@utmb.edu SUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper at http://www.nature.com/jid REFERENCES Alekseev A, Chunikhin S (1990) The experimental transmission of the tick-borne encephalitisvirus by ixodid ticks (the mechanisms, timeperiods, species and sex differences).",Non-OADS,/arxiv_data1/oa_pdf/55/5a/jid2014150a.PMC4102615.pdf
"To view a copy ofthis license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Immunological and Statistical Studies of Anti-BP180 Antibodies in Paraneoplastic Pemphigus Journal of Investigative Dermatology (2014) 134, 2283–2287; doi:10.1038/jid.2014.151; published online 24 April 2014 TO THE EDITOR Paraneoplastic pemphigus (PNP) showsclinically intractable stomatitis and con-junctivitis with polymorphous-cutaneouslesions (Anhalt et al.",Non-OADS,/arxiv_data1/oa_pdf/55/5a/jid2014150a.PMC4102615.pdf
"205 http://dx.doi.org/10.3345/kjp.2014.57.5.205Determinants of sensitization to allergen in  infants and young children Hyeong Yun Kim, MD1, Youn Ho Shin, MD2, Man Yong Han, MD2  1Department of Pediatrics, Bundang JeSaeng General Hospital, Seongnam, 2Department of Pediatrics, CHA University School of Medicine, Seongnam, Korea Atopic sensitization is a complex phenomenon that changes dynamically with age throughout childhood;  its prevalence increases with age in young children.",Non-OADS,/arxiv_data1/oa_pdf/a3/e3/kjped-57-205.PMC4102681.pdf
"Key words:  Atopy, Sensitization, Determinant, Infant  Corresponding author:  Man Yong Han, MD Department of Pediatrics, CHA Bundang Medical  Center, CHA University School of Medicine, 59  Yatap-ro, Bundang-gu, Seongnam 463-712, Korea Tel: +82-31-780-6262 Fax: +82-31-780-5239 E-mail: drmesh@gmail.com Received: 30 December, 2013 Accepted: 12 March, 2014 Copyright © 2014 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article Korean J Pediatr 2014;57(5):205-210 http://dx.doi.org/10.3345/kjp.2014.57.5.205 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction In epidemiologic studies and clinical practice, atopic sensitization is defined as a positive  allergen-specific serum immunoglobulin E (IgE) test or skin prick test to any food or  inhalant allergens.",Non-OADS,/arxiv_data1/oa_pdf/a3/e3/kjped-57-205.PMC4102681.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.5.205Kim HY, et al.",OADS,/arxiv_data1/oa_pdf/a3/e3/kjped-57-205.PMC4102681.pdf
"207 http://dx.doi.org/10.3345/kjp.2014.57.5.205Korean J Pediatr 2014;57(5):205-210 toddlerhood may prime infants for atopic sensitization in child- hood, depending on HLA genotypes.",Non-OADS,/arxiv_data1/oa_pdf/a3/e3/kjped-57-205.PMC4102681.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.5.205Kim HY, et al.",OADS,/arxiv_data1/oa_pdf/a3/e3/kjped-57-205.PMC4102681.pdf
209 http://dx.doi.org/10.3345/kjp.2014.57.5.205Korean J Pediatr 2014;57(5):205-210  2.,Non-OADS,/arxiv_data1/oa_pdf/a3/e3/kjped-57-205.PMC4102681.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.5.205Kim HY, et al.",OADS,/arxiv_data1/oa_pdf/a3/e3/kjped-57-205.PMC4102681.pdf
"211 http://dx.doi.org/10.3345/kjp.2014.57.5.211Association of wheezing phenotypes with  fractional exhaled nitric oxide in children Jung Yeon Shim, MD, PhD Department of Pediatrics, Kangbuk Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Asthma comprises a heterogeneous group of disorders characterized by airway inflammation, airway  obstruction, and airway hyperresponsiveness (AHR).",Non-OADS,/arxiv_data1/oa_pdf/51/89/kjped-57-211.PMC4102682.pdf
"Key words:  Nitric oxide, Lung function test, Phenotype, Preschool child, Wheez ingCorresponding author: Jung Yeon Shim, MD,  PhD Department of Pediatrics, Kangbuk Samsung  Medical Center, Sungkyunkwan University School  of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul  110-746, Korea Tel: +82-2-2001-2200 Fax: +82-2-2001-2199 E-mail: jy7.shim@samsung.com Received: 5 January, 2014 Accepted: 19 March, 2014 Copyright © 2014 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article   Korean J Pediatr 2014;57(5):211-216 http://dx.doi.org/10.3345/kjp.2014.57.5.211 eISSN 1738-1061•pISSN 2092-7258 Korean J Pediatr Introduction Asthma is a heterogeneous group of disorders associated with recurrent episodes of  wheezing, coughing, chest tightness, and shortness of breath.",Non-OADS,/arxiv_data1/oa_pdf/51/89/kjped-57-211.PMC4102682.pdf
http://dx.doi.org/10.3345/kjp.2014.57.5.211Shim JY  • Association of FeNO with wheezing phenotype 212also induces recurrent asthma attacks and leads to airway re - modeling.,Non-OADS,/arxiv_data1/oa_pdf/51/89/kjped-57-211.PMC4102682.pdf
213 http://dx.doi.org/10.3345/kjp.2014.57.5.211Korean J Pediatr 2014;57(5):211-216 6 years old.,OADS,/arxiv_data1/oa_pdf/51/89/kjped-57-211.PMC4102682.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.5.211Shim JY  • Association of FeNO with wheezing phenotype 214and AHR, and taken together, it appears that atopic sensitization in  early childhood may be a very important factor in the persistence of  asthma among certain children with AHR.",Non-OADS,/arxiv_data1/oa_pdf/51/89/kjped-57-211.PMC4102682.pdf
215 http://dx.doi.org/10.3345/kjp.2014.57.5.211Korean J Pediatr 2014;57(5):211-216 of FeNO that are stratified for atopy and to validate the cutoff points  according to height and age.,OADS,/arxiv_data1/oa_pdf/51/89/kjped-57-211.PMC4102682.pdf
http://dx.doi.org/10.3345/kjp.2014.57.5.211Shim JY  • Association of FeNO with wheezing phenotype 216children 1-5 years using off-line tidal breathing.,Non-OADS,/arxiv_data1/oa_pdf/51/89/kjped-57-211.PMC4102682.pdf
"217 http://dx.doi.org/10.3345/kjp.2014.57.5.217Cardiovascular risk factors of early atheroscle­ ro sis in school­aged children after Kawasaki  disease Hyun Jeong Cho, MD1, Soo In Yang, MD1, Kyung Hee Kim, MD1, Jee Na Kim, MD2, Hong Ryang Kil, MD1 1Department of Pediatrics, Chungnam National University School of Medicine, Daejeon, 2Department of Pediatrics, Inje University College of Medicine, Busan, Korea Purpose:  The aim of this study was to determine whether school-aged children with Kawasaki disease  (KD) have an increased risk for early atherosclerosis.",Non-OADS,/arxiv_data1/oa_pdf/c6/67/kjped-57-217.PMC4102683.pdf
"Key words:  Risk factors of cardiovascular diseases, Atherosclerosis, Mucocutaneous lymph node  syndromeCorresponding author:  Hong Ryang Kil, MD Department of Pediatrics, Chungnam National University Hospital, Chungnam National University  School of Medicine, 282 Munhwa-ro, Jung-gu,  Daejeon 301-721, Korea Tel: +82-42-280-7251 Fax: +82-42-255-3158 E-mail: gilhongr@gmail.com Received: 15 September, 2013 Revised: 24 October, 2013 Accepted: 6 November 2013 Copyright © 2014 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2014;57(5):217­221 http://dx.doi.org/10.3345/kjp.2014.57.5.217 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Long-term cardiovascular complications of persistent coronary arterial lesion secondary  to Kawasaki disease (KD) are well documented.",Non-OADS,/arxiv_data1/oa_pdf/c6/67/kjped-57-217.PMC4102683.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.5.217Cho HJ, et al.",OADS,/arxiv_data1/oa_pdf/c6/67/kjped-57-217.PMC4102683.pdf
"219 http://dx.doi.org/10.3345/kjp.2014.57.5.217Korean J Pediatr 2014;57(5):217-221 were 8.67 ±4.61 μmol/L, 7.85 ±3.08 μmol/L, and 6.20 ±1.15 μmol/ L respectively.",OADS,/arxiv_data1/oa_pdf/c6/67/kjped-57-217.PMC4102683.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.5.217Cho HJ, et al.",OADS,/arxiv_data1/oa_pdf/c6/67/kjped-57-217.PMC4102683.pdf
221 http://dx.doi.org/10.3345/kjp.2014.57.5.217Korean J Pediatr 2014;57(5):217-221 investigated.,Non-OADS,/arxiv_data1/oa_pdf/c6/67/kjped-57-217.PMC4102683.pdf
"222 http://dx.doi.org/10.3345/kjp.2014.57.5.222Outcome of inflammatory response after  normothermia during cardiopulmonary bypass  surgery in infants with isolated ventricular  septal defect Dong Sub Kim, MD1, Sang In Lee, MD1, Sang Bum Lee, MD1, Myung Chul Hyun, MD, PhD1, Joon Yong Cho, MD2, Young Ok Lee, MD2 Departments of 1Pediatrics and 2Thoracic & Cardiovascular Surgery, Kyungpook National University School of Medicine, Daegu, Korea Purpose:  A recent study analyzing several cytokines reported that long cardiopulmonary bypass  (CPB) time and long aortic cross clamp (ACC) time were accompanied by enhanced postoperative  inflammation, which contrasted with the modest influence of the degree of hypothermia.",Non-OADS,/arxiv_data1/oa_pdf/3d/6a/kjped-57-222.PMC4102684.pdf
"Key words:  Cardiopulmonary bypass, Ventricular heart septal defect, HypothermiaCorresponding author: Myung Chul Hyun, MD,  PhD Department of Pediatrics, Kyungpook National  University Medical Center, Kyungpook National  University School of Medicine, 130 Dongdeok-ro,  Jung-gu, Daegu 700-721, Korea Tel: +82-53-420-5704 Fax: +82-53-425-6683 E-mail: mchyun@knu.ac.kr  Received: 15 September, 2013 Revised: 9 October, 2013 Accepted: 18 November, 2013 Copyright © 2014 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article   Korean J Pediatr 2014;57(5):222-225 http://dx.doi.org/10.3345/kjp.2014.57.5.222 eISSN 1738-1061•pISSN 2092-7258 Korean J Pediatr Introduction Cardiac operations involving cardiopulmonary bypass (CPB) can induce a systemic  inflammatory response involving activated neutrophils, a disturbed balance between  proinflammatory and anti-inflammatory cytokines, with interactions among many other  mediators such as arachidonic acid derivatives, products from oxidative stress, nitric  oxide, endothelin-1 and platelet activating factor1).",Non-OADS,/arxiv_data1/oa_pdf/3d/6a/kjped-57-222.PMC4102684.pdf
223 http://dx.doi.org/10.3345/kjp.2014.57.5.222Korean J Pediatr 2014;57(5):222-225 A recent study analyzing several cytokine demonstrated that  long CPB time and long aortic cross clamp (ACC) time were  accompanied by enhanced postoperative inflammation in  contrast to the modest influence of the degree of hypothermia4).,Non-OADS,/arxiv_data1/oa_pdf/3d/6a/kjped-57-222.PMC4102684.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.5.222Kim DS, et al.",OADS,/arxiv_data1/oa_pdf/3d/6a/kjped-57-222.PMC4102684.pdf
225 http://dx.doi.org/10.3345/kjp.2014.57.5.222Korean J Pediatr 2014;57(5):222-225  9.,Non-OADS,/arxiv_data1/oa_pdf/3d/6a/kjped-57-222.PMC4102684.pdf
"226 http://dx.doi.org/10.3345/kjp.2014.57.5.226Kikuchi-Fujimoto disease mimicking malignant  lymphoma with 2-[18F]fluoro-2-deoxy-D-glucose  PET/CT in children Ji Eun Kim, MD1, Eun Kyung Lee, MD1, Jae Min Lee, MD, PhD1, Soon Hwan Bae, MD1, Kwang Hae Choi, MD1, Young Hwan Lee, MD,  PhD1, Jeong Ok Hah, MD, PhD1, Joon Hyuk Choi, MD, PhD2, Eun Jung Kong, MD3, Ihn Ho Cho, MD, PhD3 Departments of 1Pediatrics, 2Surgical Pathology, and 3Nuclear Medicine, Yeungnam University College of Medicine, Daegu, Korea Purpose:  Kikuchi-Fujimoto disease (KFD) is a benign disease, which is characterized by a cervical  lymphadenopathy with fever, and it often mimics malignant lymphoma (ML).",Non-OADS,/arxiv_data1/oa_pdf/00/42/kjped-57-226.PMC4102685.pdf
"Key words:  Kikuchi-Fujimoto disease, Lymphoma, Positron emission tomographyCorresponding author:  Jeong Ok Hah, MD, PhD Department of Pediatrics, Yeungnam University  Medical Center, Yeungnam University College of  Medicine, 170 Hyeonchung-ro, Nam-gu, Daegu  705-717, Korea Tel: +82-53-620-3531 Fax: +82-53-629-2252 E-mail: johah@med.yu.ac.kr Received: 28 May, 2013 Revised: 18 July, 2013 Accepted: 5 October, 2013 Copyright © 2014 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2014;57(5):226-231 http://dx.doi.org/10.3345/kjp.2014.57.5.226 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Kikuchi-Fujimoto disease (KFD), necrotizing histiocytic lymphadenitis is a rare disorder in  children, but a self-limited and a benign disease that was described in 1972, simultaneously  by Kikuchi1) and Fujimoto et al.2).",Non-OADS,/arxiv_data1/oa_pdf/00/42/kjped-57-226.PMC4102685.pdf
227 http://dx.doi.org/10.3345/kjp.2014.57.5.226Korean J Pediatr 2014;57(5):226-231 Lymphoma is the third most common cancer in children.,Non-OADS,/arxiv_data1/oa_pdf/00/42/kjped-57-226.PMC4102685.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.5.226Kim JE, et al.",OADS,/arxiv_data1/oa_pdf/00/42/kjped-57-226.PMC4102685.pdf
229 http://dx.doi.org/10.3345/kjp.2014.57.5.226Korean J Pediatr 2014;57(5):226-231 although the difference was not statistically significant (Table 3).,OADS,/arxiv_data1/oa_pdf/00/42/kjped-57-226.PMC4102685.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.5.226Kim JE, et al.",OADS,/arxiv_data1/oa_pdf/00/42/kjped-57-226.PMC4102685.pdf
231 http://dx.doi.org/10.3345/kjp.2014.57.5.226Korean J Pediatr 2014;57(5):226-231  14.,Non-OADS,/arxiv_data1/oa_pdf/00/42/kjped-57-226.PMC4102685.pdf
"232 http://dx.doi.org/10.3345/kjp.2014.57.5.232Myocardial atrophy in children with mitochondrial  disease and Duchenne muscular dystrophy Tae Ho Lee, MD1, Lucy Youngmin Eun, MD, PhD1, Jae Young Choi, MD, PhD1, Hye Eun Kwon, MD2, Young-Mock Lee, MD2, Heung  Dong Kim, MD, PhD2, Seong-Woong Kang, MD, PhD3 Divisions of 1Pediatric Cardiology and 2Pediatric Neurology, Department of Pediatrics, Yonsei University College of Medicine, Seoul, 3Department of Rehabilitation  Medicine and Rehabilitation Institute of Muscular Disease, Yonsei University College of Medicine, Seoul, Korea Purpose:  Mitochondrial disease (MD) and Duchenne muscular dystrophy (DMD) are often associated  with cardiomyopathy, but the myocardial variability has not been isolated to a specific characteristic.",Non-OADS,/arxiv_data1/oa_pdf/6e/6f/kjped-57-232.PMC4102686.pdf
"Key words: Myocardium, Mitochondrial diseases, Duchenne muscular dystrophy, EchocardiographyCorresponding author:  Lucy Youngmin Eun, MD, PhD Department of Pediatrics, Gangnam Severance  Hospital, Yonsei University College of Medicine,  211 Eonju-ro, Gangnam-gu, Seoul 135-720, Korea Tel: +82-2-2019-3350 Fax: +82-2-3461-9473 E-mail: lucyeun@yuhs.ac Received: 20 September, 2013 Revised: 8 October, 2013 Accepted: 21 October, 2013 Copyright © 2014 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2014;57(5):232-239 http://dx.doi.org/10.3345/kjp.2014.57.5.232 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Mitochondrial disease (MD) arises from mutations within nuclear and mitochondrial  genes, which control mitochondrial respiratory chain proteins1).",Non-OADS,/arxiv_data1/oa_pdf/6e/6f/kjped-57-232.PMC4102686.pdf
233 http://dx.doi.org/10.3345/kjp.2014.57.5.232Korean J Pediatr 2014;57(5):232-239 in atrophic change depending on the amount of stresses5).,Non-OADS,/arxiv_data1/oa_pdf/6e/6f/kjped-57-232.PMC4102686.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.5.232Lee TH, et al.",OADS,/arxiv_data1/oa_pdf/6e/6f/kjped-57-232.PMC4102686.pdf
"235 http://dx.doi.org/10.3345/kjp.2014.57.5.232Korean J Pediatr 2014;57(5):232-239 mass­for­LBM z scores were also decreased in MD (–0.94 ±1.67,  P<0.001) and DMD (–0.58 ±1.63, P=0.038).",OADS,/arxiv_data1/oa_pdf/6e/6f/kjped-57-232.PMC4102686.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.5.232Lee TH, et al.",OADS,/arxiv_data1/oa_pdf/6e/6f/kjped-57-232.PMC4102686.pdf
237 http://dx.doi.org/10.3345/kjp.2014.57.5.232Korean J Pediatr 2014;57(5):232-239 growing children.,Non-OADS,/arxiv_data1/oa_pdf/6e/6f/kjped-57-232.PMC4102686.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.5.232Lee TH, et al.",OADS,/arxiv_data1/oa_pdf/6e/6f/kjped-57-232.PMC4102686.pdf
239 http://dx.doi.org/10.3345/kjp.2014.57.5.232Korean J Pediatr 2014;57(5):232-239 impact of overweight.,Non-OADS,/arxiv_data1/oa_pdf/6e/6f/kjped-57-232.PMC4102686.pdf
"240 http://dx.doi.org/10.3345/kjp.2014.57.5.240Identification of a novel mutation in a patient  with pseudohypoparathyroidism type Ia Ye Seung Lee, MD1, Hui Kwon Kim, MD1, Hye Rim Kim, MD1, Jong Yoon Lee, MD1, Joong Wan Choi, MD1, Eun Ju Bae, MD1, Phil Soo  Oh, MD1, Won Il Park, MD1, Chang Seok Ki, MD2, Hong Jin Lee, MD1 1Department of Pediatrics, Hallym University College of Medicine, Chunchon, 2Department of Laboratory Medicine & Genetics, Samsung Medical Center,  Sungkyunkwan University School of Medicine, Seoul, Korea Pseudohypoparathyroidism type Ia (PHP Ia) is a disorder characterized by multiform hormonal  resistance including parathyroid hormone (PTH) resistance and Albright hereditary osteodystrophy  (AHO).",Non-OADS,/arxiv_data1/oa_pdf/d8/91/kjped-57-240.PMC4102687.pdf
"Key words:  Pseudohypoparathyroidism, Pseudohypoparathyroidism Type 1a, GNAS gene, Albright’s  hereditary osteodystrophyCorresponding author:  Hong Jin Lee, MD Department of Pediatrics, Hallym University Chuncheon Sacred Heart Hospital, Hallym  University College of Medicine, 77 Sakju-ro, Chuncheon 200-704, Korea Tel: +82-33-240-5230 Fax: +82-33-255-6244 E-mail: hongjlee@hallym.ac.kr Received: 17 April, 2013 Revised: 11 June, 2013 Accepted: 18 July, 2013 Copyright © 2014 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2014;57(5):240-244 http://dx.doi.org/10.3345/kjp.2014.57.5.240 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Pseudohypoparathyroidism (PHP) is a disorder of end-organ resistance primarily  affecting the actions of parathyroid hormone (PTH)1).",Non-OADS,/arxiv_data1/oa_pdf/d8/91/kjped-57-240.PMC4102687.pdf
241 http://dx.doi.org/10.3345/kjp.2014.57.5.240Korean J Pediatr 2014;57(5):240-244 wall.,OADS,/arxiv_data1/oa_pdf/d8/91/kjped-57-240.PMC4102687.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.5.240Lee YS, et al.",OADS,/arxiv_data1/oa_pdf/d8/91/kjped-57-240.PMC4102687.pdf
"243 http://dx.doi.org/10.3345/kjp.2014.57.5.240Korean J Pediatr 2014;57(5):240-244 Heterozygous inactivating mutations within Gs alpha- encoding GNAS exons are found in patients with PHP-Ia, who  also show resistance to other hormones and a constellation  of physical features called AHO.",Non-OADS,/arxiv_data1/oa_pdf/d8/91/kjped-57-240.PMC4102687.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.5.240Lee YS, et al.",OADS,/arxiv_data1/oa_pdf/d8/91/kjped-57-240.PMC4102687.pdf
"245 http://dx.doi.org/10.3345/kjp.2014.57.5.245Gastrointestinal hemangioma in childhood: a  rare cause of gastrointestinal bleeding Eon Chul Han, MD1,2, Soo-Hong Kim, MD3, Hyun-Young Kim, MD1, Sung-Eun Jung, MD1, Kwi-Won Park, MD1 1Department of Pediatric Surgery, Seoul National University College of Medicine, Seoul, 2Department of Surgery, Seoul National University College of Medicine, Seoul,  3Department of Pediatric surgery, Pusan National University Childrens' Hospital, Yangsan, Korea Gastrointestinal (GI) hemangiomas are relatively rare benign vascular tumors.",Non-OADS,/arxiv_data1/oa_pdf/bc/f8/kjped-57-245.PMC4102688.pdf
"Key words:  Cavernous hemangioma, Vascular neoplasms, Blue rubber bleb nevus syndrome,  Gastrointestinal hemorrhage, Surgery Corresponding author:  Hyun-Young Kim, MD Department of Pediatric Surgery, Seoul National  University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu,  Seoul 110-744, Korea Tel: +82-2-2072-2478 Fax: +82-2-747-5130 E-mail: spkhy2@snu.ac.kr Received: 25 June, 2013 Revised: 23 July, 2013 Accepted: 28 October, 2013 Copyright © 2014 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2014;57(5):245-249 http://dx.doi.org/10.3345/kjp.2014.57.5.245 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Gastrointestinal (GI) hemangiomas are relatively rare benign vascular tumors.",Non-OADS,/arxiv_data1/oa_pdf/bc/f8/kjped-57-245.PMC4102688.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.5.245Han EC, et al.",OADS,/arxiv_data1/oa_pdf/bc/f8/kjped-57-245.PMC4102688.pdf
"247 http://dx.doi.org/10.3345/kjp.2014.57.5.245Korean J Pediatr 2014;57(5):245-249 disseminated neonatal hemangiomatosis, and blue rubber  bleb nevus syndrome1).",Non-OADS,/arxiv_data1/oa_pdf/bc/f8/kjped-57-245.PMC4102688.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.5.245Han EC, et al.",OADS,/arxiv_data1/oa_pdf/bc/f8/kjped-57-245.PMC4102688.pdf
249 http://dx.doi.org/10.3345/kjp.2014.57.5.245Korean J Pediatr 2014;57(5):245-249 Conflict of interest No potential conflict of interest relevant to this article was  reported.,Non-OADS,/arxiv_data1/oa_pdf/bc/f8/kjped-57-245.PMC4102688.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE41 REVIEW  http://dx.doi.org/10.5653/cerm.2014.41.2.41 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2014;41(2):41-46 In vitro  maturation of human oocytes: Its role in  infertility treatment and new possibilities Eun Mi Chang1, Hang Seok Song2, Dong Ryul Lee2, Woo Sik Lee1, Tae Ki Yoon1 1Department of Obstetrics and Gynecology, Fertility Center of CHA Gangnam Medical Center, CHA University, Seoul; 2Department of Biomedical  Science, College of Life Science, CHA University, Seoul, Korea IVM refers to the maturation of immature oocytes in culture after their recovery from small antral follicles at the stage prior to selection and  dominance.",Non-OADS,/arxiv_data1/oa_pdf/43/ec/cerm-41-41.PMC4102689.pdf
"However, in addition to decreasing the  major side effects of controlled ovarian stimulation, such as OHSS,  the IVM procedure eliminates the need for frequent sonographic Received: Dec 18, 2013 ∙ Revised: Mar 22, 2014 ∙ Accepted: Mar 24, 2014 Corresponding author:  Tae Ki Yoon Department of Obstetrics and Gynecology, Fertility Center of CHA Gangnam  Medical Center, CHA University, 566 Nonhyeon-ro, Gangnam-gu,   Seoul 135-081, Korea  Tel: +82-2-3468-3401  Fax: +82-2-3468-3464  E-mail: tkyoon@cha.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/ec/cerm-41-41.PMC4102689.pdf
" http://dx.doi.org/10.5653/cerm.2014.41.2.41 Clin Exp Reprod Med 2014;41(2):41-46 42monitoring and costs less than IVF; consequently, a few experimental  studies have performed IVM in women with regular cycles and nor - mal ovaries and in situations where no suitable standard protocol ex - ists, such as oocyte donation, FSH resistance, and other contraindica - tions for ovarian stimulatory drugs.",Non-OADS,/arxiv_data1/oa_pdf/43/ec/cerm-41-41.PMC4102689.pdf
" http://dx.doi.org/10.5653/cerm.2014.41.2.41 Clin Exp Reprod Med 2014;41(2):41-46 44[42,43].",OADS,/arxiv_data1/oa_pdf/43/ec/cerm-41-41.PMC4102689.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.2.41 Clin Exp Reprod Med 2014;41(2):41-46 46in-vitro maturation of human oocytes.,Non-OADS,/arxiv_data1/oa_pdf/43/ec/cerm-41-41.PMC4102689.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE47 REVIEW http://dx.doi.org/10.5653/cerm.2014.41.2.47 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2014;41(2):47-61 Maternal effect genes: Findings and effects on  mouse embryo development Kyeoung-Hwa Kim, Kyung-Ah Lee Department of Biomedical Science, College of Life Science, CHA University, Seoul, Korea Stored maternal factors in oocytes regulate oocyte differentiation into embryos during early embryonic development.",Non-OADS,/arxiv_data1/oa_pdf/af/93/cerm-41-47.PMC4102690.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/af/93/cerm-41-47.PMC4102690.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.2.47 Clin Exp Reprod Med 2014;41(2):47-61 48Table 1.,OADS,/arxiv_data1/oa_pdf/af/93/cerm-41-47.PMC4102690.pdf
" http://dx.doi.org/10.5653/cerm.2014.41.2.47 Clin Exp Reprod Med 2014;41(2):47-61 50Fmn2-/- oocytes appear polyploidy, such as triploid and pentaploid.",Non-OADS,/arxiv_data1/oa_pdf/af/93/cerm-41-47.PMC4102690.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.2.47 Clin Exp Reprod Med 2014;41(2):47-61 52duced (about 50%) fecundity.,Non-OADS,/arxiv_data1/oa_pdf/af/93/cerm-41-47.PMC4102690.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.2.47 Clin Exp Reprod Med 2014;41(2):47-61 54by which cytoplasmic constituents in the lysosome are degraded.,Non-OADS,/arxiv_data1/oa_pdf/af/93/cerm-41-47.PMC4102690.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.2.47 Clin Exp Reprod Med 2014;41(2):47-61 56ing factor for X chromosome selection in the mouse because CTCF  plays an essential role in controlling the epigenetic switch for X inac - tivation [102].,Non-OADS,/arxiv_data1/oa_pdf/af/93/cerm-41-47.PMC4102690.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.2.47 Clin Exp Reprod Med 2014;41(2):47-61 58enzyme HR6A is a maternal factor essential for early embryonic  development in mice.,Non-OADS,/arxiv_data1/oa_pdf/af/93/cerm-41-47.PMC4102690.pdf
" http://dx.doi.org/10.5653/cerm.2014.41.2.47 Clin Exp Reprod Med 2014;41(2):47-61 60zales FA, et al.",OADS,/arxiv_data1/oa_pdf/af/93/cerm-41-47.PMC4102690.pdf
THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE62 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2014.41.2.62 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2014;41(2):62-67 Is catechol-o-methyltransferase gene polymorphism  a risk factor in the development of premenstrual  syndrome?,Non-OADS,/arxiv_data1/oa_pdf/b0/69/cerm-41-62.PMC4102691.pdf
"Serotonin has been most implicated neurotransmitter in the etiolo -Received: Feb 21, 2014 ∙ Revised: May 20, 2014 ∙ Accepted: May 21, 2014 Corresponding author:  Adnan Incebiyik Department of Gynecology and Obstetrics, Harran University School of  Medicine, Yenisehir Campus, 63300, Sanlıurfa, Turkey Tel: +904143183027  Fax: +904143183192  E-mail: dr.aincebiyik@gmail.com  This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/69/cerm-41-62.PMC4102691.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.2.62 Clin Exp Reprod Med 2014;41(2):62-67 64The symptoms had to be relieved within four days of menstruation  onset without recurrence until at least the 13th cycle day [3].,Non-OADS,/arxiv_data1/oa_pdf/b0/69/cerm-41-62.PMC4102691.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.2.62 Clin Exp Reprod Med 2014;41(2):62-67 66is no other study in the literature demonstrating a relationship be - tween PMS and COMT gene polymorphism.,OADS,/arxiv_data1/oa_pdf/b0/69/cerm-41-62.PMC4102691.pdf
http://doi.dx.org/10.1007/s00429-013-0621-8.,Non-OADS,/arxiv_data1/oa_pdf/b0/69/cerm-41-62.PMC4102691.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE68 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2014.41.2.68 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2014;41(2):68-74 The effect of various assisted hatching techniques on  the mouse early embryo development Sung Baek Park1, Hye Jin Kim2, Young Bae Choi1, Kwang Hwa Ahn1, Kee Hwan Lee2, Jung Bo Yang2, Chang Seok Yu3,   Byoung Boo Seo3 1Fertility Clinic, Mirae Ladies Hospital, Daejeon; 2Department of Obstetrics and Gynecology, Chungnam National Hospital, Daejeon; 3Department of  Animal Resources, Daegu University, Gyeongsan, Korea Objective:  In search of an ideal method of assisted hatching (AH), we compared the effects of conventional micropipette-AH and laser-AH on  the blastocyst formation rate (BFR) and blastocyst cell numbers.",Non-OADS,/arxiv_data1/oa_pdf/8b/ff/cerm-41-68.PMC4102692.pdf
"Subsequently, AH with acidic Tyrode’s solution (pH 2.4) Received: Mar 4, 2014 ∙ Revised: Apr 3, 2014 ∙ Accepted: Apr 14, 2014 Corresponding author:  Byoung Boo Seo Department of Animal Resources, Daegu University, 201 Daegudae-ro,  Gyeongsan 712-714, Korea Tel: +82-53-850-6724  Fax: +82-53-850-6729   E-mail: bbseosd@daegu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/ff/cerm-41-68.PMC4102692.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.2.68 Clin Exp Reprod Med 2014;41(2):68-74 70Figure 2.,OADS,/arxiv_data1/oa_pdf/8b/ff/cerm-41-68.PMC4102692.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.2.68 Clin Exp Reprod Med 2014;41(2):68-74 72Table 2.,OADS,/arxiv_data1/oa_pdf/8b/ff/cerm-41-68.PMC4102692.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.2.68 Clin Exp Reprod Med 2014;41(2):68-74 749.,OADS,/arxiv_data1/oa_pdf/8b/ff/cerm-41-68.PMC4102692.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE75 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2014.41.2.75 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2014;41(2):75-79 Body composition: A predictive factor of cycle  fecundity Semra Kayatas, Aysen Boza, Murat Api, Didar Kurt, Mustafa Eroglu, Sevcan Arzu Arınkan Department of Obstetrics and Gynecology, Zeynep Kamil Women and Children Diseases Training and Research Hospital, Istanbul, Turkey Objective:  To study the effect of body composition on reproduction in women with unexplained infertility treated with a controlled ovarian  hyperstimulation and intrauterine insemination programme.",Non-OADS,/arxiv_data1/oa_pdf/ce/fa/cerm-41-75.PMC4102693.pdf
"No: 2/3,  Uskudar, Istanbul 34668, Turkey  Tel: +90-530-923-00-46  Fax: +90-216-391-06-90  E-mail: arcke83@gmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/fa/cerm-41-75.PMC4102693.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.2.75 Clin Exp Reprod Med 2014;41(2):75-79 76in a controlled ovarian hyperstimulation (COH) and intrauterine in - semination (IUI) cycle.,Non-OADS,/arxiv_data1/oa_pdf/ce/fa/cerm-41-75.PMC4102693.pdf
" http://dx.doi.org/10.5653/cerm.2014.41.2.75 Clin Exp Reprod Med 2014;41(2):75-79 78either undergoing COH/IUI [6,12] or IVF [5,13-19].",OADS,/arxiv_data1/oa_pdf/ce/fa/cerm-41-75.PMC4102693.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE80 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2014.41.2.80 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2014;41(2):80-85 Vitamin D deficiency in women with polycystic ovary  syndrome Jin Ju Kim1,2, Young Min Choi2,3, Soo Jin Chae4, Kyu Ri Hwang3,5, Sang Ho Yoon6, Min Jeong Kim1, Sun Mie Kim1,   Seung Yup Ku2,3, Seok Hyun Kim2,3, Jung Gu Kim3 1Department of Obstetrics and Gynecology, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul; 2The Institute of  Reproductive Medicine and Population, Medical Research Center, Seoul National University College of Medicine, Seoul; 3Department of Obstetrics and  Gynecology, Seoul National University College of Medicine, Seoul; 4Department of Obstetrics and Gynecology, Maria Fertility Hospital, Seoul;  5Department of Obstetrics and Gynecology, Seoul Municipal Boramae Hospital, Seoul; 6Department of Obstetrics and Gynecology, Graduate School of  Medicine, Dongguk University, Seoul, Korea Objective:  To investigate: the prevalence of vitamin D deficiency in Korean women with polycystic ovary syndrome (PCOS), and the relation - ship between vitamin D status and clinical or metabolic features in this group.",Non-OADS,/arxiv_data1/oa_pdf/80/2c/cerm-41-80.PMC4102694.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/2c/cerm-41-80.PMC4102694.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.2.80 Clin Exp Reprod Med 2014;41(2):80-85 82eters and vitamin D status were analyzed separately in patients and  controls using linear regression models.,OADS,/arxiv_data1/oa_pdf/80/2c/cerm-41-80.PMC4102694.pdf
" http://dx.doi.org/10.5653/cerm.2014.41.2.80 Clin Exp Reprod Med 2014;41(2):80-85 84BMI, thus there were no differences in BMI, WC, or body and visceral  fat masses between the two groups.",Non-OADS,/arxiv_data1/oa_pdf/80/2c/cerm-41-80.PMC4102694.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE86 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2014.41.2.86 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2014;41(2):86-91 Serum luteinizing hormone level and luteinizing  hormone/follicle-stimulating hormone ratio but not  serum anti-Müllerian hormone level is related to  ovarian volume in Korean women with polycystic  ovary syndrome  Sungwook Chun Department of Obstetrics and Gynecology, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea Objective:  The aim of the present study was to investigate the relationship between ovarian follicle count and volume on ultrasonography and  serum hormone levels including the levels of the anti-Müllerian hormone (AMH) and gonadotropin in women with the polycystic ovary syn - drome (PCOS).",Non-OADS,/arxiv_data1/oa_pdf/af/eb/cerm-41-86.PMC4102695.pdf
"Women with PCOS are likely Received: Apr 18, 2014 ∙ Revised: May 20, 2014 ∙ Accepted: Jun 2, 2014 Corresponding author:  Sungwook Chun Department of Obstetrics and Gynecology, Inje University Haeundae Paik  Hospital, Inje University College of Medicine, 875 Haeun-daero, Haeundae-gu,  Busan 612-030, Korea Tel: +82-51-797-2020  Fax: +82-51-797-2030  E-mail: wooki1974@empal.com This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/af/eb/cerm-41-86.PMC4102695.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.2.86 Clin Exp Reprod Med 2014;41(2):86-91 88presented in Table 1.,OADS,/arxiv_data1/oa_pdf/af/eb/cerm-41-86.PMC4102695.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.2.86 Clin Exp Reprod Med 2014;41(2):86-91 90Inappropriate secretion of LH and an abnormal LH/FSH ratio are the  main factors associated with the continuation of the anovulatory  state in PCOS subjects.,Non-OADS,/arxiv_data1/oa_pdf/af/eb/cerm-41-86.PMC4102695.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE92 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2014.41.2.92 pISSN 2233-8233 · eISSN 2233-8241 Clin Exp Reprod Med 2014;41(2):92-95 Platelet volume indices in patients with varicocele Reza Mahdavi-Zafarghandi1, Behnam Shakiba1, Mohammad Reza Keramati2, Mahmoud Tavakkoli1 1Department of Urology, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad; 2Cancer Molecular Pathology  Research Center, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran Objective:  This study sought to evaluate platelet volume indices (mean platelet volume [MPV], platelet distribution width [PDW], and platelet  large cell ratio [P-LCR]) in varicocele patients, and compare it with platelet volume parameters in healthy controls.",Non-OADS,/arxiv_data1/oa_pdf/77/36/cerm-41-92.PMC4102696.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/36/cerm-41-92.PMC4102696.pdf
 http://dx.doi.org/10.5653/cerm.2014.41.2.92 Clin Exp Reprod Med 2014;41(2):92-95 94P-LCR were significantly higher in the varicocele group than the con - trol group.,OADS,/arxiv_data1/oa_pdf/77/36/cerm-41-92.PMC4102696.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgEditorial J Gynecol Oncol Vol.",Non-OADS,/arxiv_data1/oa_pdf/c9/8d/jgo-25-159.PMC4102728.pdf
3:159-161 http://dx.doi.org/10.3802/jgo.2014.25.3.159 pISSN 2005-0380 ·eISSN 2005-0399,Non-OADS,/arxiv_data1/oa_pdf/c9/8d/jgo-25-159.PMC4102728.pdf
Francesco Maneschi http://dx.doi.org/10.3802/jgo.2014.25.3.,Non-OADS,/arxiv_data1/oa_pdf/c9/8d/jgo-25-159.PMC4102728.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgEditorial J Gynecol Oncol Vol.",Non-OADS,/arxiv_data1/oa_pdf/be/33/jgo-25-162.PMC4102729.pdf
3:162-163 http://dx.doi.org/10.3802/jgo.2014.25.3.162 pISSN 2005-0380 ·eISSN 2005-0399,Non-OADS,/arxiv_data1/oa_pdf/be/33/jgo-25-162.PMC4102729.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgEditorial J Gynecol Oncol Vol.",Non-OADS,/arxiv_data1/oa_pdf/10/de/jgo-25-164.PMC4102730.pdf
3:164-165 http://dx.doi.org/10.3802/jgo.2014.25.3.164 pISSN 2005-0380 ·eISSN 2005-0399,Non-OADS,/arxiv_data1/oa_pdf/10/de/jgo-25-164.PMC4102730.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgEditorial J Gynecol Oncol Vol.",Non-OADS,/arxiv_data1/oa_pdf/5e/e7/jgo-25-166.PMC4102731.pdf
"3:166-167 http://dx.doi.org/10.3802/jgo.2014.25.3.166 pISSN 2005-0380 ·eISSN 2005-0399 Clinical trials, systematic reviews and guidelines compare  beneficial and nonbeneficial outcomes following interven - tions.",Non-OADS,/arxiv_data1/oa_pdf/5e/e7/jgo-25-166.PMC4102731.pdf
http://dx.doi.org/doi:10.1111/1471-0528.,Non-OADS,/arxiv_data1/oa_pdf/5e/e7/jgo-25-166.PMC4102731.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgExpert Opinion J Gynecol Oncol Vol.",Non-OADS,/arxiv_data1/oa_pdf/fc/e8/jgo-25-168.PMC4102732.pdf
3:168-169 http://dx.doi.org/10.3802/jgo.2014.25.3.168 pISSN 2005-0380 ·eISSN 2005-0399,Non-OADS,/arxiv_data1/oa_pdf/fc/e8/jgo-25-168.PMC4102732.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgMeeting Report J Gynecol Oncol Vol.",Non-OADS,/arxiv_data1/oa_pdf/d2/a0/jgo-25-170.PMC4102733.pdf
3:170-171 http://dx.doi.org/10.3802/jgo.2014.25.3.170 pISSN 2005-0380 ·eISSN 2005-0399,OADS,/arxiv_data1/oa_pdf/d2/a0/jgo-25-170.PMC4102733.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgMeeting Report J Gynecol Oncol Vol.",Non-OADS,/arxiv_data1/oa_pdf/79/91/jgo-25-172.PMC4102734.pdf
3:172-173 http://dx.doi.org/10.3802/jgo.2014.25.3.172 pISSN 2005-0380 ·eISSN 2005-0399,Non-OADS,/arxiv_data1/oa_pdf/79/91/jgo-25-172.PMC4102734.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  To evaluate uterine and ovarian cancer mortality trends in East Asian countries.",Non-OADS,/arxiv_data1/oa_pdf/42/38/jgo-25-174.PMC4102735.pdf
3:174-182 http://dx.doi.org/10.3802/jgo.2014.25.3.174 pISSN 2005-0380 ·eISSN 2005-0399,Non-OADS,/arxiv_data1/oa_pdf/42/38/jgo-25-174.PMC4102735.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/42/38/jgo-25-174.PMC4102735.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/42/38/jgo-25-174.PMC4102735.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/42/38/jgo-25-174.PMC4102735.pdf
Supplementary Table 1.   http://ejgo.org/src/sm/jgo-25-174-s001.pdf Supplementary Figure 1. http://ejgo.org/src/sm/jgo-25-174-s002.pdf Supplementary Figure 2. http://ejgo.org/src/sm/jgo-25-174-s003.pdf REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/42/38/jgo-25-174.PMC4102735.pdf
Available from: http://www.who.int/ healthinfo/mortality_data/en/.,Non-OADS,/arxiv_data1/oa_pdf/42/38/jgo-25-174.PMC4102735.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/42/38/jgo-25-174.PMC4102735.pdf
Available from: http://surveillance.cancer.gov/joinpoint/.,Non-OADS,/arxiv_data1/oa_pdf/42/38/jgo-25-174.PMC4102735.pdf
Available  from: https://www.nrdo.gov.sg/page.aspx?id=76.,OADS,/arxiv_data1/oa_pdf/42/38/jgo-25-174.PMC4102735.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  To assess the association between condom use and oral contraceptive consumption and the risk of cervical  intraepithelial neoplasia (CIN).",Non-OADS,/arxiv_data1/oa_pdf/ee/a5/jgo-25-183.PMC4102736.pdf
3:183-187 http://dx.doi.org/10.3802/jgo.2014.25.3.183 pISSN 2005-0380 ·eISSN 2005-0399,Non-OADS,/arxiv_data1/oa_pdf/ee/a5/jgo-25-183.PMC4102736.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/ee/a5/jgo-25-183.PMC4102736.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/ee/a5/jgo-25-183.PMC4102736.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  To investigate factors influencing commitment to human papilloma virus (HPV) vaccination and prior vaccination  among female college students in northern Taiwan.",Non-OADS,/arxiv_data1/oa_pdf/36/e0/jgo-25-188.PMC4102737.pdf
3:188-197 http://dx.doi.org/10.3802/jgo.2014.25.3.188 pISSN 2005-0380 ·eISSN 2005-0399,Non-OADS,/arxiv_data1/oa_pdf/36/e0/jgo-25-188.PMC4102737.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/36/e0/jgo-25-188.PMC4102737.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/36/e0/jgo-25-188.PMC4102737.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/36/e0/jgo-25-188.PMC4102737.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/36/e0/jgo-25-188.PMC4102737.pdf
http://ejgo.org/src/sm/jgo-25-188-s001.pdf,Non-OADS,/arxiv_data1/oa_pdf/36/e0/jgo-25-188.PMC4102737.pdf
Available  from: http://www.cancer.gov/cancertopics/types/cervical.,Non-OADS,/arxiv_data1/oa_pdf/36/e0/jgo-25-188.PMC4102737.pdf
Available from: http://crs.cph.,Non-OADS,/arxiv_data1/oa_pdf/36/e0/jgo-25-188.PMC4102737.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  This study was conducted to ascertain the correlation between preserved pelvic nerve networks and bladder  function after laparoscopic nerve-sparing radical hysterectomy.",Non-OADS,/arxiv_data1/oa_pdf/26/ee/jgo-25-198.PMC4102738.pdf
3:198-205 http://dx.doi.org/10.3802/jgo.2014.25.3.198 pISSN 2005-0380 ·eISSN 2005-0399,Non-OADS,/arxiv_data1/oa_pdf/26/ee/jgo-25-198.PMC4102738.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/26/ee/jgo-25-198.PMC4102738.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/26/ee/jgo-25-198.PMC4102738.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/26/ee/jgo-25-198.PMC4102738.pdf
A video clip is available at http://ejgo.org/   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/26/ee/jgo-25-198.PMC4102738.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  The aim of this study was to report on the long-term results of transabdominal ultrasound guided conformal  brachytherapy in patients with cervical cancer with respect to patterns of failures, treatment related toxicities and survival.",Non-OADS,/arxiv_data1/oa_pdf/fc/09/jgo-25-206.PMC4102739.pdf
3:206-213 http://dx.doi.org/10.3802/jgo.2014.25.3.206 pISSN 2005-0380 ·eISSN 2005-0399,OADS,/arxiv_data1/oa_pdf/fc/09/jgo-25-206.PMC4102739.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/fc/09/jgo-25-206.PMC4102739.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/fc/09/jgo-25-206.PMC4102739.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/fc/09/jgo-25-206.PMC4102739.pdf
NOW AVAILABLE ONLINE  at http://www.ejgo.org,Non-OADS,/arxiv_data1/oa_pdf/fc/09/jgo-25-206.PMC4102739.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  To compare the efficacy of metformin plus megestrol acetate (MA) with that of MA alone for treating endometrial  atypical hyperplasia (EAH).",Non-OADS,/arxiv_data1/oa_pdf/1b/01/jgo-25-214.PMC4102740.pdf
3:214-220 http://dx.doi.org/10.3802/jgo.2014.25.3.214 pISSN 2005-0380 ·eISSN 2005-0399,Non-OADS,/arxiv_data1/oa_pdf/1b/01/jgo-25-214.PMC4102740.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/1b/01/jgo-25-214.PMC4102740.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/1b/01/jgo-25-214.PMC4102740.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/1b/01/jgo-25-214.PMC4102740.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  Epithelial cell adhesion molecule (EpCAM) has experienced a renaissance lately as a binding site for targeted therapy  as well as a prognostic marker in epithelial malignancies.",Non-OADS,/arxiv_data1/oa_pdf/28/4f/jgo-25-221.PMC4102741.pdf
3:221-228 http://dx.doi.org/10.3802/jgo.2014.25.3.221 pISSN 2005-0380 ·eISSN 2005-0399,Non-OADS,/arxiv_data1/oa_pdf/28/4f/jgo-25-221.PMC4102741.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/28/4f/jgo-25-221.PMC4102741.pdf
"Within the Tumor Bank Ovarian Cancer  project (http://www.toc-network.de), tumor tissue, ascites,  serum, and blood were collected from each EOC-patient.",OADS,/arxiv_data1/oa_pdf/28/4f/jgo-25-221.PMC4102741.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/28/4f/jgo-25-221.PMC4102741.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/28/4f/jgo-25-221.PMC4102741.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/28/4f/jgo-25-221.PMC4102741.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  A number of new techniques have been developed to prevent lymphocele formation after pelvic lymphadenectomy  in gynecologic cancers.",Non-OADS,/arxiv_data1/oa_pdf/3a/b6/jgo-25-229.PMC4102742.pdf
3:229-235 http://dx.doi.org/10.3802/jgo.2014.25.3.229 pISSN 2005-0380 ·eISSN 2005-0399,OADS,/arxiv_data1/oa_pdf/3a/b6/jgo-25-229.PMC4102742.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/3a/b6/jgo-25-229.PMC4102742.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/3a/b6/jgo-25-229.PMC4102742.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/3a/b6/jgo-25-229.PMC4102742.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgIn 2013, 10 topics were selected for major clinical research advances in gynecologic oncology; these included three topics  regarding cervical cancer, three regarding ovarian cancer, two regarding endometrial cancer, and one each regarding breast  cancer and radiation oncology.",Non-OADS,/arxiv_data1/oa_pdf/70/41/jgo-25-236.PMC4102743.pdf
3:236-248 http://dx.doi.org/10.3802/jgo.2014.25.3.236 pISSN 2005-0380 ·eISSN 2005-0399,OADS,/arxiv_data1/oa_pdf/70/41/jgo-25-236.PMC4102743.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/70/41/jgo-25-236.PMC4102743.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/70/41/jgo-25-236.PMC4102743.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/70/41/jgo-25-236.PMC4102743.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/70/41/jgo-25-236.PMC4102743.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/70/41/jgo-25-236.PMC4102743.pdf
Available  from: http://www.nccn.org/professionals/physician_gls/pdf/cervical.,Non-OADS,/arxiv_data1/oa_pdf/70/41/jgo-25-236.PMC4102743.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/70/41/jgo-25-236.PMC4102743.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgThe global burden of advanced stage cervical cancer remains significant, particular in resource poor countries where effective  screening programs are absent.",Non-OADS,/arxiv_data1/oa_pdf/e2/c3/jgo-25-249.PMC4102744.pdf
3:249-259 http://dx.doi.org/10.3802/jgo.2014.25.3.249 pISSN 2005-0380 ·eISSN 2005-0399,OADS,/arxiv_data1/oa_pdf/e2/c3/jgo-25-249.PMC4102744.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/e2/c3/jgo-25-249.PMC4102744.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/e2/c3/jgo-25-249.PMC4102744.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/e2/c3/jgo-25-249.PMC4102744.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/e2/c3/jgo-25-249.PMC4102744.pdf
http://dx.doi.org/10.3802/jgo.2014.25.3.,OADS,/arxiv_data1/oa_pdf/e2/c3/jgo-25-249.PMC4102744.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgBook Review J Gynecol Oncol Vol.",Non-OADS,/arxiv_data1/oa_pdf/ac/47/jgo-25-260.PMC4102745.pdf
3:260-261 http://dx.doi.org/10.3802/jgo.2014.25.3.260 pISSN 2005-0380 ·eISSN 2005-0399,OADS,/arxiv_data1/oa_pdf/ac/47/jgo-25-260.PMC4102745.pdf
"3:261 http://dx.doi.org/10.3802/jgo.2014.25.3.261 pISSN 2005-0380 ·eISSN 2005-0399 Correction: primary, secondary, and tertiary  prevention of cervical cancer Hee Seung Kim J Gynecol Oncol 2014;25:157-8  http://dx.doi.org/10.3802/jgo.2014.25.2.157 In this book review, Professor Michael Höckel was incorrectly spelled as Micahel Höckel.",Non-OADS,/arxiv_data1/oa_pdf/ac/47/jgo-25-260.PMC4102745.pdf
"3:261 http://dx.doi.org/10.3802/jgo.2014.25.3.261 pISSN 2005-0380 ·eISSN 2005-0399 Correction: primary, secondary, and tertiary  prevention of cervical cancer Hee Seung Kim J Gynecol Oncol 2014;25:157-8  http://dx.doi.org/10.3802/jgo.2014.25.2.157 In this book review, Professor Michael Höckel was incorrectly spelled as Micahel Höckel.",Non-OADS,/arxiv_data1/oa_pdf/10/b3/jgo-25-261.PMC4102746.pdf
"2014 June;16(2):104-111 Received : 10 February 2014 Revised : 25 March 2014 Accepted : 20 May 2014 Correspondence to Yong-Sook Park Department of Neurosurgery, Chung-Ang  University College of Medicine, 102, Heukseok-ro,  Dongjak-gu, Seoul 156-755, Korea Tel : 82-2-6299-1610 Fax : 82-2-821-8409 E-mail : cuttage@cau.ac.kr ORCID : http://orcid.org/0000-0002-5931-4122 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li- censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/10/jcen-16-104.PMC4102749.pdf
"Keywords Simultaneous, Intracerebral hemorrhage, Hypertension, Multiple Journal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2014.16.2.104  Case Report INTRODUCTION The reported incidence of spontaneous intracerebral  hemorrhage (ICH) is 24.6 per 100,000 person-years, however, simultaneous multiple ICH are much more uncommon.",Non-OADS,/arxiv_data1/oa_pdf/58/10/jcen-16-104.PMC4102749.pdf
"2014 June;16(2):112-118 Received : 16 April 2014 Revised : 12 May 2014 Accepted : 29 May 2014 Correspondence to Jae Whan Lee Department of Neurosurgery, Stroke Center,  College of Medicine, Yonsei University Severance  Hospital, 50-1, Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea Tel : 82-2-2228-2150 Fax : 82-2-393-9979E-mail : leejw@yuhs.ac ORCID : http://orcid.org/0000-0002-9051-5651 This study was presented at The 6th Annual  Meeting of the Korean Young Neurosurgical Meeting.",Non-OADS,/arxiv_data1/oa_pdf/e0/e0/jcen-16-112.PMC4102750.pdf
"T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non-  Commercial License (http://creativecommons.org/li- censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.Keywords Flow diverter, Pipeline embolization device, Embolization, Giant intracranial  aneurysmJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2014.16.2.112  Case Report INTRODUCTION The natural history of giant intracranial aneurysms in- cludes high morbidity and mortality from rupture.27)  Symptomatic lesions can be present in 50% of rupture  cases, and the mortality rate is 60% in two years.6) These  aneurysms are often found in the cavernous and para-clinoid segments of the internal carotid artery (ICA).",Non-OADS,/arxiv_data1/oa_pdf/e0/e0/jcen-16-112.PMC4102750.pdf
"2014 June;16(2):119-124 Received : 25 April 2014 Revised : 25 April 2014 Accepted : 4 June 2014 Correspondence to Yoon-Soo Lee Department of Neurosurgery, Daegu Fatima  Hospital, 576-31 Sinam-dong, Dong-gu, Daegu  701-600, Korea Tel : 82-53-940-7330, 7339 Fax : 82-53-954-7417 E-mail : paulyoonsoolee@hanmail.net ORCID : http://orcid.org/0000-0003-2506-0168 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/52/jcen-16-119.PMC4102751.pdf
"Keywords Anterior cerebral artery, Dissection, Infarction, Subarachnoid hemorrhageJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2014.16.2.119  Case Report INTRODUCTION Spontaneous intracranial arterial dissection usually  occurs in the posterior circulation and is relatively rare in the anterior circulation, particularly the ante-rior cerebral artery (ACA).",Non-OADS,/arxiv_data1/oa_pdf/4b/52/jcen-16-119.PMC4102751.pdf
"Box 800212,  Charlottesville, VA 22908, United States Tel : 1-434-924-2735 Fax : 1-434-924-9656 E-mail : kcl3j@hscmail.mcc.virginia.edu ORCID : http://orcid.org/0000-0001-6217-1022 T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.Keywords Endovascular procedures, Endovascular techniques, Intracranial aneurysm,  Stent, Stroke, Subarachnoid hemorrhageJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2014.16.2.125  Technical Note INTRODUCTION Giant intracranial aneurysms are associated with a  dismal natural history due to their high propensity  for rupture.20) Traditional surgical treatment and en- dovascular approaches are associated with high com- plication rates.2)9)15) In addition, endovascular coiling  of giant aneurysms without concomitant stenting is  associated with relatively high rates of recurrence.13)  The recent addition of flow-diverting stents (FDS) to  the endovascular armamentarium has resulted in dras- tic improvement of the ability to administer safe and  effective treatment of giant aneurysms.1)14) Successful deployment of a FDS across an aneurysm neck is pre- dicated upon microcatheter access to the distal seg- ment of the parent artery past the aneurysm neck.",Non-OADS,/arxiv_data1/oa_pdf/17/33/jcen-16-125.PMC4102752.pdf
"2014 June;16(2):71-77 Received : 18 February 2014 Revised : 21 April 2014Accepted : 12 May 2014 Correspondence to Sung-Pil Joo Department of Neurosurgery, Chonnam National  University Hospital and Medical School, 8  Hak-dong, Dong-gu, Gwangju 501-757, Republic  of Korea Tel : 82-62-220-6608 Fax : 82-62-224-9865 E-mail : nsjsp@chonnam.ac.kr, nsjsp@hanmail.net ORCID : http://orcid.org/0000-0003-0871-2371 T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non-  Commercial License (http://creativecommons.org/li- censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.Keywords Arachnoid suture, Extracranial-intracranial bypass surgery, Subdural hygroma,  Mass effectJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2014.16.2.71  Original Article INTRODUCTION Subdural hygromas, which are subdural collections  of fluid such as cerebrospinal fluid (CSF), can occur under variable intracranial conditions, such as in- fection, congenital malformation, overdrainage of the  shunt system, craniofacial disproportions, post-spinal anesthesia and tearing of arachnoid membrane due to head trauma, and intracranial procedure/operation.",Non-OADS,/arxiv_data1/oa_pdf/7e/88/jcen-16-71.PMC4102753.pdf
"2014 June;16(2):78-84 Received : 15 April 2014 Revised : 30 April 2014 Accepted : 15 May 2014 Correspondence to Hyeong-Joong Yi Department of Neurosurgery, Hanyang University  Medical Center, Haengdang-dong, Sungdong-gu,  Seoul 133-792, Korea Tel : 82-2-2290-8499 Fax : 82-2-2281-0954 E-mail : hyji8499@hanyang.ac.kr ORCID : http://orcid.org/0000-0002-2678-4902 T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non-  Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.Keywords Acute hydrocephalus, Chronic hydrocephalus, Subarachnoid hemorrhage,  Lumbar drainJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2014.16.2.78  Original Article INTRODUCTION Chronic hydrocephalus after occlusion of ruptured  aneurysmal subarachnoid hemorrhage (SAH) has been  reported to range from 6 to 67%.16) The location of the  aneurysm, initial mental status, and presence of initial intraventricular hemorrhage (IVH) are risk factors for  development of chronic hydrocephalus.11)19)21)22)26) In  addition, the amount of hemorrhage in the sub- arachnoid space and ventricular system has a strong  association with development of hydrocephalus.4)5)7)12) Acute hydrocephalus develops through obstructive",Non-OADS,/arxiv_data1/oa_pdf/be/f9/jcen-16-78.PMC4102754.pdf
"2014 June;16(2):85-92 Received : 6 January 2014 Revised : 25 March 2014 Accepted : 21 May 2014 Correspondence to Jae-Taeck Huh Department of Neurosurgery, Busan-Ulsan  Regional Cardiocerebrovascular Center, Medical  Science Research Center, College of Medicine, Dong-A University, Dongdaeshin-dong 3-ga,  Seo-gu, Busan 602-715, Korea Tel : 82-51-240-5241 Fax : 82-51-242-6714 E-mail : jthuh@dau.ac.kr.ORCID : http://orcid.org/0000-0001-7018-9572 This work was supported by the Dong-A  University Research Fund.",Non-OADS,/arxiv_data1/oa_pdf/c1/9c/jcen-16-85.PMC4102755.pdf
"T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Keywords Cerebral arterial occlusion, Tissue plasminogen activator, Thrombus, T2*,  Susceptibility vessel signJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2014.16.2.85  Original Article INTRODUCTION Acute ischemic stroke is an event of the highest  urgency.",Non-OADS,/arxiv_data1/oa_pdf/c1/9c/jcen-16-85.PMC4102755.pdf
"2014 June;16(2):93-97 Received : 15 January 2014 Revised : 19 April 2014 Accepted : 23 April 2014 Correspondence to Lee A. Tan Departments of Neurosurgery, Rush University  Medical Center, 1725 W. Harrison St. Suite  855, Chicago, IL 60612, United States Tel : 419-236-8831 Fax :  E-mail : lee_tan@rush.edu ORCID : http://orcid.org/0000-0003-3497-3321 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li- censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Keywords Cerebral air embolism, Cerebral angiography Journal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2014.16.2.93  Case Report INTRODUCTION Symptomatic cerebral air embolism (CAE) is a rare  complication associated with cerebral angiography  with a reported incidence of 0.08%.2) Clinical mani- festations of symptomatic CAE may include de-creased level of consciousne ss, hemiparesis, seizures,  and neuromonitoring changes while under anesthesia.",Non-OADS,/arxiv_data1/oa_pdf/b9/a8/jcen-16-93.PMC4102756.pdf
"2014 June;16(2):98-103 Received : 27 January 2014 Revised : 9 April 2014Accepted : 2 May 2014 Correspondence to Sina Abdollahzade Jalal Al Ahmad Street, Amir Abad Avenue,   Department of Neurosurgery, Shariati Hospital,    Tehran University of Medical Sciences, Tehran,  Iran Tel : 98-21-8822-0040 Cell : 98-912-132-5746 Fax : 98-21-8822-0040 E-mail : Sina21@gmail.comORCID : http://orcid.org/0000-0002-6423-9614 T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non-  Commercial License (http://creativecommons.org/li- censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/54/jcen-16-98.PMC4102757.pdf
"Keywords Pial arteriovenous fistulas, Microsurger yJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2014.16.2.98  Case Report INTRODUCTION Intracranial pial arteriovenous fistulas (pAVF) are  rare vascular lesions accounting for only 1.6% of all vascular malformations of the brain.",Non-OADS,/arxiv_data1/oa_pdf/1f/54/jcen-16-98.PMC4102757.pdf
"At the heart of the canonical Wnt signalingpathway is the silencing of glycogen synthase kinase 3 b (GSK3 b), which, if active, phosphorylates the N terminus of any cytoplasmic b-catenin not used in cell–cell adhesion /C2112014 Lien and Fuchs This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).",Non-OADS,/arxiv_data1/oa_pdf/05/da/1517.PMC4102759.pdf
[Keywords : LEF/TCF; stem cells; Wnt signaling; b-catenin] 3Corresponding authors E-mail fuchslb@rockefeller.edu E-mail wen-hui.lien@uclouvain.be Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.244772.114.,Non-OADS,/arxiv_data1/oa_pdf/05/da/1517.PMC4102759.pdf
"Collec- tively, these observations reveal that metazoans employ multiple signaling mechanisms across all somatic tis-sues to coordinate these biological processes, maintain /C2112014 van Oosten-Hawle and Morimoto This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first sixmonths after the full-issue publication date (see http://genesdev.cshlp.org/ site/misc/terms.xhtml).",Non-OADS,/arxiv_data1/oa_pdf/c0/45/1533.PMC4102760.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/c0/45/1533.PMC4102760.pdf
[Keywords :C. elegans ; proteostasis; chaperones; stress response; trans- cellular stress signaling] Corresponding author E-mail r-morimoto@northwestern.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.241125.114.,Non-OADS,/arxiv_data1/oa_pdf/c0/45/1533.PMC4102760.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/68/42/1544.PMC4102761.pdf
[Keywords : DNA methylation; piRNA; retrotransposon; germ cells; LINE; LTR] 5Corresponding author E-mail hannon@cshl.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.244350.114.,OADS,/arxiv_data1/oa_pdf/68/42/1544.PMC4102761.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/30/8d/1550.PMC4102762.pdf
Article and publication date are online at http://www.genesdev.or g/cgi/doi/10.1101/gad.245662.114.,Non-OADS,/arxiv_data1/oa_pdf/30/8d/1550.PMC4102762.pdf
"The percentage of tRNA genes that harbor introns varies significantly, from 0% in bacteria to 5% in mice and humans to >60% in some archaea (Genomic tRNA Database, http://lowelab.ucsc.edu/ GtRNAdb).",OADS,/arxiv_data1/oa_pdf/16/d6/1556.PMC4102763.pdf
Neither defects in 3 9-to-5 9 nucleases nor a temperature-sensitive (ts) mutation of the /C2112014 Wu and Hopper This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/16/d6/1556.PMC4102763.pdf
[Keywords : tRNA splicing; tRNA ligation; intron turnover; Xrn1; Rlg1; 59to 39exonuclease] 4Corresponding author E-mail hopper.64@osu.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.244673.114.,OADS,/arxiv_data1/oa_pdf/16/d6/1556.PMC4102763.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/d1/c8/1592.PMC4102766.pdf
12Corresponding author E-mail kari.alitalo@helsinki.fi Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.237677.114.,Non-OADS,/arxiv_data1/oa_pdf/d1/c8/1592.PMC4102766.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/e7/e5/1604.PMC4102767.pdf
8Corresponding author E-mail bpfander@biochem.mpg.de Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.240515.114.,Non-OADS,/arxiv_data1/oa_pdf/e7/e5/1604.PMC4102767.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/a7/f5/1620.PMC4102768.pdf
6Corresponding authors E-mail storzg@mail.nih.gov E-mail cgrossucsf@gmail.com Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.243485.114.,Non-OADS,/arxiv_data1/oa_pdf/a7/f5/1620.PMC4102768.pdf
"San Diego, CA: Society for Neu- roscience; 2013. http://www.sfn.org/ */media/SfN/Documents/ AnnualMeeting/FinalProgram/FullAbstractPDFs/AbstractPDFs_Nano.ashx (Online).",OADS,/arxiv_data1/oa_pdf/4c/bd/40272_2014_Article_79.PMC4102824.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Correspondence: Dr DL Morris, Department of Medical & Molecular Genetics, King’s College London School of Medicine, Guy’s  Hospital, London, UK.",Non-OADS,/arxiv_data1/oa_pdf/3b/49/nihms595460.PMC4102853.pdf
AA translation AA sequences for each HLA allele were extracted from the European Bioinformatics  Institute HLA database ( http://www.ebi.ac.uk/ipd/imgt/hla/ ).,OADS,/arxiv_data1/oa_pdf/3b/49/nihms595460.PMC4102853.pdf
Online Mendelian in MAN (OMIM): http://www.omim.org References 1.,Non-OADS,/arxiv_data1/oa_pdf/3b/49/nihms595460.PMC4102853.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5745 | DOI: 10.1038/srep05745 6",Non-OADS,/arxiv_data1/oa_pdf/36/55/srep05745.PMC4102896.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5740 | DOI: 10.1038/srep05740 6",Non-OADS,/arxiv_data1/oa_pdf/a8/4d/srep05740.PMC4102898.pdf
"Cells 90, 1189–1207; doi:http://dx.doi.",OADS,/arxiv_data1/oa_pdf/af/6f/srep05734.PMC4102900.pdf
"Sigma-Aldrich Co. LLC, Aldrich Materials Science , (2014), Date of access: 11/06/ 2014, http://www.sigmaaldrich.com/materials-science.html.",Non-OADS,/arxiv_data1/oa_pdf/af/6f/srep05734.PMC4102900.pdf
"Schubert, E. F. Refractive index and extinction coefficient of materials, (2004), Date of access: 11/06/2014, http://homepages.rpi.edu/ ,schubert/Educational- resources/Materials-Refractive-index-and-extinction-coefficient.pdf.",Non-OADS,/arxiv_data1/oa_pdf/af/6f/srep05734.PMC4102900.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5734 | DOI: 10.1038/srep05734 9",Non-OADS,/arxiv_data1/oa_pdf/af/6f/srep05734.PMC4102900.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/af/fa/srep05744.PMC4102901.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ed/70/srep05600.PMC4102902.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5600 | DOI: 10.1038/srep05600 7",Non-OADS,/arxiv_data1/oa_pdf/ed/70/srep05600.PMC4102902.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/38/ea/srep05741.PMC4102903.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5741 | DOI: 10.1038/srep05741 6",Non-OADS,/arxiv_data1/oa_pdf/38/ea/srep05741.PMC4102903.pdf
"Gwyddion, http://gwyddion.net/, (2004) (Date of access: 02/04/ 2014).",Non-OADS,/arxiv_data1/oa_pdf/1a/11/srep05742.PMC4102904.pdf
All the authors intensively discussed various aspects.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e0/4a/srep05681.PMC4102905.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5749 | DOI: 10.1038/srep05749 7",Non-OADS,/arxiv_data1/oa_pdf/55/3e/srep05749.PMC4102920.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/52/21/srep05750.PMC4102923.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5750 | DOI: 10.1038/srep05750 11",Non-OADS,/arxiv_data1/oa_pdf/52/21/srep05750.PMC4102923.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Chemoresistance of human LA to cisplatin promoted by MiR-224 354 www.bjcancer.com | DOI:10.1038/bjc.2014.157,Non-OADS,/arxiv_data1/oa_pdf/1b/ff/bjc2014157a.PMC4102932.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Pro-apoptotic role of autophagy in breast cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.203 317,Non-OADS,/arxiv_data1/oa_pdf/35/be/bjc2014203a.PMC4102935.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER CD44v2 is prognostic marker for colorectal cancer 374 www.bjcancer.com | DOI:10.1038/bjc.2014.253,Non-OADS,/arxiv_data1/oa_pdf/d9/a3/bjc2014253a.PMC4102936.pdf
"All statistical analyses were performed using SPSS version 13.0 (SPSS, Chicago, IL, USA) and R software version 2.12.0 (http://www.r-project.org/), with an optional package installed, called rms (Harrell, 2012).",OADS,/arxiv_data1/oa_pdf/83/1d/bjc2014256a.PMC4102937.pdf
(Computer Program) http://CRAN.R-project.org/package=rms.,Non-OADS,/arxiv_data1/oa_pdf/83/1d/bjc2014256a.PMC4102937.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)CRM1 inhibitor in NSCLC BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.260 291,Non-OADS,/arxiv_data1/oa_pdf/64/be/bjc2014260a.PMC4102938.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER MTDH suppresses proliferation and metastasis in NSCLC 364 www.bjcancer.com | DOI:10.1038/bjc.2014.267,Non-OADS,/arxiv_data1/oa_pdf/fb/4b/bjc2014267a.PMC4102939.pdf
"DCA is currently in clinical trial (http://clinicaltrials.gov/show/ NCT01111097; Michelakis et al, 2010).",Non-OADS,/arxiv_data1/oa_pdf/79/02/bjc2014281a.PMC4102941.pdf
Metabolite peaks were quantified using the Amares fitting tool in jMRUI (http://sermn02.uab.es).,OADS,/arxiv_data1/oa_pdf/79/02/bjc2014281a.PMC4102941.pdf
"DCA is currently in clinical trial (http://clinicaltrials.gov/show/ NCT01111097; Michelakis et al , 2010).",Non-OADS,/arxiv_data1/oa_pdf/79/02/bjc2014281a.PMC4102941.pdf
"All samples were successfully amplified and analysed for 238 variant targets in a 24 multiplex polymerase chain reactions (PCR) using the OncoCarta Panel v1.0 Kit including 19 tumour-related genes such as BRAF , NRAS ,KIT and PIK3CA (http://bioscience.sequenom.com/onco- carta-panel).",OADS,/arxiv_data1/oa_pdf/17/c2/bjc2014287a.PMC4102942.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRAF andNRAS mutations in metastatic melanoma BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.287 299,Non-OADS,/arxiv_data1/oa_pdf/17/c2/bjc2014287a.PMC4102942.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Gemcitabine diphosphate choline in PDAC models BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.288 325,Non-OADS,/arxiv_data1/oa_pdf/68/21/bjc2014288a.PMC4102943.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Ficlatuzumab ±erlotinib in advanced solid tumours 280 www.bjcancer.com | DOI:10.1038/bjc.2014.290,Non-OADS,/arxiv_data1/oa_pdf/26/d3/bjc2014290a.PMC4102944.pdf
Genome-wide gene expression and in silico analysis for the identification of genes regulated by miR-451a .The TargetScan database (Release 6.2; http://www.targetscan.org/) was used for in silico identification of candidate target genes that contained miR-451a targets sites in their 30-untranslated (30-UTR) region.,OADS,/arxiv_data1/oa_pdf/9b/3f/bjc2014293a.PMC4102946.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER miR-451a functions as a tumour suppressor in HSCC 394 www.bjcancer.com | DOI:10.1038/bjc.2014.293,Non-OADS,/arxiv_data1/oa_pdf/9b/3f/bjc2014293a.PMC4102946.pdf
"For Oslo0/ULL samples, annotations for Stanford 43k cDNA array were retrieved from SMD SOURCE (http://smd.stanford.edu/cgi-bin/source/sourceSearch; UniGene Build.222).",OADS,/arxiv_data1/oa_pdf/16/ea/bjc2014297a.PMC4102947.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Nuclear CSPP1 expression in breast cancer 338 www.bjcancer.com | DOI:10.1038/bjc.2014.297,Non-OADS,/arxiv_data1/oa_pdf/16/ea/bjc2014297a.PMC4102947.pdf
http://dx.doi.org/10.1016/j.eururo.2012.06.057.,OADS,/arxiv_data1/oa_pdf/1f/0d/bjc2014311a.PMC4102948.pdf
"Oncologist 6: 56–64.Capecitabine package insert (2014) http://www.accessdata.fda.gov/ drugsatfda_docs/label/2000/20896lbl.pdf (accessed May 14, 2014).",Non-OADS,/arxiv_data1/oa_pdf/18/68/bjc2014344a.PMC4102951.pdf
Available at http://www.emqn.org (accessed 18 January 2014).,Non-OADS,/arxiv_data1/oa_pdf/0c/96/bjc2014353a.PMC4102953.pdf
Available at http://www.hgvs.org/mutnomen/ (accessed 18 January 2014).,Non-OADS,/arxiv_data1/oa_pdf/0c/96/bjc2014353a.PMC4102953.pdf
Availableat http://www.iso.org/iso/home/store/catalogue_ics/catalogue_detail_ics.htm?csnumber=56115 (accessed 18 January 2014).,Non-OADS,/arxiv_data1/oa_pdf/0c/96/bjc2014353a.PMC4102953.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Worldwide external quality assessment for EGFR gene mutation testing 420 www.bjcancer.com | DOI:10.1038/bjc.2014.353,Non-OADS,/arxiv_data1/oa_pdf/0c/96/bjc2014353a.PMC4102953.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Genetic profiles in secondary angiosarcoma 412 www.bjcancer.com | DOI:10.1038/bjc.2014.359,Non-OADS,/arxiv_data1/oa_pdf/b9/64/bjc2014359a.PMC4102954.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/05/9f/srep05748.PMC4103033.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5748 | DOI: 10.1038/srep05748 13",Non-OADS,/arxiv_data1/oa_pdf/05/9f/srep05748.PMC4103033.pdf
"Reads from each library were aligned against the Apis mellifera genome, Assembly 4.5 35using Tophat36and read counts were generated for genes using HTSeq v0.5pv2 (http://www-huber.embl.de/users/anders/HTSeq) and the Apis mellifera Official Gene Set, version 3.2.",OADS,/arxiv_data1/oa_pdf/57/c4/srep05726.PMC4103092.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/57/c4/srep05726.PMC4103092.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5726 | DOI: 10.1038/srep05726 5",Non-OADS,/arxiv_data1/oa_pdf/57/c4/srep05726.PMC4103092.pdf
Bottom-up proteomics was performed using standard methods and the metal-bound proteins (presented in the Supplement Table 2) were assigned using Protein Knowledgebase (uniProtKB) (http://www.uniprot.org/) and MetalMine (http://metalmine.naist.jp/) databases.www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5729 | DOI: 10.1038/srep05729 7,OADS,/arxiv_data1/oa_pdf/88/72/srep05729.PMC4103093.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/88/72/srep05729.PMC4103093.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5729 | DOI: 10.1038/srep05729 12",Non-OADS,/arxiv_data1/oa_pdf/88/72/srep05729.PMC4103093.pdf
Website  http://www.iucnredlist.org  [accessed 22 August 2013].,Non-OADS,/arxiv_data1/oa_pdf/ba/ae/apps.1300072.PMC4103100.pdf
Website  http://www.rub.de/spezzoo/cm/ cm_phobos.htm  [accessed 4 January 2014].,Non-OADS,/arxiv_data1/oa_pdf/b9/32/apps.1300081.PMC4103103.pdf
Website  http://www2.unil.ch/popgen/softwares/fstat.,Non-OADS,/arxiv_data1/oa_pdf/5c/66/apps.1300084.PMC4103104.pdf
"A BLAST search  of the contigs containing the loci and the  L. bicolor   nuclear and mitochondrial  genomes (genome version 1.0, MycorWeb; http://mycor.nancy.inra.fr/IMGC/LaccariaGenome/blast.html) revealed the eight loci were mitochondrial.",OADS,/arxiv_data1/oa_pdf/63/da/apps.1300086.PMC4103105.pdf
Website  http://www.geneious.com  [accessed 12 February 2014  ].,Non-OADS,/arxiv_data1/oa_pdf/63/da/apps.1300086.PMC4103105.pdf
When both  LM  and  MS  are positive (red to (http://getdata-graph-digitizer.com) from  Endler (1990 : Fig.,OADS,/arxiv_data1/oa_pdf/d9/6e/apps.1300088.PMC4103106.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/6e/apps.1300088.PMC4103106.pdf
Website  http://2013.botanyconference.org/engine/search/index.php?func=detail&aid=341 .,Non-OADS,/arxiv_data1/oa_pdf/98/59/apps.1300097.PMC4103107.pdf
"Alignments are available on the Dryad Digital Repository (http://doi.org/10.5061/dryad.5nc25;  Wofford et al., 2014 ).",OADS,/arxiv_data1/oa_pdf/6a/72/apps.1400002.PMC4103111.pdf
"Using the script  sorter.pl   ( Goremykin et al., 2010 ) on the  iPlant Discovery Environment (http://www.iplantcollaborative.org), we calcu-lated the observed variability (OV) for each base position.",OADS,/arxiv_data1/oa_pdf/6a/72/apps.1400002.PMC4103111.pdf
"DAPC and scatter plots of the ﬁ  rst two principal components were run using  adegenet    (version 1.3-9.2;  Jombart et al., 2010 ) in R (version 3.0.2; http://www.R-project.org).",OADS,/arxiv_data1/oa_pdf/6a/72/apps.1400002.PMC4103111.pdf
"2  ; http://doi.org/10.5061/dryad.5nc25;  Wofford et al., 2014 ).",Non-OADS,/arxiv_data1/oa_pdf/6a/72/apps.1400002.PMC4103111.pdf
"Primer conservation was high in all taxonomic subsec-tions for 10 of the 15 primers ( Table 3 ), and opportunities exist to  create nearby primers for taxonomic subsections that have di- verged (data available from the Dryad Digital Repository: http://doi.org/10.5061/dryad.5nc25;  Wofford et al., 2014 ).",OADS,/arxiv_data1/oa_pdf/6a/72/apps.1400002.PMC4103111.pdf
"For these, minor adjustments in primer location to more conserved adjacent re-gions would potentially increase cross-species transferability (data available from the Dryad Digital Repository: http://doi.org/10.5061/dryad.5nc25;  Wofford et al., 2014 ).",OADS,/arxiv_data1/oa_pdf/6a/72/apps.1400002.PMC4103111.pdf
http://doi.org/10.5061/dryad.5nc25,Non-OADS,/arxiv_data1/oa_pdf/6a/72/apps.1400002.PMC4103111.pdf
Website:  http://www2.unil.ch/popgen/ softwares/fstat.htm  [accessed 6 January 2014].,Non-OADS,/arxiv_data1/oa_pdf/05/e3/apps.1400016.PMC4103113.pdf
Website:  http://www.eeb.uconn.edu/people/plewis/software.php  [accessed 14 April 2014].,Non-OADS,/arxiv_data1/oa_pdf/05/e3/apps.1400016.PMC4103113.pdf
Website:   http://www.bioinformatics.org/JaMBW  [accessed 16 April 2014].,Non-OADS,/arxiv_data1/oa_pdf/9e/60/apps.1400026.PMC4103114.pdf
"Using MISA (http://pgrc.ipk-gatersleben.de/misa), we detected 2069 SSRs in 1897 con-tigs.",OADS,/arxiv_data1/oa_pdf/ee/ea/apps.1300047.PMC4103115.pdf
"Using Primer3 ( Rozen and Skaletsky, 2000 ; http://frodo.wi.mit.edu/primer3), 102 pairs of primers were designed from contigs containing at least nine repeats for dinucleotide and trinucleotide motifs, or seven repeats for tetranucleotide motifs.",OADS,/arxiv_data1/oa_pdf/ee/ea/apps.1300047.PMC4103115.pdf
This DNA sample was sent to the Cornell Evolutionary Genetics Core Facility (https://cores.lifesciences.cornell.edu/brcinfo/) for the development of microsatellite loci.,OADS,/arxiv_data1/oa_pdf/bc/f7/apps.1300052.PMC4103119.pdf
"Observed and expected heterozygosities ( Table 2 ), linkage equi-librium, and Weir and Cockerham values of inbreeding within populations ( F   IS )  were calculated with GENEPOP version 4.2 ( Raymond and Rousset, 1995 ;  Rousset, 2008 ;  http://genepop.curtin.edu.au/ ).",OADS,/arxiv_data1/oa_pdf/8c/64/apps.1300054.PMC4103120.pdf
"We cross-referenced the  results of three previous studies that used algorithms to identify putative SCNGs with published ESTs as follows: for the APVO loci (ﬁ  le 1471-2148-10-61-S1.xls  from  Duarte et al., 2010 ), we kept only those loci reported to have introns and be SCNGs in  A. thaliana  ; for the COSII set (ﬁ  le available at: http://solgenomics.net/ documents/markers/cosii.xls), we included all that were single-copy in  A. thaliana  ;  for the PPR genes (ﬁ  le NPH_2739_sm_ TableS1 .xls from  Yuan et al., 2009 ),  we kept those unique in rice and  Arabidopsis  ; and we included all ESTs between   B. napus   and  A. thaliana   ( Ilut and Doyle, 2012 ) after removing duplicates.",Non-OADS,/arxiv_data1/oa_pdf/2a/9a/apps.1200002.PMC4103123.pdf
of bands AT1G56590 702F/1535R  F: AARGAYAATTTCATCATTGTCTATGAG  900 PCR55 1  R: GCATCCATYTCTTCAACAAGGTCG   AT1G61620 F2/R2  F: GCAAAGACACTCGAAGAACA  1500 PCR60 1  R: AGGTTTGTCACACACAAGACTT   AT2G40600 F2/R2  F: TCAAATGAGACGACAATGGTT  1300 TDPCR56 1  R: CACCTCCTTTGCTTTGTTTAC   AT4G34700 F1/R1  F: GAAGTTCAATGTCAACCAAGATG  710 ANNEXT63 1  R: ACCATGAGCAATCAGTTTGT   AT5G25630 F2/R2  F: RAAGAAGGTGGAGGAGGCGT  450 TDPCR56 1  R: ACATCTGCCTTCACSTTACACTC   AT5G27620 c F1/R1  F: GAAGTTCAATGTCAACCAAGATG  1500 TDPCR54 2  R: ACCATGAGCAATCAGTTTGT   AT3G03100 c F3/R3  F: CCTACCAGATGGGAACCTCT  1500 TDPCR54 2  R: GTACCGAGTCCAGTTCTTTTG   AT3G03100 c F4/R3  F: CATAACATAGGAGCGACACTT  950 TDPCR54 1  R: GTACCGAGTCCAGTTCTTTTG   AT1G50020 F3/R1  F: GTGTGGCTCTCCTGTATCGTTT  950 TDPCR54  1  R: CGCCGAGAGTTAAGACTATCAAT   AT5G26680 5F/9R  F: AAGAGACAGGAACTGGCTAAACG  600 PCR60 1  R: TGCAAAGTGCAGCACATTGC   AT5G26680 12F/13R  F: ACTGCTCTAAAGCTTATTCGCCAG  450 PCR60 1  R: AAAGTTTCGAGCTTCATTATATGG    a  Locus ID from The Arabidopsis Information Resource database (http://www.arabidopsis.org/).,Non-OADS,/arxiv_data1/oa_pdf/2a/9a/apps.1200002.PMC4103123.pdf
"edulis   cDNAs using the    Simple Sequence Repeat Identiﬁ  cation Tool (SSRIT; http://www.gramene.org/db/markers/ssrtool;  Temnykh et al., 2001 ).",OADS,/arxiv_data1/oa_pdf/29/08/apps.1200012.PMC4103127.pdf
Website:  http://www.eeb.uconn.edu/people/plewis/software.php  [ac-cessed 18 April 2012].,Non-OADS,/arxiv_data1/oa_pdf/00/56/apps.1300092.PMC4103135.pdf
"a   Locus b Primer sequences (5 ′ –3 ′ ) c Repeat motif  d Allele size range (bp) e  Sg  _1  F: GCGTACTTATTAAATTGATTTCTATAACCG  (TTGG) 116–153  R: ACAGATGGCTTCCATGATCG   Sg_2  F: TCTAAACTGTAAGTCTTTGATGAAACC  (AATG) 167–248  R: GCCGTCAATCCTTACAATCC   Sg_3  F: TTGAAGATCAAATGCTTCCACC  (AAC) 92–182  R:  GTTT AACCAATTTGTCACTTCAGATCG   Sg  _4  F: CAATCTTGTCAGTTTAATCATTTCTTCC  (TTCC) 104–201  R:  GT TTCATAAGGAGTGGCATGTTCC   Sg_5  F: TTGTCCTGATACAAATTTCCTACTCG  (TTC) 256–296  R:  GTTT AACAATGAGAATAAGTGGACAACCC   Sg_6  F: TTTACCTTTGAATTGCGGC  (AAAT) 200–244  R:  GTTT AGTACCAATCAACCATGGGC   Sg_7  F: TTTGTATGCAAGTCAAAGGCG  (AAAG) 360–378  R:  GTTT CACAGCTGCCAATAAATCCC   Sg_8  F: TCCCTCTTTATTCTTTCAACAAACC  (AAAG) 126–172  R:  GTTT AACACCAACATTGCAATCCC   Sg_9  F: GACGTGGCTAAATTAAGGTGTACG  (AATG) 170–190  R:  GT TTGCAACGTAATCCACCTCC   Sg_10  F: CGTTTGTTCTTTGTCCCTTTCC  (ATCT) 276–330  R:  GTTT CTATACCTCGTGCGTGTCGG   Sg_11  F: GAGTCTCTTCAGTATAAGTTTATCTTGGC  (AAC) 119–155  R:  GTTT AAGACTGTCTACATTTCACCTCTCC   Sg_12  F: CTAGAAGATGTGGATTGACCAGC  (AAAT) 182–208  R:  GTTT CAAATGAGTCAGTCGGTGCC   Sg_13  F: TTGAAATGTTTGTATCATTAGGGTATGG  (AAC) 153–172  R:  GTTT CATATCCCGTTTCGGCAGG   Sg_14  F: AACCTTTGTTTGGTATGTAAATTAGG  (AAC) 317–355  R:  GTTT ATGTTTCTACGTTGGGAGGG    a  Paired-end sequence data are deposited in the Dryad   Digital Repository: http://doi.org/10.5061/dryad.72p7k ( Beck et al., 2 014 ).",Non-OADS,/arxiv_data1/oa_pdf/fd/f9/apps.1300093.PMC4103136.pdf
"http://doi.org/10.5061/dryad.72p7k        CASTOE    ,     T .",Non-OADS,/arxiv_data1/oa_pdf/fd/f9/apps.1300093.PMC4103136.pdf
"Sequence alignment ﬁ  les are deposited in the  Dryad Digital Repository (http://doi.org/10.5061/dryad.382p0;  Gostel and Weeks, 2014 ).",OADS,/arxiv_data1/oa_pdf/d3/61/apps.1300098.PMC4103138.pdf
http://doi.org/10.5061/dryad.382p0 .,Non-OADS,/arxiv_data1/oa_pdf/d3/61/apps.1300098.PMC4103138.pdf
"After the dewaxing and pretreatment steps have been completed, slides may  be processed for RNAscope ISH according to the Manual ACD protocol (RNA-scope 2.0 HD Detection Kit [Red] User Manual, http://www.acdbio.com/support/technical-doc) or semiautomated ACD RNAscope VS Assay (RNAscope VS Reagent Kit [Brown] User Manual for use with Ventana Discovery Ultra System [Ventana Medical Systems, Tuscon, Arizona, USA]; http://www.acd bio.",Non-OADS,/arxiv_data1/oa_pdf/41/5e/apps.1400011.PMC4103140.pdf
Ventana VSS software (version 12.1 with custom VSS mRNA DAB Improvements) was used to program the semiautomated RNAscope VS Assay according to manufacturer’s instructions (RNAscope VS Reagent Kit [Brown] User Manual for use with Ventana Discovery Ultra Sys-tem; http://www.acdbio.com/support/technical-doc).,OADS,/arxiv_data1/oa_pdf/41/5e/apps.1400011.PMC4103140.pdf
"Maize accessions GRMZM2G083841_T02 ( PEPC ) and GRMZM2G001696_ T01 ( PEPCK ), obtained from http://www.maizesequence.org, were submitted  to ACD for probe design and synthesis.",OADS,/arxiv_data1/oa_pdf/41/5e/apps.1400011.PMC4103140.pdf
"Figure panels were created with GNU   Image Manipulation Program (GIMP, version 2.8; http://www.gimp.org/).",OADS,/arxiv_data1/oa_pdf/41/5e/apps.1400011.PMC4103140.pdf
Protocol   modiﬁ  ed from the RNAscope VS Reagent Kit (Brown) User Manual for use with Ventana Discovery Ultra System (http://www.acdbio.com/ support/technical-doc).,OADS,/arxiv_data1/oa_pdf/41/5e/apps.1400011.PMC4103140.pdf
Proceed with the semiautomated RNAscope VS Assay protocol as  described in the RNAscope VS Reagent Kit (Brown) User Manual for use with Ventana Discovery Ultra System (http://www.acdbio.com/support/technical-doc).,Non-OADS,/arxiv_data1/oa_pdf/41/5e/apps.1400011.PMC4103140.pdf
Available from  http://www2.unil.,Non-OADS,/arxiv_data1/oa_pdf/b5/7e/apps.1200010.PMC4103141.pdf
Website  http://www2.unil.ch/popgen/softwares/ fstat.htm  [accessed   February 2002].,OADS,/arxiv_data1/oa_pdf/e4/64/apps.1300003.PMC4103143.pdf
"2 of 3  Applications in Plant Sciences   2013   1 ( 9 ): 1300014   Sakazono et al.— Lilium longiﬂ  orum   microsatellites   doi:10.3732/apps.1300014  http://www.bioone.org/loi/appsGENEPOP version 4.0.10 (http://genepop.curtin.edu.au/;  Rousset, 2008 ) and  sequential Bonferroni correction was applied for multiple tests.",Non-OADS,/arxiv_data1/oa_pdf/cb/90/apps.1300014.PMC4103146.pdf
All cloned sequences were screened for vector contamination by comparison with the UniVec Database (National Center for Biotechnology Information; http://www.ncbi.nlm.nih.gov/VecScreen/UniVec.html) prior to submission to GenBank.,OADS,/arxiv_data1/oa_pdf/8a/87/apps.1300018.PMC4103147.pdf
Website   http://www.geneious.com  [accessed 24 June 2013].,Non-OADS,/arxiv_data1/oa_pdf/8a/87/apps.1300018.PMC4103147.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/23/6c/srep05738.PMC4103151.pdf
Temperatures were deter- mined using a Tm calculator for oligonucleotides (http://www.promega.com/ techserv/tools/biomath/calc11.htm) and the salt-adjusted Tm was selected.,OADS,/arxiv_data1/oa_pdf/21/8c/srep05730.PMC4103152.pdf
Date of access: 23/06/2014Available from http://eurl.craw.eu/en/187/method-of-reference-and-sops.,Non-OADS,/arxiv_data1/oa_pdf/21/8c/srep05730.PMC4103152.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/21/8c/srep05730.PMC4103152.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5730 | DOI: 10.1038/srep05730 5",Non-OADS,/arxiv_data1/oa_pdf/21/8c/srep05730.PMC4103152.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivative Works  3.0 Unported License (CC-BY-NC-ND; http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode ).,Non-OADS,/arxiv_data1/oa_pdf/fb/09/nihms591251.PMC4103158.pdf
"WEB RESOURCES The URLs for data presented herein are as follows: CPR PTM Resource, http://cpr1.sund.ku.dk/cgi-bin/PTM.pl Mascot, http://www.matrixscience.com Online Mendelian Inheritance in Man (OMIM), http://omim.org/ Reflect, http://reflect.cbs.dtu.dk/index.html TRANCHE, http://www.proteomecommons.org HHS Public Access Author manuscript Cell Rep .",OADS,/arxiv_data1/oa_pdf/fb/09/nihms591251.PMC4103158.pdf
"Because acetylation of muscle LIM  protein is moreover known to enhance calcium sensitivity of myofilaments in  cardiomyocytes ( Gupta et al., 2008 ), our findings strongly imply that muscle-contractile  proteins are regulated by lysine acetylation in addition to the well-established role of  SUPPLEMENTAL INFORMATION Supplemental Information includes Extended Experimental Procedures, six figures, raw MS data, and five tables and can be found  with this article online at http://dx.doi.org/10.1016/j.celrep.2012.07.006 .Lundby et al.",OADS,/arxiv_data1/oa_pdf/fb/09/nihms591251.PMC4103158.pdf
"2012  Published online June 6, 2012. http://dx.doi.org/10.1038/ncomms1871 .",OADS,/arxiv_data1/oa_pdf/fb/09/nihms591251.PMC4103158.pdf
Trees were visualized using FigTree version 1.3.1 (http://tree.bio.ed.ac.uk/software/ﬁ gtree/) and midpoint rooted.,OADS,/arxiv_data1/oa_pdf/5c/8e/apps.1400015.PMC4103437.pdf
GenBank BLAST searches (http://www.ncbi.nlm.nih.gov/)  were conducted on 159 of  C. huegelii   sequences with high homology with at  least two  Eriochilus   isolates.,OADS,/arxiv_data1/oa_pdf/5c/8e/apps.1400015.PMC4103437.pdf
Website  http://www.geneious.com/  [accessed 24 April 2014].,Non-OADS,/arxiv_data1/oa_pdf/5c/8e/apps.1400015.PMC4103437.pdf
"Three software packages were used: GENEPOP on the Web for general index calculations and tests on linkage disequilibrium ( Rousset, 2008 ; http://genepop.curtin.edu.au/), MICRO-CHECKER ( van Oosterhout et al.,  2004 ) for tests on potential null alleles with a prior value of maximum allele length of 250 bp and a 95% conﬁ  dence limit, and GenAlEx   version 6.2 ( Smouse  et al., 2008 ;  Beck et al., 2008 ) for ﬁ  nding identical multilocus clones.",Non-OADS,/arxiv_data1/oa_pdf/94/31/apps.1400021.PMC4103440.pdf
Website  http://www.eeb.uconn.edu/people/plewis/software.php  [accessed 14 June 2013].,Non-OADS,/arxiv_data1/oa_pdf/a7/4e/apps.1300001.PMC4103445.pdf
Website  http://animalgenomics.ucd.ie/sdepark/ms-toolkit/  [accessed 17 June 2013].,Non-OADS,/arxiv_data1/oa_pdf/7a/ec/apps.1300002.PMC4103446.pdf
Website  http://plants.usda.gov  [accessed 17 June 2013].,OADS,/arxiv_data1/oa_pdf/7a/ec/apps.1300002.PMC4103446.pdf
"For these loci, we further investigated the  most likely gene annotations by conducting a BLASTX search against proteins in the UniRef100 database (European Molecular Biology Laboratory–European Bioinformatics Institute [EMBL-EBI], http://www.ebi.ac.uk/Tools/blastall/) ( Table 1 ).",OADS,/arxiv_data1/oa_pdf/29/03/apps.1300004.PMC4103447.pdf
Website   http://www.fzb.rs.gov.br/downloads/ﬂ  ora_ameacada.pdf  [accessed  15 December 2012].,Non-OADS,/arxiv_data1/oa_pdf/8c/f1/apps.1300005.PMC4103448.pdf
Website  http://www.geneious.com  [accessed 8 December 2012].,Non-OADS,/arxiv_data1/oa_pdf/81/9f/apps.1300019.PMC4103450.pdf
Website:  http://www.fs.fed.us/database/feis/  [accessed 19 January 2011].,OADS,/arxiv_data1/oa_pdf/05/cd/apps.1300031.PMC4103451.pdf
"For example, the free mobile app Leafsnap (http://leafsnap.com) has been devel-oped to identify tree species from photographs of their leaves.",Non-OADS,/arxiv_data1/oa_pdf/76/b4/apps.1200005.PMC4103455.pdf
Pea expressed sequence tag (EST) sequences ( http://www.ncbi.nlm.nih.gov/dbEST/ dbEST_summary.,OADS,/arxiv_data1/oa_pdf/79/76/apps.1300026.PMC4103456.pdf
"( http://gbrowse.jcvi.org/cgi-bin/gbrowse/medicago/   ) also of fer a  wealth of information for developing EST-derived genic mark-ers in closely related species using a comparative genomics ap-proach ( Smykal et al., 2012 ).",OADS,/arxiv_data1/oa_pdf/79/76/apps.1300026.PMC4103456.pdf
"Computer animations, or vid- eos, of 2D transverse and longitudinal serial sections through a  Pinus pinea   L.  cone were produced using the software virtualdub (version 1.9.10), which is freely available on the Internet (http://www.virtualdub.org/).",OADS,/arxiv_data1/oa_pdf/80/6b/apps.1300039.PMC4103457.pdf
Website:   http://www.ge-mcs.com/en/metrology/3d-metrology/vtomex-s.html   [accessed 11 July 2013].,Non-OADS,/arxiv_data1/oa_pdf/80/6b/apps.1300039.PMC4103457.pdf
Website  http://www.equisetites .de/palbot/tools/microtomography.html  [accessed 19 September 2013].,Non-OADS,/arxiv_data1/oa_pdf/80/6b/apps.1300039.PMC4103457.pdf
Website  http://www.ctlab.geo.utexas.edu/overview/  [accessed 10 May 2013].,OADS,/arxiv_data1/oa_pdf/80/6b/apps.1300039.PMC4103457.pdf
"Eighty primer pairs were designed equally among these sets using Primer3 software   ( Rozen and Skaletsky, 2000 ;  http://frodo.wi.mit.edu/primer3/ ) and tested with PCR.",OADS,/arxiv_data1/oa_pdf/54/ea/apps.1300042.PMC4103459.pdf
(GrassBase—The Online World Grass Flora [ http://www.kew.org/data/grasses-db.html ]).,Non-OADS,/arxiv_data1/oa_pdf/54/ea/apps.1300042.PMC4103459.pdf
http://dx.plos.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/54/ea/apps.1300042.PMC4103459.pdf
"Allele number, size  range, expected heterozygosity ( H   e ), and polymorphism information content  (PIC) were calculated using PIC Calculator Extra ( http://www.genomics.liv.ac.uk/animal/pic.html ).",OADS,/arxiv_data1/oa_pdf/54/ea/apps.1300042.PMC4103459.pdf
Biota Neotropica   11(2):   http://www.biotaneotropica.org.br/v11n2/en/abstract?inventory+bn02411022011 .,OADS,/arxiv_data1/oa_pdf/1b/ba/apps.1300055.PMC4103462.pdf
"The voucher specimen should be deposited in an ofﬁ  cial herbarium that  is located at a recognized institution and committed to the long-term maintenance of its collection, such as those herbaria regis- tered with Index Herbariorum (http://sweetgum.nybg.org/ih/).",Non-OADS,/arxiv_data1/oa_pdf/7f/6f/apps.1300076.PMC4103463.pdf
"Information regarding where to access these vouchers must be reported within the main text of the paper,  in a table, or as an appendix (see the Instructions for Authors [http://www.botany.org/apps/APPS_Author_Instructions.html]).",Non-OADS,/arxiv_data1/oa_pdf/7f/6f/apps.1300076.PMC4103463.pdf
Website  http://www.iapt-taxon.org/nomen/main.php?page=title   [accessed 30 August 2013].,Non-OADS,/arxiv_data1/oa_pdf/7f/6f/apps.1300076.PMC4103463.pdf
Website  http://www.blm.gov/or/efoia/fy2012/im/p/im-or-2012-010.pdf  [accessed 31 August 2013].,Non-OADS,/arxiv_data1/oa_pdf/7f/6f/apps.1300076.PMC4103463.pdf
Website  http://plants.usda.gov   [accessed 5 September 2013].,OADS,/arxiv_data1/oa_pdf/7f/6f/apps.1300076.PMC4103463.pdf
"Genetic Identiﬁ  cation Services (La Cañada Flintridge, California, USA;   http://www.genetic-id-services.com/ ) was employed to develop microsatellite-enriched libraries for  P .",OADS,/arxiv_data1/oa_pdf/40/fc/apps.1300023.PMC4103465.pdf
"PeA102 GIS  F: ACCCACCAGCTAACTCTTTTG  (CA) 14 94–138 D3 (3) JX987704  R: CCATCTGATCGTACCAACGTA   PeA103 GIS  F: CCTAATAACCCCACCCTACTAC  (GT) 15 243–299; 243–289 D3 (2) JX987705  R: AGGTCCTTTCACACTTTTGAT   PeA106 GIS  F: TCCAACTGGATGCCAACTC  (GC) 5 (AC) 15 179–187; 167–169 D2 (1) JX987706  R: TCTTGGGATCAGCGTATGC   PeB103 GIS  F: AATGGGGTTGCTGTGTCT  (GA) 19 272–314; 270–282 D4 (2) JX987707  R: TCCCTTCTCTTCCACCAC   PeB106 GIS  F: TGCTTCTTGTATGCCAAAGAG  (GTT) 9 164–226 D2 (3) JX987708  R: CCTTCTAAGGGAGATGCAGAG   PeB2 GIS  F: TTCGCTTCCTTCTTTGTTAAAG  (CT) 19 285–313 D4 (1) JX987709  R: AGGGAGGTATCACATGAGGAC   PeC104 GIS  F: CTTGAGCATGAGCTTGAGATC  (GTT) 9 146–168 D4 (1) JX987710  R: ATCAACCATGAGGAGAAGAGAG   PeC2 GIS  F: GATCCTTAGGTTTGGTTTCTTG  (GTT) 10 235–267 D3 (1) JX987711  R: TGCCCTATCAAGCATAGTTATG   Pl13 454  F: GAGGCCATATAGGGTGGTGA  (AT) 8 na; 110–132 D2 (5) JX987701  R: CACAGGATCATAGTTGCCTCG   Pl15 454  F: ATAATGGGCCTAATGATGCG  (GA) 9 145–163; 135–181 D3 (3) JX987702  R: ACTCCCTAGGCTATGCCTCC   Pl18 454  F: TGGACACTTCAGGAGCTAACA  (GA) 15 na; 188–206 D2 (5) JX987703  R: GGGAGGTGTATCCACTCCTTG    a  The two development methods were (a) microsatellite-enriched library construction by Genetic Identiﬁ  cation Services (GIS; La Cañada Flintridge,  California, USA;  http://www.genetic-id-services.com/ ) for  P .",Non-OADS,/arxiv_data1/oa_pdf/40/fc/apps.1300023.PMC4103465.pdf
"Potential primer-dimer binding can also be examined a priori using primer software programs, such as AmplifX ( Jullien, 2013 ), OLIGO (Molecular Biology Insights, Cascade, Colorado, USA; http://www.oligo.net/index.html), FastPCR ( Kalendar et al., 2011 ), or Mul-tiplex Manager ( Holleley and Geerts, 2009 ).",Non-OADS,/arxiv_data1/oa_pdf/7b/62/apps.1300027.PMC4103466.pdf
Website  http://crn2m.univ-mrs.fr/pub/amplifx-dist  [accessed 23 January 2013].,Non-OADS,/arxiv_data1/oa_pdf/7b/62/apps.1300027.PMC4103466.pdf
Website  http://www.genomics.liv.ac.uk/animal/Protocol1.html  [accessed 8 April 2013].,OADS,/arxiv_data1/oa_pdf/ff/3f/apps.1300028.PMC4103467.pdf
The length of the prox-imal and the distal root portion of the primary root were measured on images of scanned slides using ImageJ software (http://rsb.info.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/48/92/apps.1300029.PMC4103468.pdf
Available at   http://tree.bio.ed.ac.uk/software/  [accessed 11 September 2013].,OADS,/arxiv_data1/oa_pdf/65/43/apps.1300037.PMC4103470.pdf
Website   http://www.genomics.liv.ac.uk/animal/MICROSAT.PDF  [accessed 8 May 2012].,Non-OADS,/arxiv_data1/oa_pdf/6f/07/apps.1300038.PMC4103471.pdf
Website  http://www.rub.de/spezzoo/cm/ cm_phobos.htm  [accessed 5 September 2013].,Non-OADS,/arxiv_data1/oa_pdf/4b/75/apps.1300045.PMC4103472.pdf
The PerlScript MIcroSAtelitte (MISA; http://pgrc.ipk-gatersleben.de/misa/) was used to identify microsatellites in the  L. minor   chloroplast genome.,OADS,/arxiv_data1/oa_pdf/1c/e9/apps.1300099.PMC4103473.pdf
Website  http://pdf.usaid.gov/pdf_docs/PNACB166.pdf    [accessed 30 June 2014].,Non-OADS,/arxiv_data1/oa_pdf/0f/5c/apps.1400017.PMC4103474.pdf
Website  http://www.seedconsortium.org/ PUC/pdf%20ﬁ  les/23-Vegetable%20Hybrid%20Seed%20Production.pdf      [accessed 30 June 2014].,Non-OADS,/arxiv_data1/oa_pdf/0f/5c/apps.1400017.PMC4103474.pdf
"At the  AGTC, raw sequence reads were initially processed using prinseq-lite.pl (http://prinseq.sourceforge.net/) and involved removing all (1) reads with >2% length with uncalled bases (N), (2) duplicate reads, (3) reads with Q < 17, (4) reads too short in length [average length – 2(standard deviation)], and (5) reads too long in length [average length + 2(standard deviation)].",OADS,/arxiv_data1/oa_pdf/d7/ec/apps.1400029.PMC4103475.pdf
Website  http://www.geneious.com  [accessed 16 June 2014].,Non-OADS,/arxiv_data1/oa_pdf/d7/ec/apps.1400029.PMC4103475.pdf
Website  http://www.newfs.org/docs/pdf/Pterosporaandromedeaweb.pdf  [accessed 12 June 2014].,Non-OADS,/arxiv_data1/oa_pdf/d7/ec/apps.1400029.PMC4103475.pdf
Errors due to camera set up and lens distortion can be quantiﬁ  ed by analyzing area of squares in photographs of  the ‘distortion sheet’ of green squares surrounding a red square of the same area (available for download at https://github.com/heaslon/Easy-Leaf-Area/blob/master/DistortionSheet.jpg).,Non-OADS,/arxiv_data1/oa_pdf/47/82/apps.1400033.PMC4103476.pdf
The exact equations used to calculate automated selection criteria for  calibration area are available in the Python code ( https://github.com/heaslon/Easy-Leaf-Area ).,OADS,/arxiv_data1/oa_pdf/47/82/apps.1400033.PMC4103476.pdf
A Windows executable “ela.exe” for automated leaf area measurement  was built using PyInstaller ( http://www.pyinstaller.org/ ) and is available for download with required supporting ﬁ  les at  https://github.com/heaslon/ Easy-Leaf-Area/blob/master/EasyLeafArea.zip  (click on ‘view the full ﬁ  le’).,OADS,/arxiv_data1/oa_pdf/47/82/apps.1400033.PMC4103476.pdf
"The Python code “ela.py” and modiﬁ  ed versions are available for download at  https://github.com/heaslon/ Easy-Leaf- Area  and require installation of Python 2.7 ( http://www.python.org/ ),  Python imaging library ( http://www.pythonware.com/products/pil/ ), SciPy ( http://scipy.org/ ), and NumPy ( http://www.numpy.org/ ).",OADS,/arxiv_data1/oa_pdf/47/82/apps.1400033.PMC4103476.pdf
Instructions are avail- able for download at  https://github.com/heaslon/Easy-Leaf-Area/blob/master/ELAinstructions.txt .,Non-OADS,/arxiv_data1/oa_pdf/47/82/apps.1400033.PMC4103476.pdf
A video demonstration of the software is available at  http://goo.gl/zZaonf .,Non-OADS,/arxiv_data1/oa_pdf/47/82/apps.1400033.PMC4103476.pdf
Printable calibration areas and more sample  Arabidopsis    images are available for download   at  https://github.com/heaslon/Easy-Leaf-Area .,Non-OADS,/arxiv_data1/oa_pdf/47/82/apps.1400033.PMC4103476.pdf
Website  http://prometheuswiki.publish.csiro.au/tiki-index.php?%20page=Measuring+leaf+perimeter+and+leaf+area  [accessed 23 June 2014].,OADS,/arxiv_data1/oa_pdf/47/82/apps.1400033.PMC4103476.pdf
Website  http://www.gimp.org/  [accessed 23 June 2014  ].,Non-OADS,/arxiv_data1/oa_pdf/47/82/apps.1400033.PMC4103476.pdf
"METHODS AND RESULTS   Assembled RNA sequencing (RNA-seq) data of  S. canadensis   L. (71,433  contigs) was obtained from the Plant OneKP Project repository (https://sites.google.com/a/ualberta.ca/onekp/home), and a similarity search of the contigs against the National Center for Biotechnology Information (NCBI) nr database was conducted using the BLASTX algorithm ( Altschul et al., 1990 ) with an  E -value cutoff of 1.0E-5.",OADS,/arxiv_data1/oa_pdf/19/39/apps.1400035.PMC4103478.pdf
d  Accession number in Plant OneKP Project database (https://sites.google.com/a/ualberta.ca/onekp/home).TABLE 1.,OADS,/arxiv_data1/oa_pdf/19/39/apps.1400035.PMC4103478.pdf
SRR1283191  ; http://www.ncbi.nlm.nih.gov/sra).,OADS,/arxiv_data1/oa_pdf/ee/8b/apps.1400037.PMC4103479.pdf
"Putative sequences of algae, plants, ani-mals, or microorganisms, which are often present in epiphytic samples, were identiﬁ  ed and removed using the ntBLAST search on http://www.ncbi.nlm.gov.",OADS,/arxiv_data1/oa_pdf/ee/8b/apps.1400037.PMC4103479.pdf
Website  http://www.the-scientist.com/?articles.view/articleNo/29245/title/When-is-self-plagiarism-ok-/  [accessed 20 June 2014].,Non-OADS,/arxiv_data1/oa_pdf/c8/13/apps.1400055.PMC4103480.pdf
Retrieved from:  http://c.web.umkc.edu/cowande/plague.htm  [accessed 15 June 2014].,Non-OADS,/arxiv_data1/oa_pdf/c8/13/apps.1400055.PMC4103480.pdf
Website  http://www.ithenticate.com/resources/papers/ethics-of-self-plagiarism  [accessed 15 June 2014].,Non-OADS,/arxiv_data1/oa_pdf/c8/13/apps.1400055.PMC4103480.pdf
Website  http://blogs.nature.com/news/2012/04/eminent-chemist-denies-self-plagiarism-in-space-dinosaurs-paper.html  [accessed 20 June 2014].,Non-OADS,/arxiv_data1/oa_pdf/c8/13/apps.1400055.PMC4103480.pdf
Website  http://ori.hhs.gov/sites/default/ﬁ  les/plagiarism.pdf  [accessed 15 June 2014].,Non-OADS,/arxiv_data1/oa_pdf/c8/13/apps.1400055.PMC4103480.pdf
